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Abstracts 
1. French 
 L’électroporation est une méthode physique de délivrance de molécules dans les cellules ou tissus. 
Le transfert des petites molécules se déroule vraisemblablement par diffusion à travers de présumés 
electropores alors que le transfert d’ADN plasmidique est plus compliqué et reste à élucider. Lors de 
l’application des impulsions électriques, la membrane devient perméable et l’ADN est électrophorétiquement 
poussé vers celle-ci où il est inséré en agrégats distincts pendant une dizaine de minutes. Ensuite, l’ADN est 
internalisé, navigue à travers le cytoplasme jusqu’à atteindre le noyau où l’expression de l’ADN est initiée. 
Mon travail de thèse se concentre sur l’internalisation et le trafic intracellulaire de l’ADN, deux étapes assez 
peu décrites dans le cadre de l’électroporation. 
 L’internalisation de l’ADN semble se faire majoritairement par endocytose. L’utilisation 
d’inhibiteurs pharmacologiques de l’endocytose et de marqueurs fluorescents permet de conclure que 
l’endocytose médiée par la clathrine et les rafts lipidiques ainsi que la macropinocytose sont impliquées 
(respectivement 25%, 50% et 30%). L’endocytose semble être la principale (sinon la seule) voie par laquelle 
les agrégats d’ADN entrent dans les cellules. De plus amples recherches doivent être menées pour dépeindre 
précisément le mécanisme d’internalisation de l’ADN d’autant plus que l’endocytose médiée par les rafts 
lipidiques représente un large panel de possibilités (caveoline, flotilline, GEEC…). Nos résultats sont en 
accord avec la distribution spatiotemporelle de l’ADN observée à la membrane. 
 Une fois dans le cytoplasme, l’ADN semble suivre le trafic endosomal classique. La colocalization 
en dynamique effectuée dans des cellules exprimant séparément plusieurs marqueurs d’endosomes (Rab5, 
Rab11, Rab9 et Lamp1) démontre que l’ADN est présent dans les endosomes précoces, tardifs et de 
recyclages dans des proportions calculées pour être respectivement 70%, 50% et 30%, valeurs moyennées 
sur l’heure qui suit l’électrotransfert. Entre 1-2 h après la délivrance, 60% de l’ADN est situé dans des 
structures marquées Lamp1 avec une prédominance probable des lysosomes. Ces résultats sont en accord 
avec l’observation de l’ADN toujours présent en agrégats dans le cytoplasme et ils renforcent l’observation 
d’un mécanisme d’endocytose mentionné précédemment. 
 L’ADN dans le cytoplasme est transporté activement par les filaments d’actine et les microtubules. 
L’utilisation d’inhibiteurs pharmacologiques combinée au suivi de particules uniques effectué sur un grand 
nombre d’agrégats d’ADN clairement démontre que le cytosquelette contrôle la migration de l’ADN dans le 
cytoplasme. L’ADN exhibe le mouvement typique des endosomes avec des phases intermittentes de 
transport actif et de diffusion. Les phases de transport actif ont en moyenne une vitesse de 250 nm/s, une 
persistance de 6 s et engendre un déplacement de 1,3 µm. Cependant, les distributions de ces paramètres sont 
larges avec des vitesses allant de 50 nm/s à 3400 nm/s, des déplacements de 0,1 µm à 12 µm et des durées de 
2 s à 30 s. Ces résultats confirment d’autres travaux qui présentent les microtubules comme un moyen de 
migration de l’ADN dans les cellules. Cela est aussi en accord avec la présence de l’ADN dans des 
endosomes vu que leurs membranes contiennent des protéines (probablement Rabs) capables de se lier aux 
  
moteurs moléculaires. De plus, cela explique comment les gros agrégats d’ADN peuvent traverser le 
cytoplasme dense et atteindre avec succès le noyau, phénomène improbable par simple diffusion. 
 Le chemin de l’ADN que nous décrivons est efficace étant donné que la perturbation d’une étape 
intermédiaire entraine une réduction de l’expression génique. Bien que nos découvertes doivent être 
confirmées et nécessitent de plus amples investigations, la prochaine étape clé à comprendre est 
l'échappement supposé de l'endosome qui doit forcement se réaliser afin d’obtenir une expression de l’ADN. 
2. English 
 Electroporation is a physical method of delivery of molecules into cells or tissues. The transfer of 
small molecules most likely occurs via diffusion through putative induced electropores whereas the transfer 
of plasmid DNA is more complex and remains to be elucidated. During the electric field pulses, the 
membrane becomes permeable and the DNA is electrophoretically pushed on it where it is inserted as 
discrete clusters for tens of minutes. After the electric pulses, DNA is internalized, navigates through the 
cytoplasm until it reaches the nucleus where DNA expression is initiated. This PhD work focuses on the 
internalization and intracellular trafficking of the DNA, two steps rather enigmatic in the context of 
electroporation. The relevant cell structures that could participate into these steps are the endocytotic 
machinery followed by the endosomal trafficking and the cytoskeleton (actin filaments and microtubules). 
 DNA internalization seems to be mainly performed via endocytosis. The use of pharmacological 
endocytic inhibitors combined with endocytic markers led us to the conclusion that clathrin- and lipid raft-
mediated endocytosis as well as macropinocytosis are involved (25%, 50% and 30%, respectively). 
Endocytosis seems to be the main (if not the only) path by which DNA aggregates enter the cells. More 
investigations have to be done to depict precisely the DNA internalization mechanism especially because 
raft-mediated endocytosis represents a large panel of possibilities (caveolin, flotillin, GEEC…) which are 
worth describing. These findings are in agreement with the observed spatiotemporal distribution of the DNA 
aggregates at the membrane (clusters of few hundreds of nm persisting for few min and inaccessible from the 
extracellular medium). 
 Once inside the cells, DNA seems to follow the classical endolysosomal trafficking. Dynamic 
colocalization performed in cells expressing separately several labeled endosomal markers (Rab5, Rab11, 
Rab9 and Lamp1) allows us to conclude with no ambiguity that DNA is present in early, recycling and late 
endosomes in proportions calculated to be respectively 70%, 50% and 30% over the hour following the DNA 
electrotransfer. Between 1-2 h after delivery, 60% of the DNA is located in Lamp1-structures with most 
probably a predominance of the lysosomes. These results are in agreement with the observed DNA being still 
in clusters in the cytoplasm and it reinforced the earlier mentioned mechanism of endocytosis. 
 DNA in the cytoplasm is actively transported by both the actin filaments and the microtubules. The 
use of pharmacological inhibitors combined with SPT performed on a high number of DNA aggregates 
clearly shows that cytoskeleton mediates the DNA journey in the cytoplasm. DNA exhibits the typical 
motion of endosomes with intermittent phases of active transport and diffusion. Under our experimental 
conditions, active motion phases features on average velocity of 250 nm/s and persistence of 6 s and leads to 
  
a displacement of 1.3 µm. However, distributions of theses parameters are broad with velocities from 50 
nm/s to 3400 nm/s, displacements from 0.1 µm to 12 µm and persistence from 2 s to 30 s. These findings 
confirm previously published article pointing at the microtubules as a means of DNA migration in the cells. 
It is also in agreement with DNA being in endosomes since their membranes process proteins (probably 
Rabs) that can bind molecular motors. In addition, it explains how such big DNA clusters can travel through 
the highly crowded cytoplasm since successful to reach nucleus diffusion is improbable.  
 The DNA route(s) we described correspond to the efficient one(s) since disturbance of any 
intermediate step results in a reduced gene expression. Although our findings must be confirmed and further 
investigated, the next key step to unravel is the putative endosomal escape that has to occur for successful 
gene expression. 
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 Gene therapy was first introduced in the 80’s, and relies on the delivery of genetic material (mainly 
DNA) to the nucleus of cells, so that its product is expressed and generates a therapeutic effect. Different 
approaches are possible: 
- Correcting a defective gene by providing a functional one to the cells 
- Introducing a gene encoding a therapeutic protein 
- Transferring a gene provoking cell death 
- Delivering antisense DNA that inhibits the synthesis of a protein or the replication of a virus. 
Therefore, gene therapy leads to applications with a scope far beyond healing genetic diseases, since DNA 
can, in principle, replace any medication controlling protein synthesis. Gene therapy seems to be an excellent 
alternative to fight diseases currently not curable or only partially treated with classical pharmaceutical 
approaches. Moreover, gene therapy offers many advantages compared to the employment of recombinant 
proteins. Recombinant proteins are expensive to produce and are rapidly cleared from the blood flow, while 
gene therapy provides to a long-term and eventually regulated production of a therapeutic protein. In gene 
therapy, gene expression is local, therefore side effects due to exogenous proteins in the bloodstream are 
prevented. 
 The main drawback for the utilization of gene therapy as a medical treatment is the lack of 
effectiveness of the current methods. Several biological barriers (extracellular medium, plasma membrane, 
cytoplasm, nuclear envelope) hinder gene targeting into the nucleus. Regardless of the method of delivery in 
vivo (intramuscular or intravascular injection, inhalation, ect.), it will inevitably come into contact with the 
extracellular environment. Most likely due to nucleases, intravenously injected naked DNA has a half-life 
within serum in the range of 1.2 min to 21 min, depending on the topology of the DNA (Houk et al., 1999). 
DNA that escapes nucleases can also bind to non-targeted proteins and cells which can inhibit its activity, or 
segregate it for degradation and/or removal. The immune system is another obstacle to consider. While 
mostly associated with viral approaches, immune activation can occur for some non-viral methods as well. 
This is thought to be due to unmethylated CpG (cytosine-phosphate-guanine) motifs on the plasmid DNA 
and their recognition by Toll-like receptors (Zhao et al., 2004). When the vector reaches the target cell, it 
then faces a second important barrier which is the plasma membrane. Naked DNA alone does not associate 
with the plasma membrane due to the high amount of negative charges that both the DNA and the cell 
surface bear. Gene transfer methods provoke or facilitate DNA endocytosis or direct entry into the 
cytoplasm. Vectors that access the cytoplasm via endocytosis are directed to the endosomal trafficking. In 
that case, an additional barrier for DNA to overcome is the escape from the endosomes before its degradation 
in the lysosomes. Once in the cytosol, DNA has to traffic to the nucleus for gene expression to occur. 
Intracellular migration can represent a significant barrier for successful DNA delivery as well. First, 
nucleases present in the cytoplasm can degrade free DNA. Second, the cytoplasm is a viscous crowded 
environment that decreases the mobility of macromolecules (Luby-Phelps, 2000; Lukacs et al., 2000). Thus, 
if DNA is released, from the plasma membrane or even from an endosomal membrane, at a site distant from 
the nucleus, its diffusion is not likely to be an efficient means of reaching the nucleus. DNA that has 
successfully traversed the barriers previously mentioned finally encounters the nuclear envelope. Depending 
Introduction 
 
- 3 - 
on cell types, DNA doses and detection methods, only 1% to 5% of the plasmids locate within the nucleus 
after their delivery (Cohen et al., 2009). The majority of DNA that has entered the cell will, in fact, never 
reach the nucleus. While DNA transfer is higher within dividing cells, even the rupture of the nuclear 
envelope does not completely abolish nuclear import as a barrier to delivery (Ludtke et al., 2002). Therefore, 
the “ideal vehicle for gene transfer must have the following properties: specificity to target cells, efficient 
gene delivery, resistance to metabolic degradation and/or attack by the immune system, minimum side 
effects, and eventually controlled temporal gene expression” (Burgain-Chain et al., 2013). 
 There are numerous gene transfer methods in vivo that are usually separated into two categories: 
viral and non-viral. Viruses are the most efficient vehicles because they have innate mechanisms to target 
cells, to overcome cell membranes and to reach the nucleus. However, viral methods have some 
disadvantages such as high costs for their production and more importantly they can induce undesired effect 
like immune response, pathogen reversion, mutagenesis and carcinogenesis. Due to these limitations, the 
delivery of genetic material by non-viral methods may be of great value for the development of gene therapy 
especially when repeated administration is needed. Non-viral methods are classified into two groups 
according to the vector employed: chemical and physical. Chemical approaches include cationic lipid-DNA 
complexes (lipoplex), cationic polymer-DNA complexes (polyplex) or both lipids and polymers in 
complexes with DNA (lipopolyplex). The lipids or polymers encapsulate and condense DNA via 
electrostatic interactions between the positively charged lipids or polymers and the negatively charged DNA. 
DNA is consequently more protected against nuclease activity, especially if PEGylation is performed, and 
the reduced particle size, in addition to the net positive charge, favor plasma membrane crossing. The 
complexes enter the cell via endocytosis or fusion with the plasma membrane. For lipoplexes, endosomal 
escape is mediated by fusion between the lipids of the lipoplexes and those of the endosomal membranes. 
For the polyplexes, the polymers act as a proton sponge that first prevents endosomal acidification and 
second induces a higher influx of ions that swells and lyses the endosomal compartment. One advantage of 
the chemical methods is that the cell targeting can be enhanced by linking specific ligand to the lipids or 
polymers. One disadvantage is the toxicity and loss of the vectors when injected in vivo. Due to their 
positive charge, the particles can interact with many proteins of the serum (albumin, glycoproteins, 
immunoglobulins, fibronectin …) or blood cells (Cullis et al., 1998). Physical approaches are mostly based 
on a mechanical or physical destabilization of the plasma membrane allowing access to the cytoplasm. The 
simplest method consists in hydrodynamic injection of naked DNA into the target tissue via the bloodstream. 
The rapid injection of a large volume increases the vascular pressure, opens the vascular pores and allows 
DNA to overcome the plasma membrane of surrounding cells. This method is efficient only in highly 
vascular tissues (liver, kidney, muscle). However, because of the rapid degradation of the DNA, it is more 
efficient to combine it with another physical method. Microinjection of DNA directly into the nucleus is very 
efficient since there are no biological barriers to cross but the cost, the difficulty and the low number of cells 
that can be treated this way represent serious disadvantages for clinical applications. Lasers can be used to 
destabilize cell membrane (putative pores) and introduce molecules into the cytoplasm. This method is very 
efficient in vitro and can be used in many tissues but suffers from low accessibility in vivo since laser light 
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penetration depths are low. The issue of superficial penetration is encountered also with gene gun methods. 
The latter utilizes metal nanoparticles coated with DNA that are accelerated and bombarded onto the tissue 
of interest. Particles traverse membranes and DNA is released in the nucleus. Another physical method is 
sonoporation, where the application of ultrasound in the presence of microbubbles alters nearby membranes. 
Upon absorption of ultrasound waves, air-filled microbubbles cavitate, oscillate, collapse and release local 
shock waves that can induce local disruption of the plasma membrane in the form of transient pores allowing 
the passage of DNA. Finally, electroporation, which is the method of interest for this PhD work, relies on the 
application of electric fields that destabilize membrane permeability and molecules such as DNA can enter 
cells via a mechanism that is presumed to be based on the formation of pores. It is one of the more efficient 
techniques among non-viral methods but it does not reach the efficiency observed for viral approaches. For 
all mentioned non-viral methods, the general issue is the lack of gene transfer efficiency and the lack of 
knowledge about the detailed mechanisms by which plasmid DNA gets over the numerous biological 
barriers to finally reach the nucleus where it can be read by the cell machinery. 
 
 
Figure 1: Schematic mechanism of plasmid DNA electrotransfer. During the application of the electric pulses, the 
plasma membrane is permeabilized (step 1), the negatively charged DNA electrophoretically migrates toward the 
positive electrode (step 2) and interacts with the electropermeabilized membrane by forming aggregates (step 3). The 
mechanism of electrophoretically driven insertion and the translocation (step 4) of the DNA through the cell membrane 
are not yet characterized but two models can be proposed. The DNA could pull the membrane during its insertion and 
initiate the formation of an endosome-like vesicle, or the DNA could be inserted where an electropore is formed, pull 
and pass through it. Once inside the cell, DNA migrates in the cytoplasm (step 5) where two possibilities exist. Either 
DNA uses the cytoskeleton to be actively transported or DNA diffuses toward the highly crowded cytoplasm. 
Subsequent steps are the crossing of the nuclear envelope (step 6) and the expression in proteins of the DNA (step 7). 
Using fluorescence microscopy, several steps of the DNA electrotransfer could be observed such as (a) the DNA 
aggregate formation, (b) the DNA remaining as aggregates at the nucleus vicinity and (c) the successful DNA 
expression visible as EGFP fluorescence signal. From (Chabot et al., 2013)                                                                                                    
 The objective of my PhD work was to improve the understanding of the mechanisms involved in 
gene delivery by electroporation. This approach is interesting for many reasons. It is easy to perform, cheap, 
safe and promises a great future for the delivery not only of plasmid DNA but all kinds of molecules from 
small drugs to proteins and other nucleic acids (Neumann et al., 1972; Gehl, 2003; Escoffre et al., 2007). 
This method is exploited to potentiate the therapeutic effects of genes (electrogenetherapy, genetic 
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vaccination) in clinical trials (Daud et al., 2008; Low et al., 2009; Sardesai et al., 2011) and those of 
anticancer drugs in clinics (electrochemotherapy) (Mir et al., 2006). In addition, all types of tissues can be 
treated by electroporation with, however, pronounced differences in efficiency (Andre et al., 2004). One of 
the most extensively used tissues for electrotransfer is skeletal muscle since there, electrotransfer is very 
efficient. It offers promising treatment for muscle disorders, but one can also use skeletal muscles as 
endocrine organs that produce and release the proteins into the blood circulation to exert a therapeutic effect 
at distance. Numerous studies have proved that gene electrotransfer can induce long-term therapeutic effects 
in various diseases such as cancer, muscle and blood disorders, arthritis, cardiac diseases (Burgain-Chain et 
al., 2013). Although, electroporation has been discovered some decades ago (Neumann et al., 1972), little is 
known about the exact way electric fields disturb membranes and how molecules take advantage of this 
disturbance to access the cytoplasm. 
 The application of an external electric field alters the resting transmembrane potential difference 
which exists along all cell membranes and is uniform. When the induced potential difference overcomes a 
critical value, the membrane becomes permeable to otherwise non-permeant molecules (Fig. 1, step 1). 
Under well controlled conditions, the electropermeabilization is reversible and the plasma membrane can 
return into its initial state after a progressive resealing. The physicochemical structures driving the 
permeability are thought to result from the reorganization of lipids into pores, hence the term electroporation. 
Although pores on cell membrane were never observed, simulations predict the formation of hundreds of 
thousands of them among which a large part (98%) are small pores (1 nm radius) and a very small part (2%) 
are macropores with an average radius of 20 nm (Krassowska et al., 2007). However, in the absence of 
experimental evidences of their existence, one prefers to speak about membrane defects or transient 
permeable structures. The passage of small molecules, below 4 kDa, seems to follow a diffusion-like process 
according to the gradient of concentration with a rapid and direct access to the cytoplasm (Golzio et al., 
2004). The latter phenomenon supports the standard theory of pore formation. However, this model does not 
apply to all molecule sizes. Instead, there are several fundamental differences about the way small molecules 
and DNA cross the plasma membrane. While small molecules diffuse during and after the application of the 
electric field, up to the end of the resealing, DNA stays at the membrane for several minutes (Escoffre et al., 
2011) (Fig. 1, step 3). Although membrane defects are stable for several minutes and simulations show pores 
to be large enough to allow its passage, DNA stops its progression at the membrane and stays there for about 
ten minutes (Golzio et al., 2002b). Therefore, the DNA internalization is achieved after membrane resealing, 
i.e. after the disappearance of the membrane defects responsible for the passage of the small molecules. This 
hints at a more complex mechanism for DNA electrotransfer. Another fundamental difference, compared to 
small molecules, is that the DNA must be present during the electric field to have any chance to be 
internalized (Golzio et al., 2002b). Small molecules, if added after the pulses, can still diffuse through the 
membrane whereas DNA, even if added immediately after the end of the electric pulses, can not pass. This 
fact is explained by the necessity of an electrophoresis force to bring the DNA into contact with the 
membrane (Fig. 1, step 2). Short durations of electric fields (~µs) are sufficient to permeabilize membranes, 
but not for DNA electrotransfer, because DNA electrophoresis is absent. The consequence is that DNA 
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accumulates only on one side of the cell. One interesting aspect is, although permeabilization alone is not 
sufficient for DNA transfer to occur, it is necessary since DNA electrophoresis applied alone does not lead to 
gene delivery as well. The membrane defects are therefore not directly responsible for the DNA 
internalization but they definitely play a role. The distribution of the DNA is not uniform but instead plasmid 
DNA clusters along the permeabilized area of the plasma membrane (Fig. 1a). Clusters are visible as patches 
the size of which has been estimated to lie between 100 nm and 500 nm. Particles of such size cannot easily 
cross the plasma membrane, which might be a reason why it takes about 10 minutes to reach the cytoplasm. 
DNA is not only clustered but inserted and immobile at the membrane for about 10 minutes. Evidences hint 
at the “existence of two classes of plasmid DNA/membrane complexes: i) complexes of low stability from 
which plasmid DNA can leave and return to the pulsation buffer, and ii) complexes of high stability, where 
plasmid DNA cannot be removed even by applying electric pulses of reversed polarity. Only plasmid DNA 
belonging to the second class leads to effective gene expression” (Faurie et al., 2010). Fortunately, the 
second class is the most abundant, under standard frequencies for the electric fields. Very shortly after the 
end of the application of the electric field, the DNA clusters are protected against degradation from 
extracellular nucleases meaning that they are inserted and enclosed into the membrane (Klenchin et al., 
1991) (Fig. 1, step 4). One possibility is that an endocytosis-like process occurs as it is the case for many 
viral or chemical vectors. The shape, lifetime, size, stability, and resistance from degradation of the DNA 
complexes at the membrane are consistent with the formation of a vesicle around it. An endocytosis 
mechanism is the only available way cells possess to internalize big size particles and consists in a well 
orchestrated machinery deforming the membrane around a cargo. To perform such membrane invagination 
and cut the bud form the plasma membrane, several minutes are necessary. The hypothesis of endocytosis 
has been suggested and some articles have been published on that topic. However in these examples, 
electroporation was used for the delivery of proteins or the conditions of the electric field were drastically 
different from the one used in the context of the delivery of plasmid DNA (Glogauer et al., 1993; Rols et al., 
1995; Antov et al., 2004; Antov et al., 2005). When plasmids enter the cytoplasm by means such as 
electroporation, they need to travel distances ranging from 1 µm in small cells to hundreds of micrometers in 
larger cells (Fig. 1, step 5). DNA clusters observed at the membrane, once in the cytoplasm, keep the patch-
like structures up to their arrival at the vicinity of the nucleus (Fig. 1b). Unlike small molecules which need a 
few seconds to reach the nucleus, DNA needs much longer time. About 30 minutes after the application of 
the electric field, DNA is distributed randomly in the cytoplasm with some aggregates still close to the 
plasma membrane and some that seem to be closer to the nuclear envelope (Golzio et al., 2002b). Gene 
expression is detected at the earliest 3 h after the application of the electric field (Fig. 1, step 7 and 1c) (Rols 
et al., 1998b). The way DNA navigates in the highly crowded cytoplasm is not determined yet. The sole 
involvement of diffusion is improbable, since even single DNA fragments of 2000 bp are immobile (Lukacs 
et al., 2000). However, DNA reaches the nucleus, since expression is detected. The involvement of the 
cytoskeleton is possible. The research group of Dean showed that stabilization of the microtubules, using 
taxol, enhances DNA expression after delivery by electroporation (Vaughan et al., 2006). In addition, they 
showed that DNA could interact with the microtubules in the presence of cell extracts, meaning that DNA 
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can interact with some proteins, which themselves bind to microtubules. It is therefore possible that 
electrotransferred DNA uses the cytoskeleton as means of transport in the cytoplasm. This would explain 
how the observed big DNA aggregates can be found in the perinuclear region. 
 
 In this PhD work, the involvement of the cytoskeleton in the internalization and transport of 
electrotransferred DNA, as well as the different possible endocytic pathways have been investigated. The 
aim was to better understand how DNA penetrates the plasma membrane and travels inside the cell to be able 
later to control and optimize the electroporation method. Understanding intracellular trafficking is crucial to 
improve the ability of plasmids to reach the nucleus following not only electroporation, but all methods of 
gene delivery. For example, it has been observed that lipoplexes accumulate in the perinuclear region after 
endocytosis, but following endosomal escape, the DNA must still travel some distance to enter the nucleus 
(Zerial et al., 2001; Fattakhova et al., 2006). Therefore, independently of the manner by which DNA is 
transferred into a cell, at some point it has to navigate in the cytosol towards the nucleus. For safety reasons, 
it is also necessary to precisely identify the delivery mechanisms to avoid undesired side effects in clinical 
applications which have been observed in virus-based clinical trials (Brakebusch et al., 2003; Escoffre et al., 
2012a).  
 
Figure 2: Overview of the fluorescence-based methods performed during this PhD work. DNA interaction with the 
membrane and internalization were investigated using single-cell level analysis using fluorescence microscopy. 
Colocalization studies were performed between DNA and the actin cytoskeleton and some endocytic markers. At the 
cytoplasm level, mainly single particle tracking methods were conducted, as a first step, with DNA alone and, as a 
second step, in a two-color manner with endosomal markers. As a complement of the microscopy methods, 
investigations at the cell population level were performed in which the overall DNA electrotransfer efficiency was 
evaluated using flow cytometry. 
 To address the above described hypotheses, the use of fluorescence-based techniques is of pivotal 
importance. They are powerful methods of investigation because of their specificity, sensitivity and high 
spatiotemporal resolution. Fluorescence microscopy is the technique of choice for the detection of signal at 
the subcellular level in living cells and for the subsequent localization, spatiotemporal tracking and 
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identification of interacting partners of the object of interest. There is a large panel of microscopy methods 
and one can select the suitable system according to the question to be addressed. Flow cytometry 
experiments can shed light on the efficacy of DNA delivery at the scale of a cell population. In this PhD 
work, several methods were employed from simple one color wide-field or confocal microscopy to two-color 
single particle tracking (Fig. 2). Fluorescence-based techniques were used to detect DNA and partners at the 
different stages of the electroporation process (Fig. 1 steps 3-7 and Fig. 2). At the membrane level, the 
formation of fluorescent DNA aggregates has been followed via intensity measurements and the involvement 
of the actin cytoskeleton has been verified using the disrupting drug latrunculin B and flow cytometry. 
Complementary observations were performed by imaging the organization of the actin cytoskeleton during 
the first steps of the DNA delivery. These results are described in chapter 1 of the results and discussion part. 
DNA internalization has been investigated through colocalization studies with known endocytic markers 
(CTB, TF, and dextran) and gene expression studies using numerous pharmacological inhibitors of 
endocytosis (chapter 2 of the results and discussion part). Afterwards, DNA migration in the cytoplasm has 
been quantitatively described using single particle tracking experiments (chapter 3 the results and discussion 
part). The localization over time, with suitable time scale and spatial resolution, of a fluorescent particle 
highlights precisely the different modes of motion that particle can follow inside a cell. It can reveal the 
participation of different cellular components in the movement of the particle. It is actually the only way to 
access such type of information. As a first step, DNA aggregates were tracked in intact cells. The 
information obtained served to describe the DNA aggregate kinetics in the cytoplasm. Afterwards, DNA was 
tracked in cells treated with drugs altering either the actin or the tubulin filaments to discriminate the 
contribution of each transport system. Finally, in chapter 4 of the results and discussion part, further 
characterization of the DNA intracellular trafficking was performed using simultaneous particle tracking of 
DNA and some endo-lysosomal proteins such as some Rabs and the Lamp1 proteins. Dynamic colocalization 
identifies without any ambiguity molecules that interact with each other or at least share subcellular 
compartments. The combination of analyses at the single-cell level using microscopy and measurements at 
the cell population level using flow cytometry enables an overview of the local mechanisms and their 
relevance in the DNA transfer to the cell nucleus. Before the description of the results obtained during my 
PhD work, the general background part of this manuscript reports the different biological and physical 
aspects implied in the topic. In a first chapter, details about the cytoskeleton composition and functions are 
given. Chapter 2 reviews the different mechanisms of endocytosis and the intracellular trafficking routes of 
incoming cargos in cells. In chapter 3, the principle of fluorescence and microscopy tools are described with 
a focus on single particle tracking. Finally, chapter 4 provides the state of art of electroporation with a 
description of the electropermeabilization and DNA electrotransfer processes.   
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Chapter 1: The cytoskeleton 
 The cytoskeleton is a fiber network present in the cytoplasm of all cells. It has first been discovered 
to be responsible for the cell shape, hence its name. Eukaryotic cells have three types of cytoskeleton, actin 
filaments or microfilaments, tubulin filaments or microtubules and intermediate filaments (Alberts et al., 
2002) (Fig. 3). The filaments are polymers of proteins with specific organization, localization and functions. 
Even though they are called skeleton, they do not have a rigid and stable structure. Instead, they have a 
highly dynamic behavior and undergo permanent polymerization and depolymerization. The filaments can be 
organized in branched networks, cables, bundles according to the function they have to fulfill. This high 
level of organization is regulated by a hundreds of proteins (linking, cross-linking, anchoring, capping, 
severing proteins …). Most of the mechanic properties of the cells come from the cytoskeleton, and they 
have role in many other processes. A non-exhaustive list of functions includes cell shape regulation, cell 
motility, cell division (mitotic ring formation and contraction), internal structure maintenance e.g. cell 
compartments, anchoring to neighbor cells, separation of the chromosomes during mitosis, contraction of 
muscle cells, formation of protrusions and membrane involutions, intracellular transport of organelles and 
proteins … 
 
 
Figure 3: The cytoskeleton of eukaryotic cells. It is composed of three types: the actin filaments, the intermediate 
filaments and the microtubules from the thinner to the thicker. Images were recorded using transmission electron 
microscopy (Alberts et al., 2002). 
I. The actin cytoskeleton 
 Actin is a 43 kDa protein of 375 amino-acids. It is one of the most abundant proteins in eukaryotic 
cells. It can represent 15% of the protein mass in muscle cells. The monomer form, globular or G-actin, has 
several subunits and a central cleft where a nucleotide (ATP or ADP) and a divalent cation, like magnesium 
or calcium, bind (Fig. 4a). G-actin spontaneously assembles in filaments (F-actin) of 7 nm diameter by a 
polymerization-like process (Fig. 4b). Microfilaments have a double strand helical conformation of 37 nm 
turn (13 G-actins). All actin units point in the same direction called the pointed end, the other extremity 
being called barded end, which gives a structural polarity to the filament. 
I.1. Actin polymerization 
 Assembly starts by a slow phase of nucleation because actin dimers or trimers are unstable (Pollard, 
1986). Spontaneous nucleation occurs only when the actin concentration is higher than a critical value. 
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Afterwards, G-actin polymerizes very fast from the preformed nuclei. This is called the elongation step or 
polymerization step even though there are no covalent bonds between actin monomers. Once formed, 
filaments are in equilibrium between dissociation of the filament at one end and association of the monomers 
at the other end (steady-state). In addition to the structural polarity, actin filaments have a kinetic polarity 
due to differences in polymerization rates (Pollard et al., 2003). Monomers associate 10 times faster at the 
(+) or barbed end than at the (-) or pointed end (Fig. 4c). Moreover, ATP-actin associates better than ADP-
actin. When polymerized, ATP-actin hydrolyzes rather fast in ADP-Pi-actin (half-life 2 s), the Pi dissociation 
is slower with a half-life of 6 min (Pollard et al., 2003). The latter properties together with the polarity of the 
filaments create the so called treadmilling phenomenon: the (+) end of the filaments tends to capture most of 
the ATP-actin monomers which hydrolyze afterwards in ADP-actins, therefore, at the (-) end, which is less 
active, actin units are mainly actin previously incorporated at the (+) end. The ADP-actin, being less stable, 
shifts the equilibrium to the depolymerization. Consequently, at one extremity, the actin filament 
permanently grows and at the other end it permanently dissociates, the released ADP-actin is recycled in 
ATP-actin that can bind again at the (+) end. This generates a molecular motor capable of mechanical work 
on which are based cell mobility and membrane trafficking as two examples. The stall force for a single 
polymerizing filament can reach 10 pN (Theriot, 2000; Ladoux et al., 2012). 
 
 
Figure 4: Actin structure and polymerization. (a) Actin monomer structure (ribbon and space-filling models). It has 
a bi-globular shape with a central cleft where a nucleotide and a cation bind. (b) Actin polymerization steps. The 
spontaneous nucleation of unstable dimers and trimers of actin is followed by a rapid elongation phase. Actin units 
point all in the same direction, the pointed end, the opposite end being called barded end. (c) Elongation rate constants 
are higher at the barded end and with ATP-actin (T) compared to ADP-actin (D). Once ATP-actin incorporated, it rather 
rapidly hydrolyzes in APD-Pi, the dissociation of the Pi is a slower process. (a) and (b) are taken from (Pollard et al., 
2009), (c) is from (Pollard et al., 2003). 
I.2. Actin-binding proteins 
 There are more than hundred actin-binding proteins, i.e. proteins that interact with actin monomers 
or filaments, to maintain a pool of actin monomers, initiate polymerization, restrict filaments length, regulate 
the assembly and turnover of the filaments, control the spatial organization, or connect to other intracellular 
structures (Winder et al., 2005) (Fig. 5). Among actin-binding proteins are profilin which promotes 
nucleotide exchange and subsequently accelerates the regeneration of ATP-actin, and ADF/cofilin that severs 
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and depolymerizes ADP-actin but also favors actin turnover. Because the nucleation step is unfavorable, 
Arp2/3 complex, formin or spire proteins interact with actin (G or F) to generate faster new filaments. To 
control and limit the fast actin elongation step, capping proteins bind to the barded end of the filaments and 
prevent further addition of actin units. In addition to proteins that assist the polymerization process, some 
proteins participate in the building of the cytoskeleton network by connecting the filaments in organized 
structures like bundles and branched meshes (-actinin, fascin, fimbrin). To assist intracellular processes, 
actin-binding proteins serve to connect the microfilaments to other elements of the cell such as membranes 
or other cytoskeleton components. In vitro studies demonstrated that actin-based motility requires a little 
number of actin-associated proteins which are ADF/cofilin, profilin, Arp2/3 complex, and capping protein 
(Loisel et al., 1999). Nevertheless, the majority of processes based on the treadmilling property of the actin 
filaments involve a considerably larger number of actin-binding proteins including regulators. Actin-binding 
proteins are regulated by numerous signaling pathways in order to modulate the spatiotemporal activity of 
actin dynamics. Their best described regulators are the Rho-family small GTPases. 
 
 
Figure 5: Actin-binding proteins. There are numerous actin-binding proteins taking part in several aspects of the 
cytoskeleton functions. They regulate the actin polymerization and structural organization and serve as intermediates 
connecting actin filaments to other components such as other filaments and membranes. From (Winder et al., 2005) 
I.3. Actin structures 
 Actin can organize in two types of superstructures, bundles and branched networks, and localize at 
different sites in the cell. Higher order organizations are necessary to generate powerful and diverse 
mechanical properties. 
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I.3.a. Bundles 
 The actin network is organized as parallel or anti-parallel alignment of microfilaments creating linear 
patterns (Fig. 6a). It is generally achieved either by proteins having two actin-binding domains or by 
complexes of proteins having each one actin-binding site (Winder et al., 2005). The architecture of such 
proteins or complexes determines the stiffness of the bundles. Tight actin bundles are obtained through 
fascin or fimbrin proteins found in microvilli, filopodia, or invapodia (Revenu et al., 2004), looser structure 
can be achieved via the -actinin present in stress fibers (Pellegrin et al., 2007). Such organization is 
supported by formins (Faix et al., 2006; Pollard, 2007) (Fig. 6b). The protein consists of FH2 donut-shaped 
dimer domains interacting with the barded end of a filament and FH1 domains that tether multiple profilin-
actin complexes near the barbed end. It considerably accelerates monomer incorporation such that more than 
hundred actin units can be polymerized in 1s. Because FH2 domains remain attached to the barded end, it 
also prevents the filament from capping. 
 
 
Figure 6: Bundle of actin. (a) Representation of filament bundles in filopodia. Formins, present at the tips, drive 
filament elongation. Filaments are bundled by fimbrin and fascin. From (Lambrechts et al., 2008) (b) Formins initiate 
the nucleation and assists the elongation of the actin filament at the barbed end. They bind profilin-actin monomer such 
that polymerization occurs and remain associated to the growing (+) end of the filament. From (Pollard, 2007). 
I.3.b. Branched networks 
 Filaments are arranged in Y or X-junctions that create a meshed structure usually consisting of short 
filaments (Revenu et al., 2004) (Fig. 7a). It is mediated by proteins or complexes containing multiple actin-
binding domains that are in general separated by a long and/or flexible spacer region which allows a more 
perpendicular arrangement of the filaments (Winder et al., 2005). A frequently involved protein is the 
filamin (X-junctions) but the main crosslinker is the Arp2/3 complex which is in addition an actin nucleation 
complex (Pollard, 2007). Lamellipodia, lamella, ruffles and the actin cortex are organized in branched 
networks (Chhabra et al., 2007). The Arp2/3 complex consists of 7 subunits and binds to already existing 
actin filaments and initiates the polymerization of another filament (Pollard, 2007). It anchors the pointed 
end of the daughter filament to the mother filament and the free barded end of the daughter filament grows 
away from the complex (Fig. 7b). The regulation of this network construction is taken in charge by the 
WASP (Wiskott–Aldrich syndrome protein) or WAVE (WASP-family verprolin-homologous protein) 
proteins by bringing together an actin monomer and the Arp2/3 complex which mimic the actin nuclei 
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necessary for the elongation to occur. A high capping activity is associated with this process to prevent 
extensive elongation (Schafer, 2004a). 
 
 
Figure 7: Branched network of actin. (a) Representation of branched elongating actin filaments in a lamellipodium. 
The Arp2/3-complex initiates the formation of new branches on existing filaments. Cofilin increases filament turnover 
by severing existing filaments and by inducing depolymerization or by creating new free barbed-ends. From 
(Lambrechts et al., 2008) (b) Actin monomer first bind to the WASP protein, which is a member of the nucleation-
promoting factors. WASP recruits then the Arp2/3 complex which gets activated by linking to the side of an actin 
filament. The complex mimics an actin nucleus and a new filament grows. From (Pollard et al., 2009). 
I.4. Actin localizations and functions 
 Although actin filaments are dispersed throughout the cell, they are most highly concentrated at the 
periphery of the cell, just beneath the plasma membrane. The spatiotemporal control over the polymerization 
state of the microfilaments together with interactions with appropriate molecular structures, establish the 
base of the so called motility. In response to signaling, the actin cytoskeleton is engaged in many cellular 
processes such as cell adhesions to the extracellular matrix or to other cells, cell morphology, cell migration, 
endocytosis, intracellular trafficking (Pollard et al., 2009; Olson et al., 2010)… (Fig. 8). The contribution of 
the actin network in these cell processes can be as structural elements or as scaffolds for signal transduction.  
 
 
Figure 8: Actin localization and functions. (a) Actin found at the plasma membrane take part in many mechanisms 
such as cell migration, connection to substrates or other cells, internalization of particles via endocytosis, intracellular 
trafficking… It is also used for structural functions to maintain organelles at the appropriate positions. From  (Olson et 
al., 2010) (b) Cell migration process. From (Ladoux et al., 2012) 
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I.4.a. Cell adhesion to the substrate 
 The connection of cells to the extracellular matrix is mediated by a complex assembly of proteins 
involving the integrin receptors (Fig. 9) (Brakebusch et al., 2003; Ladoux et al., 2012). Ligand (collagen, 
fibronectin) binding to integrins leads to its clustering and the recruitment of actin filaments and signaling 
proteins that generates focal adhesions (FAs). Actin filaments are organized into stress fibers which, due to 
the myosin II, possess contractile properties (Pellegrin et al., 2007). The combination of the contractile 
machinery and mechanosensitive proteins present at several level of the cell (signaling, membrane, 
cytoskeleton and associated proteins) creates a mechanoresponsive network. This network participates in cell 
shape, cell polarity, and cell migration.  
 
 
Figure 9: Schematic representation of a focal adhesion. Mediated by integrins, actin filaments are organized into 
contractile fibers that anchor the cell on the substrate. From (Ladoux et al., 2012) 
I.4.b. Cell migration 
 “Cell migration is a highly orchestrated multistep process” (Ridley, 2006; Ladoux et al., 2012). 
Before cell migration occurs, a polarized morphology must be created. At the cell front, substantial 
protrusions of the membrane are generated via the polymerization of actin (lamellipodia, filopodia). 
Lamellipodium provides a tight brush-like structure able to push along a broad length of plasma membrane 
whereas the filopodium serves more as sensor and explores the local environment. At the leading edge of the 
lamellipodium, the cell generates focal adhesions to anchor the protrusion and drag the cell body. To move 
forward, the cell retracts its trailing edge by combining acto-myosin contractility of the stress fibers and 
disassembly of adhesions at the cell back (Fig. 8b). 
I.4.c. Cell-cell adhesion 
 The junction between cells is organized by assemblies of proteins among which are cadherins 
(Kobielak et al., 2004; Cavey et al., 2009). The initial cell contact is an opportunistic event consequent to the 
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exploratory activities of branched actin protrusions (lamellipodia, ruffles). It induces cadherin clustering 
which triggers actin rearrangement through the recruitment of signaling proteins (Fig. 10). On the one hand, 
new branched networks drive contact expansion and on the other hand -actinin linked cables formation 
stabilizes the junctions by connecting actin networks of both cells. 
 
 
Figure 10: Model of cell-cell adhesion formation. Initial cell-cell contacts are formed by exploratory filopodia or 
lamellipodia. Cadherin is recruited to anchor actin filaments of both cells. From (Kobielak et al., 2004) 
I.4.d. Actin and endocytosis 
 Rather than being a passive barrier that must be disassembled for vesicle internalization, actin can be 
considered to play an active role in assisting and even driving certain stages of the endocytic process. The 
finding that actin cytoskeleton contribute to the endocytic process derived from the use of pharmacological 
drugs altering actin turnover. In mammalian cells, actin disruption inhibits clathrin-mediated uptake and the 
formation of coated vesicles (Lamaze et al., 1997; Fujimoto et al., 2000). However, the blocking of 
endocytosis seems to be partial in mammalian cells whereas it is complete in yeast (Ayscough et al., 1997; 
Ayscough, 2000). Actin polymerization produces the mechanical forces required to invaginate membrane 
regions, mediate vesicle scission, or push newly formed vesicles away from the plasma membrane 
(Qualmann et al., 2002). The detailed functions of the actin cytoskeleton in endocytosis are described in 
chapter 2 of the general background part. 
I.4.e. Actin rocketing 
 Actin rocketing is form of actin-related motility used by organelles. It was first discovered while 
studying the intracellular motions of the parasitic bacteria Listeria where a similar coupling of bacteria 
movement and actin polymerization was observed (Theriot et al., 1992). A burst of actin polymerization in 
the form of comet tail at the edge of intracellular particles pushes them in one direction. Listeria recruits the 
motility machinery from the cytoplasm of infected cells to facilitate the infection of surrounding cells and 
hijack the immune surveillance. The actin polymerization-based transport gradually propel the particles at 
0.1-0.5 µm/s (Pantaloni et al., 2001). Comet tails have been also observed at the surface of viruses 
(Frischknecht et al., 1999), endosomes (Merrifield et al., 1999), and endogenous vesicles (Rozelle et al., 
2000).  
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I.4.f. Intracellular transport 
 Actin filaments can be used as rails to transport diverse cargos or they can be used as frame to 
anchor organelles. A class of proteins called myosins can interact with both the filament and the cargo. Some 
have in addition the ability to travel along the filaments in one direction. The myosin superfamily comprises 
18 classes (Berg et al., 2001). Humans possess about 40 myosin genes, among which about 25 are 
unconventional (greatly differ from myosin II) and spread over at least 11 classes. Myosins are composed of 
three modules, the head, neck and tail domains. They associate with the cargo through the tail region and 
interact with the microfilament via the head regions, or motor domains, which use ATP to drive movement 
along actin filaments. During ATP hydrolysis cycles, the motor domain undergoes strong filament binding 
(ADP-bound or no nucleotide), conformational change, filament unbinding (ATP- or ADP-Pi-bound), 
conformational relaxation, filament rebinding and so forth. Coordinated ATPase cycles alternately on each 
motor domain induce the protein to mechanically move step-wise in one direction. The motor head define the 
direction of the movement while the tail determine the identity of cargo with which it interacts and therefore 
the function and localization of the protein. Myosins differ in the time spent in the strongly bound state and 
in the rate at which they consume ATP. The neck or middle domain acts as a lever arm that amplify the 
conformational changes of the motor domain (Geeves, 2002). Myosins step sizes directly depend on the 
length of the lever arm and can generate large movements such as the 36-nm step taken by myosin V and 
myosin VI. In most myosins, calmodulin (or calmodulin-like) light chains bind at the region of the lever arm 
and control its rigidity (Wolenski, 1995). 
 While conventional myosin II is almost exclusively involved in producing muscle contraction, 
unconventional myosins have intense activities at the cell cortex, mediate organelle transport, and regulate 
signal transduction (Hartman et al., 2012) (Fig. 11a). Myosins I is the second largest class after myosin II, 
and seem to be key partner for the functions such as motility, endocytosis, and exocytosis (Mermall et al., 
1998). Relevant classes for organelles transport are the myosins classes V and VI. They share several 
properties such as homodimerization providing two coordinated motor heads and therefore processivity. 
Motors alternate binding and release from actin in a hand-over-hand fashion and both myosin classes have 
step size of on average 36 nm. Even though myosin VI has a short level arm that should span over about 10 
nm, it has a larger angle swing (Spudich et al., 2010) (Fig. 11b). This particularity is a unique feature of 
myosin VI, but what is the most exceptional property of myosin VI is that it produces force that acts toward 
the minus end of actin filaments, which is the opposite direction to all other characterized myosins (Wells et 
al., 1999). Myosin VI is found associated with endocytic vesicles, the Golgi apparatus and membrane ruffles 
(Fig. 11c) (Sweeney et al., 2007). It contributes to several phases of the endocytic process including the 
formation and movement of vesicles. It interacts with coated vesicles via adapters such as Dab2 and Sap97 
and with uncoated vesicles through for instance GipC. 
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Figure 11: Myosin motors. (a) Myosins can bind diverse cargo such as lipids, proteins embedded in membrane, actin, 
protein complexes or RNA complexes. (b) Myosin V and myosin VI structures and their respective walking direction. 
(c) Membranes and myosins. Myosin can be associated with nearly all cellular membranes where it act as anchor or 
motor for transport. (a) and (c) from (Hartman et al., 2012) and (b) from (Sweeney et al., 2010) 
II. The microtubules 
 Tubulin is a 55 kDa globular protein of 450 amino-acids. The common members of the tubulin 
family are -tubulin and -tubulin which have about 50% sequence identity (Burns, 1991). Both have a 
nucleotide (GTP) binding site but the GTP bound to the -tubulin monomer is physically trapped and never 
hydrolyzed or exchanged. - and -tubulin assemble to form a heterodimer subunit of 8 nm that is the base 
of the microtubules (Fig. 12a). Tubulin heterodimer polymerizes in linear protofilaments that associate 
laterally (- and - interactions) and close to form a 25 nm diameter hollow cylindrical lattice (Fig. 12b). 
In vivo, predominately 13 protofilaments are necessary to build the microtubule wall. The lateral bonds 
between monomers in adjacent protofilaments deviate from the horizontal with a 10° pitch, thereby forming 
a helical path that travels up the microtubule lattice. This path is called a 3-start helix because each turn of 
the helix spans three tubulin monomers, and three such parallel helices must be started to cover the entire 
surface of the microtubule lattice. This results in the microtubule having a seam where  monomers are 
laterally adjacent to  monomers. Due to the head-to-tail association of  heterodimers in the 
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protofilaments, microtubules have a structural polarity. The (+) end is the side where -tubulin are exposed 
and the (-) end is the side where -tubulin are exposed (Amos et al., 1974). 
 
 
Figure 12: Microtubule structure and polymerization. (a) - and -tubulin bind in heterodimers which assemble to 
form protofilaments. (b) The hollow cylindrical microtubule comprises typically 13 parallel protofilaments that 
generate a lattice seam (red dashed line). (c) Dynamic instability of microtubules. Assembly and disassembly of 
microtubules is driven by the binding, hydrolysis and exchange of GTP on the -tubulin. GTP-tubulin adds on the 
growing microtubule. Its hydrolysis generates GDP-tubulin curved structure that, when occurring at the microtubule 
end, induces shrinkage of the microtubule by depolymerization (microtubule catastrophe). The presence of GTP-tubulin 
(by polymerization or from remnant GTP-tubulin the lattice) maintains a straight structure favoring GTP-growing or 
rescue. From (Akhmanova et al., 2008). 
II.1. Tubulin polymerization 
 Microtubule polymerization occurs in two phases, nucleation and elongation. The nucleation starts 
by the spontaneous assembly of - and -tubulin monomers in very stable heterodimers. The assembly of 6 
to 12 heterodimers is necessary to start a microtubule. The nucleation is a rather slow step and depends on 
the concentration of GTP-tubulin (Job et al., 2003). Although the microtubule lattice can be formally 
described as helical, it does not assemble by a classical helical polymerization. Microtubules appear to grow 
as a bidimensional sheet of interacting protofilaments that later close into a tube (Fig. 12c). Like the actin 
polymerization, the microtubule assembly has treadmilling dynamics. The structural polarity of the 
microtubules induces kinetics polarity where the (+) end grows faster than the (-) end (Desai et al., 1997). 
During polymerization, GTP bound to -tubulin (at the exchangeable or E-site) is hydrolyzed. The resulting 
GDP does not exchange while -tubulin remains in the polymer. Upon depolymerization, the released 
tubulin subunits can exchange GDP for GTP and undergo another round of polymerization. GTP hydrolysis 
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is known to occur rapidly during polymerization and drives a conformational change. The step correlating 
with the conformational change is often not hydrolysis itself but the phosphate (Pi) release (Vale, 1996). A 
slight delay between polymerization and hydrolysis of the GTP by -tubulin creates a GTP-tubulin cap. 
While in the lattice, GDP-tubulin cannot adopt the fully curved conformation, thus the energy of GTP 
hydrolysis is stored as mechanical stress. This stress is released when the GDP-tubulin subunits are exposed 
at microtubule ends and drives a rapid depolymerization phase. This event is called microtubule catastrophe 
(Fig. 12c). When the GTP-tubulin subunit binds again or when the catastrophe reaches remnant GTP-tubulin 
in the lattice, the conformation goes back into a straight protofilaments and microtubules polymerizes back. 
This is called microtubule rescue. Microtubules are said to be in dynamic instability because they experience 
periods of persistent microtubule growth interrupted by occasional switching to rapid shrinkage. The 
polymerization dynamics of microtubules are central to their biological functions: they allow microtubules to 
rapidly reorganize, to differentiate spatially and temporally in accordance with the cell context, and to 
generate pushing and pulling forces during polymerization and depolymerization, respectively (Inoue et al., 
1995). Dynamic instability allows microtubules to explore the three dimensional space of the cell in order to 
find specific target sites on the cell periphery (Gundersen, 2002).  
II.2. Microtubule-binding proteins 
 In living cells, microtubule-associated proteins (MAPs) nucleate, stabilize or destabilize 
microtubules. They play a crucial role in the regulation of microtubule dynamics, both spatially and 
temporally. MAPs function by targeting soluble, non-polymerized tubulin subunits, the microtubule wall 
lattice and/or microtubule ends. A distinction is drawn between structural MAPs and motor MAPs, the latter 
class will be described in detail in another section. Among the structural MAPs are some proteins that 
associate and specifically accumulate at the (+) ends of microtubules (+TIPs standing for plus end tracking 
proteins) (Schuyler et al., 2001). They control the microtubule dynamics, growth directionality and 
interactions with components of the cell cortex (Fig. 13). During the recent years, the family of +TIPs has 
extended steadily (Akhmanova et al., 2005) and has been shown to contain cytoplasmic linker proteins 
(CLIPs), CLIP associated proteins (CLASPs), end-binding proteins (EBs), dynactin complex, and a number 
of other proteins such as kinesin-13 family members. EB proteins usually increase microtubule dynamics and 
can prevent microtubule catastrophe events (Akhmanova et al., 2008). By contrast, kinesin-13 family 
members destabilize microtubules and promote catastrophe. CLIP-family members function as microtubule 
rescue factors that contribute to the converting of shrinking microtubules into growing ones. CLASPs are 
usually microtubule-stabilizing factors. The most studied stabilizing MAPs are Tau, MAP2 and MAP4, the 
first two being strongly expressed in neurons. Other MAPs have a destabilizing effect on microtubules, either 
by severing microtubules or by inducing depolymerization. Three proteins, katanin, spastin, and fidgetin 
regulate the number and length of microtubules (Zhang et al., 2007). In particular, they increase the number 
of microtubule catastrophe which is a major mechanism that is employed for cellular microtubule length 
regulation. 
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Figure 13: Plus end tracking protein functions. +TIPs control the different aspects of microtubule dynamics and are 
involved in many cellular interactions such as connections between microtubules and the cell cortex, actin filaments, 
endoplasmic reticulum or vesicles. They also participate in the creation of the different structures microtubules can 
adopt like centrosomes, kinetochores or spindles by transporting microtubule end along other microtubule. From 
(Akhmanova et al., 2010) 
II.3. Microtubule structures and functions 
 Dynamic microtubules can be organized into a number of characteristic intracellular architectures 
that are associated with distinct cellular functions. Microtubule patterns observed in vivo may be roughly 
categorized into three classes: asters, antiparallel overlaps, and bundles (Fig. 14) (Dogterom et al., 2013). 
These three patterns, alone or in combinations of two, capture many of the microtubule architectures in a 
wide variety of cell types. In non-dividing mammalian fibroblasts, microtubules are typically nucleated by a 
centrosome with their plus ends pointing outwards, extending as a radial array toward the cell periphery to 
facilitate motor-driven intracellular trafficking. Antiparallel overlap zones in the center of mitotic spindles 
are areas where microtubule plus ends meet and overlap in a controlled fashion with the help of associated 
(motor) proteins (Miyamoto et al., 2004; Glotzer, 2009). Similar patterns, although with inverted 
microtubule polarity, are found in the interphase microtubule array of fission yeast cells that keep the nucleus 
positioned in the center of the cell (Janson et al., 2007). Highly organized mixed-polarity bundles of 
microtubules are found associated with the cortex of plant cells, where they are thought to assist in 
unidirectional cell growth, as well as in neuronal cells, where they are used for bidirectional transport. 
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Figure 14: Microtubule patterns observed in vivo. Tree classes of simple microtubule patterns: asters, anti-parallel 
overlaps, and bundles. From (Dogterom et al., 2013) 
II.3.a. Asters 
 The organization as radial array toward the cell periphery is due to the microtubule-organizing center 
(MTOC). In most animal cells there is a single, well-defined MTOC called the centrosome, located in the 
cytoplasm near the nucleus (Fig. 15a). The centrosome is a complex structure organized by a pair of 
perpendicular centrioles (Fig. 15b). Each centriole is composed of nine triplets of microtubules and is 
surrounded by pericentriolar material that contains proteins implicated in microtubule nucleation and 
organization. Among them, -tubulin associates with other proteins to form a ring complex, the -TuRC (-
Tubulin Ring Complex), onto which heterodimers of -and -tubulin are added to build a microtubule 
(Fig. 15c). The pericentriolar material contains several copies of -TuRC. Microtubules are thus polarized 
with a (-) end capped and anchored at the MTOC and a (+) end generally localized at the periphery of the 
cell. Through the dynamic instability, the (+) ends explore the cytoplasm in a very dynamic manner allowing 
newly formed regions of the cytoplasm to rapidly fill with microtubules and facilitate recruitment of 
membrane systems using microtubule-related motor proteins (Tanaka et al., 1991). The presence of 
centrosome plays a fundamental role in the function and intracellular dynamics of microtubules by 
preventing spontaneous polymerization of microtubules in the cytoplasm and thereby a random spatial 
organization of microtubules. This gives a cell a defined polarity which serves to organize the cytoplasm, 
position the nucleus and organelles, and which is the base of an organized intracellular trafficking and 
transport. 
 
 
Figure 15: Microtubule organization in aster. (a) In non-dividing animal cells, microtubules (red) form a radial array 
nucleated at a single MTOC (blue) which is located close to the cell nucleus. From (Luders et al., 2007). (b) The 
centrosome is composed of a pair of centrioles (cylinder) surrounded by pericentriolar material (PCM, blue). 
Microtubules are nucleated from -TuRC (black) embedded in the PCM. From (Wiese et al., 2006) (c) Microtubule 
nucleation by the -TuRC. -TuRC mimics a growing microtubule on which  tubulin dimers (blue, yellow) 
polymerize. A complex of proteins (purple, red) and -tubulin (green) associate to form a capped nucleation site. In this 
model, -tubulin interacts in a side-by-side manner. Another model suggests head-to-tail interaction. From (Job et al., 
2003). 
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II.3.b. Bundles 
 Microtubules can form dense parallel bundles. These bundles are especially abundant in neuronal 
cells (axons and dendrites, Fig. 16). They can be found either in uniform orientation with all microtubule (+) 
ends pointing toward the axon tip, or they can be found with mixed orientation where the microtubule (+) 
end faces the cell body or the dendritic tip. To obtain and maintain this bundle structure, microtubules have 
to interact with some MAPs which enable crosslinking. The prevalent crosslinker in axonal microtubules is 
the Tau protein and the most abundant one in dendritic microtubules is the MAP2 protein (Conde et al., 
2009). Both proteins bind along the sides of microtubules and contribute to their stabilization. Tau-mediated 
bundles in the axon have generally edge-to-edge spacing of ~20 nm and are hexagonally packed (Chen et al., 
1992). Axonal microtubule bundles 10-100 microtubules in a typical cross section (Fadic et al., 1985). 
Bundles serve a variety of functions including the maintenance of the mechanical integrity and shape of the 
axon, the promotion of axonal growth, and the facilitation of the cargo transport (Goldstein et al., 2000; 
Guzik et al., 2004).  
 
 
Figure 16: Microtubule organization as bundles in axons and dendrites. Tau protein mediates the formation of 
microtubule bundles of uniform orientation in axons, whereas microtubule-associated protein 2 (MAP2) crosslinks 
microtubules in mixed orientation in dendrites. From (Conde et al., 2009) 
II.3.c. Antiparallel overlap 
 In dividing animal cells, two centrosomes combine with an antiparallel overlap zone to build a 
mitotic spindle that is responsible for the accurate segregation of chromosomes and the orientation of the 
plane of cleavage (Fig. 17a). Astral microtubules attach to the cell cortex and position the central spindle, 
while microtubule bundles or kinetochores in the spindle regulate cytokinesis (Glotzer, 2009). Central 
spindle assembly involve kinesin motor proteins and MAPs among which are the protein regulating 
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cytokinesis 1 (PRC1), the centralspindlin complex and the chromosome passenger complex (CPC) (Fig. 17). 
PRC1 is the microtubule crosslinker protein (Walczak et al., 2010). It interacts directly with the microtubules 
and preferentially localizes where overlap is antiparallel. It also interacts with KIF4 kinesin which 
accumulation limits the microtubule growth at the (+) end thus the overlap length. Centralspindlin complex 
consists of kinesin-6 motor proteins, which concentrate the complex at the microtubule (+) ends, and CYK4, 
which may preferentially bind the complex to antiparallel microtubules (Mishima et al., 2002). The 
combined presence of PRC1 and centralspindlin induce a robust bundling of the microtubules by greatly 
stabilizing them. CPC initially binds microtubules at the locus of the chromosome centromeres which are at 
the mitotic spindle during anaphase. (Carmena et al., 2012). It remains at this position while chromosomes 
migrate towards the pole and serve as localization signal of the spindle that is recognized by the 
centralspindlin complex and the cell cortex.  
 
 
Figure 17: Microtubule organization as antiparallel overlap in the mitotic spindle. During anaphase, chromosomes 
move towards the poles of the cell and CPC is released. It recruits centralspindlin complex and PRC1 is transported by 
KIF4. Centralspindlin and PRC1 accumulate and mediate the strong bundling of antiparallel microtubules. From 
(Glotzer, 2009) 
II.4. Motor proteins 
 The inherent polarity of microtubules allows for the directional flow of information within the cell. 
Microtubule motors from the kinesin and dynein families use this polarity to transport cargoes from and to 
the nucleus. The collective transport of intracellular particles along a specific cellular direction is a 
fundamental process in cell biology. 
II.4.a. Kinesins 
 Kinesin superfamily proteins (KIFs) contain 45 members grouped into 15 classes (from 1 to 14B) 
(Lawrence et al., 2004). The position of the motor domain in the protein (NH2-, COOH-terminal or in the 
middle) defines the three major types of KIFs (N-, C- or M-type, respectively) (Miki et al., 2001). N-kinesins 
are responsible for transport towards (+) ends of the microtubules, C-kinesins move towards (-) ends and M-
kinesins depolymerize microtubules. Only the kinesin 13 family contains M-type kinesins and only the 
kinesin 14A and 14B families contain C-types kinesins. N-types kinesins represent the vast majority of KIFs. 
Like myosins, kinesins use the chemical energy of ATP to generate conformational changes that drive motile 
force. They are involved in axonal, dendritic, conventional intracellular and intraflagellar transport (Soldati 
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et al., 2006; Hirokawa et al., 2009). Examples of intracellular cargoes that move within the cell via kinesins 
are mitochondria (Nangaku et al., 1994), ER-Golgi complexes (Terasaki et al., 1994; Wozniak et al., 2006), 
endosomes and lysosomes (Bananis et al., 2000; Brown et al., 2005; Hirokawa et al., 2009) (Fig. 18a). 
Typically, kinesins have a motor, a coiled-coil and a globular tail domains (Hirokawa et al., 2005). However, 
KIFs have varying molecular shapes (Fig. 18b). Kinesin I (KIF5) protein consists of two heavy and two light 
chains (Vale et al., 1985). It has a rod-like structure consisting in two globular heads (10 nm in diameter), a 
stalk, and a fan-like end, with a total length that can reach 80 nm. Although many KIFs form homodimers, 
some are monomeric (KIF1A and KIF1B), other are heterodimers (KIF3B and KIF3C assemble with KIF3A) 
or heterodimers (Hirokawa et al., 2005) (Fig. 18b). KIF3A-KIF3B or KIF3A-KIF3C heterodimers assemble 
with kinesin superfamily associated protein 3 (KAP3) to form a heterotrimeric complex called the KIF3 
complex or kinesin II. Kinesins usually use scaffold and adaptor proteins to interact with their cargoes, but 
they can sometimes directly bind to them. The interaction cargo-motor is highly specific, even if there is 
redundancy in some cases. 
 
 
Figure 18: Microtubule-related transport in non-neuronal cells. (a) KIFs motor proteins are involved in the 
transport of cargoes between the plasma membrane, the endosomal compartments, the ER and the Golgi. Motors 
travelling toward microtubule (+) ends, such as KIF5, KIF3 and the kinesin 3 family motors (KIF1C, KIF13A and 
KIF16B), tug against motors moving towards (-) ends, like cytoplasmic dynein (CyDn), KIFC2 and KIFC3. From 
(Hirokawa et al., 2005) (b) Principal members of the kinesin superfamily proteins. Motor domains are in orange or 
yellow and the tail domains in blue. From (Hirokawa et al., 2009) 
II.4.b. Dyneins 
 Dyneins are (-) end directed motors. It uses ATP-hydrolysis to generate force and move in a step-like 
manner on microtubules (Mallik et al., 2005). Although other motor proteins (myosins and kinesins) 
represent rather large families, dyneins are divided only in two major classes, axonemal and cytoplasmic 
dyneins. The classification is based on both functional and structural aspects (Fig. 19a). Axonemal dyneins 
control ciliary and flagellar beating whereas cytoplasmic dyneins are responsible for intracellular transport, 
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mitosis, cell polarization and migration. There are two forms of cytoplasmic dynein, cytoplasmic dynein 1 
and cytoplasmic dynein 2, which form homodimers but have different distributions and functions. 
Cytoplasmic dynein 2 proteins are almost all located within and around the base of cilia and flagella, where it 
is responsible for retrograde transport (Porter et al., 1999; Mikami et al., 2002). Cytoplasmic dynein 1 is 
much more abundant and is present in all cells having microtubules. It binds and transports vesicles shuttling 
between the ER and the Golgi apparatus (Fath et al., 1997), endosomes and lysosomes (Goodson et al., 
1997; Soldati et al., 2006) (Fig. 18a). It also transports or maintains at the microtubule (-) ends diverse 
protein- and RNA-containing complexes (Jansen et al., 2012). Additionally, cytoplasmic dynein 1 is present 
at the kinetochores, where it is implied in the removal of checkpoint proteins to allow for the entry into 
anaphase. In association with the cell cortex, it contributes to cell division and directed migration.  
 Compared to other motors, cytoplasmic dynein structure is very complex (1.2 MDa) and involves 12 
chains with 2 heavy chains containing the motor units, 2 intermediate chains, 2 light intermediate and 6 light 
chains, several of which can associate with various cargos (Fig. 19b) (Hook et al., 2006). Cytoplasmic 
dynein head comprises 6 AAA modules (ATPases associated with various cellular activities) and one non-
AAA+ domain that assemble in a ring-like structure (Soldati et al., 2006). A 15 nm long stalk links the 
dynein head to the globular microtubule-binding domain (Gee et al., 1997). This unique structure has to 
interact with many intracellular partners in order to regulate several aspect of cell physiology. For that 
purpose, dynein associates with the accessory factor dynactin. Dynactin seems to function as an adapter that 
regulate the binding of dynein to several cargoes such as membranes, microtubules, and chromosomes 
(Holleran et al., 1998). In addition, dynactin may enhance long-range transport by increasing the processivity 
of the motor (King et al., 2000).  
 
 
Figure 19: The dynein motor. (a) There are two classes of dynein: axonemal and cytoplasmic. Axonemal dynein 
mediates beating of flagella. Cytoplasmic dynein mediates intracellular transport. (b) Cytoplasmic dynein structure. 
Cytoplasmic dynein is a homodimer. The heavy chain has a tail domain (blue) and a motor domain structured as a ring 
of AAA domains (yellow) that mediate ATP hydrolysis and non-AAA domain (green). The microtubule-binding 
domain is a small globular domain at the tip of a coiled-coil. The tail domain of the heavy chain mediates the 
homodimerization and serves as scaffold for the dimerization of the intermediate (gray) and light intermediate (red) 
chains. The light chains (green, yellow, pink) assemble on the intermediate light chains. From (Hook et al., 2006)  
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Chapter 2: Endocytosis 
III. Overview 
 Membranes are essential cellular structures that separate the cell body from the surroundings and 
form the boundaries of subcellular compartments like the nucleus, the Golgi apparatus, mitochondria, 
vesicles and others. Membranes are semipermeable, meaning that they allow for the passage of specific 
molecules and prevent the passage of others. The basic element of membranes is the phospholipid which has 
a hydrophilic head and hydrophobic tails. They spontaneously organize in a bilayer in aqueous solution to 
minimize the exposure of their hydrophobic tails. The first model of the membrane was a simple two-
dimensional fluid with sporadically embedded proteins (fluid-mosaic model). In fact, membranes consist in 
many different lipids and huge amounts of proteins that organize in domains and distort the thickness of the 
membrane. To guaranty its first function of compartmentalization, cells strictly regulate the integrity of their 
membranes. However, plasma membranes are much more than a frozen physical barrier. They have essential 
functions such as internalizing material necessary to the cell survival, sensing and informing the cell about 
the extracellular environment, and removing from the cells the waste material. To serve both as barrier and 
communication platform, membranes possess sophisticated translocation systems that regulate the molecule 
delivery. Among these systems are membrane budding and fusion that transport material between exterior 
and interior (endo-, exocytosis) of the cells but also between the intracellular compartments. 
  
 Endocytosis refers to any mechanism by which a portion of the plasma membrane folds inward the 
cells and is internalized, together with engulfed extracellular material, as a vesicle (Fig. 20). “Endocytosis 
counterbalances the continuous delivery of new membrane to the cell surface by exocytosis, regulates the 
abundance of proteins in the plasma membrane, controls the signaling output of receptors, and mediates 
cellular uptake of nutrients” (Ferguson et al., 2012). In most of the cases, this process is stimulated by the 
binding or the interaction of the cargo with some sensor proteins present at the plasma membrane. Cargo can 
be lipids, proteins (as growth factors…), other molecules (hormones, nutrients…), extracellular fluids but 
also viruses or bacteria that can use endocytosis to infect cells. Endocytosis also regulates the membrane 
composition which is adjusted according to the environment of the cell, its physiological status and its needs. 
Several pathways exist according to the lipid/protein machinery involved in the process which must be 
tightly regulated in order to appropriately respond to the cell environment. This machinery can be divided 
into 6 ensembles: the cargo, the lipids, the coat components, the GTPases, the regulators, the fission complex 
and the actin cytoskeleton and related proteins (Mayor et al., 2007). 
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Figure 20: Classification criteria for endocytic mechanisms. The molecular machinery involved in endocytosis can 
be classified into 6 groups: the cargo, the lipids, the coats, the GTPases, the regulators, the fission complex and the actin 
cytoskeleton. From (Mayor et al., 2007) 
III.1. Classification 
 Endocytosis can be described according to the morphology of the nascent and newly formed 
vesicles, the proteins involved in their formation and/or the internalized material. The first level of the 
classification separates pinocytosis which concerns the uptake of fluids and solutes from phagocytosis which 
internalizes large particles (Fig. 21). Since phagocytosis takes place only in specific cell types (macrophages, 
neutrophils, and dendritic cells), it is not described in this manuscript. By contrast, pinocytosis concerns all 
cell types and is subdivided in several paths. The best described endocytic process is the clathrin-mediated 
endocytosis (CME). It is possible to distinguish it from the other paths, using electron microscopy, because 
the clathrin coat can be visible around membrane pits or vesicles (Doherty et al., 2009). It is therefore often 
the basis for the endocytosis classification and these other pathways are grouped into clathrin-independent 
(CI) endocytosis. Among CI pathways, the most described pathway is the caveolae-mediated endocytosis. It 
is present at the membrane of many cell types and can be so abundant that it represents one third of the 
membrane area (Doherty et al., 2009). Caveolae pits are visible as flask-shaped invaginations of about 60-
80 nm in diameter. Pinocytosis can also occur by macropinocytosis which is associated to intense membrane 
ruffling. This aspect plus the relatively large size of the formed vesicles led to the creation of a separated 
class. Clathrin- and caveolae-independent pathways are further divided into several categories that suffer 
from a lack of knowledge about the proteins and cargo involved as well as about their functions in the cells. 
Nevertheless, investigations have identified some required partners that define them as Arf6-dependent, 
flotillin-dependent, Cdc42-dependent and RhoA-dependent endocytosis. These proteins are not specific for 
these pathways but are necessary in order for them to occur. Tubular invagination is an often observed 
morphology associated with clathrin- and caveolae-independent pathways. 
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Figure 21: Actual classification of the endocytic pathways. Among pinocytosis, clathrin-dependent or clathrin-
independent routes are possible. The CI pathways are categorized first according to the involvement of the caveolae 
coat, and then by other components (Arf6, flotillin, Cdc42, RhoA). Another CI pathway is macropinocytosis which is a 
class of its own, because it arises from membrane ruffles and the comparably large sizes of the vesicles. From (Sahay et 
al., 2010) 
III.2. Lipids 
 As the main membrane component, lipids are essential for endocytosis. They are the base of 
structures called lipid rafts. Lipid rafts are microdomains of the plasma membrane enriched in cholesterol, 
sphingomyelin and glycosphingolipids. These domains correspond to liquid-ordered phases of the membrane 
surrounded by liquid-disordered phase regions. One characteristic that induced their discovery is their 
resistance to extraction with non-ionic detergents. Rafts seem to be relatively small (~50 nm) which prevent 
their observations with classic optical microscopy. They seem to be relatively abundant at the plasma 
membrane. Even though lipid rafts share common composition, they do not have all identical content in 
lipids and proteins. The presence or not of the caveolin protein has lead to the classification of the lipid rafts 
into two groups, the caveolae and the glycosphingolipid-enriched membranes (GEM) also called non-
caveolae or rafts. They act as a platform of communication between extracellular medium and the cell by 
controlling cell signaling. To fulfill this function, several mechanisms may be involved. Rafts may initially 
contain incomplete signaling pathway until a receptor is activated and/or a molecule is recruited. Rafts may 
serve to limit signaling by providing a physical sequestration of signaling components or by suppressing the 
activity of the signaling proteins located in the rafts (Pike, 2003). Lipid rafts are internalized by many 
endocytic pathways such as caveolae-, flotillin-, Arf6-, RhoA-, and Cdc42-dependent endocytosis.  
 Phosphatidylinositol (PtdIns) and its phosphorylated products (phosphoinositides), 
phosphatidylinositol-bisphosphate and -triphosphate (PI(4,5)P2/PIP3), are of special interest in endocytosis 
because they play a crucial role for the recruitment and regulation of cytoplasmic proteins selectively at the 
plasma membrane (Di Paolo et al., 2006). They interact with both signaling and cytoskeletal components 
necessary for endocytosis and trafficking. A study using PI(3,5)P2 or PI(4,5)P2 as bait to pull proteins out of 
a cell extract showed that 388 cytoplasmic proteins were captured (Catimel et al., 2008). Among them were 
50 GTPases or their regulators, 67 proteins associated with membrane trafficking and cargo transport, 37 
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kinases and phosphatases, and 49 proteins involved in the regulation of the actin cytoskeleton. PI(4,5)P2 (in 
most cases also PIP3) binds all the known endocytic clathrin adaptors and many other endocytic factors, 
including dynamin. Interactions of PI(4,5)P2 with various proteins can cause its clustering/sequestering, 
resulting in membrane domains in which PI(4,5)P2 and specific proteins are concentrated (Saarikangas et al., 
2010). Enrichment of PI(4,5)P2 induces actin filament assembly in mammalian cells (Rozelle et al., 2000) 
while sequestration of PI(4,5)P2 leads to defects in the cortical actin (Raucher et al., 2000). PI(4,5)P2 and 
PIP3, often in concert with GTPases, participate in the recruitment and activation of a wide variety of actin 
regulatory proteins at the plasma membrane (Fig. 22) (Di Paolo et al., 2006; Saarikangas et al., 2010). 
PI(4,5)P2 binds N-WASP, or its activators, which in turn activates the Arp2/3-mediated nucleation of actin. 
PI(4,5)P2 facilitates actin filament elongation by promoting the dissociation of capping proteins, such as 
gelsolin and CapZ. The actin-binding and depolymerization activities of ADF/cofilin can be efficiently 
inhibited by PI(4,5)P2. In addition, through their binding to profilin, PI(4,5)P2 and PIP3 promote the 
dissociation of actin-monomer-profilin complexes, thus making G-actin available for polymerization. 
 
 
Figure 22:  Local increase in the PI(4,5)P2 concentration affects many aspects of the actin cytoskeleton. The 
activity of WASP and WAVE family proteins is enhanced by PI(4,5)P2. These proteins promote Arp2/3-mediated actin 
filament assembly. Filament barbed end capping proteins are inhibited by PI(4,5)P2. Actin filament disassembly and 
monomer sequestering are diminished through inhibition of ADF/cofilin by PI(4,5)P2. From (Saarikangas et al., 2010) 
III.3. Coat components 
  To create endocytic vesicles, first, a curvature has to be imposed on the membrane such that the bud 
can be formed. Coat proteins (clathrin, caveolin, and flotillin) induce or stabilize membrane curvature. By 
their insertion into the membrane layer, clathrin coat and adaptor proteins (AP), generate membrane-bending 
(Anitei et al., 2012). The recruitment and assembly of the clathrin coat is partially controlled by the local 
distribution of the PtdIns in membranes. In artificial membranes, clathrin preferentially polymerizes at 
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regions in liquid-disordered phases, which are easier to bend compared to domains in liquid-ordered phases 
enriched in cholesterol and sphingomyelin. Caveolin and flotillin induce membrane-bending through their 
clustering. As observed for the internalization of Shiga toxin, for which no coat proteins are involved, 
membrane curvature appears to be created by compacting glycosphingolipids.  
III.4. GTPases 
 This is a superfamily of enzymes that bind and hydrolyze GTP in their G domain. By shuttling 
between GDP- and GTP-bound forms, as inactive and active forms respectively, they serve as molecular 
switches for signal transduction (Wennerberg et al., 2005). For all endocytic pathways, Ras-superfamily or 
small GTPases are primordial because they recruit proteins from the cytosol and localize them at the suitable 
membrane domains. They are categorized into eight subfamilies including Ras, Rho, Rab and Arf classes.  
 Ras (Ras sarcoma) GTPases function as signaling hubs in response to various extracellular stimuli. 
Upon activation, Ras interacts with multiple downstream effectors which control cytoplasmic and nuclear 
signaling cascades.  
 Rho (Ras homologous) GTPases are the regulators of several facets of actin dynamics (Ridley, 
2006). The best characterized Rho GTPases are RhoA that controls the formation of contractile acto-myosin 
fibers, Rac1 that generates actin filaments in lamellipodial network and membrane ruffling, and Cdc42 that 
leads the formation of filipodial protrusions (Fig. 23).  
 
 
 
Figure 23: GTPases and effectors regulating actin dynamics. The Rho GTPases and Arf6 control the formation of 
the different actin structures (bundles, branched networks and stress fibers) and other actin-related proteins involved in 
actin polymerization, filament capping or monomer sequestering. From (Swanson, 2008) 
 Rab (Ras-like proteins in brain) GTPases regulate the trafficking of vesicles and proteins between 
the organelles of the endocytic and secretory pathways (Zerial et al., 2001). Rab proteins are involved in the 
vesicle budding from the donor compartment, in its transport towards the acceptor compartment, and in the 
vesicle fusion with the latter. There are approximately 70 different human Rabs which are therefore the 
largest branch of the Ras superfamily. 
 Arf (ADP ribosylation factors) GTPases represent a group of six small GTPases which regulate 
membrane traffic and organelle structure in eukaryotic cells (Qualmann et al., 2002). Among these, Arf6 acts 
specifically at the level of the plasma-endosomal membrane. Arf6 seems to cycle between the plasma 
membrane, the early and recycling endosomes (D'Souza-Schorey et al., 1998). Moreover, the unique feature 
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of Arf6 is its aptitude to interact with cortical actin (Fig. 23) (Radhakrishna et al., 1996; D'Souza-Schorey et 
al., 1997).  
III.5. Regulatory proteins 
 As mentioned above, GTPases shuttle between GDP (inactive)- and GTP (active)-bound states. 
Their interconversion is regulated by GEFs (Guanine nucleotide exchange factors) and GAPs (GTPase-
activating proteins). GEFs activate GTPases by stimulating the release of GDP that permits the loading of 
GTP. GAPs bind to activated GTPases and promote their GTPase activity. In a more general manner, 
“protein phosphorylation/dephosphorylation is at the heart of controlling the physical properties of 
endocytosis and of integrating these physical properties into the signal transduction network” (Liberali et al., 
2008). Therefore, regulation passes by enzymes responsible for the addition (kinases) or the removal 
(phosphatases) of a phosphate on signaling proteins. Liberali et al. listed about 30 protein kinases 
phosphorylating about 70 endocytic machinery components (Liberali et al., 2008). All stages of endocytosis 
have components regulated by such mechanism: coats, adaptors, shaping, fission, actin, GTPases, motors, 
docking, and fusion (Fig. 24). These kinases can in turn activate other kinases, about 60 of which are 
identified to be linked to the endocytic processes which therefore form a highly sophisticated signaling 
network.  
 
 
Figure 24: Endocytic components and the protein kinases. This network is composed of 69 endocytic components, 
32 protein kinases that directly phosphorylate them, and 59 protein kinases that interact with the first level of proteins 
kinases. From (Liberali et al., 2008) 
III.6. Fission mechanism 
 Once the membrane is deformed as a spherical bud or tubule, fission is indispensable for the vesicle 
to be formed and further trafficked in the cytosol. The key actor of the fission mechanism, and found in 
several endocytic pathways, is the dynamin protein. Dynamins are GTPases of the DLPs (dynamin-like 
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proteins) family of proteins which act in membrane remodeling. Dynamin polymerizes in spiral around the 
neck of budding vesicles and separate the vesicle bud from the plasma membrane via its GTPase activity 
(Fig. 25a). The “conformational changes produced by GTP hydrolysis are transduced into a movement 
relative to adjacent ring of dynamin that, when propagated along the polymer, is expected to produce a force 
on membranes” (constriction or stretching) (Chappie et al., 2011; Ford et al., 2011; Ferguson et al., 2012). 
When dynamin depolymerizes, the underlying tubular membrane get unstable and spontaneously vesicle 
scission occurs (Anitei et al., 2012). 
  
 
Figure 25: Putative mechanism of dynamin-mediated membrane fission. (a) Dynamins polymerize through 
interactions between the ‘stalk’ regions of the proteins. Upon GTP hydrolysis, the G domains of adjacent rings dimerize 
(yellow stars) and initiate a conformational change at the origin of the membrane constriction. Fission is complete when 
dynamins depolymerize. From (Ferguson et al., 2012) (b) During vesicle fission, dynamin accumulates at the vesicle 
neck and recruits cortactin which activates the nucleation of actin filaments via Arp2/3. Actin polymerization aids the 
fission process by pushing the vesicle bud away from the plasma membrane. From (Kessels et al., 2005) 
 In vitro, dynamin alone is sufficient to constrict and cut tubular lipid membranes (Roux et al., 2006; 
Pucadyil et al., 2008), but, in vivo, the fission process is performed with the help of several other factors 
such as: the induction of membrane tension by the actin cytoskeleton (polymerization or myosins) (Fig. 25b) 
(Roux et al., 2006; Taylor et al., 2011), and by the asymmetrical distribution of lipids at the neck (Liu et al., 
2009); the destabilization of the membrane by membrane-binding proteins such as the BAR (Bin–
amphiphysin–Rvs) proteins (Frost et al., 2009); the degradation of PI(4,5)P2 inducing the dissociation of 
dynamin and other endocytic factors after GTP hydrolysis (Chang-Ileto et al., 2011). Proteins binding to 
dynamin often do it at the Src-homolgy-3 (SH3) domains. Upon interaction, these SH3 domains induce a 
strong GTPase activity. Proteins recruited by dynamin act as regulators as well. 
 In yeast, in which dynamin is absent, vesicle fission requires forces generated by actin 
polymerization and possibly the myosin I homologue recruited at the basis of the invagination. In 
mammalian cells, tubular endocytic vesicles engulfing the Shiga toxin are formed via an actin-dependent but 
dynamin-independent internalization. Actin-related motors may drive the fission process (Anitei et al., 
2012). Possibly, the tug-of-war between motors (actin-based, microtubule-based, or both) along membrane 
tubules can produce or contribute to the required membrane tension for the vesicle scission since it is the 
General background - Chapter 2: Endocytosis - III. Overview  
 
- 34 - 
case for endosome fission. The formation of membrane domains creates line tension at their edges and 
additional tension applied would provoke spontaneous scission (Anitei et al., 2012). 
III.7. Actin cytoskeleton related proteins 
 In addition to the well established involvement of actin ruffling in macropinocytosis (cf. section V), 
actin dynamics are important for most of the other endocytic processes. Actin cytoskeleton participates in 
clathrin-mediated endocytosis (Gottlieb et al., 1993; Merrifield et al., 2002) and in the caveolae-mediated 
uptake of SV40 (Pelkmans et al., 2002), both being dynamin-dependent. Actin is also required for the 
dynamin-dependent but clathrin- and caveolae-independent internalization of cytokine receptor  chain 
(CRc) (Sauvonnet et al., 2005). Furthermore, actin has a role in the dynamin-dependent uptake of receptor 
tyrosine kinases (RTKs) which is mediated by circular dorsal ruffles (Orth et al., 2006) as well as for the 
dynamin, clathrin and caveolae-independent internalization of GPI-anchored proteins (GPI-AP) (Chadda et 
al., 2007).  
 Arp2/3 appears as the hub for the regulation of actin dynamics in most, if not all, internalization 
pathways. The actin nucleating complex can be activated at different steps of the endocytic process by 
several nucleation promoting factors (NPFs) such as WASP, N-WASP and WAVE (Anitei et al., 2012). 
These “proteins are now recognized as scaffold proteins that convert signals from protein-protein and 
protein-membrane interactions into actin polymerization” (Takenawa et al., 2007). Cortactin, another NPF, 
seems to participate in the dynamin-dependent endocytosis of CRc, RTKs, and clathrin-mediated 
endocytosis (Girao et al., 2008). These NPFs are recruited to membrane microdomains and activated by Rho 
GTPases and their effectors (Fig. 23). In addition to Arp2/3, formins are also involved in membrane 
trafficking such as Dia1 that promotes actin polymerization in bundles and stress fibers.  
 Even before endocytosis is initiated, the actin cytoskeleton could have a role. Cortical cytoskeleton 
underlying the plasma membrane may confine the endocytic machinery to certain domains of the membrane 
either by trapping it, the network serves as physical barrier that impedes diffusion, or by anchoring it through 
the binding with endocytic components. It has been observed an increased lateral mobility of GFP-labeled 
clathrin-coated pits, after disruption of the actin filament with latrunculin B (Gaidarov et al., 1999). This 
strongly suggests the role of actin cytoskeleton as a barrier to diffusion. Furthermore, sites of clustered 
membrane proteins to be taken up and sites of clathrin-coated pits were described as ordered arrays 
corresponding to the pattern of underlying actin stress fibers and these arrays were shown to depend on an 
intact actin cytoskeleton (Qualmann et al., 2002).  
 Actin cytoskeleton can also deform or invaginate the plasma membrane by creating a curvature 
which facilitates membrane pinch off by the coating proteins. In vitro, local membrane curvature can be 
generated separately by the actin cytoskeleton or by membrane associated proteins, but, in cells, these two 
components are often closely connected (McMahon et al., 2005). Proteins bearing a membrane 
binding/deforming module, the BAR domain, are numerous and constitute the BAR superfamily. All steps of 
endocytosis involve different membrane curvatures that are induced and/or sensed by BAR proteins 
(Fig. 26a). These proteins contain several other domains that link them to the actin machinery (Takenawa et 
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al., 2007). The SH3 domain binds WASP which, in turn, activates the Arp2/3 complex and initiates actin 
polymerization in branched network (Fig. 26b). WH2 (WASP homology 2) domains bind directly to actin 
monomers and promote its assembly. Additionally, BAR proteins have Rho GAP/GEF domains that, as 
above mentioned, regulate the GTPase activity of Rho proteins themselves controlling the different 
structures the actin network can build.  
 
 
Figure 26: Actin and BAR proteins in endocytosis. (a) Schematic representation of the different curvatures the 
plasma membrane is submitted to during the formation of the endocytic vesicle. Colors code for the degree of 
membrane curvature and correspond to the localization of different BAR proteins. From (Qualmann et al., 2011) (b) 
Typical domains of a BAR protein. The BAR domain is at the N-terminal of the protein and possesses the membrane 
binding/deforming activity. The SH3 domain is at the C-terminal of the protein and coordinates the actin dynamics 
regulation. From (Takenawa et al., 2007) (c) Actin localization in the different steps of endocytic processes. From 
(Kaksonen et al., 2006) 
 Another role of the actin cytoskeleton concerns the crucial step of the vesicle fission. When 
polymerizing at the neck of the pit, the actin machinery generates force capable of pushing the vesicles away 
from the plasma membrane. In A431 cells, receptor-mediated endocytosis remains blocked at the step of 
invaginated coated pits when incubation with the actin depolymerizing drug, latrunculin A, is performed 
(Lamaze et al., 1997). Dynamin can initiate actin polymerization via interactions with several actin-binding 
proteins such as cortactin, intersectin and syndapin (Kessels et al., 2005). These proteins bind to dynamin, 
the Arp2/3 complex, actin filaments and N-WASP. For instance, the multidomains protein cortactin recruits 
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and activates the Arp2/3 complex at its N-terminal, binds directly to actin due to the presence of multiple 
actin-binding domains and interacts with dynamin at its SH3 domain (Fig. 25b). Cortactin could serve as 
intermediate between the vesicle fission and the actin polymerization modules. Another possibility of 
connection between these modules could directly come from dynamin. Dynamin, when assembled in rings at 
the vesicle neck, aligns actin bundles and promotes their elongation by removing the capping protein gelsolin 
(Gu et al., 2010). Dynamin could also be related to the actin dynamics through BAR proteins. Some BARs 
can first dimerize and then polymerize in filaments around tubular membranes, via end-to-end interactions 
(Anitei et al., 2012). As described above, in addition to their function as inducer or stabilizer of membrane 
curvature, many BARs bind WASP and other actin regulators providing the force necessary to elongate the 
tubule. Nowadays, it is not clear yet how exactly the connection between dynamin and F-actin arises and 
how it controls the vesicle scission.  
 Actin can also promote the movement of endocytic vesicles further into the cytoplasm. A burst of 
actin polymerization takes place at the edge of the vesicles in so called comet tails. Actin rocketing may be 
used for driving the vesicles towards the microtubules. It could assist the fusion of endosomes as well. Actin 
comet tails have been observed at the vicinity of endosomes, pinosomes, clathrin-coated and secretory 
vesicles (Frischknecht et al., 1999; Merrifield et al., 1999; Rozelle et al., 2000).  
 At the vicinity of the internalization sites, actin may facilitate the formation of the pits and/or the 
passage of newly formed vesicles by locally disassembling. Vesicles could diffuse more easily and better 
come into contact with the microtubules. It has been observed that in the close surrounding of clathrin-coated 
pits, actin fibers are almost absent (Fujimoto et al., 2000). 
IV. Clathrin-mediated endocytosis 
 A large variety of transmembrane receptors and their ligands are internalized via the CME which 
was for a long time called receptor-mediated endocytosis (Doherty et al., 2009).  Clathrin-coated vesicles 
(CCV) can assemble from the plasma membrane but also from intracellular compartments. For CCV 
formation at the plasma membrane, there is a wide range of possible adaptors and accessory proteins that can 
be used, which reflects the pathway adaptation to the cargo. CCV formation is described via fives steps: 
nucleation, cargo selection, coat assembly, scission and uncoating (Fig. 27) (McMahon et al., 2011). The 
first stage involves the formation of a membrane invagination called a pit. It is mediated via the assembly of 
a nucleation module created at PI(4,5)P2-rich sites which recruit FCHO (FCH domain only) proteins. Such 
proteins possess F-BAR domain that can bind very low curvature membrane and have a membrane-bending 
activity required for the further process. The FCHO protein recruits the AP2 (adaptor protein 2) protein that 
mediates the cargo selection. AP2 acts as a major hub of interactions. It binds to the membrane via PI(4,5)P2, 
to the cargo through its interaction with cargo-specific adaptor proteins and its interaction with the 
cytoplasmic tail of the transmembrane receptor. In addition, it recruits and binds clathrin with the help of 
other accessory adaptor proteins such as epsin. Clathrin is composed of light and heavy chains, three of 
which form the basic building blocks of clathrin coats, the so-called triskelia. These three-legged structures 
can assemble into a lattice of pentagons and hexagons due to the relative flexibility of the angle formed by 
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the legs of the triskelion (Schmid, 1997; Owen et al., 2000). The clathrin assembly around the nascent pit 
forms the basket shaped clathrin-coated pit (CCP). Polymerization of the clathrin stabilizes the membrane 
curvature and aids in the formation and constriction of the vesicle neck. When the polymerization reaches the 
point where only a neck shape remains between the forming coated vesicle and the plasma membrane, the 
vesicle scission step is required for the budding. The scission is mediated by the dynamin proteins. It is 
recruited by protein containing BAR domain that preferentially binds membrane with high curvature 
(amphiphysin, endophilin, SNX9). They all contain SH3 domain that interact with the Proline-rich sites of 
dynamin. Dynamin polymerization around the neck favors its GTP hydrolysis and results in membrane 
fission. The clathrin is afterwards released from the vesicle via the auxilin-mediated recruitment of the 
ATPase HSC 70 (heat shock cognate). The area of the membrane where the neck fission occurred is 
uncoated. This defect in the clathrin cage is the place where the disassembly is initiated. The naked vesicle 
can undergo further trafficking in the cell to deliver the cargo to the appropriate compartment.  
 
 
Figure 27: The clathrin-coated vesicle cycle. (a) Clathrin-coated vesicle formation is divided in five steps: nucleation, 
cargo selection, coat assembly, vesicle scission and uncoating. (b) To each step is associated specific protein 
recruitment and activity. The signaling cascade is rather complex and involve several major hubs (FCHO, AP2, clathrin, 
dynamin, auxilin …) which are highlighted using colored circles. Connections between the different central proteins are 
shown with thicker lines. From (McMahon et al., 2011) 
V. Caveolae-mediated endocytosis 
 Caveolae are flask-shaped invaginations of the plasma membrane that are present and can be very 
abundant in many cell types. They are a class of lipid rafts, the cholesterol and sphingolipid-rich 
microdomains of the plasma membrane in which many endocytic and signal transduction functionalities are 
clustered (Conner et al., 2003; Sahay et al., 2010). Caveolae are defined as pits of 60-80 nm diameter 
covered by a coating appearing as a spiral lace in electron microscopy (Parton et al., 2007). This appearance 
is due to the hairpin-like caveolin-1 protein that first oligomerizes (about 15 monomers, shown as dimers in 
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Fig. 28a) and then polymerizes, with side-by-side interactions, into filaments. Caveolins have a domain that 
inserts into the cytoplasmic side of the membrane invagination and a domain that binds cholesterol (Fig. 
28a). Cholesterol is of a high importance for the formation and maintenance of caveolae since its depletion 
induces a flattening of caveolae vesicles (Rothberg et al., 1992; Westermann et al., 2005) and increases the 
lateral mobility of GFP-caveolin-1 (Thomsen et al., 2002). Cholesterol is thought to promote the deeper 
insertion of caveolin in the membrane (Parton, 2003). Caveolin insertion into the membrane confers it a 
membrane-bending activity that promotes and stabilizes the membrane invagination (Parton, 2003). In 
addition, Caveolin-1 binds and promotes clustering of multiple molecules including lipids (cholesterol, 
glycosphingolipid), fatty acids, and membrane proteins (Conner et al., 2003). These interactions often take 
place at the scaffolding domain of caveolin which holds the protein in an inactive state (Reeves et al., 2012) 
(Fig. 28a). Caveolins work together with another group of proteins termed cavins (Parton et al., 2013). 
Cavins are large complexes of proteins that are recruited to stabilize the caveolin oligomers (Fig. 28b). In 
addition, cavins are substrates of the protein kinase C (PKC) and thus are thought to recruit PKC. Two 
further components of the caveolar machinery are EHD2 (Eps-15 homology domain-containing protein 2) 
and PACSIN2 (PKC and casein kinase substrate in neurons 2) (Parton et al., 2013). EHD proteins are similar 
than dynamin in their activities; they oligomerize into rings inducing highly curved membrane (tubules) 
through ATP (instead of GTP) hydrolysis. EHD2 is not necessary for the formation of the caveolae, but is a 
negative regulator. Its “depletion results in increased caveolin mobility and caveolae budding, suggesting 
that EHD2 and dynamin might work reciprocally to regulate caveolae endocytosis” (Parton et al., 2013). 
PACSIN proteins are BAR domain proteins that can sense and modulate membrane curvature. PACSIN2 
binds to the N-terminus of caveolin (Fig. 28b) and binds dynamin via its SH3 domains, providing a possible 
link between the vesicle invagination and scission steps. Indeed, caveolae-mediated endocytosis is dynamin-
dependent (Henley et al., 1998; Oh et al., 1998; Yao et al., 2005). Other major partners are Src kinases, PKC 
(Sharma et al., 2005) and actin recruitment (Pelkmans et al., 2001; Pelkmans et al., 2002; Sharma et al., 
2004). Recently, the link between caveolae and stress fibers was confirmed and requires the RhoA GTPase 
and the actin-binding protein filamin A (Parton et al., 2013). The formation of the actin stress fibers is 
controlled by the Abl kinase and the mDia1 formin which, in addition, align caveolin-1 on these fibers. 
Filamin A appears as one key element for caveolin-mediated endocytosis since it is an intermediate between 
the actin fibers and the membrane bound caveolin-1. Filamin A is necessary to the distribution and 
anchorage of caveolin at the plasma membrane. The internalization of caveolae requires the phosphorylation 
of filamin A by PKCα. The Arp2/3 actin polymerization pathway is also indispensable for caveolae 
organization and internalization. The molecular basis for the link between cargo molecule, caveolae-
localized receptors and triggered endocytosis remains to be elucidated.  
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Figure 28: Caveolae-mediated endocytosis. (a) Schematic representation of the caveolin insertion into the plasma 
membrane. The hydrophobic hairpin-like domain of caveolin is inserted into the membrane while the N and C termini 
remain in the cytoplasm. The scaffolding domain binds cholesterol (and other molecules) via conserved basic (+) and 
bulky hydrophobic residues (red circles). The formation of palmitoyl groups at the C-terminal domain toward the lipid 
bilayer contributes to the caveolin binding. From (Parton et al., 2007) (b) The cavin–PACSIN2 complex stabilize 
caveolae and serve as intermediate to recruit other regulators at the plasma membrane. From (Parton et al., 2013) (c) 
Caveolae and the cytoskeleton. The localization of caveolae along actin stress fibers is shown to require RhoA and 
filamin A. Caveolae internalization requires dynamin 2, filamin A phosphorylation by PKCα and actin cytoskeleton. 
From (Parton et al., 2013) 
 Caveolae represent just one class of cholesterol-rich microdomains on the plasma membrane. Others, 
generally called rafts, serve, as well, as domains where specific lipids (glycolipids) or proteins are sorted. As 
it is the case for caveolae-mediated endocytosis, these rafts can be at the origin of specific endocytic 
mechanisms the extent of which remains to be elucidated. Due to their small size, they can also be engulfed 
in any endocytic vesicle.  
VI. Clathrin- and caveolin- independent endocytosis 
 These endocytic pathways only begin to be described and are, for the moment, grouped in one class 
named clathrin- and caveolin-independent endocytosis for the obvious reason that neither the clathrin nor the 
caveolin proteins are involved in these pathways. Although the current knowledge about these endocytic 
processes is rather poor, each pathway seems to be important for cell physiology. They appear to form 
different vesicle shapes (spherical or tubular buds), to interact with specific cargo and to target the newly 
formed vesicles to different compartments in the cytoplasm. The recent identification of cargo internalized 
via these pathways provides tools based on which their characterization can be unraveled (Conner et al., 
2003). These cargo include glycosylphosphatidylinositol-anchored proteins (GPI-APs), interleukin 2 (IL-2), 
SV40, cholera toxin B (CTB), growth hormones as well as extracellular fluid. Several of them enter by 
multiple endocytic processes which render the characterization more difficult. Nevertheless some effectors 
required for their internalization have been identified and these effectors are utilized to name the different 
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pathways, i.e. RhoA-dependent, Cdc42-dependent, flotillin-dependent, and Arf6-dependent (Sahay et al., 
2010). Most of these effectors are not specific for one pathway but they appear to be mandatory to the 
pathway they define. As rafts, all clathrin- and caveolin-independent endocytosis necessitate specific lipid 
compositions and are cholesterol-dependent. However, unlike caveolae-mediated endocytosis, most of these 
pathways are not dependent on dynamin although the involvement of dynamin remains controversial.  
VI.1. RhoA or IL-2 pathway 
 This pathway was discovered while studying the internalization of the β chain of the IL-2 receptor 
(IL-2R-β) hence the other given name. This pathway is dependent on the GTPases RhoA and dynamin as 
shown by the strong inhibition of IL-2R-β uptake in cells having dominant negative (DN) phenotype for 
dynamin and RhoA (Lamaze et al., 2001). By contrast, IL-2R-β internalization was unaffected in cells where 
DNs for clathrin-mediated endocytosis (clathrin polymerization, Eps15, AP180) were expressed. After IL-2 
binding, IL-2R-β partitions into lipid rafts. It is not known if RhoA is required for the proper distribution the 
IL-2R-β into the rafts or if it is involved in the formation of the endocytic vesicle. Given that RhoA GTPases 
are central regulators of actin dynamics, it could be that actin cytoskeleton assists the process. This 
hypothesis is reinforced by the fact that IL-2 pathway depends on the activity of Rac1, another Rho GTPase, 
and of PAK1 and PAK2 (p21-activated kinase 1 or 2), other important regulators of actin dynamics (Grassart 
et al., 2008). These three proteins are in involved in membrane ruffling and essential for macropinocytosis 
(cf. section V). RhoA-dependent endocytosis seems to internalize the c cytokine and the IgE receptors as 
well (Sauvonnet et al., 2005; Fattakhova et al., 2006).  
VI.2. Cdc42 or CLIC/GEEC pathway 
 This pathway is often associated with the uptake of GPI-APs. The involvement of the Cdc42 GTPase 
has been discovered while studying the uptake of the GPI-anchored folate receptor (FR-GPI) (Sabharanjak et 
al., 2002). This study showed that DN construct of Cdc42 drastically reduced FR-GPI uptake via a clathrin, 
caveolae-, dynamin-independent pathway. In addition, internalization of FR-GPI is distinct from the one of 
IL-2R- and is unaffected by inhibitors of RhoA (toxin B or DN construct). This pathway is associated with 
long tubular buds which engulf large amount of extracellular fluid such that it can represent the main fluid-
phase endocytosis in some cell types. The initial observation of large invaginations formed independently of 
the clathrin protein and devoid of mainly clathrin-dependent cargo gave the name of clathrin-independent 
carriers (CLICs). A protein specific for CLIC has been identified, GRAF1. It has been observed to mark 
tubular compartments responsible for the uptake of glycosphingolipids, GPI-APs and fluid-phase (Lundmark 
et al., 2008). Decreasing GRAF1 expression induced a significant decrease in the internalization of these 
cargoes. GRAF1 contain a membrane-bending BAR domain, a SH3 domain (known to interact with 
dynamin) and a pleckstrin homology (PH) domain which binds PI(4,5)P2 and is thus responsible for the 
recruitment of GRAF1 at the plasma membrane (Lundmark et al., 2008). It is likely that GRAF1 has a role in 
the deformation of the membrane and in the vesicle scission. The fact that GRAF1 can bind to dynamin, 
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suggesting a role of the GTPase in the CLIC pathway, contradicts the earlier statement that GPI-APs uptake 
is dynamin-independent (Sabharanjak et al., 2002). Newly formed GPI-APs tubular endosomes can fuse 
together to generate organelles distinct from the early endosomes that are named GPI-APs enriched early 
endosomal compartments (GEECs). (Sabharanjak et al., 2002). The Cdc42-dependent pathway is the main 
non-caveolar route of entry for CTB, ricin and VacA (Mayor et al., 2007). As Rho GTPase, Cdc42 activation 
is linked to the recruitment of the actin machinery which therefore may be involved in this pathway.  
VI.3. Flotillin-dependent pathway 
 Flotillins are similar than caveolins because they are scaffolding protein, they insert into the inner 
leaflet of the plasma membrane through hydrophobic hairpin-like domains and they oligomerize (flotillin 1 
and flotillin 2 complexes), but they localize into invagination devoid of caveolin (Frick et al., 2007). Their 
partition into microdomains as well as their participation in endocytic process is likely to be upon the control 
of their phosphorylation state (Qualmann et al., 2011). The direct participation of flotillins in endocytosis has 
been recently shown while studying the internalization of the GPI-AP CD59 and of the glycosphingolipid 
GM1, the CTB receptor (Glebov et al., 2006; Otto et al., 2011). The use of siRNA against flotillin 1 and of 
DN construct for dynamin reduced the uptake of both CD59 and CTB showing that dynamin-independent 
endocytosis of these cargoes is flotillin-dependent. In addition, CTB and GPI-APs internalization via 
flotillins has been shown to not depend on clathrin, Eps15 and caveolin (Glebov et al., 2006; Frick et al., 
2007; Ait-Slimane et al., 2009). In vivo, CTB internalization was unaffected after knocking down of the 
flotillin but its toxicity was reduced suggesting that flotillin-dependent route would be the only one by which 
CTB is transported to the ER (Saslowsky et al., 2010). Shiga toxin and ricin intracellular trafficking, but not 
uptake, also depends on flotillin but in an opposite manner than CTB, with an increased toxicity upon 
flotillin depletion (Pust et al., 2010).  
VI.4. Arf6 pathway 
 A possible new pathway dependent on the Arf6 GTPase has been first suggested by a study 
investigating on the internalization of the GPI-APs CD59 and of the major histocompatibility protein class I 
(MHC I) (Naslavsky et al., 2004). At early stage after endocytosis, both were shown to cointernalize into 
Arf6-positive endosomes devoid of clathrin-dependent cargo. Unlike transferrin, activation of Arf6 increased 
the uptake of CD59 and MHC I and provoked an accumulation into Arf6-endosomes thus preventing their 
delivery to the sorting endosomes and lysosomes. Arf6, known to be involved in membrane trafficking and 
actin regulation, also stimulates the formation of PI(4,5)P2 (Naslavsky et al., 2004). However, a direct 
participation of Arf6 in CI endocytic processes themselves has never been established. Moreover, GPI-APs 
have been observed in Cdc42 and flotillin-dependent endocytosis, whether these pathways are distinct or 
related to the Arf6 one remains to be determined. Clathrin- and dynamin-independent but Arf6-dependent 
endosomal trafficking has been also observed for the internalization of  β1 integrin, carboxy peptidase E, E-
cadherin and IL-2 (Mayor et al., 2007). 
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VII. Macropinocytosis 
 When not occurring spontaneously, “macropinocytosis can be defined as a transient, growth factor-
induced, actin-dependent endocytic process that leads to a non-selective internalization of fluid and 
membrane into large vacuoles” (Mercer et al., 2009). Its unique feature comes from the extensive membrane 
ruffling activity induced by the activation of the actin machinery. Macropinocytosis can internalize particles, 
such as bacteria and viruses, which can stimulate membrane ruffling without activation through growth 
factors (Francis et al., 1993; Watarai et al., 2001; Mercer et al., 2009). The ruffles are classified in three 
groups:  lamellipodia-like (planar folds), circular ruffles (cup-shaped extensions) and blebs (large membrane 
protrusions) (Fig. 29a). Lamellipodia and circular ruffles are generated by actin polymerization and blebs are 
probably due to local loss of interactions between the actin network and the plasma membrane. By folding 
back onto the membrane, ruffles engulf nearby fluid/particles and membrane fusion events drive the closure 
into vesicles (Fig. 29b). Because macropinosome formation is not maneuvered by a particle or a coat, these 
are heterogeneous in size, with diameter varying between 0.2 µm and 10 µm, and irregular in shape. 
 Macropinocytosis, when not spontaneous, is generally induced by growth factors that binds receptor 
tyrosine kinases (RTKs) which initiate a signaling cascade that modulate actin dynamics and engender 
membrane ruffling (Fig. 29c). RTKs activate Ras GTPases which act as a major hub to mobilize the 
signaling pathways necessary for macropinocytosis to occur. Ras activate Rac1, phosphatidylinositol-3-
kinase (PI3K), Rab5, and Arf6. Together, they control the stimulation of macropinocytosis through actin 
modulation, the macropinosome closure and the membrane trafficking. Rac1, a Rho GTPase, triggers the 
three types of membrane ruffles by activating directly effectors of actin polymerization (WAVE, Arp2/3) or 
through activation of PAK1 and PI5K (Swanson, 2008). PAK1 is one of the most important kinases for the 
macropinocytic process and it is required during all stages. It regulates cytoskeleton dynamics (ruffling, actin 
turnover) and mobility by activating actin effectors, and it is involved in the closure of the macropinosomes 
by activating CtBP-1 (C-terminal binding protein 1)/BARS. PI3K promotes ruffling and macropinosome 
formation, is crucial for the closure of the macropinocytic cavities (via protein kinase C (PKC) and Rab34) 
and possibly for macropinosome fusion as well. PKC can also be recruited directly by RTKs or by other 
activators independently of a previous stimulation of RTKs by ligands. In addition, PI3K is important for the 
formation of lipid microdomains at the internalization sites that concentrate signaling and actin modulation 
components. Besides Rac1, other Rho GTPases activated are RhoA, stimulating myosin-dependent 
contractility and actin polymerization (formin), and Cdc42, activating WASP and Arp2/3. The contractile 
activity is required for macropinosome closure. While macropinosomes arising from circular ruffles seem to 
have dynamin dependence for the closure step, macropinosomes formed from blebs and lamellipodia are 
dynamin-independent. For the latter cases, CtBP-1/BARS are believed to fulfill this role. Rab5 relocalizes in 
ruffles to promote ruffle-associated actin crosslinking, to assist closure of macropinosome and is targeted to 
the nascent macropinosomes for further role in the intracellular trafficking. Arf6, as a membrane remodeling 
and trafficking GTPase, also contributes to the entire process by recycling Rac1. In addition to its role in the 
intracellular trafficking of macropinosomes, Arf6 can induce Ras-independent macropinocytosis. To amplify 
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the above described signaling cascade, RTKs recruit c-Src which activates as well actin effectors, Rac1 and 
PI3K. Other important elements for successful macropinocytosis are Na+/H+ exchangers and cholesterol. 
Although unclear, the role of Na+/H+ exchangers is so important that their inhibitors (amiloride or EIPA) are 
often used as the main test to identify macropinocytosis. Their inhibition prevents membrane ruffling likely 
by preventing Rac1 and Cdc42 signaling (Koivusalo et al., 2010). The role of cholesterol is probably to 
maintain the integrity of the lipid microdomains without which localization of signaling and actin 
components is disturbed. 
 
 
 
Figure 29: Actin dynamics and signaling involved in macropinocytosis. (a) Plasma membrane ruffling can be 
lamellipodia-like protrusions, circular ruffles and blebs. Blue lines correspond to actin filaments and the red ones to 
regions of the membrane being later part of the macropinosomes. (b) Macropinosome closure. Lamellipodia are likely 
to fold back onto the plasma membrane, circular ruffles to combine and blebs may collapse next to the formation of a 
vacuole. In all cases, the closure requires membrane fission (yellow stars). (c) Signaling of RTKs-stimulated 
macropinocytosis. Activation of RTKs by ligands induces their dimerization and initiates a multibranched signaling 
cascade involving GTPases, kinases, adaptors and other factors. They are responsible for the actin modulation, which 
initiates the macropinosome formation, the macropinosome closure and trafficking. Solid arrows represent direct 
activation and dashed arrows correspond to interactions that serve as signal amplifiers. From (Mercer et al., 2009) 
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VIII. Intracellular trafficking 
 Once internalized in primary endocytic vesicles, the intracellular pathways followed by 
physiological ligands and membrane components are the same than those used by viruses, bacteria or any 
other vectors. The endosomal machinery is responsible for molecular sorting and thus for molecular 
recycling, degradation, storage and delivery to other intracellular compartments. Although the pathway is 
elusive because there is a continuum, one can define early endosomes (EEs), late endosomes (LEs), 
recycling endosomes (REs), and lysosomes (Fig. 30). Between EEs and LEs, intermediate organelles called 
maturing endosomes (MEs) or multivesicular bodies (MVBs) contain regulatory proteins of both EEs and 
LEs and serve as precursors for LEs. The endosomal system is closely connected with and dependent on the 
secretory pathway through the shuttling of vesicles between endosomes and the trans-Golgi network (TGN), 
the endoplasmic reticulum (ER), or the plasma membrane. A disturbance of one step causes an alteration of 
the whole process (disruption or retardation). Complex feedback and feed-forward regulatory cycles control 
the endosomal trafficking. It involves numerous GTPases, kinases, phosphatases, and other factors among 
which Rab GTPases appear as specific markers for the different organelles since their distribution is 
restricted (Gruenberg, 2001). 
VIII.1. Early endosomes 
 Originally described as the first organelle receiving internalized cargo and fluid, EEs are now 
defined as the main molecular sorting endosomes (Helenius et al., 1983). The mechanism by which they 
arise is not completely understood, but it is likely that they derive from the fusion of the primary endocytic 
vesicles with each other. EEs receive endocytic vesicles formed after clathrin-, caveolae, RhoA, Cdc42 and 
Arf6-dependent endocytosis (Mayor et al., 2007). In other words, all endocytic vesicles are routed to the EEs 
except for macropinosomes which, in some cell types, can fuse with EEs or form a distinct population 
(Hewlett et al., 1994; Khalil et al., 2006). EEs are typically small and located close to the plasma membrane. 
Their morphological structure is complex with tubular and vacuolar domains which separate content to be 
recycled from content to be further routed. The tubular domains contain most of the membrane from which 
vesicles for recycling emerge. The vacuolar domains contain most of the volume from which MEs and LEs 
originate. In the vacuolar domains of the EEs, the formation of intralumenal vesicles (ILVs) already starts 
through inward budding of the endosomal membranes. It sequesters membrane components to be degraded 
and represents an additional level of sorting. The pH in EEs is mildly acid to promote conformational 
changes in proteins that drive the release of the ligands from the receptors. EEs need about a 10 min to 
recycle membranes and fluids away while the rest of the content is kept and accumulated over longer periods 
(Maxfield et al., 2004). Rab5 is a key membrane protein which together with its effectors, a PI3K complex 
(VPS34/p150) that generates PIP3, marks the identity of the organelle (Zerial et al., 2001; Behnia et al., 
2005). Rab5 is present during the entire lifetime of EEs and is the main regulator of the maturation into LEs. 
EE membranes contain many microdomains of various composition and function including domains rich in 
Rab5, Rab4, Rab11, Arf1, and caveolae (Vonderheit et al., 2005; Rojas et al., 2008; Hayer et al., 2010). A 
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lot of these domains are located into the membrane of the tubular domains from which they generate vesicle 
carriers addressed to distinct organelles such as the plasma membrane, REs, the TGN and LEs (Bonifacino et 
al., 2006).  
 
 
Figure 30: Schematic representation of the endosomal system. It is mainly composed of early endosomes (EEs), 
maturing endosomes (MEs), late endosomes (LEs), recycling endosomes (REs), and lysosomes. EEs, located close to 
the plasma membrane, have tubular and vacuolar domains. From the tubular domains are formed vesicles transported 
directly to the plasma membrane, the REs, or the TGN. The vacuolar domains, containing most of the volume and the 
intralumenal vesicles (ILVs) separate from the EEs and are transported on the microtubules (dyneins) toward the 
perinuclear area. During the journey, MEs and then LEs exchange Rabs (Rab5, Rab7, Rab9) on their membranes and 
increase the pH in the lumen. Mature LEs can fuse with each other or with lysosomes to generate endolysosomes where 
degradation already occurs. Lysosomes are the end points of the degradation pathway. Most of the plasma membrane 
components are recycled, but membrane proteins routed to the degradation pathway are sequestered into ILVs formed 
by inward vesiculations of endosomal membranes. From any endosome, vesicles can rise and be transported to the TGN 
or the ER. From (Mercer et al., 2010) 
VIII.2. Recycling endosomes 
 Recycling vesicles routed to the plasma membrane can emerge directly from EEs or even at earlier 
stage in the endocytic pathway. The Rab GTPases likely involved in such fast recycling are Rab4 and Rab35, 
but the precise way they participate in the process is not clear (Grant et al., 2009). Macropinosomes seem to 
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recycle their content and membranes this way, meaning that after fusion of recently formed 
macropinosomes, they form a distinct population where molecule recycling is directly performed. However, 
to process fine recycling, cells use the REs which are located nearby the microtubule organizing center and 
the Golgi (Ullrich et al., 1996; Perret et al., 2005). Like EEs, REs have tubular and vacuolar domains which 
are a sign of intensive trafficking activities. They are formed by the fusion of vesicles coming from EEs and 
of exocytic vesicles containing newly synthesized proteins in the Golgi (Ang et al., 2004; Lock et al., 2005; 
Murray et al., 2005). One important function of REs is to deliver membranes to region of considerable 
membrane and cytoskeletal reorganization as it is the case in endocytosis (van Ijzendoorn, 2006). It seems 
that cells utilize REs to extract cargo from the degradation pathway as well. The main marker that identifies 
the organelle is Rab11 which appear to be required to target the vesicle carriers to the plasma membrane 
(Ullrich et al., 1996). Rab11 is also found in the TGN suggesting that it may control transport from the REs 
to the Golgi. The GTPase Rab22A is also important and is involved in the trafficking of the vesicles coming 
from EEs.  
VIII.3. Maturating and late endosomes 
 Vacuolar domains of EEs dissociate to form MEs and later LEs. They contain ligands released from 
the receptors, proteins, particles such as viruses, and solutes engulfed with the bulk fluid which all have been 
sorted by EEs. In order to generate LEs, Rab7 proteins are recruited by Rab5-GTP which results in 
Rab5/Rab7 hybrid endosomes or MEs where, however, Rab7 partition into different domains than Rab5 and 
Rab4 (Vonderheit et al., 2005). MEs, initially in the cell periphery, are transported by the microtubules 
toward the perinuclear area. During the transport, maturation proceeds and vesicles fuse with each other to 
create larger organelles. The newly formed LEs keep on modifying until they contain only molecules to be 
degraded or those required for their functioning. LEs sort out molecules to deliver to the TGN or ER, create 
additional ILVs, exchange membrane components, lower the pH and acquire lysosomal components. The 
transformation is tightly regulated by the recruitment of membrane proteins (Rab9, Lamp1). Rab9 
microdomains come from the Golgi accompanied by mannose 6-phosphate receptors carrying newly 
synthesized lysosomal enzymes (Kornfeld, 1992). It returns to the Golgi to deliver sorted molecules. 
Therefore, Rab9 is a marker of LEs and of the vesicles shuttling between LEs and TNG. LEs contain both 
Rab7 and Rab9 but they do not localize in the same microdomains (Barbero et al., 2002). LEs experience 
transient (‘kiss-and-run’) fusions with the lysosomes. To resist against hydrolase activity, they acquire 
lysosomal proteins such as Lamp1 (lysosomal-associated membrane protein 1). LEs eventually undergo full 
fusion with lysosomes, 10-40 min after LEs formation, to generate another hybrid organelle called 
endolysosomes (Luzio et al., 2007). Endolysosomes contain markers of both organelles and are not easy to 
distinguish from LEs. 
VIII.4. Lysosomes 
 The lysosomes are the end-point of the endosomal pathway. Its function is to terminate the 
degradation of the incoming cargoes or to store lysosomal components, such as hydrolases and membrane 
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components protected by LAMPs. Lysosomes are located near the nucleus and enclose vacuoles of very 
heterogeneous content and size due to the large variety of possible cargo, fusion events and multiple feeder 
pathways, the endosomal one being the main. They differ as well by the degree of degradation their cargo is 
submitted. Cells use lysosomes to control its sensitivity to external stimuli by selectively degrading receptors 
and ligands. In gene delivery, lysosomes represent a barrier to efficient targeting of DNA into the nucleus. 
Lysosomes, as well as the ER, the Golgi, and endosomes, are, in term of topology, continuous with the 
extracellular media, therefore the escape of molecules from any of these compartments involve the crossing 
of a lipid bilayer. 
VIII.5. Transport 
 Endosomes are motile, and their movements are correlated to the stage of maturation they are and to 
their function. Consistently with the spatiotemporal maturation of endosomes, it has been demonstrated that 
the endosome position, with respect to the nucleus,  is a key factor that influence endosome size, content and 
number (Collinet et al., 2010). The numerous small endosomes at the cellular periphery are progressively 
replaced by larger and less abundant endosomes (fusion events) while approaching the nucleus. During their 
formation EEs are exhibit slow, short-range back and forth movements, whereas during the maturation, 
endosomes experience fast, long-range saltatory oscillations with a net displacement directed to the 
perinuclear area, where exchange with the Golgi-apparatus, ER and lysosomes are possible. Endosome 
transport is mediated by both the microtubule-related motor family proteins, kinesins and dynein (Nielsen et 
al., 1999; Bananis et al., 2000; Hoepfner et al., 2005; Soldati et al., 2006; Driskell et al., 2007; Loubery et 
al., 2008). Microtubule-associated machinery serves as anchor that organize the organelles as well, since its 
alteration induce the dispersion of LEs and lysosomes, in addition to delayed maturation and degradation 
(Bayer et al., 1998; Vonderheit et al., 2005; Driskell et al., 2007). The membrane trafficking regulator Rab 
GTPases are thought to be the intermediate that link endosomal membranes to the motor proteins (Murray et 
al., 2003). They may act as receptors either by direct interactions or via adapter proteins. 
VIII.6. Bypass of the endosomal compartments? 
 Once internalized, caveolar vesicles can fuse with early endosomes or fuse with each other to 
generate Rab5-independent caveosomes (Pelkmans et al., 2001; Parton et al., 2007). Although slower, the 
interesting feature of this pathway is the apparent bypass of the lysosomes (Conner et al., 2003). 
Caveosomes are distinct from EEs and REs and were first described as intermediate compartments in the 
trafficking of SV40 virus from the plasma membrane directly to the ER (Pelkmans et al., 2001). However, 
such compartments are subjected to controversy since recent studies find no evidence of their existence 
(Hayer et al., 2010; Parton et al., 2010). Rab5-independent EEs (GEEC) seems also to be involved in the 
constitutive transport of GPI-APs and sphingolipids from the cell surface to the Golgi (Puri et al., 2001; 
Nichols, 2002; Nichols, 2003). 
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 Chapter 3: Fluorescence and microscopy 
1. Microscopy, an important tool for cell biology 
 Optical microscopy is a technical tool to view samples which are too small to be seen directly by the 
human eye. The combination of a light source and lenses for the magnification of the sample led to a 
powerful method of observation and quantification. For any investigation, a certain contrast between the 
object of interest (signal) and the rest of the sample (background) must be present. For that purpose, 
fluorescence microscopy is the ideal tool since it aims at revealing only the objects of interest in an otherwise 
black background. This approach for contrast generation is superior to absorption techniques in which 
objects are stained with agents that absorb light. In fluorescence microscopy, even single fluorescent 
molecules are visible if the sample does not show autofluorescence. Because of its intrinsic selectivity, 
fluorescence imaging has become the basis of microscopy at the service of biology. The success of 
fluorescence as an investigative tool in studying the structure and dynamics of matter or living systems arises 
from the high sensitivity of fluorimetric techniques, the specificity of fluorescence characteristics due to the 
microenvironment of the emitting molecule, and the ability of the latter to provide spatial and temporal 
information. Thousands of fluorescent probes have been synthesized which provide a means of labeling 
virtually any imaginable aspect of biological systems. The large spectral range of available fluorophores 
allows simultaneous imaging of different cellular, subcellular or molecular components. In addition, the co-
opting of intrinsically fluorescent gene products, most notably the green fluorescent protein (GFP) and its 
variants, has allowed molecular biologists to genetically tag protein components of living systems and 
opened a new era for fluorescence. The combination of fluorescence and optical microscopy techniques 
make it possible to highlight phenomena occurring at the nanometer scale with a high sensitivity. There has 
been dramatic growth in the use of fluorescence for cellular and molecular imaging. The progress in 
instrumentation has considerably improved the sensitivity of detection such that fluorescence imaging can 
reveal the localization at the level of single-molecules. 
2. Principles of fluorescence 
 The phenomenon of luminescence is the emission of photon (ultraviolet, visible or infrared) from an 
electronically excited species (Valeur, 2001b). Fluorescence is a particular case of luminescence where the 
mode of excitation is absorption of light. When a molecule absorbs a photon, the energy possessed by the 
photon is transferred to the molecule. If the energy carried by the photon is high enough, it brings the 
molecule into an electronically excited state. The relaxation to return into the ground state can result in 
fluorescence emission but other pathways are possible: internal conversion, intersystem crossing, 
intramolecular charge transfer, conformational change, electron transfer… Fluorescence and some other 
processes of relaxation can schematically be well visualized using the Perrin-Jablonski diagram (Fig. 31a). 
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Figure 31: Representation of the different energy transitions between electronic states of a molecule after light 
absorption. (a) Perrin-Jablonski diagram. (b) Absorption, fluorescence and phosphorescence spectra with their relative 
positions in term of energy or wavelength (). (c) Characteristic times of all phenomena. S/T = singlet/triplet electronic 
state, IC = internal conversion, ISC = intersystem crossing. From (Valeur, 2001b) 
 Singlet electronic states are denoted S0 (fundamental electronic state or ground state), S1, S2 (excited 
states)… and triplet electronic states are denoted T1, T2… For each electronic state, several vibrational 
energy levels exist and are populated according to the Boltzmann distribution. At room temperature, most of 
the molecules are in the lowest vibrational level of the ground state S0. The absorption of photons by a 
molecule, which is a very fast process (10-15 s), is shown as vertical arrows starting from S0 and pointing to 
vibrational levels of S1 or S2.  
 Absorption of a photon (low ) can bring a molecule into singlet excited states of higher energy than 
the singlet electronic state S1 (Fig. 31a). The molecule then relaxes first by a process called internal 
conversion (IC). It is a transition between two isoenergetic vibrational levels belonging to electronic states of 
same multiplicity. This transition is followed by a vibrational relaxation bringing the molecule into the 
ground vibrational level of S1. Vibrational relaxation is a radiationless energy loss that always brings the 
molecule into the ground vibrational level of any electronic state. Internal conversions as well as vibrational 
relaxations are both processes much faster than fluorescence emission (10-13-10-11 s) (Fig. 31c). Since 
fluorescence lifetimes are typically near 10-8 s, internal conversion and vibrational relaxation are both 
complete before emission of the photon. The internal conversion S1S0 is possible but much less efficient 
for fluorophores because of the large energy gap between these levels. 
 The radiating relaxation S1S0 corresponds to fluorescence emission (Fig. 31a). The fluorescence 
spectrum is located at higher wavelengths (lower energy) than the absorption spectrum because of the energy 
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loss in the excited states due to vibrational relaxations (Fig. 31b). According to the Stokes rule, the 
wavelength of fluorescence emission should always be higher than that of absorption. The gap between the 
maximum of the first absorption band and the maximum of the fluorescence one is called the Stokes shift. 
Another general property of fluorescence is that the same fluorescence emission spectrum is generally 
observed irrespective of the excitation wavelength. This is known as the Kasha's rule. This is due to the fact 
that IC and vibrational relations always occurs much faster than the emission of a photon, so the molecule is 
in the ground vibrational level of S1 before it had time to emit a photon. Given that similar vibronic states 
and energy transitions (S0 and S1) are involved in both absorption (first band) and fluorescence emission, the 
fluorescence spectrum often resembles the first absorption band spectrum (‘mirror image’ rule) (Fig. 31b). 
Emission of a photon is as fast as absorption of a photon (10-15 s). Nevertheless, excited molecules stay in the 
S1 state for a certain time (10 ps – 100 ns) before emitting a photon or undergoing other relaxation processes 
(Fig. 31c). Thus, after excitation of a population of molecules by a very short pulse of light, the fluorescence 
intensity decreases exponentially with a characteristic time, reflecting the average lifetime of the molecules 
in the S1 excited state (excited-state lifetime). 
 Another path of relaxation is called intersystem crossing (ISC) (Fig. 31a). It is a spin transition 
between two isoenergetic vibrational levels belonging to electronic states of different multiplicity. Even if it 
is a so-called forbidden transition, many fluorescent molecules have triplet electronic state vibrational energy 
levels that overlap with the ground vibrational level of S1. Intersystem crossing can be fast enough            
(10-9-10-7 s) to compete with fluorescence. It is followed by a relaxation to the ground vibrational level of T1. 
The transition T1S0 is possible and is in many cases accompanied by the emission of a photon which is 
called phosphorescence. This transition is unlikely since it requires the electron to undergo again a forbidden 
spin transition. Therefore it necessitates a relatively long time to occur, reflected by the lifetime of the triplet 
electronic state T1 that is up to 1 s (Fig. 31c).  In the meantime, if another photon is absorbed by the 
molecule, it can provoke triplet-triplet transitions further delaying any light emission. This phenomenon can 
induce some issues for any fluorescence-based techniques. First, molecules can be trapped in the triplet 
excited states. They are thus removed from the pool of fluorescent molecules and the collected fluorescence 
is weaker. But the most important issue arises from the fact that molecules in the triplet excited state can 
further go through photochemical reactions causing the irreversible loss of their fluorescent property. This is 
called photobleaching that, in addition to destroying the fluorescent molecule, can be toxic for biological 
samples. 
3. Fluorescent probes 
 In fluorescent molecules, the fluorophore is the signaling specie. It acts as a signal transducer that 
converts the information (presence of an analyte) into an optical signal. Whereas many substances have 
intrinsic fluorescence (autofluorescence), only a few are useful for specific labeling of components in 
biological systems.  
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3.a. Organic fluorophores 
 Fluorescence microscopy takes advantage of synthesized compounds that have some degree of 
conjugated double bonds. Such compounds often have -electron systems that easily distribute outer orbital 
electrons over a wide area. These compounds are optimal because the energy gap between excited state and 
ground state is small enough that relatively low energy photons in the visible part of the electromagnetic 
spectrum can be used to excite electrons into electronic excited states. In general, the more conjugated bonds 
in the molecule, the lower the excited energy requirement and the longer the wavelength the exciting light 
can be. However, the efficiency, as measured by fluorescent quantum yield, decreases with the number of -
bonds. Cyanines (fluorescein, rhodamine, texas red) and other dye families provide a large choice and cover 
the whole visible spectrum. Organic dyes can be attached to a large variety of molecules including proteins 
and nucleic acids using well established conjugation protocols (Chen et al., 2005). The biggest advantage of 
organic fluorophores is their small size (300-1200 Da) which is often negligible compared to the size of the 
molecule they are linked to, which therefore keep their functionality. However, labeling a target biomolecule 
requires the organic dye to be attached to a purified version of the biomolecule, outside the cellular 
environment. As a result, for intracellular applications the labeled proteins must be reintroduced into the 
cytosol, creating many experimental difficulties. Another labeling strategy is immunofluorescence where the 
target protein is revealed by the binding of dye-conjugated antibody but it requires cells to be fixed and 
permeabilized which prevent living cell observation and investigations on cell membranes.  
3.b. Fluorescent proteins 
 Rather than being labeled with organic fluorophores via bioconjugation chemistry, proteins can be 
genetically modified to become fluorescent. For this, the DNA sequence encoding for the fluorescent protein 
can be added into the genome so that, upon protein biosynthesis, a fusion product of the target protein and 
the fluorescent protein will be expressed by the cell. The advent of genetically encoded fluorescent markers 
(for which the Nobel Prize for Chemistry was awarded in 2008) has revolutionized biological research which 
could then selectively visualize molecules or cellular compartments, and record their properties in living 
systems (Zhang et al., 2002; Giepmans et al., 2006). 
 The extraction of the protein responsible for the green fluorescence of the Aequorea Victoria 
jellyfish was performed in 1962 (Shimomura et al., 1962). It took 30 years to elucidate the primary amino 
acid structure (Prasher et al., 1992) and demonstrate that green fluorescent protein (GFP) could be employed 
as a useful marker for gene expression (Chalfie et al., 1994) in cells evolutionarily far from the jellyfish. 
During the next several years, a number of “enhanced” genetic variants showing fluorescence emission 
spectral profiles in the blue, cyan, green, yellow, orange and red regions of the visible spectrum were 
developed by engineering specific mutations of the original GFP nucleotide sequence (Zacharias et al., 2006; 
Remington, 2011). A multitude of fluorescent reporters and sensors, such as GFP and its many variants, can 
now be prepared and inserted into the genome of various organisms, offering a wide flexibility to approach 
complex biological questions. Genetically modified proteins are particularly useful for the investigation of 
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intracellular processes, since the proteins are directly generated through the natural protein synthesis 
pathway. Whereas the labeling specificity is undeniable, fluorescent proteins present some limitations the 
first of which being their sizes. GFP and mutants have a molecular weight about 30 kDa representing 2 nm to 
4 nm physical dimension. Fluorescent proteins can therefore disturb the system they are linked to. Another 
limit is their low photostability and their rather weak light absorption even compared to organic dyes. 
3.c. Colloidal quantum dots 
 Colloidal quantum dots (QDs) are probably the most prominent example of nanomaterials used in a 
biological context (Michalet et al., 2005; Parak et al., 2005). Quantum dots are semiconductor nanocrystals 
iwhich diameter varies between 2 nm and 10 nm. Depending on the material and the size of the particle, QDs 
emit fluorescence at different wavelengths in the visible or infrared region. Once dispersed and 
functionalized, QDs can be used as biological fluorescent probes (Bruchez et al., 1998; Chan et al., 1998). 
QDs functionalization consists in building a shell made of streptavidin or antibodies directed to the target 
protein. This step can considerably increase the size of the QDs which is then often between 20 nm and 
30 nm (Pellegrino et al., 2004; Carion et al., 2007). Due to their crystalline nature, they have distinct optical 
properties compared to conventional organic fluorophores or fluorescent proteins. QDs absorb over a large 
spectral range and emit on a narrow spectral window. They have a quantum yield such that they can be easily 
detected individually. The biggest advantage of QDs is their extremely high photostability compared to any 
other fluorescence probe.  
4. Fluorescence microscopy 
 The shift of the emission spectra compared to the excitation spectra of a fluorescent probe (Stokes 
shift) is the critical property that makes fluorescence such a powerful technique. It is therefore possible to 
separate exciting light from emitted one using filters and thus to selectively image the object that is 
fluorescent. However, with multiple fluorescent samples, the selectivity can be partially lost. Given the broad 
excitation and emission spectra of each fluorophore, even spectrally shifted fluorophores can be excited by 
the same wavelength and exhibit overlapping emission. These overlaps can cause confusing crosstalk or 
bleed-through between signals associated with different fluorophores in the same sample. The principle of 
fluorimetric technology is simple. A light source is necessary to excite the probe. If it is a polychromatic 
source, a monochromator (or broader filter) can be inserted into the path for a selection of the desired 
wavelength. The emitted light from the sample is collected by a photodetector in front of which filtering out 
the source excitation is needed. This can be achieved using a monochromator or broader range filters. It is on 
this base that fluorescent microscopes are built. Objectives are added to image and magnify the sample. 
4.a. Light sources 
 Fluorescence microscopy requires intense and near-monochromatic light sources. There are several 
different strategies for fluorescence illumination. Traditionally, the intensities needed for comfortable 
General background - Chapter 3: Fluorescence and microscopy 
 
- 53 - 
viewing by eye or camera come from arc lamps (Xenon arc lamps or Mercury-vapor lamps). Xenon lamps 
have the advantage of being relatively even in the coverage of wavelengths throughout the UV, visible and 
near infrared but have rather weak light intensities. Mercury lamps exhibit spectra with several extremely 
intense lines. If these lines coincide with the excitation spectrum of the fluorophores, it provides brighter 
light. The development of bright light-emitting diodes (LEDs) raises the possibility that arc lamps will 
someday be replaced by these lightweight, inexpensive light sources. In the past few years, optical 
microscopy has experienced an increase in the application of laser light sources. Although often expensive, 
lasers have the advantage of low divergence, high monochromaticity, coherence, and high and stable 
intensity. They are essential in scanning confocal microscopy and many other advanced light microscopy 
techniques relying on single-molecule detection or non-linear optics. There are several kinds of lasers based 
on gas (Helium-neon, Argon, Krypton), liquid (dye), solid-state (doped crystals, e.g. Titanium-sapphire, 
Ytterbium-doped YAG), semi-conductor (diodes, gallium arsenide) as lasing media. Many wavelengths, 
wave types (pulsed or continue) and powers are available. 
4.b. Objectives 
 Objectives are perhaps the most important component of a microscope because they are responsible 
for the primary image formation, they play a central role in determining the quality of the images, and they 
determine the magnification and the resolution of the system (Abramowitz et al., 2002). The majority of 
fluorescent microscopy techniques use epi-illumination meaning that the objective serves to both illuminate 
(condenser) the sample and collect the emitted light. Fluorescence is emitted in all directions so its collection 
can be made from any position relative to the excitation path. By contrast, exciting light is directed toward 
the sample meaning that photons that have not been absorbed are transmitted through it or reflected. 
Objectives in epi-illumination collect only the reflected part of the exciting light which is much weaker than 
the transmitted part rendering its separation from the fluorescent light easier. 
 Schematically, an objective is a lens. In epi-illumination, the exciting light (collimated beam) is 
coupled into the back aperture of the objective which focuses the light into the sample. The distance f at 
which the focus is made will define the magnification and the numerical aperture (NA) of the objective. 
Objectives with high focal length have low magnification and low NA. Since refractive indexes of materials 
are wavelength-dependent, red light will focus on the optical axis at a further distance than blue light or 
green light (chromatic aberration). Likewise, since lenses have spherical shapes, monochromatic rays of light 
will focus at different points according to the path they follow across the lens (spherical aberration). By 
means of numerous additional internal glass lens elements, correction of theses aberrations among others 
(astigmatism, field curvature) is possible. Nowadays, the highest level of correction (and expense) is found 
in plan apochromatic objectives which have chromatic corrections for up to 5 wavelengths, spherical 
correction for up to 4 colors and field curvature correction. 
 The NA of an objective characterizes the cone of light that can exit or enter the front lens in the 
medium it is designed to work in. It is defined by:  
  sinnNA   
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where n is the refractive index of the medium and  the half angle of the light cone. The larger the half angle 
, the greater number of photons that can be collected and that can be used to excite the sample. Objectives 
are designed to image samples with air, water or oil as medium between the front lens and the sample. High 
refractive mediums refract less light and thus allow for greater light collection and emission. Oil immersion 
is of special interest because its refractive index (~1.52) matches the glass refractive index. Given most of 
the samples lays on coverslips made of glass, the match between refractive indexes of lens, immersion 
medium and coverslip creates a less disturbed optical path. 
 When light encounter an aperture (lens or physical opening), it is diffracted. Plane incident waves 
(such as collimated beam) are converted to spherical waves when crossing circular apertures. The generated 
waves interfere and constructive and destructive interferences create a so called Airy diffraction pattern. 
Therefore exciting light is not focused as point but as an Airy pattern and the collected fluorescence, even 
when emitted by a single fluorophore, is imaged as an Airy pattern as well. The radius r of the first dark ring 
after the central bright spot called the Airy disk is given by: 
  NAnDfr /61.0sin/61.022.1     
where f is the focal length of the lens and D the diameter of the beam crossing the lens (if smaller than the 
lens diameter). The consequence is that fluorescing objects smaller than the Airy disk can not be seen at their 
actual size but at the size of the Airy disk. Another consequence is that two fluorescing objects will be 
distinguishable only if the distance separating them equals at least the size, i.e. the diameter, of the Airy disk 
(Rayleigh criterion). Since in epi-illumination, the objective acts also as a condenser, the limit of the 
resolution R of the microscope is therefore given by (Abbé diffraction limit): 
    NANANANAR objectiveobjectivecondenser 2222.122.1    
4.c. Beam splitter and filters 
 In epi-illumination, exciting light and fluorescence emission overlap in the light path. The separation 
of the emission from the excitation light requires a special kind of beam splitter called dichroic mirror. The 
dichroic beam splitter mirror is designed to be used in light paths at 45°. It is often designed to reflect one 
(narrow or broad) range of wavelengths, corresponding to the exciting light, and transmit all other 
wavelengths. Dichroics are often used with two additional filters: the excitation filter, which preselects the 
exciting wavelengths, and an emission filter that only allows for the passage of the longer wavelength light. 
These three filters can be mounted all together on a so called filter cube that is positioned on a wheel (or 
linear block) containing several cube holders and is present at the back of the objectives. However, since the 
alignment of the dichroic is rarely perfect (the 45° angle is not exact), the image from one cube to another 
can be slightly offset. One can therefore use dichroic mirrors that reflect two or more narrow wavelength 
ranges (dual, triple, quadruple bands/lines dichroic) adjusted on the exciting lights, with the advantage of 
keeping the same filter (alignment) in the light path. In that case, excitation and emission filters are not 
mounted on a cube but rather on wheels, located before or after the microscope, allowing the fast switching 
from one channel to the other. With these three elements, the beam splitting dichroic mirror, the excitation 
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and the emission filters, the separation of the exciting light from the emitted light can be very efficient. For 
example, a modern filter set might pass only one photon in 10 000 of the wrong excitation color to the 
specimen, and there is a similar ratio in the return light. Such high ratios are absolutely required for imaging 
small numbers or single fluorescent molecule. 
4.d. Detectors 
 In order to get an image of the sample, the emitted photons have first to be detected and second, the 
information has to be transposed into a digital image. Basically, photon detectors have some surface where 
absorption of photons produces an electric signal (current or voltage) that is proportional to the number of 
photons absorbed. The two most important families of detectors reflect the two different approaches to 
capturing microscope image data (Weeks et al., 2000). Charge-coupled device (CCD) detectors or 
complementary metal-oxide semiconductor (CMOS) sensors consist of an array of photodetectors for 
simultaneous detection of photons from the whole image in a wide-field or multifocal scanning (e.g. spinning 
disc confocal) microscopy system. Photomultiplier tube (PMT) and avalanche photodiode (APD) detectors, 
on the other hand, are single point detectors. To construct the image, it is necessary to move either the 
sample or the excitation laser in a way (scanning) and to read the intensities of each position. The sensitivity 
of all types of photon detectors depends on two factors: the detection limit, and the quantum efficiency 
(electron output/photon input). The image of the sample is composed of an array of pixels, each pixel 
corresponding to a photodetector. For each pixel is attributed a value proportional to the number of photon 
striking the photodetector. The range of values (gray scale) that pixel can have depends on the number of bits 
used to code the electric signal generated by the absorption of the photons. 
5. Wide-field and confocal microscopes 
 While there are many fluorescence microscopy techniques, in this section, only wide-field (WF) and 
laser scanning confocal (LSC) microscopes will be described. In WF microscopy, the sample is illuminated 
on a relatively large area (Fig. 32a). The light source is generally non-coherent and polychromatic (lamps, 
LEDs). The desired excitation wavelength is selected using an appropriate excitation filter. The advantage is 
that fluorescence is simultaneously emitted from the entire illuminated area and thus fast acquisition is 
possible. The disadvantage is that not only the focal plane, i.e. the plane of observation, emits fluorescence 
but also out-of-focus planes close to the focal plane. It results in an unwanted background signal that reduces 
the quality of the desired one. This is one reason why the LSC microscopy was introduced (Fig. 32b). In that 
case, a pinhole is added on the emission path to reject out-of-focus signal and thus only in focus signal 
reaches the detector. Because confocal microscopy collects an even smaller fraction of the total fluorescence 
emitted by the sample, the excitation intensity required to image this fluorescence must be higher than in WF 
microscopy. Lasers, which are coherent, monochromatic light sources with low divergence, provide the 
required energy and in addition, allow for a better focused illumination of the sample. Only a very small area 
of the sample is illuminated and scanning of the sample is necessary to get the final image. The scanning of 
the sample represents the main disadvantage of LSC because the time needed to cover the area of interest can 
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be relatively long. Another disadvantage is that the amount of photobleaching per detected photon is higher 
due to the high energy of the source. However, this can be minimized by using low laser power, high 
detector sensitivity, and maximal objective numerical aperture. 
 
 
Figure 32: Fluorescence microscope. (a) Wide-field microscope is characterized by a large spatial illumination of the 
sample allowing for the observation and recording of all emitted fluorescence signals of that area at the same time. Out-
of-focus fluorescent photons also reach the detector decreasing the quality of the in focus image. (b) Confocal 
microscope is characterized by focused illumination, and imaging of only the in focus fluorescence signal due to 
pinholes. The imaging of the sample requires a scanning of the region of interest which is time consuming. Inspired 
from (Valeur, 2001a).  
 The basis for choosing between these systems is their ability to maximize the signal to noise ratio 
(S:N) from the sample as well as the noise they add to the signal due to illumination variations and signal 
detection. For instance, a quantitative comparison of WF microscope and LSC microscope found that for thin 
living cells a WF microscope produced images with better S:N largely due to a more stable illumination 
system, while a LSC microscope out-performed the WF microscope on thick samples, where the dominant 
source of noise is out-of-focus light (Swedlow et al., 2002). In a conventional confocal set-up, the image 
acquisition frequency is normally less than 10 frames per second, because not only the laser has to scan the 
sample, but it is also necessary to integrate the intensity signal during at least 10 μs per pixel. By contrast, 
the image acquisition time in wide-field set-ups normally ranges from 1 to 30 ms (Levi et al., 2006; Kural et 
al., 2007), but may be as short as 25 μs (Kusumi et al., 2005). Thus, conventional confocal microscopy is 
useful only for studies of processes with relatively slow dynamics.  
6. Single particle tracking 
 Several fluorescence microscopy techniques have been developed to measure the motion of 
molecules, the two most widely used being fluorescence recovery after photobleaching (FRAP) (Axelrod et 
al., 1976), and fluorescence correlation spectroscopy (FCS) (Magde et al., 1972). In both cases, the 
determined mobility properties correspond to the average behavior of the observed molecules (bleached area, 
observation volume). In recent years, single-molecule and single-particle techniques have each become 
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essential tools in the fields of biophysics and cell biology (Weiss, 1999). One of the main reasons for the 
strong impact of these techniques is that they provide crucial information which is averaged out in traditional 
ensemble methods. Single particle tracking (SPT) has constituted a remarkable new tool for the study of 
dynamics in biological processes. The method consists in the following of the positions of individual most 
often fluorescent particles based on recording images in a wide-field or confocal fluorescence microscope 
over time, and then locating the particle of interest in every recorded frame of the stack using a specific 
algorithm (Anderson et al., 1992; Saxton et al., 1997; Levi et al., 2007). When obtained under suitable 
spatiotemporal resolution, these trajectories can be analyzed statistically to extract quantitative information 
about the mechanism involved in the particle motion. SPT can easily discriminate populations of particles 
having different motion properties and can explore complex processes where one particle switches between 
different motion mechanisms. The number of applications of this technique has grown significantly, based 
mainly on advances in microscopy and labeling techniques which have led to significant improvements in 
the accuracy and speed of these methods. 
 There are generally two sides to the tracking problem: (i) the recognition of relevant objects and 
their separation from the background in every frame, and (ii) the association of objects from frame to frame 
and making connections. 
6.a. Single molecule/particle localization 
 In an optical microscope, a point-like particle forms a diffraction limited image giving a symmetrical 
signal distribution around the center, with the maximum intensity at the center of the spot and a width 
approximately equal to λ /(2NA). For visible light, the imaged particle has at least a diameter of about 
200 nm. Thus, if particles are close to each other within this diffraction limit, it is not possible to determine 
their individual positions. When the distances among particles exceed this limit, the position of each object 
will correspond to the center of the intensity distribution I(x,y) of its image which is determined by the point 
spread function (PSF). The most reliable approximation of the PSF is given by a two-dimensional (2D) 
Gaussian with a full-width-at-half-maximum (FWHM) equal to w (Anderson et al., 1992; Schmidt et al., 
1995; Zhang et al., 2007; Holtzer et al., 2009): 
 















 



2
2
2
2
2
)()(
2ln4exp
2ln4
),(
w
y
w
x
w
NyxI
yx


  with   NAw 03.1  
where µx and µy are the x and y coordinates of the center of the distribution and N is the total number of 
detected photons. The positions can be determined with a nanometer precision although the typical size of 
the image, w, is larger than the object (Yildiz et al., 2003). 
 The identification and position analysis, using 2D Gaussian fit, is computationally highly demanding 
especially when numerous of objects are on the image. One simple and rapid way of determining the position 
of the object is to calculate the center of mass (centroid) of its image for each axis: 
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where Iij is the intensity at the pixel (i,j), n and m the total number of pixels in the x- and y-axis. The 
advantage of this method is that it does not use any prior knowledge concerning the shape of the intensity 
profile, and can therefore by employed to objects which are larger than the diffraction limit  or for which 
imaging errors appeared (Falcon-Perez et al., 2005). 
 The position accuracy of an experimental set-up depends on many factors, including the detector 
noise, the amount of photons detected per particle, the position of the object relative to the center of a 
detector pixel, the localization method used, and the magnification of the set-up (Ober et al., 2004). A 
general method used to calculate the error in a position measurement, when applied to single-molecule 
imaging, has estimated that the (lateral) position accuracy is typically of about 30 nm (Bobroff, 1986; 
Thompson et al., 2002; Lommerse et al., 2004). The error in the particle position x or y is given by 
(Thompson et al., 2002): 
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where s is the standard deviation of the PSF (Gaussian or other), a the pixel size of the image and b the 
background noise. Therefore, the first term refers to the photon noise, the second to the pixelation noise, i.e. 
the effect of finite size of the pixels in the image and the third term refers to the background noise including 
the fluorescent noise and the detector noise. The larger the number of photons detected the better position 
accuracy. The background noise has a strong influence in the position accuracy determination making 
precise localization in cells more complicated due to autofluorescence noise. In addition, out-of-focus signal, 
significant in WF microscopy, increase the background noise. Background noise limits also the effective 
duration of the tracking experiments due to photobleaching of the objects of interest. 
 Particle detection usually requires a beforehand reduction of the background noise and the definition 
of an intensity threshold above which pixels are considered to be potentially part of an object. Particles of 
interest are then selected depending on their size, shape and intensity. From the x- and y-coordinates of the 
particles, obtained for each frame they are detectable, the trajectories can be reconstructed. 
6.b. Trajectory reconstruction 
 The most straightforward and most often used strategy to solve the issue of associating the particle 
positions is to apply local nearest-neighbor linking (Guzik et al., 2004; Hill et al., 2004). When the particle 
density is low and recording time appropriate, this linking strategy gives excellent results. However, in 
higher particle density, the available information to resolve potential ambiguities in the matching process is 
limited. Often the particles all have similar appearance; they may disappear, (re)appear, split or merge. More 
consistent results can be achieved by using global rather than local linking strategies. Examples include 
spatiotemporal tracing (Hirokawa et al., 2005) and graph-based optimization approaches (Hill et al., 2004; 
Hirokawa et al., 2009). Alternatively, various Bayesian estimation approaches have been explored (Guzik et 
al., 2004; Kahana et al., 2008; Kim et al., 2008). This procedure is performed using efficient automatic 
algorithms. However, a manual checking is necessary since some mistakes can emerge, such as the 
possibility of objects being tracked or detected on cellular fragments, glass surface, or non-transfected cells, 
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the jump of a trajectory from one particle to another and the discontinuity of a trajectory that may appear as 
fragments. These problems can be reduced by working at low particle density (Kobielak et al., 2004) and 
corrections can be performed using manual reconnection tools or using partially manual tracking algorithms 
both of which are time consuming and subject to operator subjectivity. The problem of “connecting the dots” 
is practically always solved by linear interpolation, resulting in piecewise-linear trajectories. If the time 
between two consecutive images is small with respect to the motion kinetics, a linear interpolation suits well. 
If the motion kinetics is much faster than the time between two consecutive images, the linear connection 
will not approximate correctly the real movement and calculated parameters can be strongly underestimated. 
6.c. Trajectory analysis 
 A variety of measures can be computed straightforward such as the total trajectory length (the total 
distance traveled), the distance between start and end points (the net distance traveled or displacement), the 
maximum distance to the start (or any other reference) point, the total trajectory time, the instantaneous 
speed or angle, the confinement ratio (also referred to the straightness index) (Beltman et al., 2009; 
Meijering et al., 2012). A more sophisticated measure computable from a trajectory is the mean square 
displacement (MSD). It is a very important analysis since it provides information on the surroundings and 
the eventual interactions of the particle with cellular components by determining the motion behavior. MSD 
depicts the average of the squared distances between a start and end position within one trajectory for all 
time lags of certain duration nΔt (Qian et al., 1991; Anderson et al., 1992; Saxton et al., 1997). For a 2D 
trajectory having N successive positions (1,2,…,i,…N), where each position i has (xi ; yi) coordinates and 
each successive images have t time lag, the MSD is defined by: 
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With increasing time lag, inherently less data are available and the MSD values become irrelevant (Qian et 
al., 1991). MSD should always be calculated for time lags corresponding to less than 20-25% of the total 
number of points in the trajectory (Saxton et al., 1997). This can result in a difficulty to discriminate between 
the different diffusion modes and sometimes between diffusion and active transport.  
 By inspection of the resulting MSD-time curve, information about the mode of motion can be 
obtained and can then be interpreted in a biological context (Fig. 33) (Anderson et al., 1992; Huang et al., 
2011): 
- Normal (or Brownian) or anomalous diffusion are described by: 
 
Dtr 42   
where D is the diffusion coefficient and  distinguish between Brownian diffusion ( = 1) and anomalous 
( < 1). The factor 4 is specific for diffusion in 2D and is replaced by 6 for 3D tracking. For Brownian 
motion or random walk, the MSD increases linearly with time. Anomalous diffusion occurs generally when 
the free diffusion of the particle is hindered by obstacles. 
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- Confined diffusion is indicated by an asymptotic behavior of the MSD for large time lags. The 
MSD is given by: 
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where <rc2> is approximate of the size of the confinement area and A1 and A2 are positive constant 
determined by the geometry of this area. The asymptotic value of the MSD for large Δt can be used to 
estimate the size of the confinement <rc2>. Confinement is observable only for long observation times 
compared to the one the particle needs to encounter several times the barrier. For short observation times, 
confined diffusion appears as normal or anomalous diffusion. The ultimate case, where <rc2> equals zero, 
represents immobile particles. 
- Active transport or directed motion is described by a quadratic dependence of the MSD on time: 
   Dtvtr 422   
where v is the velocity of the particle. Superimposed on this motion is normal diffusion with the diffusion 
coefficient D. 
 
Figure 33: Mean square displacement fit plots. The time dependence of the MSD allows the classification of the type 
of motion behavior. A linear plot indicates normal diffusion (red). A quadratic dependence indicates directed motion 
(blue). When the MSD asymptotically approaches a maximum value, it indicates confined diffusion (green). Any 
regime between normal and confined diffusion indicate anomalous diffusion (purple) where normal diffusion is 
hindered by obstacles. From (Ruthardt et al., 2011). 
 The most important motion parameters are velocity, diffusion coefficient, directionality, position, 
and for alternating movements, run length and duration, as well as the duration of the pauses. Average values 
of these motion statistics can be valuable, but histograms of their distributions are even more informative, 
and can reveal whether there are multiple populations within the sample. The limitation of the MSD, because 
of averaging and oversimplification of the transport, is the loss of the transient intermittent nature of the 
transport. Indeed, mostly in biological sample, one particle can exhibit several modes of motion within one 
trajectory. It has become more and more common to segment the trajectories into portions delimiting change 
in the motion behavior. Several approaches have been suggested for single particle trajectory analysis and 
demonstrate their utility with sample data from living cells: 
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- The directional persistence of trajectories (Lehrman, 1999). It is based on the determination of 
time-dependent directional changes in the trajectory. The directional changes are evaluated by a turning 
angle between each set of points on the trajectory. The points are defined by window of specified duration 
that is moved on the length of the trajectory. By sliding the window along the trajectory, the distribution of 
turning angles for a particle is obtained as a function of lag time (Merrifield et al., 2002). The distribution of 
turning angles indicates relative incidence of random, persistently directional, or anti-persistent motion of the 
particles. For random motion, successive turning angles are independent and can exhibit any value in the 
range [-π;π] with equal probability in each time window. For persistent or anti-persistent motion, the 
directionality is, respectively, correlated or anti-correlated between successive time intervals. Directional 
persistence can indicate local flow or drift or existence of active transport. Anti-persistent motion may be 
caused by local trapping or by motor switching, inducing rapid changes in direction when observed at 
characteristic lag times (Miki et al., 2001). 
 
- The temporally resolved detection of active regimes (Mishima et al., 2002). In this method, a 
measure of the directional persistence is determined for sliding time windows and is combined with the MSD 
scaling exponent  in each window. When the defined conditions for the local MSD scaling and the angle 
correlation function occur simultaneously, active regime is defined and assumed to result from molecular 
motor-driven transport. It is possible to evaluate their frequency of appearance and temporal persistence. 
 
- The temporally resolved detection of trapping regimes (Murase et al., 2004). The method requires 
consideration of the entire trajectory as an image, initially without regarding time, to detect regions with 
large step density. A particle within confinement, on the same scale as its radius, will exhibit many back-
and-forth steps. This will produce a dense region in the image of the trajectory that can be detected with an 
appropriately chosen density threshold. The mode of motion is confirmed by the local MSD. MSD of a 
trajectory segment in a trap will have a plateau (α = 0), which is proportional to the trap size (Nangaku et al., 
1994; Oh et al., 1998). A diffusive trajectory of a particle randomly sampling its immediate region will 
exhibit no MSD plateau. 
 
- The trajectory spread in space, calculated through the radius of gyration (Pelkmans et al., 2002). 
The distance that a particle travels in a given time depends on the forces driving its motion and the 
microenvironment. Differences in activity and mechanics of two samples can be evaluated by comparing the 
traveled distance away from the start or the spread of the trajectories in those regions (Pelkmans et al., 2002). 
The amount of spread of a trajectory can be evaluated with the radius of gyration (Rg), or other measures of 
distances at a given time. The radius of gyration provides an averaged measure of the trajectory size. High 
Rg values indicate high traveled distance and correlates with high amplitude MSD. It can therefore be an 
approach to distinguish the different modes of motions.  
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7. Applications of SPT 
 Motion statistics are an excellent way to interrogate dynamic cellular processes in order to 
understand underlying mechanisms. The most important applications include the study of molecular motors, 
motor-driven transport processes and motion processes in membranes. 
7.a. Molecular motors  
 SPT of fluorescently labeled molecules allows for the detection of the motion and stepping dynamics 
of motor proteins. This approach provided the first direct demonstration of the hand-over-hand processive 
stepping mechanism of single myosin V and kinesin-1 molecules (Yildiz et al., 2003; Yildiz et al., 2004). 
With ~104 photons collected per second from a single cyanine dye, Cy3, attached to one head of the dimeric 
motors, the head could be localized with ~0.5 s temporal and ~1 nm spatial resolution over time periods of 
~1 min. The 36 nm and 8 nm step size have been calculated via SPT experiments with two different cyanine 
dyes or quantum dots attached to the two heads of myosin V. Heads could be colocalized with 6-10 nm 
accuracy, providing further support for the hand-over-hand mechanism of processive movement (Churchman 
et al., 2005; Warshaw et al., 2005). In a similar approach, the broadly distributed step size of myosin VI was 
attributed to a mixture of large and small steps with narrow distributions (Nishikawa et al., 2010).  
 The analysis of directed motion phases of molecular motors in vitro and in vivo allows for the 
calculation of their velocity. Courty et al. measured single kinesin in vivo mean velocity of about 600 nm/s 
and mean processivity of about 1.8 s (Courty et al., 2006). Mean values of 220-1200 nm/s have been 
observed for dyneins and for kinesins velocities ranging from 200 nm/s to 1600 nm/s have been reported 
(Mallik et al., 2005; Jamison et al., 2010; Bhat et al., 2012) The mean velocities of myosin as actin-related 
motor proteins were determined to lie between 50 nm/s and 300 nm/s for myosin VI and between 250 nm/s 
and 500 nm/s for myosin V (Sweeney et al., 2007; Pierobon et al., 2009; Ali et al., 2011).  
 The velocities of organelles moving either toward the (+) or the (-) end of microtubules showed a 
quantized distribution with peaks located at multiple values of a basal velocity. This result was interpreted 
considering that multiple copies of motors are required to transport organelles in vivo (Kural et al., 2005; 
Smal et al., 2007; Swanson, 2008; Sweeney et al., 2010). In contrast, only one copy of processive motors is 
usually enough to carry a big bead in vitro, pointing out the importance of in vivo transport experiments to 
understand the function and regulation of motor proteins.  
7.b. Motor-driven processes 
 The entire internalization process of polyplexes has been recorded into trajectories with a temporal 
resolution of 300 ms (de Bruin et al., 2007). After attachment to the cell membrane and uptake, the 
polyplexes showed trajectories with three phases of motion: phase I exhibited slow and directed motion, 
phase II indicated normal, anomalous and/or confined diffusions, and phase III consisted of fast and long 
range active transport. Particles in phase I had typical velocities of about 0.015 μm/s and this phase appeared 
shortly after internalization. Therefore, it was interpreted as movement under the control of the actin 
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cytoskeleton. Phase II diffusion simply reflected the highly crowed cytoplasm where cytoskeleton and 
organelles are obstacles for the free diffusion of the polyplexes. Phase III was attributed to active transport 
mediated by kinesins and dynein motors with velocities up to 4 μm/s and a stop-and-go motion characteristic 
for microtubule-mediated transport resulting from the cycle of binding and unbinding of the motors (Suh et 
al., 2004; Cui et al., 2007; de Bruin et al., 2007). SPT experiments revealed similar process for intracellular 
migration of many particles including polyplexes systems (Suh et al., 2003; Suh et al., 2004; Bausinger et 
al., 2006; Lai et al., 2007; Lai et al., 2008b), lipoplexes (Sauer et al., 2009; Akita et al., 2010), organelles 
(Ichikawa et al., 2000; Pilling et al., 2006; Toshima et al., 2006; Osborne et al., 2009; Li et al., 2012) and 
viruses (Seisenberger et al., 2001; Lakadamyali et al., 2003; Babcock et al., 2004; Rust et al., 2004; Ewers et 
al., 2005; Suk et al., 2007). By choosing specific probes (pH sensitive or self-quenching dyes) or using 
multicolor fluorescence microscopy, the mechanism of internalization and intracellular trafficking can also 
be addressed.  Acidification of the endosomes containing influenza viruses was measured to occur after a 
phase of fast transport (Lakadamyali et al., 2003). Virus fusion took place in the perinuclear area where 
endosomes exhibited saltatory bidirectional movements. After internalization, clathrin vesicles uncoating 
was usually followed by the rapid movement mentioned above (Rust et al., 2004). Investigation of particles 
intracellular transport includes identifying endocytic pathways, quantifying transport rates and recognizing 
transport modes. This information can be used to point rate-limiting steps to intracellular carrier delivery, 
which in turn will highlight ways to improve delivery efficiency. 
7.c. Membrane organization and function 
 SPT constituted a very important technique to understand some aspects of the organization of 
cellular membranes since it provides the tool to observe the motion of lipids and proteins in situ. By using 
this approach, different authors could verify that the motion of membrane components is not random as it 
would be expected according to the Singer and Nicolson fluid mosaic model (Terasaki et al., 1994). By 
recording trajectories of lipid molecules (Tilney et al., 1992b; Thomsen et al., 2002) and membrane proteins 
(Tilney et al., 1992a; Tomishige et al., 1998), it has been observed that the motion of both components in 
natural membranes is highly restricted. Several works from the group of Kusumi (see references in (Kusumi 
et al., 2005)) described this motion as “hop diffusion” i.e. the protein or the lipid diffuses freely within a 
compartment until it shifts to another compartment. This behavior seems to be a consequence of steric 
hindrance between the cytoplasmic domains of protein with the cytoskeleton meshwork in close proximity to 
the bilayer (Vale et al., 1985; Tomishige et al., 1998). In the case of small lipid molecules, the restriction 
seems to arise from the presence of membrane proteins anchored to the actin filaments directly in contact 
with the membrane, which act as rows of pickets that temporarily confine lipids (Thomsen et al., 2002). This 
model explains fairly well the behavior of some membrane components in some cell types. However, its 
generalization may not be straightforward and other mechanisms should also be taken into account 
(Valentine et al., 2001; van Drunen Littel-van den Hurk et al., 2008). In particular, it has been shown that the 
diffusion properties of membrane proteins could change with the structural/biological state of the protein 
(Walczak et al., 2010), adding a higher level of complexity to the membrane structure and function. 
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Chapter 4: Electroporation 
I. Electropulsation 
I.1. Historic 
I.1.a. Electropermeabilization 
 The first in vitro studies about the effects of pulsed electric fields on living cells were performed in 
the 1960-1970’s decades. The effects were described as a reversible or irreversible rupture of membranes 
called dielectric breakdown (Coster, 1965; Sale et al., 1968; Neumann et al., 1972; Crowley, 1973; 
Zimmermann et al., 1974). This physical phenomenon was afterwards called electroporation or 
electropermeabilization because molecules which otherwise could not penetrate cells, could now traverse the 
cell membrane. Under optimal conditions, cells are electropermeabilized only for a transient period (Mir et 
al., 1988). 
 The first in vivo electropermeabilization application was performed at the end of the 1980’s with the 
electrofusion of Hela and cornea cells (Grasso et al., 1989; Heller et al., 1990). Electrofusion is obtained by 
the permeabilization of adjacent cells. Electropermeabilization can also be used to deliver drugs. Already in 
1988, in vitro evidence appeared about considerable increase of bleomycin toxicity (~106) in electroporated 
cells compared to cells not exposed to a field (Orlowski et al., 1988). Bleomycin is an anticancer molecule 
which breaks single and double stranded DNA, thus provoking cell death. Its efficiency depends on 
intracellular concentration levels but it does not easily pass through plasma membranes. Large improvements 
of its penetration in tumor cells after electropulsation followed by high cell toxicity have highlighted the 
potential use in vivo of this technique to treat cancer. Since 1991, this property has been successfully 
developed in vivo (Mir et al., 1991a) up to clinical applications to treat tumors. It became a major application 
of electroporation and it is called electrochemotherapy (ECT) (Belehradek et al., 1993; Belehradek et al., 
1994; Mir et al., 1999). Numerous clinical trials have been performed using bleomycin or cisplatin as 
anticancer drug to treat mainly cutaneous or subcutaneous tumors in humans (Mir et al., 1998b; Rols et al., 
2000; Gothelf et al., 2003) or horses, cats and dogs (Rols et al., 2002; Cemazar et al., 2008) but also on 
breast cancer (Rebersek et al., 2004). 
I.1.b. DNA electrotransfer 
 The first in vitro DNA electrotransfer on eukaryotic mammalian cell was performed in suspension in 
1982 (Neumann et al., 1982; Wong et al., 1982). Mouse lyoma cells deficient of the thymidine kinase (tk-) 
became tk+ after exposure to high voltage direct current (8 kV/cm) in the presence of plasmid DNA carrying 
the tk gene. It was described that the electric shock destabilized and permeabilized the cell membrane in 
suspension, therefore facilitating the entry of the exogenous DNA inside the cell. Two years later, 
confirmation of this result opened the way for the development of electroporation meaning the use of electric 
fields to induce in vitro cell permeabilization and allow for the transfer of nucleic acids (Potter et al., 1984). 
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Numerous publications demonstrated that electroporation can be used on different cell types like bacteria 
(Calvin et al., 1988), yeast (Ganeva et al., 1995), immortal cells (Toneguzzo et al., 1986; Andreason et al., 
1988; Andreason et al., 1989; Rols et al., 1992a; Sandri et al., 2003) or primary culture cells (Espinos et al., 
2001). Nowadays, this method is routinely used on prokaryotic and eukaryotic cells, plant or mammalian 
cells. The optimization of the electric parameters allows for the transient permeabilization of the cell 
membrane while maintaining good cell survival (Bonnafous et al., 1999). 
 The first in vivo DNA electrotransfer was performed on skin with the use of exponentially decaying 
electric pulses (Titomirov et al., 1991). In 1996, series of square wave electric pulses of short duration 
(100 µs) successfully transfected liver cells (Heller et al., 1996a). In 1998, four independent research groups 
proved the efficiency of DNA electrotransfer using longer pulse duration (5-50 ms) in skeletal muscle 
(Aihara et al., 1998; Mir et al., 1998a), in tumors (Rols et al., 1998a) and in liver (Suzuki et al., 1998). From 
that period in vivo gene electrotransfer developed successfully in liver, bladder, skeletal muscle, brain, heart, 
blood vessels, kidney, testicles, spinal cord, cornea, retina, tendon, spleen, lung, adipose tissue and more (see 
references in (Andre et al., 2004; Mir et al., 2005)). In all the cited cases, animal models (rat, mouse, rabbit, 
monkey), plasmid types (reporter gene or gene with biological or therapeutic interest), electrodes (plates or 
needles), pulsation protocols (number, duration, strength, frequency of the pulses) and the duration of the 
treatment were different (Mir et al., 2005). This highlights the necessity to adapt conditions to the cell/tissue 
targeted. For a comparison with injection of naked plasmid DNA, electrotransfer induces 10-1000 fold 
increase of transfection efficiencies (Mir et al., 1999; Cappelletti et al., 2003) and it reduces interindividual 
variability (Mir et al., 1999; Hartikka et al., 2001).  
I.2. Electric field characteristics 
 Electric fields are generated by electrically charged particles. The application of an electric current at 
the terminal of electrodes creates an electric potential difference U or voltage between these electrodes. 
Depending on the geometry of the electrodes, the electric field can be uniform or not. Two parallel plate 
electrodes produce a uniform electric field which strength E is defined by the ratio of the potential difference 
U by the distance d between the electrodes. The characteristics of the electric current (alternating, direct, 
pulsed) determine those of the electric field (alternating, direct, pulsed). Typical pulse wave shapes delivered 
by high voltage pulse generators are square-wave or exponentially decaying. Square-wave pulses generate an 
electric field having constant strength E and duration T (Fig. 34a). Exponentially decaying pulses create 
electric fields which decrease in strength over time following an exponential law. 
 For electroporation of cells or tissues, frequently, parallel electrodes connected to a high voltage 
pulse generator delivering square-wave pulses are used. Therefore, the electroporation conditions are 
characterized by the strength E (= U/d for plate electrodes) of the electric field, the pulse duration T, the 
number of pulses N and the delay between two pulses or period P commonly given in frequency (f=1/P) 
(Fig. 34a). The independent control of each parameter allows many combinations suited for different 
applications and the induction of specific effects on cells (Weaver et al., 2012). Efficient transfer of 
molecules in mammalian cells is obtained for electric field strengths between 100 V/cm and 1000 V/cm, 
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pulse duration ranging from µs to ms, repetition rate in the order of 10 and a frequency of about 1 Hz 
(Fig. 34b). 
 
 
Figure 34: Scheme of the electric pulse series and map of their effects or applications in cells. (a) Square-wave 
pulses are defined by the voltage U, the duration T, the period P or the frequency f, and the repetition N. (b) 
Applications and effects of electroporation (EP) in cells depending on the strength and the duration of the electric field 
(Weaver et al., 2012). IRE = irreversible electroporation, ECT = electrochemotherapy. 
I.3. Cell in suspension and electric equivalent 
 The lipid bilayer (with or without the proteins) of the cell membrane has a very low conductivity 
(~10-6 S/m) (Park et al., 2011). It separates two solutions having, in comparison, high ionic conductivity 
(~1 S/m): the cytoplasm and the extracellular medium (Krassowska et al., 2007). The cell membrane has the 
electrical property of a dielectric or insulator. The gradient of ions existing towards the interface between the 
cell membrane and the medium can be approximated as a capacitor. Therefore, the whole system comprising 
the extracellular medium, the membrane, and the intracellular medium can be electrically modeled as series 
of capacitors and resistors (Fig. 35). 
 
 
Figure 35: Equivalent of a cell in suspension in electric circuit. (a) Schematic representation of a cell in suspension. 
(b) Equivalent electric circuit. The conductive extracellular medium and cytoplasm are equivalent to resistors, the 
membrane is equivalent to a dielectric and together with the external and internal surface of the membrane are 
equivalent to capacitors.  
I.4. Induced membrane potential difference 
 The cell membrane is an electric insulator that separates two ionic conductive media (the extra- and 
the intracellular media). The gradient of concentration of ions between each side of the membrane generates 
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a resting potential difference 0 that is homogeneous all along the cell membrane. The value of 0 
depends on the cell type (~70 mV). A cell subjected to an electric field will disturb the field lines 
(Zimmermann, 1982). The current is forced to flow around the cell and the ionic layers at the membrane 
interface are reorganized (Fig. 36). The larger line distortion is located at the sides of the membrane facing 
the field lines. With increasing electric field strength, the cell membrane progressively resists less until it 
reaches a critical state where the conductive intracellular medium contributes to the total conductance. At 
high electric fields, the membrane becomes conductive. 
 
 
Figure 36: Schematic representation of the electric field lines around or through a spherical cell. The cell 
membrane conductivity is extremely low. The current flows around the spherical cell and the field lines are distorted. At 
a certain field value, the membrane allows for the field lines to cross towards the cell interior. Increasing the electric 
field increases the number of field lines crossing the cell and the cell membrane becomes conductive (Zimmermann, 
1982). 
 The redistribution of the ions at each side of the cell surface together with the redistribution of the 
charges inside the cell membrane creates an induced potential difference i through the cell membrane. 
i can be modeled for a uniform electric field E by solving the Laplace equation and considering several 
assumptions (Fig. 37): 
- the cell in suspension is approximated to a dielectric shell. 
- the thickness d of the shell (membrane) is everywhere very small compared to the smallest semi-
axis of the cell (radius r when the cell is a spherical). 
- the intra- and extracellular media are pure conductors. 
 
 
 
Figure 37: Schematic representation of a cell in a uniform electric field. The cell in suspension is represented as a 
spherical shell. The thickness d of the membrane is very small compared to the radius r of the cell. The uniform electric 
field is obtained by the application of an electric pulse at the extremity of two parallel conductive plates (of infinite 
length). 
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 The induced potential difference i at a point M of the cell membrane at a time t after the rise of 
the electric field pulse is given by (Schwan, 1957; Zimmermann et al., 1974; Kinosita et al., 1977c; Teissie 
et al., 1993; Escoffre et al., 2007): 
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: angle formed between the direction of the electric field and the normal of the point M on the membrane. 
f: factor related to the shape of the cell. When the cell is spherical: f = 1.5. For other shapes such as 
ellipsoids, r is the semi-axis aligned along the electric field and f can be modeled as well (Bernhardt et al., 
1973). 
g(): factor linked to the conductivity of the membrane (m), of the intra- (i) and extracellular (e) media. 
To take into account that the membrane is not a pure dielectric because some conducting leaks are present, 
the factor g is introduced: 
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membrane conductivity is extremely low compared to the conductivity of the intra- and extracellular media, 
g() = 1. 
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capacitance of the membrane. When the membrane is a pure dielectric sphere (m = 0), the charging time is 
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. c (~µs) is very small compared to conventional electric field pulse 
durations (longer than 100 µs) (Weaver et al., 2012). 
 
At the steady state, considering the cell as a spherical insulator shell, i can be written with a simplified 
expression: 
)cos(5.1),( ErtMi   
 The induced potential difference at the cell membrane i is, therefore, directly proportional to the 
size of the cell and the strength of the electric field. In addition, it is correlated with the vectorial property of 
the electric field. It is not uniform along the cell membrane. i is maximum at the side of the membrane 
facing the electrodes ( = 0° or 180°) and decreases progressively along the cell surface up to the poles 
where i = 0 ( = 90° or 270°).  
I.5. Other physicochemical consequences 
I.5.a. Electrochemical effect 
 Under the application of electric currents, oxidation-reduction reactions occur at the electrode 
surface that can create very reactive chemical species like free radicals or release metallic ions. These 
reactions depend on the type of electrodes (steel, stainless steel, aluminum, copper …), on the composition 
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of the solution the electrodes are immersed in and on the parameters of the electric field (Edebo et al., 1968; 
Friedrich et al., 1998). The generated compounds can affect the cell viability and modify the characteristics 
of the electric field due to the change of property of the medium (Friedrich et al., 1998; Loste et al., 1998; 
Kotnik et al., 2001). To reduce these effects, platinum, gold or stainless steel electrodes can be used (Tomov 
et al., 2000). 
I.5.b. Thermal effect 
 Any electric current of intensity I going through a conductive medium of resistance R induces a 
heating of the medium called Joule heating. The heat production Q during a period of time t is defined by 
Joule’s law for direct current: tRIQ  2 .  
 The extra- and intracellular media can be considered as resistors, the application of an electric 
current will produce heat that can affect cell viability. If we assume a total conversion of the electric energy 
into heat, the application of a single square-wave pulse with E (V/m) being thus constant over the pulse 
duration T (s) and a constant conductivity  (S/m) of the medium, the temperature production T° is defined 
by the relation (Loste et al., 1998; Weaver et al., 2012): 
 

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TET o 2  
Cp being the specific heat capacity and  the density of the sample.  
 The pulsation buffer we used can be assimilated to phosphate buffer saline which has a conductivity 
of 1.2 S/m, a specific heat capacity and density close to water meaning respectively 4 180 J/kg.K and 
1000 kg/m3. Each pulse having an electric field strength of 400 V/cm and a duration of 5 ms generates a 
temperature increase of 2.3 K. The more electric pulses are applied, the more the temperature increases. 
Nevertheless, the time between two pulses allows for heat dissipation that can be large enough to avoid 
strong temperature increase (Loste et al., 1998).  
I.5.c. Field effects 
I.5.c.i. At the cell level 
 Orientation 
 Cell membranes are charged and have permanent dipoles. When external electric fields are applied, 
cells turn towards the field lines such that the global energy of the system is reduced (Zimmermann, 1982). 
In case of a spherical free system, like cells in suspension, cells will rotate around their center. In case of 
non-spherical free system, like elliptical bacteria in suspension, cells will orientate their main axis parallel to 
the line of the field (Eynard et al., 1992). 
 Electrophoresis 
 Cells have a negative net surface charge. The application of an electric field can induce cells to 
migrate towards the positively charged electrode (anode). According to the cell type, the surface charge 
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varies and therefore the cell response to the electric field varies as well. Some cells known for their ability to 
migrate have been shown to move preferentially towards the cathode under the effect of the electric field 
(Orida et al., 1982; Farboud et al., 2000; Finkelstein et al., 2004). 
 Dielectrophoresis 
 In case of non-uniform electric field, the induced dipoles are not identical along the cell membrane. 
This will cause the cell to migrate to areas of high electric field (even when alternating). When two cells get 
closer due to electrophoretic migration, the attractive forces between the dipoles are higher than the 
electrostatic repulsions. Cells organize in chains towards the higher potential electrode (Pohl et al., 1971; 
Pilwat et al., 1981). This phenomenon can also occur with uniform electric fields but at very high cell 
density (Zimmermann, 1982). High cell density disturbs field lines such that individual cells sense non-
uniform fields. 
I.5.c.ii. At the molecular level 
 Electrophoresis and orientation of the membrane components 
 Cell membrane contains numerous of charged components that are sensitive to electric fields. During 
the application of the electric field, the different charges, positive or negative, are redistributed creating new 
dipoles. These induced dipoles and the already existing ones move towards the direction of the field lines. 
For instance, the polarized receptor of the concanaviline A (Con A) has been observed to accumulate at the 
side of the cell membrane facing the negative electrode (Poo et al., 1977). Transferrin (Tf) and low density 
lipoprotein (LDL) receptors are redistributed under the application of the electric field but the distribution 
pattern is less clear (Cho et al., 1994).   
II. Electropermeabilization 
II.1. Threshold 
 During the application of the electric field, the induced potential difference towards the cell 
membrane i is added to the resting potential difference of the cell 0 which depends on the cell type 
(Tekle et al., 1990; Teissie et al., 1993). Considering the assumptions about the system described above 
(Fig. 37),  is given by: 
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When the absolute value of the resulting  reaches or is larger than a threshold value c, corresponding 
to a critical electric field value Ep, a permeabilization state of the cell membrane is initiated due to local 
defects. The critical potential difference varies according to the cell type. c is between 200 mV and 
500 mV for animal, vegetal or bacteria cells (Teissie et al., 1981; Robello et al., 1989; Tomov et al., 1989; 
Marszalek et al., 1990; Teissie et al., 1993). The existence of a threshold value c for the membrane 
potential difference is the major characteristic of the so called electropermeabilization. 
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 The value c is generally the same for most of biological membranes (~300 mV). It means that the 
electric field critical value Ep for which the electropermeabilization appears is simply related to the size (and 
the shape) of the cell. The smaller the cell, the higher the applied electric field has to be to reach the 
permeabilization state of the cell membrane. Thus, the conditions of the electric field have to be adjusted 
according to the target cells. For eukaryotic cells (diameter between 10 µm and 30 µm), the Ep value is close 
to 1000 V/cm and for bacteria Ep is in the order of 6000 V/cm. Likewise, CHO cells which have a larger 
diameter than human erythrocytes need about half the electric field strength to be electropermeabilized (Rols 
et al., 1992b). The cell size dependence of the electric field threshold explains as well why adherent cells 
require lower electric field (300 V/cm for CHO cells) than cells in suspension (700 V/cm) to be 
permeabilized (Rols et al., 1990c; Rols et al., 1998a; Golzio et al., 2004). One can take advantage of the size 
dependence property for selective molecule delivery into the largest cells present in fluids or tissues. When 
pulsing the blood, leucocytes (immune cells) can be permeabilized whereas erythrocytes (red cells) are 
unaffected (Sixou et al., 1990). Mature adipocytes can be electroporated in adipose tissue allowing for their 
specific labeling in vivo (Granneman et al., 2004).  
 With respect to the size of the different organelles existing in the cell cytoplasm, it appears that 
conditions necessary for the permeabilization of cell membranes should keep intracellular components 
unresponsive. For instance, electropermeabilization in vitro of isolated mitochondria necessitates 10 to 100 
times higher electric field strength than the usual conditions for the permeabilization of the cell membranes 
(Collombet et al., 1997). By contrast, intense but very short pulses can induce permeabilization of small 
sized membranes (organelles) without affecting larger sized membranes (cell membranes). The critical value 
Ep can be achieved before the large sized membrane reaches its steady state. Recent technology based on the 
use of nanosecond pulsed electric fields (nsPEFs) consists in using large external fields (10-300 kV/cm) 
applied in pulses of nanosecond duration (10-300 ns) (Beebe et al., 2005). nsPEFs applied to cell 
suspensions generate cytosolic electric currents which exponentially decrease due to the charging time of the 
cell membrane (Vernier et al., 2004; Gowrishankar et al., 2006; Vernier et al., 2006a). This electric field 
present in the cytoplasm can induce potential difference across intracellular membranes such as those of 
vesicles and other organelles, if higher than their critical value (Beebe et al., 2005; Tekle et al., 2005; Kolb 
et al., 2006). 
II.2. Asymmetry 
 The position dependence of the induced potential difference i engenders a position dependence of 
the resulting potential difference  as well. At the side of the membrane facing the anode, the resting and 
induced potential difference are both negative, the membrane is hyperpolarized (Fig. 38a). By contrast, the 
side of the membrane facing the cathode is depolarized. The polarization of the cell surface has been 
experimentally demonstrated for instance on sea urchin eggs (Fig. 38b) (Gross et al., 1986; Hibino et al., 
1991; Kinosita et al., 1991; Hibino et al., 1993). 
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Figure 38: Asymmetry of the cell membrane potential and permeabilization due to electric fields. (a) Schematic 
representation of the potential difference across the cell membrane and consequences in terms of voltage and 
permeabilization. Inspired from (Teissie et al., 1993). (b) Membrane potential difference of sea urchin eggs labeled 
with RH292 and observed using fluorescence microscopy before and during the application of an electric pulse (Hibino 
et al., 1993). (c) Electropermeabilized areas of NIH3T3 cells labeled with ethidium bromide and observed using 
fluorescence microscopy after the application of electric fields of different strength (Tekle et al., 1990). E stands for 
electric field, Ep for electropermeabilization threshold and Ef for electrofusion threshold. The white dash line in (c) 
represents the cell surface.   
 This asymmetry of the cell membrane potential can be transposed to the cell membrane 
permeabilization. The first area of the cell membrane reaching the permeabilization threshold is at the anode 
for  = 180°. Increasing the electric field above the corresponding value Ep expands the cell membrane area 
facing the anode achieving the c. At a second threshold value of the electric field Ef (for electrofusion), 
c is also reached at the side of the cell facing the negative electrode. Increasing the electric field above the 
Ef value increases the surface area being permeabilized on both sides of the cell membrane. Considering the 
cell as sphere and a uniform electric field, the permeabilized area Aperm of the cell surface can be predicted 
(Rols et al., 1990b; Teissie et al., 1999): 
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where Atot is the cell surface, E the applied electric field strength. 
 
 Therefore, the electropermeabilization of the cell membrane is local and asymmetric. The surface of 
the cell membrane being permeabilized only depends on the electric field strength (Fig. 39a). These 
predicted properties have been confirmed in different cell types via observations of the entry of external 
probes such as ethidium bromide (Fig. 38c) (Mehrle et al., 1985; Marszalek et al., 1990; Tekle et al., 1990; 
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Tekle et al., 1991; Djuzenova et al., 1996; Gabriel et al., 1997). The area affected by the electric field also 
depends on the shape and the orientation of the cell within the electric field lines (Valic et al., 2003). 
II.3. Reversibility 
 The electropermeabilization of the cell is only transient (Neumann et al., 1972). For lipid bilayers, 
the lifetime duration of the permeated state is very short (~µs). Measurements of the membrane conductance 
showed that the reversibility process begins as soon as the electric field is turned off (Benz et al., 1981; Benz 
et al., 1983). For animal cells, the uptake of molecules after the application of the electric field demonstrates 
that the permeabilization state remains for some minutes after the last pulse and then the cells go back into 
their initial impermeable state (Escande-Geraud et al., 1988; Rols et al., 1990b; Tekle et al., 1991; Rols et 
al., 1998c; Bier et al., 1999; Gehl et al., 2002). This process is called membrane resealing. The duration of 
the resealing is strongly dependent on the temperature (Kinosita et al., 1977b; Teissie et al., 1994). At room 
temperature, in isoosmolar buffer, half of the permeabilized cells become again impermeable after 6 min 
(Rols et al., 1990c). At 37 °C, the resealing is very fast, at 4 °C, cells preserve the permeabilized state for 
more than 30 min (Teissie et al., 1994). At room temperature, quantitative analysis of the resealing shows 
that it is a first order process with a rate constant under the control of the cumulated pulse duration. The 
higher the pulsation duration and number, the longer is the resealing. A more recent analysis shows that 
several resealing processes coexists, while some have very short lifetimes (~ms), one persists for several 
minutes at room temperature (Teissie et al., 1999; Pucihar et al., 2008). 
 However, the application of electric field significantly higher than the critical value Ep can induce an 
irreversible permeabilization of the cell membrane (Gabriel et al., 1995). Subsequent cell death can be very 
fast (15 min) or delayed (24-48 h). Increasing the number or the duration of the electric pulses over the 
optimal conditions, determined for a given cell type, engenders cell death. 
II.4. Associated molecule exchange 
 Electropermeabilization enables a cellular entry of small molecules (up to 4 kDa) of any chemical 
nature. This is observed during the seconds and minutes following the pulse. Most of the exchange takes 
place after the pulse (Gabriel et al., 1997; Gabriel et al., 1999) and is naturally larger when the density of the 
membrane defects is high. Experimental results collected from measurements of conductance in cell 
suspension (Kinosita et al., 1977c; Kinosita et al., 1979) or from observations of single cells using 
fluorescence microscopy (Gabriel et al., 1997; Gabriel et al., 1999) shows that the level of permeabilization 
is strongly under the control of the pulse duration (Rols et al., 1990b; Gabriel et al., 1997). If the delay 
between the pulses is sufficiently short (~s) such that the membrane resealing becomes negligible, successive 
pulses have additive effect (Rols et al., 1990b). The electropermeabilized surface of the cell is controlled by 
the electric field strength and the density of the membrane defects is controlled by the pulse duration and 
number (Fig. 39) (Rols et al., 1998c). However, concerning the pulse duration and number, a saturation 
effect occurs. At fixed electric field strength, for pulse durations larger than 100 µs and pulse number larger 
than 5, the permeabilization rate reaches a plateau (Rols et al., 1998c; Satkauskas et al., 2005). 
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Figure 39: Influence of the parameters of the electric field on the surface permeabilization (electric field strength 
E, pulse duration T and number N). (a) At fixed N and T, the permeabilized area of the cell surface (gray) increases 
with increasing E. (b) At fixed E, the density of the transient permeable structures (light to dark gray) increases when 
increasing N and/or T. Inspired from (Rols et al., 1998c). The electric field direction is perpendicular to the cell section 
represented. 
 Small molecule delivery towards the electropermeabilized membrane is mostly driven by the 
gradient of concentrations existing across the membrane. Using Fick’s law, the flow  at a time t after the 
application of the electric field (strength E, duration T, number N) for a given solute S (Montane et al., 1990; 
Rols et al., 1990b; Rols et al., 1998c) is given by: 
tTNk
sperm eTNSfPAtS
),(),(),(   
Ps: permeability coefficient of S across the membrane. 
d
D
Ps   where  is the partition coefficient of S 
between the medium and the membrane, D is the diffusion coefficient across the membrane and d is the 
thickness of the membrane (Neumann et al., 1999). 
S: concentration gradient of S across the membrane. 
f(N,T): fraction of the membrane brought into a permeable state. It is related to the density of the defects at 
the membrane which depends on the pulse number and duration (N, T).   
k(N,T): resealing process constant. The lifetime duration of the defects follows a first order process with a 
rate constant under the control of the pulse number and duration (N, T). 
 
 The entry of small molecules depends, therefore, on the surface of the membrane brought into the 
permeable state (under the control of E) and the level of permeability of that surface (under the control of N 
and T). 
II.5. Transient permeabilization structures 
 The first observation about the effect of the electric field was made on lipid films (Crowley, 1973). 
Under the application of the electric field, the free charges accumulate at each side of the films. Having 
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opposite signs, they attract each other creating an electric compression force that stretches and shrinks the 
lipid film. Over a critical value of the electric field, this compression triggers an irreversible rupture. This 
model explains the cell death at high field conditions but does not explain the persistence and reversibility of 
the permeabilization.  
 
 
Figure 40: Life cycle of an electropore. Only water (red) and phospholipid head groups (yellow, P) are shown. The 
creation of an electropore starts with the introduction of a water defect inside the lipid bilayer (pore initiation). This 
engenders a reorganization of the lipids around the defect (pore construction). As long as the electric field is present, 
this phenomenon expands until the formation of a mature pore (pore maturation). Once the electric field is turned off, 
pore annihilation begins. At this moment, the pore is quasi-stable (pore destabilization). The size of the pore decreases 
since water and phospholipid head groups move out of the bilayer interior (pore degradation). The head groups separate 
again into two distinct layers (pore deconstruction) and water is rapidly removed (pore dissolution) such that the initial 
structure of the membrane is restored. From (Levine et al., 2010). 
 Other models involve the formation of reversible pores (electroporation) (Abidor et al., 1979; 
Chernomordik et al., 1983; Sugar et al., 1984; Sugar et al., 1987; Glaser et al., 1988; Weaver, 1993). It is 
based on the fact that membranes are not perfect assemblies of lipids and proteins but have structural defects 
that allow for the movement of lipids in the matrix. The application of the electric field delivers the 
necessary energy to tip over the lipids and create hydrophilic pores (Sugar et al., 1984; Weaver, 1993). The 
pores open a passage for hydrophilic molecules which in normal conditions do not cross the membrane. The 
pores are reversible as long as they do not exceed a critical size provoking the membrane rupture. Many 
molecular simulations on lipid bilayers confirm and complete the model of pore formation that can be 
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initiated with high surface tension and/or electric field (Leontiadou et al., 2004; Tieleman, 2004; Vernier et 
al., 2004; Tarek, 2005; Vernier et al., 2006b; Wohlert et al., 2006; Levine et al., 2010). The pore creation 
would in fact be initiated by the formation of a water column driven by the electric field (Fig. 40). The 
electropore models is further supported by the observation of pores in giant vesicles (Zhelev et al., 1993; 
Tekle et al., 2001; Riske et al., 2005; Portet et al., 2009) and by the observed diffusion of small molecules 
(Mehrle et al., 1985; Tekle et al., 1990; Tekle et al., 1991; Djuzenova et al., 1996; Gabriel et al., 1997). 
 However, the lifetime of pores or any field-induced lipid structure is very short (~ms) (Teissie et al., 
1999; Krassowska et al., 2007; Shil et al., 2008), the membrane resealing should therefore be almost 
immediate after the application of the electric field. Moreover, this model does not fully explain the passage 
of macromolecules with sizes exceeding the pore sizes (1-20 nm) (Abidor et al., 1979; Chernomordik et al., 
1983; Glaser et al., 1988; Krassowska et al., 2007; Shil et al., 2008; Levine et al., 2010). Finally it has been 
shown that the lipids are not the only molecular structure involved in the permeabilization process. Indeed, 
the membrane proteins and cytoskeleton are shown to be involved in the permeabilization (Teissie et al., 
1981; Schwister et al., 1985; Rols et al., 1992b; Teissie et al., 1994).  
 To conclude, membrane lipids are clearly involved in the electropermeabilization. A NMR analysis 
shows the modification of the orientation of the polar head of the phospholipids in the permeabilized area of 
CHO cells (Lopez et al., 1988). Partial loss of the asymmetrical distribution of the phospholipids is shown in 
membrane of erythrocytes (Dressler et al., 1983; Haest et al., 1997). The electropore model, even if it does 
not elucidate the whole permeabilization process, remains the usual and the best explanation for the diffusion 
of small molecules. It explains the creation and expansion steps of the electropermeabilization. The 
involvement of proteins is a key feature for the long-lived permeated state of the membrane following the 
electric field. Because the molecular structures responsible for the electropermeabilization of the biological 
membrane are not clearly defined, they are often referred as transient permeable structures (TPS). 
 
Electropermeabilization can be described in five steps (Teissie et al., 2005): 
- creation (ns): the electric field induces a membrane potential difference and reaches the critical 
value Ep. Some membrane defects are generated and the permeabilization begins. 
- expansion (µs): these defects propagate on the cell surface when the electric field strength is larger 
than Ep and the density of the defects increase as long as the field is present (cumulated duration). 
- stabilization (ms): the cell permeabilization remains when the electric field is lower than Ep. 
- resealing (min): the cell membrane slowly looses its permeability up to its initial impermeable 
state. 
- memory (h): the cell viability is preserved but some structural changes and physiological 
properties recover on a much longer time. 
II.6. Cellular response 
 When the cell membrane is electropermeabilized, a swelling can occur due to the disturbance of the 
osmotic balance (Kinosita et al., 1977a; Kinosita et al., 1977c; Kinosita et al., 1977b; Schwister et al., 1985). 
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If the osmotic imbalance between the cytoplasm and the extracellular medium becomes too high, an 
irreversible rupture of the membrane takes place. 
 Ultrastructural changes (microvilli) and deformations (blebs) have been observed on the 
electropermeabilized membrane of animal cells (Escande-Geraud et al., 1988; Gass et al., 1990). This 
implies an alteration of the cytoskeleton that can induce a loss of membrane integrity and a local 
disconnection of the membrane with the protein matrix beneath (Biswas et al., 1999). 
 The application of electric fields is a stress for the cells and reactive oxygen species (ROS) can be 
generated (Gabriel et al., 1994; Sabri et al., 1996). This phenomenon depends on the parameter of the 
electric field and is localized at the permeabilized membrane (Gabriel et al., 1994). 
II.7. Applications 
 According to the electric field strength, pulse duration, number and frequency, the 
electropermeabilized membrane acquires new properties that allow for applications in biotechnology and 
medicine.  
II.7.a. Electropermeabilization 
 Electric fields induce controlled transient and non-specific membrane permeabilization. It provides 
access to the cytoplasm to molecules that otherwise do not cross the membrane or have low permeant 
characteristics. This concerns a large pool of molecules of different sizes, charges and properties. Indeed, in 
addition to small molecules, macromolecules can be transferred such as proteins (antibodies, toxins…) and 
nucleic acids (DNA, RNA…). For the loading of small molecules (less than 4 kDa), the term 
electropermeabilization is often used. For the loading of proteins, we use electroloading and for DNA we 
employ the term electrotransfer or electrotransfection.  
 The main medical application of electropermeabilization is the delivery of cytotoxic drugs into 
tumors called electrochemotherapy (ECT). Electric fields increase or allow for the passage of the anticancer 
drugs bleomycin and cisplatin with very high efficiency into cells and tissues (Orlowski et al., 1988; Sersa et 
al., 1998). After initial studies performed starting in early 1990s (Mir et al., 1991a; Mir et al., 1991b; 
Belehradek et al., 1993; Domenge et al., 1996; Glass et al., 1996; Heller et al., 1996b; Mir et al., 1998b; 
Sersa et al., 1998; Sersa et al., 2000; Gothelf et al., 2003; Sersa, 2006), ECT is now being used in routine 
clinical practice mainly in Europe, where there are currently 16 countries with more than 100 clinical centers 
offering it to their patients (Miklavcic et al., 2012). “ECT is used in treatment of cutaneous and subcutaneous 
tumors of different histological types with response rate of 84.1 % and long lasting complete response rate of 
59.5 %” (Mali et al., 2013). Such success is attributed to the development of the ESOPE project (European 
Standard Operating Procedures for Electrochemotherapy). It provides standard procedures based on results 
after treatment of cutaneous nodules of different histology with bleomycin or cisplatin (Gehl et al., 2006; 
Marty et al., 2006; Mir et al., 2006). All studies converge to the same conclusions: “ECT is an effective 
treatment for tumor nodules; it is easy and quick with minimum side effects; it improves quality of life of 
patients with progressive disease; it is a treatment of choice for tumors refractory to any other conventional 
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treatments; it can be used before conventional treatments to reduce tumor size; it is an organ and function 
sparing treatment and it is the treatment of choice for hemorrhagic and painful tumors” (Sersa, 2006). The 
high efficiency of ECT to treat cutaneous and subcutaneous tumors leads research to develop methods to 
treat tumors less accessible such as internal tumors and tumors of larger size. Recent technical advances, 
especially on the design of the electrodes (Mahmood et al., 2011; Miklavcic et al., 2012), permit the 
treatment of metastases in the liver and bone, brain tumors, and colorectal and esophageal tumors. Clinical 
experiences in these new fields of application of electrochemotherapy emerge (Agerholm-Larsen et al., 
2011; Edhemovic et al., 2011; Miklavcic et al., 2012). 
II.7.b. Electrofusion 
 Electrofusion is a two-step process. It requires the electroporation of cell membranes and a physical 
contact between two electroporated cells (Zimmermann, 1982; Saunders et al., 1986; Teissie et al., 1986). 
The electric field parameters defined for cell electropermeabilization are comparable to those needed cell 
electrofusion. The main differences between the two processes are the critical voltage required for 
electrofusion, which is higher than for electroporation given that both sides of the membrane have to be 
permeable (Teissie et al., 1993; Abidor et al., 1994; Teissie et al., 1998), and the duration of the fusogenic 
state, which lifetime is smaller compared to the resealing process (Sowers, 1986; Teissie et al., 1986; Ramos 
et al., 2000). Several important applications have been developed such as immunotherapy and antibody 
production. Immunotherapy applications mainly concern the fusion of dendritic cells (antigen presenting 
cells) with tumor cells (Kugler et al., 2000; Orentas et al., 2001; Hayashi et al., 2002; Siders et al., 2003; 
Trevor et al., 2004; Shu et al., 2006; Sukhorukov et al., 2006; Siders et al., 2009; Hu et al., 2013). The 
hybrid cell combines properties of both cells meaning that it produces antigens against the tumors. Such 
hybrid cells can activate the immune system efficiently via the T lymphocytes and reduce tumors sizes. 
Dendritic cells can also be electrofused with, for instance, islet cells to produce hybrids able to treat diabetes 
(Yanai et al., 2013). Very effective production of antibodies can be generated by electrofusion of B 
lymphocytes (which produce antibodies). This technique can be used in the laboratory for antibody 
production and also finds clinical applications (Karsten et al., 1988; Foung et al., 1989; Vanduijn et al., 
1989; Hui et al., 1993; Karsten et al., 1993; Dessain et al., 2004; Yu et al., 2008).  
II.7.c. Electroinsertion  
 It is possible to insert proteins having a transmembrane domain into the membrane of 
electropermeabilized lipid vesicles, red blood cells, CHO cells and K562 cells (Mouneimne et al., 1990; el 
Ouagari et al., 1993; Raffy et al., 1995; Raffy et al., 1997; Raffy et al., 2004). 
II.7.d. Irreversible electroporation 
 Irreversible electroporation has been described “as an alternative minimally invasive surgical 
technique in medicine for tissue ablation”. The electric fields have strength in the range of 1.5 kV/cm and 
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duration of about 300 ms. Three series of 10 pulses are usually applied. For in vivo applications, the use of 
mathematical models to position the electrodes and calculate the optimal field parameters are of great help 
for effective treatment (Davalos et al., 2005; Miller et al., 2005; Edd et al., 2006; Al-Sakere et al., 2007; 
Rubinsky et al., 2007). 
 Irreversible electroporation can also be useful for microbial deactivation in water and food treatment 
(Morales-de la Pena et al., 2011). The applied electric pulses cause irreversible damage of treated cells and 
they should thus be chosen carefully (Teissie et al., 2002). Pulse strength for microbial inactivation is in the 
range of 20-35 kV/cm, pulse duration is some milliseconds or less, and ten to hundreds pulses can be applied 
(Zhang et al., 1995; Angersbach et al., 2000; Beveridge et al., 2002). For food preservation, electric field 
strengths are lower. The main issue is to choose parameters which are efficient to deactivate cells and 
necessitate minimal power consumption (Lebovka et al., 2000; Lebovka et al., 2002; Toepfl et al., 2007). 
III. DNA electrotransfer 
 DNA electrotransfer is one of the successful non-viral methods used to transfer genes into cells in 
vitro and in vivo. It has the main advantages of being easy to perform, fast, reproducible and safe. Gene 
electrotransfer and expression appear as a complex and multistep process, which requires 
(i) permeabilization of the plasma membrane, (ii) electrophoretic migration of the DNA (iii) DNA/membrane 
interaction, (iv) translocation of the plasmid across the membrane (v) intracellular migration, and (vi) DNA 
passage through the nuclear envelope (Golzio et al., 2002b; Golzio et al., 2004; Escoffre et al., 2009b). 
III.1. Threshold 
 For DNA electrotransfer to occur, the electric field strength has to be larger than a minimum value 
corresponding to the electropermeabilization threshold (Wolf et al., 1994; Golzio et al., 2002b). In vitro, the 
threshold corresponds to the value Ef giving permeabilization of the side facing the cathode (Golzio et al., 
2002b). Regardless of the cell viability, increase of the electric field strength improves the DNA transfer up 
to a certain level where transfection efficiency decreases again (Chu et al., 1987; Wolf et al., 1994; Hui, 
1995). This corresponds to cell viabilities between 30% and 80%. Moreover, the transfection efficiency has 
been shown to be directly proportional to (1-Ep/E) which corresponds to the definition of the 
electropermeabilized area (Wolf et al., 1994). Therefore, the larger the cell surface brought to the permeable 
state, the higher the transfection level. The importance of the cell permeabilization has also been proved in 
vivo using MRI (Paturneau-Jouas et al., 2003). The areas where permeabilization was shown, using contrast 
agent (gadopentate dimeglumine), corresponded to the areas where the plasmid coding for the -
galactosidase was expressed. Optimal DNA electrotransfer conditions depend on the cell type and the 
physiological state such as the phase in the cell-division cycle (Winterbourne et al., 1988; Kalinski et al., 
1997; Lurquin, 1997; Golzio et al., 2002a).  
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III.2. Electrophoretic component 
 DNA electrotransfer is possible only if the DNA is present before the application of the electric field. 
When DNA is added after the electropermeabilization even after very short time (2 s), the transfection 
efficiency is insignificant in mammalian cells and tissues (Winterbourne et al., 1988; Bahnson et al., 1990; 
Klenchin et al., 1991; Sukharev et al., 1992; Wolf et al., 1994; Eynard et al., 1997; Rols et al., 1998a; Mir et 
al., 1999), yeast (Ganeva et al., 1995; Eynard et al., 1997) and bacteria (Taketo, 1988; Xie et al., 1990; 
Eynard et al., 1997). It has been mentioned that the permeable structures allowing for the DNA to enter in 
cells were present only when the electric field was present meaning that these structures were short-lived 
ones (Wolf et al., 1994). The reason is simply that the DNA requires electrophoresis to be able to interact 
with the cell membrane. DNA is highly negatively charged as the cell surface is. The electrophoresis could 
be a means to overcome the electrostatic repulsion existing between DNA and membrane. The importance of 
the electrophoretic component has been highlighted first by growing cells in a monolayer such that the 
polarity of the field would bring molecules towards or away from the cells. Polarity inducing the migration 
of negatively charged compounds towards the cells engenders 10 times higher transfection efficiencies than 
inverted polarity (Klenchin et al., 1991). Moreover, the addition of agents reducing the electrophoretic 
mobility, such as cations to reduce the net charge of the DNA or Ficoll to increase the viscosity of the 
medium, show a concentration dependent decrease of the transfection efficiency. In addition, when a short 
and high voltage (HV) inducing electropermeabilization but not DNA electrotransfer is followed by a long 
low voltage (LV), DNA transfection becomes efficient (Sukharev et al., 1992). The LV alone does not 
induce electropermeabilization and DNA electrotransfer. These observations were confirmed in vitro and in 
vivo for numerous tissues (Mir et al., 1999; Satkauskas et al., 2002; Pavselj et al., 2005; Satkauskas et al., 
2005; Saito et al., 2006; Andre et al., 2008; Kanduser et al., 2009; Pavlin et al., 2010). 
III.3. Asymmetry 
 The involvement of the electrophoretic component leads to an asymmetrical interaction of the DNA 
with the membrane. Visualization on the single-cell level of fluorescently labeled DNA using microscopy 
confirmed that DNA interacts with the cell only on one side (Golzio et al., 2002b; Faurie et al., 2004; Phez et 
al., 2005; Rebersek et al., 2007; Faurie et al., 2010; Escoffre et al., 2011; Escoffre et al., 2012b). It is the 
side of the cell facing the cathode (Fig. 41a). DNA electrophoresis makes it moving in the direction of the 
electric field lines towards the anode. If a cell is on its way and the electric field lower than the threshold 
value, DNA flows along the cell membrane as the field lines do (Zimmermann, 1982; Neumann, 1992). If a 
permeabilized cell is on its course, field lines traverse the membrane and DNA is brought to the cell surface. 
The asymmetrical interaction of the DNA with the cell membrane is directly linked to the direction and the 
polarity of the electric fields (Golzio et al., 2002b; Faurie et al., 2004; Phez et al., 2005; Rebersek et al., 
2007; Faurie et al., 2010; Escoffre et al., 2011; Escoffre et al., 2012b). When applying bipolar electric field 
(alternating current), DNA interaction is visible on both sides of the cell facing the electrodes (Fig. 41b). 
When applying bipolar and crossed electric fields, DNA interaction with the membrane is visible all along 
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the cell membrane. Changing polarity and orientation has been shown to improve gene expression in vitro 
and in vivo (Tekle et al., 1991; Faurie et al., 2004; Saito et al., 2006; Faurie et al., 2010). 
 
 
Figure 41: Asymmetry of the DNA interaction with the membrane on adherent cells. (a) Formation of DNA-
membrane complexes only on one side of the cell surface (facing the cathode) under unipolar conditions. (b) Formation 
of DNA-membrane complexes on both sides of the cell surface in bipolar conditions. From (Rebersek et al., 2007)  
III.4. DNA-membrane interaction 
 DNA-membrane complexes are formed only when the electric field is present, and grow as local 
aggregates as a function of the electric field strength E and the cumulated duration NT, when this duration is 
larger than about 1 ms, (Fig. 42) (Golzio et al., 2002b; Escoffre et al., 2011; Escoffre et al., 2012b; Haberl et 
al., 2013).  The length L of the cylinder with the electrophoretically accumulated DNA content at the 
membrane surface is given by: 
 ENTL   
where µ is the electrophoretic mobility of the DNA molecules. µ = 1.5 10-4 cm2/Vs (Neumann, 1992). For an 
electric field applied as 10 pulses of 5 ms and 0.4 kV/cm, L = 30 µm, which gives an accumulation factor of 
30. 
 
 
Figure 42: Influence of the parameters of the electric field on the DNA accumulation at the cell surface (electric 
field strength E, pulse duration T and number N). (a) At fixed N and T, the area of DNA accumulation or the 
number of DNA aggregates at the cell surface increases with increasing E. (b) At fixed E, the amount of DNA 
accumulating in the aggregates increase when increasing N and/or T. Inspired from (Escoffre et al., 2012b). 
General background - Chapter 4: Electroporation - III. DNA electrotransfer 
 
- 82 - 
 Once the field is turned off, the growth of the plasmid aggregates is stopped. The plasmid-membrane 
interaction is not evenly distributed on the permeabilized areas but is detected in association with membrane 
at some sites called competent sites with sizes ranging from 0.1 µm to 0.5 µm (Fig. 41,42) (Golzio et al., 
2002b). Already after the first pulse, the sites are defined and the following pulses induce only the linear 
accumulation of the DNA at these sites (Fig. 42b) (Escoffre et al., 2011; Escoffre et al., 2012b). The electric 
field is necessary for the creation of these sites which are competent within a millisecond time range 
(Fig. 42a). The strength E controls the number of competent sites and the cumulated duration of the pulses 
controls the amount of DNA added in (Golzio et al., 2002b; Escoffre et al., 2011; Escoffre et al., 2012b). 
 The DNA-membrane interaction is not only an accumulation of plasmids at the membrane surface 
level, but also a plasmid insertion into the permeabilized membrane occurs. The DNA complexes formed at 
one side of the cell are still present and thus resist to electrophoresis if an electric field of inverted polarity is 
applied (Golzio et al., 2002b; Faurie et al., 2004; Rebersek et al., 2007). However, recent work has shown 
the importance of the delay between the pulses (Faurie et al., 2010). When this delay is 100 µs or lower, the 
overall interaction (both sides of the cell) measured after the electric field series is higher under unipolar 
conditions compared to bipolar ones. If the delay is set to 10 s, the overall interaction under bipolar 
conditions is about twice that of the unipolar ones. Some DNA, first accumulated at the membrane, leaves 
the complexes through opposite electrophoretic force if applied within the 10 s. The quantification of the 
DNA amount present at the membrane after each pulse, measured only on one side of the cell, shows indeed 
a removal of the DNA due to the inverted polarity (Phez et al., 2005). This loss was partial and represented 
only about 20% with a delay of 2 s between inverted fields. Over the pulse application, the resulting DNA 
amount increases for the first 9 pulses after which neither accumulation nor removal is measured. “These 
results reveal the existence of two classes of plasmid DNA-membrane complexes: i) complexes of low 
stability from which plasmid DNA can leave and return to the pulsation buffer, and ii) complexes of high 
stability, where plasmid DNA cannot be removed even by applying electric pulses of reversed polarity” 
(Faurie et al., 2010). A time span between 2 s to 10 s appears to be needed to get a stable plasmid-membrane 
complex, after a 5 ms pulse. Complexes of high stability represent DNA irreversibly inserted into the 
membrane. 
 The plasmid aggregates, which are anchored in the membrane after the electric field application, can 
nevertheless remain sensitive to the degrading action of nucleases added post-pulse, even if these are known 
not to cross the membrane (Eynard et al., 1997). For CHO cells, up to 1 min after the application of the 
electric field, the addition of DNase in the cell solution disturbs gene expression. This time varies according 
to the cell type or the tissue and can be much shorter (Taketo, 1988; Klenchin et al., 1991; Wolf et al., 1994; 
Ganeva et al., 1995; Eynard et al., 1997). The presence of DNase only 2-3 s before the application of the 
electric field was sufficient to suppress gene expression (Klenchin et al., 1991; Ganeva et al., 1995). The 
DNA is inserted into and protected by some undefined structures that need about 1 min to be formed. The 
DNA translocation through the membrane is relatively slow and achieved after the end of the 
electropulsation. Several minutes after the electropulsation, plasmids are still present at the cell surface 
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(Golzio et al., 2002b). The biophysical structure of the membrane-plasmid complex remains to be 
characterized. 
III.5. DNA Internalization 
 The way the DNA is internalized is not yet well understood. Several models are proposed, some do 
not explain all experimental observations and others have to be proved. 
III.5.a. Electropores 
 Krassowska’s model corroborates the first proposed mechanism, in which single DNA plasmid 
crosses the membrane via stable macropores (Smith et al., 2004; Krassowska et al., 2007; Kennedy et al., 
2009). These field-generated defects are due to the modulation of the cell membrane potential. The model 
relies on tension-coupled pores that do not bring membrane rupture (a dramatic aspect of the classical 
electropore model (Neumann et al., 1982; Weaver et al., 1996)). It predicts the creation of several hundreds 
of thousands of pores in which a large population (98%) contains small pores (1 nm radius) and a small 
population (2%) contains large pores (20 nm radius on average but up to 400 nm). The distribution of the 
pore populations at the poles of the cell facing the electrodes as well as the creation and expansion time 
scales are fairly consistent with experimental evidences. This model predicts pores large enough to allow for 
the plasmid uptake, even in its circular conformation, given that the effective radius of the DNA varies 
between 5 nm and 15 nm for a 7 kb plasmid (Fig. 43a) (Rybenkov et al., 1997). These pores stay opened for 
the entire duration of the electropulsation giving the necessary time for the plasmid to access the cytoplasm 
(Sukharev et al., 1994). 
 
 
Figure 43: Models of DNA internalization in cells through electropores. (a) Electric pulses induce macropores large 
enough to let DNA diffusing through them. (b) DNA interacts with cationic lipids (red) at the pore edges and via 
coalescence of the pores DNA passes through the membrane. From (Escoffre et al., 2009a) 
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 However, this model is confronted with experimental contradictions the first of which is the 
resealing time. The resealing time of such pores lies within a millisecond which is far faster than the 
observed permeabilization which lasts several minutes (Rols et al., 1990a; Tekle et al., 1991; Bier et al., 
1999; Gehl et al., 2002). In addition, for CHO cells, plasmid accessibility to DNase up to one minute 
following the end of electropulsation shows that the internalization of the plasmid take place after 
electroporation (Eynard et al., 1997). Theoretical models calculate that stable pores have radiuses of only a 
few nanometers and that larger pores are unstable (Freeman et al., 1994; Joshi et al., 2000). These models 
are confirmed experimentally (Schwister et al., 1985; Glaser et al., 1988; Kakorin et al., 2002). 
Krassowska’s model can nonetheless be reconciled with the finding that plasmid entry into the cell occurs 
post-pulse. It has been proposed that plasmid translocation depends on the plasmid-membrane (cationic 
lipids like sphingosines) interactions and may occur by a coalescence of many small 1 nm pores (Fig. 43b) 
(Neumann et al., 1996; Hristova et al., 1997; Rols et al., 1998b; Rols et al., 1998c). The slow transfer of 
DNA through the electropermeabilized membrane (1 min) reflects the time needed for the pores occluded by 
DNA to coalesce into large enough pores to allow for its passage (Neamtu et al., 1999). 
III.5.b. Electrophoresis 
 Another model proposes that, although electropores or defects are involved, the DNA entry inside 
the cell takes place under the control of DNA electrophoresis. It concentrates the plasmid molecules near the 
membrane surface and pushes them through the putative electropores (Winterbourne et al., 1988; Klenchin et 
al., 1991; Sukharev et al., 1992; Spassova et al., 1994; Tekle et al., 1994). The external electric field 
imposed onto the cell does not penetrate through the initially intact membrane. As soon as electropores or 
defects are formed, the electric field crosses the membrane through these conducting structures (Fig. 36) 
(Zimmermann, 1982). The lines of electric field are concentrated in the pores, so the strength of the electric 
field E in the pore and in its vicinity is higher than that in the bulk (Klenchin et al., 1991; Sukharev et al., 
1992). At appropriate field polarity, the polyanionic DNA experiences a strong attraction to the pore. Even if 
the defect size (~1 nm) is smaller than the effective diameter of DNA, the DNA can enter the cell. The 
electrophoretic pressure of DNA onto the electropermeabilized membrane is strong enough to create a path 
(Bananis et al., 2000). The mechanical interaction between the pores and the plasmid induces an adjustment 
of the pore sizes and/or lifetimes that allow plasmid entry into the cell. It assumes that the DNA molecule 
may prevent resealing of the membrane if it is still partially through the pore when the field is turned off. The 
plasmid may interact with the electropermeabilized membrane in three possible ways (Fig. 44) (Sukharev et 
al., 1992):  
(i) The DNA aligns according to the electric field direction and moves toward the permeabilized 
membrane. The plasmid may interact with a single membrane defect (pore) which becomes wider upon 
plasmid interaction by the action of electrophoretic forces (Fig. 44a). 
(ii) The linear plasmid passage can be initiated by penetration of one end of the thread, which then 
leads the whole molecule through one pore under the electrophoretic force (Fig. 44b). 
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(iii) The DNA molecule can be involved in two (or more) pores and moved by electrophoretic forces. 
It cuts the membrane between these pores as a sharp thread can do (Fig. 44c). 
 
 
Figure 44: Models of DNA internalization in cells via electrophoresis. (a) Non-linear DNA is aligned with the 
electric field line and is electrophoretically pushed through one pore that becomes wider upon its passage. (b) Linear 
DNA has one end inserted in the pore and the electrophoretic force drives the DNA through it. (c) Linear DNA has two 
(or more) insertions in the membrane where the pores are and its electrophoresis cut the membrane between these pores 
(white part of the membrane). From (Sukharev et al., 1992) 
 This model, especially (i), can explain the observed accumulation and insertion of the non-linear 
DNA at the membrane (Golzio et al., 2002b; Faurie et al., 2004; Phez et al., 2005; Rebersek et al., 2007; 
Escoffre et al., 2011), including the minute range resealing and the slow translocation of the DNA through 
the cell membrane very well.  
 However, if electrophoresis is the only driving force for the plasmid translocation, comparable 
transfection efficiencies should be observed for equivalent ENT values (field strength and cumulated pulse 
duration). In the case of HeLa cells, the number of transfected cells as a function of ET values is different 
according to whether short or long electric pulses are used (Hui, 1995). Then, for constant ENT values, 
transfection level depends on T (Rols et al., 1998c). For that reason, the electrophoretic movement cannot be 
the only driving force for the plasmid internalization into the cells but it clearly supports the formation of 
DNA aggregates inserted in the membrane such that it is part of the actual model. 
III.5.c. Endocytosis (-like?) 
 A mechanism of endocytosis-like was first suggested after the trapping of DNA inside a giant 
unilamellar vesicle (GUV) under the application of electric fields (Chernomordik et al., 1990). DNA entered 
the GUV filled with ethidium bromide, which is a DNA fluorescent probe, but no fluorescence was detected 
until sonification of the GUV which is known to break membranes. This was interpreted as the DNA 
entering the GUV via the formation of a vesicle inside the GUV. Lately the ability to generate lipid vesicles 
and tubules inside GUV during electropulsation has been observed using fluorescence microscopy (Portet et 
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al., 2009). Endocytic process for DNA internalization has been mentioned by Klenchin et al (Klenchin et al., 
1991) and Tsong et al. (Tsong, 1991) without giving any experimental evidence of its existence. Other 
models are based on the observations of macromolecules entry, which are not DNA, and for most of the case 
where electric field conditions were very different from the usual DNA electrotransfer conditions. 
 
 
Figure 45: Models of DNA internalization in cells via endocytosis-like mechanism. (a) DNA electrophoresis brings 
the DNA molecule(s) at the membrane defect (pore) and provides the force to generate membrane invagination that 
buds off in vesicle containing DNA. From (Klenchin et al., 1991) (b) Low electric field conditions induce local 
segregation of charged membrane components (lipids and proteins) in the outer leaflet of the cell membrane. The 
difference of charge density across the membrane generates spontaneous membrane curvature and facilitates molecule 
absorption at the surface. From (Antov et al., 2005) 
(i) It is believed that electrophoretically driven DNA can provide the necessary force to initiate a 
membrane invagination where membrane defects are present (Fig. 45a) (Klenchin et al., 1991; Tsong, 
1991; Sukharev et al., 1992). This membrane invagination could then bud off inside the cell and the DNA 
would be trapped in endosome-like vesicles.  
(ii) The term electroendocytosis often refers to endocytic-like vesicles formation under low (but 
long, several minutes) electric fields (LEF) conditions that do not bring the membrane into the permeable 
state. The endocytosis would be stimulated by the redistribution of the charges (lipids, proteins) in the cell 
membrane due to the electric field (Antov et al., 2004; Antov et al., 2005). Indeed local lateral 
electrophoresis of proteins and lipids only in the outer leaflet of the membrane induces a local difference 
of charge density across the membrane that leads to a spontaneous membrane curvature towards the 
cytoplasm (Fig. 45b). The difference of charge density would also be responsible for the membrane 
fission into vesicles (Antov et al., 2005). 
(iii) Under electropermeabilization conditions, endocytosis and especially macropinocytosis have 
been suggested due to experimental evidences but no clear mechanism has been proposed. The formation 
of endocytic-like vesicles is cytoskeleton dependent. It could be due to the collapse of electroinduced 
formation of ruffles, microvilli, blebs at the surface of the membrane (Lambert et al., 1990; Glogauer et 
al., 1993; Rols et al., 1995). If DNA is present at the locus where the collapse takes place it could be 
internalized in the macropinosomes. 
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(iv) Tsong et al. (Tsong, 1991) suppose that the denaturation of membrane proteins (e.g. protein 
channels) or any mechanical injury due to the electric field itself or the associated joule heating, leads to 
some cell repair mechanisms consisting in the internalization of the damaged proteins/membrane into 
vesicles for recycling. DNA being present nearby the surface (via electrophoresis or not) would be 
engulfed in these vesicles. 
 
 The model (i) assuming DNA electrophoretically driven formation of membrane invagination is 
indirectly supported by the formation of DNA-membrane structures inserted into the membrane only if DNA 
is present during the electric field pulses (Golzio et al., 2002b; Faurie et al., 2004; Phez et al., 2005; Escoffre 
et al., 2012b). DNA sensitivity to nuclease action up to one minute after the pulses would reflect the time 
needed for the closure of the membrane invagination. The persistence of the DNA at the membrane level for 
several minutes would be the time necessary to bud off the vesicle. 
 The first evidence of electroinduced endocytosis concerned the model (iii) with the internalization of 
macromolecules such as albumin and gold particles (Lambert et al., 1990). Observations with fluorescence 
and electron microscopy showed the macromolecules being trapped in vesicles. Electron microscopy showed 
also an increase of membrane ruffling and vesiculations for electroporated cells which were already observed 
by other groups (Escande-Geraud et al., 1988; Popov et al., 1988; Gass et al., 1990; Pehlivanova et al., 
2012). Quantifications with flow cytometry confirmed significant increase of FITC-BSA translocation into 
the cell after electropulsation (Zimmermann et al., 1990; Glogauer et al., 1993). Disruption of the actin 
cytoskeleton with the cytochalasin B drug inhibited its entry (Glogauer et al., 1993). Glogauer et al. 
measured in addition an enhanced uptake of lucifer yellow, another fluid-phase endocytic marker, of 
membrane lipids and of membrane glycoproteins (Con A) due to electric fields. Observations, using 
microscopy, confirmed the presence of electroinduced vesicle patterns inside electroporated cells with FITC-
BSA, FITC-Con A, -galactosidase, 70 kDa FITC-dextran (Zimmermann et al., 1990; Glogauer et al., 1993; 
Rols et al., 1995). In addition, the -galactosidase entry was completely suppressed when microtubules were 
disrupted using the colchicine drug (Rols et al., 1995). All these investigations concerned proteins and not 
DNA. Apart from the possible actin dependence, any further characterization of the cell components 
involved in the internalization was performed. Interestingly, the macromolecules were added to the cell up to 
4 h after the application of the electric field. Their presence during the electropulsation sometimes revealed 
homogeneous labeling of the cytoplasm (Zimmermann et al., 1990; Rols et al., 1995). This is a fundamental 
difference compared to DNA which cannot enter cells if added after the pulses. The mechanisms allowing 
for the uptake of macromolecules (proteins) into vesicles after the electropulsation cannot explain the DNA 
uptake. The later observations of DNA in aggregates at the membrane and inside the cytoplasm, however, 
support an endocytic process (Golzio et al., 2002b). Moreover, post-pulse temperature has a strong effect on 
DNA expression (Rols et al., 1994; Eynard et al., 1997). Cell cultured 10 min only at 4 °C after the 
application of the electric field showed almost no expression. Increasing the temperature up to 37 °C 
increases the transfection efficiency. The processes occurring in the 10 min following the pulsation are cell 
dependent. Maybe a combination of models (i) and (iii) occurs with an electrophoretically driven insertion of 
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the DNA in the membrane, accompanied or not with membrane invagination, and a cytoskeleton dependent 
mechanism (ruffles, microvilli, blebs) enabling the vesicle formation. 
 The involvement of endocytosis was also shown to take place for LEF conditions (model (ii)). LEF 
conditions mean series of direct current electric pulses with electric field strengths from 2 V/cm to 
100 V/cm, pulse durations from 90 µs to 2 ms, frequencies between 100 Hz and 1000 Hz and exposure time 
range of 1-10 min (Rosemberg et al., 1997). A recent study compared the uptake of PI as 
electropermeabilization probe and the uptake of FM4-64 as lipid membrane probe. This work clearly 
demonstrates that LEF conditions stimulate vesicles formation without bringing the cell into the permeable 
state (Lin et al., 2011). The threshold of electroendocytosis is lower than the one of electropermeabilization. 
Increasing the electric field strength increases the number of vesicles. Electric fields higher than the 
permeabilization threshold still stimulate endocytosis, therefore hinting at that electroendocytosis taking 
place in parallel to permeabilization process. However, even if the pulse duration was similar to the optimal 
one for DNA electrotransfer (ms), exposure time to the electric field and frequency were much higher 
(respectively 10-60 s and 100 Hz). Only macromolecules such as BSA or dextran were investigated. The 
absorption at the membrane and uptake across the membrane of FITC-BSA was highly increased under LEF 
exposure (Rosemberg et al., 1997; Antov et al., 2004; Antov et al., 2005). FITC-BSA observations using 
microscopy show vesicle patterns and colocalization with a membrane probe (labeled DHPE) confirming the 
presence of vesicles enclosing the macromolecules. The enhanced uptake of the small fluid-phase marker 
lucifer yellow confirms the presence of endocytic processes (Antov et al., 2004; Mahrour et al., 2005). 
Absorption of the macromolecule is temperature independent but its uptake depends on temperature (Antov 
et al., 2004; Antov et al., 2005). The local lateral electrophoresis of charged lipids and proteins would induce 
local depletion of membrane in negative charges that would facilitate interaction with macromolecules 
(Antov et al., 2005). This mechanism can occur at low (4 °C) or physiological temperature (37 °C). Even if 
the local difference of charge density could generate spontaneous membrane curvature, the further 
invagination and the budding off of the vesicles, probably because of cell machinery involvement, is optimal 
at 37 °C. Indeed, the use of inhibitors showed that LEF stimulates vesiculation or uptake through 
microtubule dependent and clathrin-dependent pathways whereas caveolin-dependent endocytosis does not 
seem to be involved (Antov et al., 2004; Lin et al., 2011). Other LEF stimulated pathways should therefore 
concern macropinocytosis and pathways independent of clathrin and caveolin. Support for the contribution 
of macropinocytosis comes from measured enhancement of membrane ruffling at the cathode side under 
LEF (Li et al., 2002). It is interesting to note that when BSA is present during the LEF, there is significantly 
higher absorption and uptake (Antov et al., 2005). This is interpreted such that electrophoresis of the 
macromolecule increases the collision rate with the cell membrane. The contribution of the macromolecule 
electrophoresis represents 70% of the increased BSA absorption compared to non-field treated cells. The 
macromolecule electrophoretic component has a high importance as it is the case for DNA electrotransfer. 
Nevertheless, BSA added after the pulsation still can be internalized. LEF conditions do not bring the 
membrane into the permeable state which is a minimum requirement for DNA to interact with the membrane 
and its further expression in cells. This fundamental difference supposes that in parallel to the mechanism 
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involved in LEF conditions, must take place additional physical/chemical structures created only during 
electropermeabilization. It could be that this concerns the stable insertion of the DNA at sites where 
membrane defects (pores?) are present. 
 To my knowledge, model (iv) has no direct evidence for its involvement in the transfer of DNA or 
other molecules due to electropulsation. Cell membrane repair can lead to endocytosis for extracting 
damaged parts of the membrane or to compensate exocytosis bringing new functional components at the 
membrane (Idone et al., 2008; Draeger et al., 2011). Pore forming proteins such as bacteria toxins or 
membrane attack complex (MAC) of the blood complement leave some transmembrane pores that are 
eliminated by endocytosis. Any membrane repair mechanism involving exocytosis and endocytosis is 
initiated by calcium influx through the damaged membrane. Electroinduced DNA binding to the surface and 
DNA expression due to electroporation are both improved in a concentration dependent way if calcium is 
present in the pulsation buffer (Xie et al., 1990; Neumann et al., 1996). Moreover, with the use of 
microelectrodes, local intracellular calcium is shown to be recruited at the locus of the electroporated 
membrane (Hai et al., 2012). Electroporation is also shown to activate exocytosis since lysosome content is 
released at the cell surface. It is even proposed to use electroporation to quantify lysosomal exocytosis 
competences of cells (Huynh et al., 2004). Since exocytosis is activated due to cell repair mechanisms after 
electroporation, one can expect endocytosis to occur to maintain cell membrane length. Whether this 
endocytosis process occurs and whether DNA is present in these vesicles has to be proved. 
 
 The electroinduced internalization of membrane lipids as vesicles, the electroinduced entrapment of 
macromolecules, other than DNA, into intracellular vesicles, the electrostimulation of fluid-phase 
endocytosis and the temperature dependence of these processes lead to the hypothesis that electrotransferred 
DNA could be internalized by endocytosis as well. The hypothesis of DNA endocytosis is fairly consistent 
regarding the large size of the DNA and the formation of local aggregates inserted into the membrane for 
several minutes. There is a clear need of investigations in that direction. In the meantime of my PhD, one 
article was published concerning this topic. The use of endocytic inhibitors (chlorpromazine, genistein and 
dynasore) has been shown to reduce DNA expression in cells (Wu et al., 2011). It gives strong hints at the 
involvement of clathrin-, caveolin-, and dynamin-dependent endocytosis. It is important to note that any 
endocytosis-like model would only explain the internalization of large molecules as it does not support the 
free membrane crossing of small molecules. It has therefore to be considered to occur in parallel to another 
model valid for small molecule exchange. 
III.6. Intracellular migration 
 The cytoplasm contains a dense cytoskeleton network (microfilaments, microtubules, and 
intermediate filaments), along with a variety of cellular organelles and abundant amounts of proteins and 
other molecules. This mesh-like structure hinders the diffusion of plasmid DNA. The mobility of small 
molecules (i.e. less than 500-750 Da) in the cytosol is reduced to only 3-4 fold less than in water, but the 
mobility declines rapidly with the larger sized molecules (Seksek et al., 1997; Luby-Phelps, 2000). The 
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mobility of microinjected plasmid DNA is extremely small or even non-existent in the cytoplasm or cell 
nucleus (Dowty et al., 1995; Luby-Phelps, 2000; Lukacs et al., 2000; Dauty et al., 2005). Under the 
conditions induced during electropermeabilization, the time a plasmid DNA takes to reach the nucleus is 
significantly longer (several hours) than the time needed for a small molecule (few seconds) (Golzio et al., 
2002b). It is observed to cross the cytoplasm in the aggregated form. DNA expression is detected 3 h after 
the pulsation, reaches is maximum at around 12 h and stays at this level of expression for 16 additional hours 
before decreasing (Rols et al., 1998b). When 20 min depletion of ATP content in the cell is performed up to 
2.5 h after pulsation, the efficiency of transfection is affected but not the cell viability. Depletion performed 
3 h or later after the electrotransfer does not affect DNA expression. These results show that the intracellular 
route of DNA is dependent on cellular energy levels and therefore is based on cell driven processes. It is 
possible that plasmids interact with cytoskeletal motors, such as viruses and other vectors do, and travel 
towards to the nucleus in a directed manner. Electrotransferred plasmid DNA could use the microtubules and 
their associated motor proteins to navigate in the cytoplasm (Vaughan et al., 2006; Vaughan et al., 2008; 
Badding et al., 2013). Indeed, A459 cells first electroporated in the presence of luciferase reporter plasmid 
DNA and then incubated with taxol, a drug that stabilizes the microtubules, exhibited higher DNA 
expression. Other drugs such as nocodazole which disrupts the microtubules, or actin altering drugs did not 
affect DNA expression (Vaughan et al., 2006). However, microinjected DNA expression (GFP) in TC7 cells 
was decreased when microtubules were disrupted or dynein inhibited. In the meantime of my PhD work, 
interaction between electroporated plasmid and the motor protein dynein has been highlighted (Badding et 
al., 2013).  
 Given the different models of internalization, DNA could enter the cell in a free form (electropores 
or electrophoresis) or could be trapped into some endosome-like vesicles. In the first case, DNA would not 
remain free for a long time. It is known that DNA released in the cytoplasm, after a direct entry 
(microinjection) or after endosomal escape, will rapidly form complexes with DNA-binding proteins, 
polyamines and other polycations (Fath et al., 1997). These complexes could serve as charge neutralization, 
and the induced condensation of the DNA, reducing therefore its size, may allow enhanced motion. It could 
as well protect DNA from its otherwise rapid degradation (Lechardeur et al., 1999). It is possible that some 
of the proteins that bind the DNA serve as adapters to interact with cytoskeleton-based motors. DNA does 
not bind directly to motor proteins so the only way free DNA could use intracellular transport would be 
through intermediary proteins. If DNA enters via an endocytic (-like) process, the membrane of the 
endosomes should therefore already contain the proteins that interact with motor proteins. Endosomes, as 
cell organelles, are efficiently transported through the cell cytoplasm and DNA could take advantage of this 
machinery to reach the nucleus. Coonrod et al. found that all exogenous DNA, including electrotransferred 
ones, colocalized to some extent with cathepsin B, a lysosomal protease, 3 h after the application of the 
electric field (Fattakhova et al., 2006). After electroporation, DNA can be routed to the lysosomal 
compartment and this could be due to a beforehand endosomal trafficking.  
 DNA present in the cytosol after being electrotransferred can be lost before reaching the nucleus, for 
example because of cell division. Stability of plasmid DNA has been quantitatively assessed by 
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microinjection. In such experiments, 50% of the DNA is shown to be eliminated in 1-2 h from HeLa and 
COS cells and in 4 h from myotubes (Lechardeur et al., 1999). Cytosolic elimination of plasmid DNA cannot 
be attributed solely to cell division, since its decrease is also observed in non-dividing cells. Transient 
accumulation of 3’-OH DNA ends is consistent with a fragmentation of the DNA by nuclease. Encapsulation 
of microinjected DNA into stabilized lipid particle delays its degradation for more than 3-fold. Inhibition of 
lysosomal degradation activity by the chloroquine drug induces higher gene expression in many transfection 
methods (Frischknecht et al., 1999; Fujimoto et al., 2000; Fattakhova et al., 2006; Frick et al., 2007). 
 
 The intracellular route of electroporated DNA remains to be elucidated. Involvement of the cell 
machinery seems to be a requirement since DNA diffusion is unlikely as a means of efficient trafficking and 
some evidences point at the cytoskeleton as a partner for the DNA migration. The DNA structure in the 
cytoplasm is completely unknown. It could be free or trapped in vesicles. What is observed is that it keeps its 
aggregated form up to its localization in the perinuclear region and a part of it is probably located into 
lysosomal compartments.  
III.7. Crossing the nuclear envelope 
 The nuclear envelope represents the last, and very important, obstacle to the expression of the 
plasmid DNA. Direct observations 24 h after the electropulsation show that even in DNA expressing cell, 
most of the DNA visible in aggregates remains at the perinuclear region (Golzio et al., 2002b). Only a small 
fraction crossed the nuclear envelope which was nevertheless sufficient to induce well detected expression. 
The lack of efficient nuclear import of plasmid DNA from the cytoplasm was first identified more than 20 
years ago. While molecules smaller than 40 kDa can diffuse through the nuclear pore complexes, larger 
molecules must carry a specific sequence so called the nuclear localization sequence, in order to cross (Dean 
et al., 1999). The relatively large size of plasmid DNA (2-10 MDa, 1 kbp = 0.66 MDa) makes it unlikely that 
the nuclear entry occurs by passive diffusion. With regard to quiescent cells, transfection levels in dividing 
cells are greatly higher which means that DNA takes advantage of destabilization of the nuclear envelope 
during mitosis to enter into the nucleus. The synchronization of the electrotransfer with the mitotic phase has 
been proved to increase DNA delivery (Takahashi et al., 1991; Schwachtgen et al., 1994; Brunner et al., 
2002; Golzio et al., 2002a), supporting the hypothesis that the melting of the nuclear membrane greatly 
facilitates the direct access of DNA to the nucleus. However, at least some of the plasmids used for 
electroporation contain the DTS sequence (DNA nuclear targeting sequence). The presence of this sequence 
is shown to significantly increase interactions with importins, proteins involved in the nuclear import, further 
nuclear localization of the DNA and its expression (Young et al., 2003; Badding et al., 2013). It is an 
interesting observation requiring further investigations in order to conclude about the possible import of 
DNA via nuclear pores. 
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III.8. Associated gene expression 
 The involvement of DNA electrophoresis as an important step for successful DNA electrotransfer 
leads to the statement that the duration and number of pulses also control the transfection efficiency. Indeed, 
at fixed electric field strength, pulses of millisecond range achieve better transfection than pulse of 
microsecond range (Chu et al., 1987; Knutson et al., 1987; Kubiniec et al., 1990; Wolf et al., 1994; Hui, 
1995; Eynard et al., 1997; Mir et al., 1998a; Rols et al., 1998c; Mir et al., 1999; Golzio et al., 2002b; Phez et 
al., 2005). Likewise, larger pulse numbers increase the transfection level. As a confirmation, when applying 
non-permeant LV after permeant HV, increasing the number and the duration of the LV increases gene 
expression (Satkauskas et al., 2002; Satkauskas et al., 2005; Cemazar et al., 2009; Cepurniene et al., 2010). 
The frequency of the pulse is also important. Increasing the delay between the pulses over 1 s, or 100 s for 
HV+LV conditions, strongly decreases gene expression (Wolf et al., 1994; Satkauskas et al., 2002). In CHO 
cells, DNA transfection has been shown to linearly depend on the pulse number N and on the 
electropermeabilized surface (Wolf et al., 1994). The logarithm of the transfection depends linearly on the 
logarithm of the pulse duration T (Wolf et al., 1994). Therefore, the gene expression can be written, for field 
conditions not affecting to large extend the cell viability, (Wolf et al., 1994; Teissie et al., 1999; Escoffre et 
al., 2009a):  
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where K is a constant and f(DNA) a function depending on DNA. It is a complex dependence on, for 
instance, DNA concentration. From a certain concentration, high levels of DNA are toxic (Winterbourne et 
al., 1988; Rols et al., 1992a; Sukharev et al., 1992; Wolf et al., 1994; Vandermeulen et al., 2007)  
 
 Like for small molecule exchange, gene expression depends on the surface of the membrane brought 
into the permeable state (under the control of E), the level of permeability of that surface (under the control 
of N and T). However, for the transfer of small molecules, pulse durations are about hundred of 
microseconds, for DNA transfer, pulse durations are in the millisecond range to ensure DNA electrophoresis 
necessary for DNA to interact with the membrane. 
III.9. Applications 
 DNA electrotransfer in vivo is in many cases more efficient than other non-viral methods such as 
gene gun in the liver (Muramatsu et al., 1997), liposomes in the brain or the cornea (Tsujie et al., 2001; 
Blair-Parks et al., 2002) or cationic lipids in the synovial tissue (Ohashi et al., 2002). Gene expression is 
transient with durations between some weeks (Aihara et al., 1998; Blair-Parks et al., 2002; Dean et al., 2003) 
and several months (Mir et al., 1998a; Mir et al., 1999; Vicat et al., 2000). It is possible to repeat the 
electrotransfer procedure and still reach identical levels of transfection than obtained the first time (Hoover et 
al., 2000; Payen et al., 2001). Electrotransfection of multiple genes in parallel is easily achieved (Goto et al., 
2004). By adapting the procedure to the target tissue, electrotransfer has been successfully applied in various 
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species into various tissues including skeletal muscle, skin, tumors, liver, lungs, kidneys, brain, retina, 
cornea, and heart with minimal tissue damage (Trezise, 2002; Mir et al., 2005; Prud'homme et al., 2006). 
One of the most widely used tissues is the skeletal muscle because it offers many advantages (Prud'homme et 
al., 2006). It is large and easy to access and its organization in long parallel fibers has an optimal orientation 
regarding the direction of the electric field, it thus promotes delivery across the entire length of the fibers. 
Since skeletal muscle cells do not divide, gene expression is stable for a long period. Most importantly 
skeletal muscle produces biologically active proteins and releases them into the bloodstream. Therefore, 
muscle can be used as protein delivery system for distant targets (Goldspink, 2003). The skin is the second 
most broadly used tissue for gene electrotransfer (Gothelf et al., 2010a). It is accessible and large areas can 
be treated. Some epidermal cells, the keratinocytes can also produce and release proteins into the 
bloodstream. Other interesting cells are antigen-presenting cells which are major actors for immunotherapies 
such as vaccination. The first clinical trial on humans was for the treatment of skin cancer (Daud et al., 
2008). However, therapeutic applications concern not only cancers (Heller et al., 2010) but also 
cardiovascular diseases (Adachi et al., 2002), autoimmune diseases (Bloquel et al., 2004), monogenic 
diseases (Gollins et al., 2003), organ specific disorders (Tanaka et al., 2002) and vaccination (Bakker et al., 
2004; Perez et al., 2004).  
III.9.a. Ectopic secretion of protein 
 Gene transfer is an interesting alternative to repeated administrations of recombinant proteins 
because the protein is expressed in a relatively stable manner. Numerous studies with reporter genes showed 
the potential of electrotransfer in muscles for the secretion of proteins at therapeutic levels into the blood 
(Trollet et al., 2006; Trollet et al., 2008). Muscles are good candidates for the secretion of cytokines, 
interleukins, growth and coagulation factors (Kreiss et al., 1999; Bettan et al., 2000). Electrotransfection of 
muscles with plasmids coding for the erythropoietin (Epo) induces a long-term increased production of the 
red blood cells and extends their half lifetime with therapeutic effects in -thalassemia and anemia in mouse 
models (Kreiss et al., 1999; Rizzuto et al., 2000; Maruyama et al., 2001; Payen et al., 2001; Samakoglu et 
al., 2001; Fabre et al., 2008; Gothelf et al., 2010b). DNA electrotransfer in beating cardiac muscle, unlike 
common methods, enhances the delivery of plasmid coding for the VEGF growth factor which stimulates 
revascularization in coronary artery diseases (Ayuni et al., 2010; Marshall et al., 2010). These studies show 
the feasibility of DNA electrotransfer and safe use for heart diseases. Skeletal muscle can be used for the 
secretion of cytokines increasing the survival of mouse model of myocarditis (Adachi et al., 2002). 
Electroporation in skin enhances delivery of plasmid coding for the FGF-2 growth factor that induces 
vascularization and can be used against ischemia (Dean, 2010). DNA electrotransfer into skeletal muscle for 
the production of insulin can be used to treat diabetes (Martinenghi et al., 2002). The transfer of plasmid 
encoding carnitine palmitoyltransferase 1 (CPT1), enzyme regulating the entry of long-chain fatty acyl CoA 
into mitochondria, improves insulin-mediated functions in muscles of insulin-resistant rats subjected to diet 
with high fat content (Bruce et al., 2009). Electroporation in muscle with plasmid carrying interleukins (IL-4, 
IL-10) protects mice against rheumatoid arthritis (Kim et al., 1996; Perez et al., 2002; Saidenberg-
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Kermanac'h et al., 2003; Ho et al., 2004). One session of electrotransfer of plasmid coding for receptors that 
inhibits IL-1 reduced clinical signs of the disease and gave similar results than repeated injection the 
recombinant protein (Kim et al., 2003; Bloquel et al., 2004; Jeong et al., 2004). 
III.9.b. Intracellular protein production 
 The concept of gene therapy was initially developed for monogenic diseases. The idea is to replace 
the identified defective gene by exogenous DNA carrying functional proteins. Duchenne muscular dystrophy 
(DMD) is characterized by a mutation of the gene coding for dystrophin. The absence of functional 
dystrophin engenders muscle degeneration. DMD is a good model for gene therapy since small amounts of 
dystrophin are sufficient to compensate the defective protein and invert the apparent phenotype. The first 
demonstration of local restoration of dystrophin by DNA electrotransfer was performed in dystrophic dog 
muscle (Pichavant et al., 2010). Beforehand, gene electrotransfer in muscle of dystrophic mouse model has 
been shown to efficiently induce full-length dystrophin expression (Gollins et al., 2003; Murakami et al., 
2003; Ferrer et al., 2004; Molnar et al., 2004). It shows that electroporation is only little damaging tissues 
since the fragile dystrophic muscle could well tolerate the applied electric field and even could produce in 
significant amount the protein in the following hours. 
III.9.c. DNA vaccination 
 The idea behind genetic immunization simply consists in injecting a naked plasmid encoding a 
relevant antigen into muscle or skin that will produce antigens in sufficient amounts to initiate targeted 
immune response (Rochard et al., 2011; Sardesai et al., 2011). Advantages are multiples. The target tissue 
takes in charge the entire synthesis of the protein and the processing and presentation of the antigen to the 
lymphocytes. This renders the method cheap, fast and easy. Indeed, DNA is easy and cheap to produce 
compared to proteins or any antigens and it is a stable molecule that can be stored for relatively long periods 
in normal conditions. In addition, naked DNA is the only vector that does not generate anti-vector immune 
response meaning that this approach is safer than the others in term of infection. Finally, because they are 
produced directly by the tissue, antigens are synthesized in their native form and in a stable manner. 
However, efficiencies in immunization are not as high as in classical vaccination techniques and the potential 
risk of DNA integration into the cell genome remains to be evaluated before larger scale use. This type of 
immunization is often developed for vaccination (virus, bacteria), for anticancer immunotherapy, and to 
induce the production of antibodies in high yields. Anticancer immunotherapy is described in the next 
section. 
 Comparison between injection alone or followed by electroporation have demonstrated an increase 
in both cellular and humoral response after electric fields were applied. The addition of electroporation 
provide 10-100 fold augmentation of immune response and defense against pathogen in numerous animal 
models of diseases such as HIV/SIV, malaria, hepatitis B and C, human papilloma, anthrax and influenza 
(see references in (Sardesai et al., 2011). The first human clinical trial has been recently completed and 
concerns the still incurable HIV disease (Vasan et al., 2011). Electroporation, compared to intramuscular 
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injection alone, considerably increases the rate, magnitude and duration of the immune response. The 
vaccine contains 2 plasmids each carrying on 2 antigens under the control of different promoters. The 
average magnitude response was 70-fold higher for one antigen and about 20-fold higher for the others. 
Electroporation permits to reduce the quantity of injected vaccine since 1 mg dose combined with 
electroporation gave higher immune response rates than 4 mg dose simply injected. In parallel, delivery by 
electroporation enhances the quality of the T cell response through the production of several cytokines. 
Another human clinical trial concerned the use of electroporation for the treatment of hepatitis C virus 
(HCV). Electroporation induces a robust T cell immune response against HCV. 70% of the participants 
showed a complete and rapid response (4 weeks) and 83% continued to be free of the virus after six month 
against 40-50% for delivery without electroporation. Other trials on humans using electroporation for the 
delivery of HIV vaccines but also of influenza, human papilloma virus and malaria vaccines have been 
performed or are on going (Bodles-Brakhop et al., 2009; Rochard et al., 2011; Sardesai et al., 2011). The 
results confirm that human DNA vaccination using electroporation is safe and able to significantly elicit the 
immune response.   
III.9.d. Cancer treatment 
 It is the main application domain of gene therapies. The four main approaches are the activation of 
immune response (Bernal et al., 2012), the utilization of suicide gene (Shibata et al., 2002; Goto et al., 
2004), the prevention of tumor angiogenesis (Finetti et al., 2012) and the compensation of defective 
functions due to the loss of tumor suppressor gene or the creation of an oncogene (Prabha et al., 2012). 
These methods can be combined to obtain collaborative effects as it is the case after delivery by 
electroporation of HSV-TK suicide gene and IL-21 immune gene (Hanari et al., 2007). Electrogenetherapy 
can be used in combination with electrochemotherapy, because these two approaches employ different 
process to treat tumor cells. Anticancer agents, injected into the tumor, eradicate the diseased cells and DNA, 
injected at the tumor periphery, transfect healthy cells which can for instance stimulate the immune system 
(Heller et al., 2000).  
 Treatments based on the electroporation-mediated expression of cytokines into tumors are widely 
studied. IL-12, IL-18, IL-2, IFN-α reduce the growth of different tumors and improve animal survival 
(Tamura et al., 2003; Craig et al., 2008; Cemazar et al., 2010; Heller et al., 2010). The first clinical trial on 
humans was for the treatment of skin cancer (melanoma) via electrotransferred IL-12 encoding plasmid 
(Daud et al., 2008). The results showed the safety, reproducibility and clinical efficacy of the strategy 
including cases of remission. Significant necrosis of most of the treated tumors was observed. Interestingly, 
electroimmunotherapy results in the treatment of tumors non-exposed to electric fields which means that a 
systemic response is induced as well (Heller et al., 2010). Since DNA electrotransfer in tumor cells is at the 
moment not very efficient, intramuscular or intradermal gene transfer can be efficiently performed for the 
treatment of tumor at distances. As described above, the produced protein can be released into the vascular 
system and exert therapeutic effects. This DNA vaccination strategy can be very useful for surgically 
inaccessible tumors as well as for metastasis. Some cancer cells express tumor specific or tumor associated 
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antigens (Bei et al., 2010). Therefore, vaccination strategies targeting these specific antigens will help to 
fight cancer such as melanoma, testicular and prostate cancer. Human clinical trials on prostate cancer 
through intramuscular electrotransfer of a plasmid encoding the prostate membrane specific antigen (PMSA) 
have been performed (Low et al., 2009; Chudley et al., 2012). There are significant evidences of improved 
humoral immune responses to DNA vaccination, when delivered by electroporation. Although DNA, simply 
intramuscularly injected, induces some antibody responses (10-fold increase), DNA injection followed by 
electroporation is considerably more effective with up to 400-fold increase of antibody level. It also appears 
that multiple dosing with DNA combined with electroporation induces higher levels of antibody and 
responses can persist for up to 18 months, whereas multiple injections alone result only in very slight 
changes of the antibody production (Low et al., 2009). Several other human clinical trials are currently active 
and attempt to treat prostate cancer (prostate specific antigen), melanoma (xenogenic tyrosinase), or 
leukemia (DOM-Wilm’s tumor epitope fusion antigen), but the majority is still in preclinical phase. 
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Chapter 1: Actin cytoskeleton and DNA electrotransfer 
 Most of the results presented in this chapter have been published, therefore the text contain portions 
that literally cite the article (Rosazza et al., 2011). This work started during my master thesis in Marie-Pierre 
Rols’ research group in Toulouse. Some results, even though obtained during my master research, are 
presented here because of their relevance and complementary with the results obtained during my PhD work. 
 This chapter highlights the relationship existing between the electrotransfer of plasmid DNA and the 
actin cytoskeleton. The mechanism of DNA transfer does not consist in free diffusion through the electrically 
permeabilized membrane as it is the case for small molecules (below 4 kDa). Instead, the DNA accumulates 
at, yet unidentified, competent sites of the plasma membrane generating aggregates or patches of DNA 
visible on the membrane side facing the cathode. These DNA aggregates are anchored and stable for several 
minutes. They are afterwards found in the cytoplasm meaning that they cross the plasma membrane, 
apparently keeping their structure. Diffusion of particles of such size is rather improbable, our hypothesis is 
that endocytosis-like processes may occur. The actin cytoskeleton is found mainly at the periphery of the cell 
and is highly connected to the plasma membrane. It is involved in many processes occurring at the 
membrane level such as endocytosis or any membrane deformation events and the formation and maintain of 
protein clusters. Early stages of endosomal transport are also actin-related. It is therefore legitimate to 
suggest that actin can be involved in the formation/translocation/transport of the DNA aggregates.  
 First of all, to determine if the actin network can be involved anywhere in the DNA electrotransfer 
process, we performed gene expression experiments on latrunculin B treated CHO cells and compared 
transfection efficiencies with non-treated control cells. Latrunculin B is a molecule that disrupts actin 
filaments. By binding to the actin monomer form, it sequesters with it and shifts the equilibrium toward the 
depolymerization of the actin filaments. Secondly, in order to get insights on a microscopic level, single-cell 
level approaches were preferred. We performed two complementary strategies of visualization of the actin 
organization. The first was to use phalloidin-rhodamine123 as a fluorescent label specific for filamentous 
actin. It gives a good spatial resolution but requires fixation of the samples (Verderame et al., 1980). The 
second strategy was to transiently express actin fused with EGFP allowing for dynamical observations. 
Quantification of the DNA/membrane interaction in control and latrunculin B treated-cells was also 
performed. 
I. Results 
I.1. Determination of the latrunculin B incubation condition 
 Prior to all investigations, we had to determine the conditions of incubation for the latrunculin B 
drug such that the concentration is high enough to disrupt the actin filaments but does not affect the cell 
viability and morphology. It has been arbitrarily decided to do 1 h incubation, and 24 h incubation was also 
tested in order to treat cells over the time needed for the gene expression experiments. Based on the violet 
crystal method, viability was calculated in relation to control cells which did not have drug treatment. The 
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optimal conditions of incubation found are 0.1 µM for 1 h at 37 °C (Fig. 1b,m). Under these conditions the 
density of actin filaments was reduced, but cell viability (80%) and morphology were rather unaffected. 
Higher concentrations, however, led to changes in cell morphology and viability. 
 
 
Figure 1: Effect of latrunculin B on the actin cytoskeleton organization and viability of CHO cells. (a-l) 
Filamentous actin was stained with phalloidin-rhodamine123 after incubation with latrunculin B in different conditions 
and after fixation of the sample. The observations were performed using confocal microscopy. (a,g) non-treated cells, 
(b-f) 1 h incubation, (h-l) 24 h incubation at 37 °C at 0.1 µM (b,h), 0.5 µM (c,i), 1 µM (d,j), 2 µM (e,k) or 10 µM (f,l) 
(for each condition, a minimum of 50 cells were observed). Scale bar = 20 µm. (m) Cell viability measured using violet 
crystal performed after identical incubation conditions as described above. 
I.2. Effect of actin disruption on gene expression 
 In order to investigate whether the actin cytoskeleton has an effect on the DNA transfer mediated by 
electric fields into cells, we measured EGFP reporter gene expression on cells which were treated with 
latrunculin B. We evaluated both the percentage of fluorescent cells (i.e. transfection level) and the mean 
fluorescence intensity (i.e. the transfection efficiency). Latrunculin B incubations were performed 1 h or 30 
min before application of the electric field in the presence of plasmid DNA (L1hT/L30T in Fig. 2). The 
objective is to eventually disturb the DNA/membrane interaction step. Treatments were also performed 1 h 
and 24 h after the exposure to the electric field and DNA (TL1h and TL24h respectively in Fig. 2) with the 
aim to potentially disturb the DNA translocation and transport through the cytoplasm. An intermediate 
condition was tested with 30 min drug incubation before and after the transfection (L30TL30 in Fig. 2). 
Three different control experiments without any drug treatment were additionally measured. The first control 
corresponds to cells not exposed to an electric field (NT in Fig. 2), the second to cells exposed to an electric 
field (E in Fig. 2) and the third one represents cells exposed to electric pulses in the presence of plasmid 
DNA (T in Fig. 2). This last control was used as a reference with all the data being normalized in relation to 
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it. It is important to notice that only viable cell populations were analyzed to not take into account the drug 
and electric field mediated cell mortality, even though it is limited due to use of optimal conditions for both 
the latrunculin B incubations and the parameters of the electric field. 
 
 
Figure 2: Gene expression in CHO cells treated with latrunculin B before or after exposure to electric fields. 
Cells were transfected with pEGFP-C1 plasmid DNA via the application of 10 pulses of 5 ms at 0.4 kV/cm and 1 Hz. 
Different latrunculin B incubations were tested and EGFP expression was measured using flow cytometry: (a) 
transfection level, (b) transfection efficiency both normalized in relation to the non-treated transfected control cells (T). 
NT = non-treated and non-transfected cells, E = cells exposed to electric field (no DNA), L1hT/L30T = latrunculin B 
incubation for 1 h or 30 min before the transfection, L30TL30 = latrunculin B incubation 30 min before and after 
transfection, TL1h/TL24h = latrunculin B incubation for 1 h or 24 h after the transfection (SEM, n = 4-7). 
 Pre-treatments with latrunculin B (L1hT/L30T/L30TL30) significantly decrease both transfection 
levels and efficiencies, respectively, by 20-30% and 30-40%, compared to the reference cells (T) (Fig. 2a,b). 
It indicates that the alteration of the actin network before the application of the electric field has a negative 
effect on the success of the gene expression. Latrunculin B treatments performed after DNA electrotransfer 
(TL1h and TL24h) do not alter the percentage of transfected cells (Fig. 2a). At the moment of the application 
of the electric pulses, control and post-treated cells are exactly in the same conditions. However, the 
transfection efficiency decreased by about 20% for the 1 h post-treated cells (TL1h) and increased by about 
40% for the 24 h post-treated population (TL24h) (Fig. 2b). The samples for which the drug was added 30 
min before and after transfection (L30TL30) give expression at levels and efficiencies in between L1hT and 
TL1h (Fig. 2a,b). These results show that the actin cytoskeleton has an influence on the gene expression. In 
the first step(s) of DNA transfer, the actin cytoskeleton seems to be essential for optimal expression, whereas 
later on, interactions with the actin network appear to be a limiting factor in the plasmid DNA transfer 
process. 
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 Since these experiments identify the actin cytoskeleton as a cellular component influencing the DNA 
electrotransfer process, the following experiments aim at better understanding where and how actin filaments 
take part in the mechanism. Gene expression decreases when the actin network is disrupted before or shortly 
after the DNA electrotransfer. This can imply that the interactions of the DNA with the membrane and the 
DNA translocation into the cytoplasm are disturbed. 
I.3. Effect of actin disruption on DNA/membrane interaction 
 The strategy is similar to that applied in the gene expression experiments, meaning that the actin 
cytoskeleton was disrupted, using latrunculin B, and the effect on the DNA behavior at the plasma 
membrane was measured. To observe and quantify the eventual change of the DNA/membrane interaction, a 
single-cell level approach is necessary and realized using fluorescence microscopy. For that purpose, CHO 
cells were pulsed in the presence of fluorescently labeled DNA (TOTO-1). After qualitative observations, we 
quantified the localized fluorescence emission (Fig. 3). This was performed along the cell membrane where 
the DNA accumulation takes place. Intensity profiles detect local fluorescence intensity increase which is 
directly related to the number of fluorescent molecules locally present. 
 
 
Figure 3: Visualization and quantification of the DNA/membrane interaction in CHO cells after latrunculin B 
drug treatment. The cells were pulsed in the presence of TOTO-1 labeled plasmid DNA (pEGFP-C1) with the 
following parameters: 10 pulses of 5 ms at 0.4 kV/cm and 1 Hz. (a, upper row) control cells, (a, lower row) 
latrunculin B treated cells (0.1 µM, 37 °C, 1 h before the application of the electric field) (in both conditions, 34 cells 
were visualized). The black arrow on the right side indicates the direction of the electric field. Scale bar = 20 µm. (b) 
intensity profile along the cell membrane where DNA accumulates (yellow line) (c) fluorescence intensity distribution 
of the DNA aggregates in control (black, n = 330) and treated cells (gray, n = 154), histograms are fitted using a log-
normal distribution (black or gray line), (c inset) mean fluorescence intensity of the DNA aggregates (+ SEM). 
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 For the control cells, the DNA/membrane interaction is characterized by the formation of DNA 
aggregates at the plasma membrane facing the negative electrode (Fig. 3a) as previously described (Golzio et 
al., 2002b). For the treated cells, the DNA/membrane interaction is clearly less visible, in terms of 
fluorescence intensity and number of aggregates, but the DNA remains visible as clusters at the membrane 
(Fig. 3a). From the fluorescence intensity profile, at the membrane level of each cell (Fig. 3b), we could plot 
the distribution of the fluorescence intensity of the DNA aggregates (Fig. 3c). We observed a strong shift to 
lower fluorescence intensities for DNA aggregates formed at the membrane of the treated cells. For the 
control cells, the mean fluorescence intensity of the aggregates was 12 949 ± 476 a.u. while for the treated 
cells the mean fluorescence intensity was 6 480 ± 514 a.u. (Fig 3c inset). The difference was highly 
significant (p = 5.10-10). This hints at the actin cytoskeleton being involved in the accumulation of the DNA 
inserted into the plasma membrane. It is noteworthy that even after disruption of the actin cytoskeleton some 
DNA was still located in patches on the membrane. Thus it seems that actin can enhance the amount of DNA 
in the patches on the membrane, but is not needed for the patch formation. 
 
 From the last results, the actin cytoskeleton appears to be positively engaged in the DNA/membrane 
interaction step. To further investigate the role and the structure by which actin interacts with the plasmid 
DNA, we performed fluorescence microscopy on actin-labeled cells. 
I.4. Effect of the electric field on the actin cytoskeleton in the presence of DNA 
 The first objective was to determine to what extent the application of electric pulses in the presence 
of DNA could affect the organization of the actin cytoskeleton. To this end, we performed single-cell level 
experiments with actin labeled using the phalloidin-rhodamine123 dye. We observed the formation of actin 
patches (Fig. 4). Phalloidin specifically labels actin in filamentous form meaning that actin polymerization 
occurred. These actin patches corresponded in location, time, number and size to the DNA aggregate 
occurrence (Fig. 3a upper row). Indeed, these patches were localized only at the plasma membrane facing 
the negative electrode, which is the area where the DNA interacts with the membrane. They were observable 
only 10 min after the application of the electric field. This value corresponds to the average persistence time 
of the DNA aggregates. Observations at 5 min, 1 h and 4 h did not highlight differences between control 
cells and electrotransferred cells. The average number of actin patches was 8.4 ± 3.9 per cells. The number of 
DNA aggregates was 7.2 ± 3.8, counts based on the observations of the DNA/membrane interaction of the 
control cells taken from the previous experiments (Fig. 3). Their size seemed comparable to the one of the 
DNA aggregates. These actin structures were never observed when the electric field was applied in the 
absence of DNA. These observations suggest that actin could be involved in the DNA/membrane interaction 
and/or DNA crossing of the membrane. 
Results and discussions - Chapter 1: Actin cytoskeleton and DNA electrotransfer - I. Results 
 
- 103 - 
 
Figure 4: Effect of the DNA electrotransfer on the organization of the actin cytoskeleton in CHO cells. Cells were 
pulsed in the presence of the pEGFP-C1 plasmid DNA with the following parameters: 10 pulses of 5 ms at 0.4 kV/cm 
and 1 Hz. Cells were fixed 10 min after the application of the electric field, stained with phalloidin-rhodamine123 and 
observed using confocal microscopy. (a-e) actin patches formation in different cells (32 cells were observed), (f) z-stack 
projection rotated around the x-axis. Plus and minus signs indicate the electrode positions. White arrows on the pictures 
point to the actin patches formed at the plasma membrane facing the negative electrode. Scale bar = 20 µm. 
 
Figure 5: Effect of the DNA electrotransfer on the organization of the actin cytoskeleton in EGFP-actin 
expressing CHO cells. CHO cells transiently expressing the EGFP-actin protein were pulsed in the presence of 
pEGFP-C1 plasmid DNA with the following parameters: 10 pulses of 5 ms at 0.4 kV/cm and 1 Hz. Observations were 
performed using wide-field fluorescence microscopy. (a,b) one cell observed before the application of the electric field 
and 6 min after, (c-e) different cells at different times after the application of the electric field (25 cells with actin 
patches were observed), (f) time series of one cell. Plus and minus signs indicate the electrode positions. White arrows 
on the pictures point to the actin patches formed at the plasma membrane facing the negative electrode. Scale bar = 10 
µm. 
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 To complete and confirm these results, we performed similar experiments with another method. 
Instead of using phalloidin-conjugated dye, we observed the actin cytoskeleton of living CHO cells 
transiently expressing EGFP-actin. Once again, the formation of actin patches at the plasma membrane 
facing the negative electrode was observed (Fig. 5), with an average number of 8.5 ± 3.9 patches per cell. 
Time series acquisitions gave information about the lifetimes of these structures. They began to be visible 3- 
5 min after the application of the electric field, i.e. approximately 5 min after the formation of the DNA 
aggregates (Fig. 5b,f). The disappearance of some of the actin patches started after approximately 15-20 min 
(Fig. 5f), while other patches persisted at the plasma membrane for up to 45 min (Fig. 5e). In conclusion, 
actin polymerized in patches a few minutes after the DNA/membrane interaction was established and could 
stay in this stage until 45 min. 
 
 In order to prove that the actin patches were a direct consequence of the presence of DNA and 
coincided with the location of the DNA aggregates, we performed two color colocalization studies on living 
cells. We electrotransferred fluorescent DNA labeled with POPO-3 into CHO cells which transiently 
expressed EGFP-actin. Our observations showed that DNA aggregates and actin patches colocalized well 
(Fig. 6). Actin polymerized exactly at the positions where the DNA interacted with the plasma membrane. 
These observations strongly suggest that actin is actively involved in the uptake of DNA by the CHO cells. 
 
 
Figure 6: Visualization of the DNA/membrane interaction and the actin cytoskeleton in EGFP-actin expressing 
CHO cells. CHO cells transiently expressing the EGFP-actin protein were pulsed in the presence of POPO-3 labeled 
plasmid DNA (pEGFP-C1) with the following parameters: 10 pulses of 5 ms at 0.4 kV/cm and 1 Hz. Observations were 
performed using wide-field microscopy between 5 min and 30 min after application of the electric field. (a,d,g,j) 
POPO-3 labeled DNA, (b,e,h,k) EGFP-actin protein expression, (c,f,i,l) merge of the two channels (18 cells clearly 
showed colocalization between DNA and actin). The black arrow on the right side indicates the direction of the electric 
field. Scale bar = 5 µm. 
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II. Discussion 
 A primary limitation of gene therapy, especially non-viral gene therapy, is the difficulty in achieving 
high levels of gene expression. The plasma membrane and nuclear envelope as well as the dense cytoplasmic 
meshwork are all obstacles to DNA transfer which must be overcome by the DNA in order to reach the 
nucleus and to be transcribed. A number of studies have been devoted to understanding the mechanisms by 
which the DNA overcomes the barriers presented by the plasma membrane and nuclear envelope, while 
processes occurring in the cytoplasm are only recently being investigated. Our study has focused on the actin 
cytoskeleton and its implication in the mechanism of gene delivery mediated by electric field. 
II.1. Actin and DNA coincide at the plasma membrane level 
 The results show that only when DNA was present during the application of the electric field the 
formation of actin patches at the plasma membrane occurs. Their characteristics were similar to those of the 
DNA aggregates (Golzio et al., 2002b). They had the same location (plasma membrane facing the negative 
electrode), similar persistence (tens of minutes after the application of the electric pulses), the same number 
(7-8 per cell), and comparable size and distribution. These observations were performed using two different 
labeling strategies (phalloidin-conjugated dye and EGFP-actin transient expression). Moreover, the actin 
patches colocalized with the DNA aggregates. The observation of the EGFP-actin CHO cells gave 
information about the lifetime of these patches and their fate in cells. They became detectable the earliest 3 
min after the application of the electric field and some stayed localized at the plasma membrane for up to 45 
min. The observed colocalization and the similarities in the behavior of actin patches and DNA aggregates 
leads us to suggest that actin is actively involved in the process of DNA entry and transport in the cytoplasm. 
It is the first time in the case of gene transfer mediated by electric field that a correlation between changes in 
the actin cytoskeleton and DNA electrotransfer is seen. 
II.2. Actin is involved in DNA accumulation at the cell membrane 
 Disruption of the actin network leads to a significant decrease of the DNA accumulation at the 
plasma membrane. It did not change the way the DNA interacts with the membrane, i.e. the formation of 
aggregates. Despite the fact that actin does not appear to play a role in the initial formation of the 
DNA/membrane complexes, it could play an important role in the quantity of DNA interacting with the 
plasma membrane. The decrease in accumulation of DNA at the membrane level, when the actin network is 
altered, could mean that the actin cytoskeleton participates in the transition from low to high stability 
complexes. It has been suggested that the DNA is trapped in the membrane during the application of the 
electric field (Golzio et al., 2002b; Faurie et al., 2010) but it remains accessible until 5 min after the last 
electric pulse (Eynard et al., 1997). Indeed, the DNA is sensitive to DNAse action in the few minutes 
following the electropermeabilization, indicating access to external molecules. The DNA is protected later 
on, at a time corresponding to the end of the permeabilized state (Rols et al., 1990a). This time coincides 
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with the appearance of the actin patches. In addition, it was shown that the lifetime of the permeable state is 
dependent on the cytoskeleton (Teissie et al., 1994). It seems that there is a correlation between the 
permeable state of the membrane, the enclosing of the DNA, and the actin polymerization at the membrane. 
It is possible that the DNA trapping and thus DNA accumulation are actin-dependent even if in this time 
range no actin polymerization was detectable. The actin polymerization in patches colocalizing with the 
DNA was observable starting from 3 min. These observations suggest that the DNA may be enclosed in 
structures where actin polymerization occurs. During the time in which these structures are formed, the 
membrane is permeable and the DNA remains accessible. 
II.3. Actin is involved in the first step(s) of DNA internalization/trafficking 
 Disruption of the actin network leads to a lower gene expression when treatments were performed 
before or after the application of the electric field. The lower expression level for the pre-treatment can be 
explained by the lower accumulation of DNA observed at the membrane. If less DNA interacts with the 
plasma membrane, less DNA enters/migrates within the cell to the nucleus and less DNA is available for 
expression. Ondrej et al. (Ondrej et al., 2007) did similar experiments on fibroblasts transfected via lipoplex 
formation. After transfection, they performed latrunculin B treatment using higher concentrations and 
counted much lower numbers of plasmid copies in the nucleus. The lower expression for the post-treatment 
suggested that the internalization and early transport of the DNA is actin-dependent. This could arise from an 
eventual disturbance of the actin patch formation by the presence of latrunculin B. Surprisingly, the 
expression level was higher when the treatment was performed for 24 h. We propose that the dense actin 
network, while being useful at earlier stages of transfection (interaction with the membrane, internalization, 
early transport), could restrain the later stage of the DNA transport/diffusion. Verkman and colleagues have 
shown that DNA fragments longer than 2000 bp showed no translational diffusion through the cytoplasm 
(Lukacs et al., 2000). More recent work from this group has shown that the actin cytoskeleton is the principal 
structure that limits this passive diffusion through the cytoplasm and that disruption of the actin cytoskeleton 
by drugs results in an increase in the diffusion of large macromolecules or linear DNA fragments (Dauty et 
al., 2005). Our findings can thus be interpreted by an endocytic-like phenomenon which explains the entry 
and trafficking of electrotransferred plasmid DNA within the cell, with the actin cytoskeleton being involved 
in the membrane invagination and the early stage of the transport. Further long-range transport would take 
place via the tubulin network (Schafer, 2002; Soldati et al., 2006; Ross et al., 2008). Vaughan et al. have 
previously shown that a stabilization of the microtubule network enhances electrotransferred plasmid 
expression (Vaughan et al., 2006; Vaughan et al., 2008). They also demonstrated the ability of plasmid DNA 
to interact with the microtubules via other proteins, which suggests an active movement along the 
microtubule network. Our results are in agreement with their findings, a disruption of the actin network may 
facilitate the movement of the DNA by reducing the crowding around it. While it has been previously 
mentioned that electrotransferred plasmids may move along the microtubule network and likely use dynein 
as the molecular motor that facilitates movement toward the nucleus (Vaughan et al., 2006), this part of the 
work sheds light on the involvement of actin in this process. 
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II.4. A proposed mechanism  
 The way the electrotransferred DNA crosses the plasma membrane is still unknown. It is possible 
that an endocytic process occurs (Fig. 7, left side). The budding structure from the plasma membrane is a 
prerequisite for any endocytic pathway (Doherty et al., 2009). All types of endocytosis require the 
involvement of actin for both the budding step and the early stage of the endosomal transport. The time 
needed for the internalization step is in agreement with what we have observed (Conner et al., 2003; Bellve 
et al., 2006). Electroendocytic processes have already been proposed by other research groups (Klenchin et 
al., 1991; Rols et al., 1995; Satkauskas et al., 2001; Antov et al., 2005). Membrane actin polymerization is 
known to occur when a high amount of PIP2, which is highly negatively charged, is present in the membrane 
(Schafer, 2004b). PIP2 recruits dynamin proteins which polymerize at areas of high membrane curvature 
(Roux et al., 2010). Dynamin subsequently initiates the actin polymerization. It is possible that the high local 
density of negative charge in the DNA aggregate could trigger a similar response from the actin network. 
The electrophoretically driven insertion of the DNA into the membrane could pull the plasma membrane and 
initiate the formation of a vesicle (Fig.7, left side, steps 4,5). As it is the case for extracellular pathogens, 
membrane invaginations could also form due to the DNA aggregates, without any assistance from the cell 
machinery (Romer et al., 2007). Thus, binding to the membrane and a subsequent connection to the actin 
network could be a very general means for particle engulfment and transport which could be exploited by 
both pathogens (bacteria, viruses) and non-viral vectors (Fig. 7, step 6). The second model suggested to 
explain molecular uptake mediated by the electric field is internalization through electropores, resulting in 
direct access to the cytoplasm (Fig. 7, right side) (Neumann et al., 1982; de Gennes, 1999; Escoffre et al., 
2009b). In addition to the fact that pores were never observable, one of the limits of this model is that 
molecules above 4 kDa do not show any diffusion motion through the plasma membrane (Escoffre et al., 
2009b). The DNA interacts during tens of minutes with the membrane and moreover forms aggregates 
whose size was evaluated to be between 100 nm to 500 nm (Golzio et al., 2002b). This is much larger than 
the pore size estimation of 1 nm to 20 nm (Escoffre et al., 2009b). However, it remains possible that the 
DNA accumulates where pores are formed and that its electrophoretically driven insertion in the membrane 
pulls the pore (Fig. 7, right side, steps 4,5) (Klenchin et al., 1991). The vesicle-like structure formed could 
be recognized as an endocytic vesicle and induce a similar response from the cell as for an endocytic process, 
with the recruitment of dynamin at the neck of the vesicle-like structure and as a consequence 
polymerization of actin in a patch around it (Fig. 7, step 6). Further intracellular trafficking involves the 
microtubules and their associated motors (Vaughan et al., 2006), with which DNA may interact via adapter 
proteins or by the intermediate of the proteins present in the vesicle (Fig. 7, step7).  
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Figure 7: DNA electrotransfer possible mechanisms. It is a multi-step process. During the application of the electric 
pulses, the plasma membrane is permeabilized (step 1), the DNA, because of its negative charge, electrophoretically 
migrates toward the positive electrode (step 2). It interacts with the electropermeabilized membrane facing the negative 
electrode and forms aggregates (step 3). The electrophoretically driven insertion (step 4) and the translocation (step 5) 
of the DNA through the plasma membrane are not yet characterized but two models can be proposed. The DNA could 
pull the membrane during its insertion and initiate the formation of a vesicle. We can in this case speak about 
electroendocytosis (left side). Alternatively, the DNA could be inserted where an electropore is formed, pull it, and 
initiate the formation of a vesicle-like structure (right side). The plasma membrane is in interaction with the actin 
network via connecting proteins. The presence of vesicle or vesicle-like structure may induce the recruitment of actin-
associated proteins and initiate its polymerization where the lipid-DNA complex is located (step 6). Other data indicate 
that DNA migration in the cytoplasm might occur via motor proteins interacting with the microtubule network (step 7) 
(Vaughan et al., 2006; Vaughan et al., 2008). The DNA could either be enclosed in the vesicle or naked, and interacting 
with protein(s) providing the connection between it and the microtubule network. Subsequent steps are the crossing of 
the nuclear envelope and the expression in protein of the DNA sequence (not represented in the illustration here). 
II.5. Conclusion 
 We have shown that the actin cytoskeleton plays an important role in the gene transfer process 
mediated by the electric field in CHO cells. While it appears to be actively involved in the success of the first 
transfer step(s), it seems that it hinders DNA motion at later stages. If the actin cytoskeleton has a role in an 
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active transport process, it should have it only at the early stage. We propose that the DNA, after being 
electrophoretically pushed to the membrane, accumulates in sites surrounded by actin anchored in the plasma 
membrane. The actin could polymerize around the DNA aggregates as a consequence of an endocytosis-like 
process. This involvement of actin in the crossing and/or transport of plasmid DNA is observed in gene 
delivery methods mediated by endocytosis such as liposome-mediated transfer (Bausinger et al., 2006; 
Ondrej et al., 2007). Certain bacterial pathogens and many viruses use the actin cytoskeleton and its 
associated motor proteins for intracellular movement (McDonald et al., 2002; Lakadamyali et al., 2003; 
Forest et al., 2005; Gouin et al., 2005; Schelhaas et al., 2008). 
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Chapter 2: DNA endocytosis 
 Some of the results described in this chapter have been published, therefore the text contain portions 
that literally cite the article (Rosazza et al., 2012). From the previous results, it appears that endocytosis is a 
possible way for the electrotransferred DNA to overcome the plasma membrane of cells and reach the 
cytoplasm. There are many endocytic processes that can occur: macropinocytosis, clathrin-mediated 
endocytosis, caveolin/raft-mediated endocytosis, clathrin- and caveolin-independent endocytosis among 
which some can be dynamin-dependent or independent. Some are rather well described while little is known 
about others. It is therefore impossible nowadays to depict precisely the pathways involved in the DNA 
electrotransfer. Other reasons are that many molecules or proteins are involved in endocytic processes and 
many of them are common to several pathways. The lack of precise knowledge and of easy tools to well 
distinguish one pathway from the other engenders difficulties for a good mapping of the potential DNA 
endocytosis mechanism. Therefore the aim here is to give some answers about how DNA is internalized and 
which cellular structures are involved. Most current methods for studying internalization of particles involve 
either exclusion of specific endocytic mechanisms using inhibitors of endocytosis and cell mutants or 
colocalization of particles with specific endocytic markers and structures. The main issue with these methods 
is that neither chemical inhibitors nor endocytic markers are specific. Indeed, inhibitors can disturb multiple 
endocytic pathways and markers can utilize several endocytic mechanisms. This is the reason why this work 
combines both methods and in addition provides quantifications. To discriminate better the different 
pathways, two to three inhibitors per pathway were chosen and several concentrations tested. Their effects on 
gene expression in CHO cells were first measured using flow cytometry to get statistics at large cell 
populations. The colocalization studies were then conducted in living CHO cells between electromediated 
DNA and three endocytosis markers (transferrin, cholera toxin B and dextran) at the single-cell level using 
fluorescence microscopy. 
I. Results 
I.1. Effect of the different endocytic inhibiting drugs on cell viability 
 An important prerequisite for the study of gene expression after endocytic inhibition is the use of 
such drugs in non or low cytotoxic concentrations. For that purpose, we determined the CHO cell viability at 
24 h, based on crystal violet staining, after incubation of the drugs at different concentrations during 1 h. 
Because of the lack of specificity of the drugs, two to three drugs were used to inhibit the three main 
endocytosis classes: macropinocytosis, clathrin-mediated endocytosis and caveolin/raft-mediated 
endocytosis. Here is a brief description of the drug effects (Ivanov, 2008; Sahay et al., 2010; Iversen et al., 
2011; Xiang et al., 2012):  
- Methyl-beta-cyclodextrin (MCD): general inhibitor of endocytosis. It extracts the cholesterol 
from the membrane therefore altering the structure of domains rich in cholesterol. It induces a dissociation of 
the proteins from the lipid rafts. This has been observed as a mislocalization of the caveolin in fibroblasts. 
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MCD inhibits the entry of several ligands caveolin/raft-dependents. It has a rather low specificity for these 
pathways and high concentrations of MCD also inhibit other endocytic pathways as for instance the entry 
of transferrin via the clathrin-mediated endocytosis by blocking the invagination of the pits (Rodal et al., 
1999) and macropinocytosis by blocking membrane ruffling (Grimmer et al., 2002). 
- Wortmannin (Wort): inhibitor of macropinocytosis (constitutive and stimulated one). It inhibits the 
PI3Ks (phosphoinositide 3-kinases) which are responsible for the formation of the lipid microdomains in 
ruffles and macropinocytic cups that serve as platforms for signaling and cytoskeletal modulation. PI3Ks are 
also essential for the closure of the cups and possibly the fusion of macropinosomes (Araki et al., 1996; 
Swanson, 2008). 
- Ethyl-isopropyl-amiloride (EIPA): inhibitor of macropinocytosis (constitutive and stimulated one). 
It inhibits the Na+/H+ exchangers which are very important for the macropinocytosis. Amiloride prevents 
induction of membrane ruffling likely by preventing Rac1 mediated-signaling which is essential for the 
process (West et al., 1989; Mercer et al., 2009; Koivusalo et al., 2010). 
- Chlorpromazine (CPZ): inhibitor of the clathrin-mediated endocytosis. It reduces the amount of 
clathrin and AP2 complexes at the membrane and inhibits their assembly (Wang et al., 1993). It has a rather 
good specificity because it does not interfere with caveolin/raft-mediated endocytosis, but it could inhibit 
macropinocytosis either due to its incorporation into the membrane, that increases its fluidity, or because it 
inhibits the phospholipase C which is an important regulator for macropinocytosis (Ivanov, 2008). 
- Monodansylcadaverine (MDC): inhibitor of the clathrin-mediated endocytosis. The mechanism of 
action is not well known yet, but it inhibits the transglutaminase protein which seems to block the 
polymerization of the clathrin essential for the endocytosis to occur. It has a good specificity. It does not 
interfere with caveolin/raft-mediated endocytosis but contradictory results make conclusions about the 
eventual effect on macropinocytosis difficult (Ivanov, 2008). 
- Filipin (Fil): inhibitor of the caveolin/raft-mediated endocytosis. It sequesters cholesterol thus 
disturbing the structure and function of the cholesterol-rich domains at the membrane. It induces the 
distortion of the caveolae, the lack of clustering of the GPI-anchored proteins in the rafts, and the inhibition 
of ligand entry through lipid rafts. It has a good specificity because it does interfere, or only little, with 
clathrin-mediated endocytosis and macropinocytosis. 
- Genistein (Gen): inhibitor of the caveolin/raft-mediated endocytosis. It is a tyrosine kinase inhibitor 
(Akiyama et al., 1987). It inhibits the recruitment of dynamin, indispensable for the events in the caveolae-
mediated uptake mechanism. It also causes local disruption of the actin network at the site of endocytosis. 
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Figure 8: Cell viability after incubation with different endocytic inhibitors. Cell viability was measured 24 h after 
drug incubations through crystal violet staining. Each drug was incubated for 1 h and different concentrations were 
tested. (a) Wortmannin (Wort), (b) Chlorpromazine (CPZ), (c) Filipin (Fil), (d) Ethyl-isopropyl-amiloride (EIPA), (e) 
Monodansylcadaverine (MDC), (f) Genistein (Gen), (g) Methyl-beta-cyclodextrin (MCD). 
 There is a rather good correlation between drug concentration and cell viability (Fig. 8). All drugs 
have some cytotoxic effects on CHO cells when applied in high concentrations. Nevertheless, in each case, 
several concentrations show from very good to acceptable cell viabilities (90%-60%). For the later on 
experiments, the chosen concentration ranges are:  
- Wort: 0.02 µM - 0.5 µM. 
- EIPA: 10 µM - 100 µM. Cell viability has not been measured at 10 µM, but it should be between 
100% and 85% estimated by extrapolation. 
- CPZ: 1 µM - 50 µM. 
- MDC: 50 µM - 200 µM 
- Fil: 0.1 µM - 2.5 µM 
- Gen: 50 µM - 150 µM 
- MCD: 1 µM - 5 µM 
I.2. Effect of endocytic inhibition on gene expression 
 In order to evaluate whether endocytic processes are potential internalization pathways that DNA 
can follow after application of the electric field, we measured EGFP reporter gene expression on cells which 
were treated with the different endocytic inhibitors. Both the percentage of fluorescent cells (i.e. transfection 
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level) and the mean fluorescence intensity (i.e. the transfection efficiency) were measured using flow 
cytometry. Drug incubations were performed 1 h before the application of the electric field in the presence of 
plasmid DNA. Control cells represent transfected but otherwise untreated cells. They are used as reference 
with all data being normalized in relation to them. It is important to notice that only viable cell populations 
were analyzed in order to no take into account the cell mortality due to the drug treatment and the application 
of the electric field. 
 
 
Figure 9: Gene expression in CHO cells after treatment with different endocytic inhibitors. Flow cytometry results 
of EGFP reporter gene expressions 24 h after separate treatment of CHO cells with different concentrations of methyl-
beta-cyclodextrin (MCD), wortmannin (Wort), chlorpromazine (CPZ), filipin (Fil), ethyl-isopropyl-amiloride (EIPA), 
monodansylcadaverine (MDC) and genistein (Gen). Incubations were performed 1 h before the application of the 
electric field (10 pulses at 0.4 kV/cm, 5 ms and 1 Hz) in the presence of the pEGFP-C1 plasmid DNA. (a) Percentage of 
fluorescent cells (transfection level) and (b) mean fluorescence intensity (transfection efficiency) (SEM, n = 5-7). 
Controls represent transfected, but otherwise untreated cells. * p < 0.05 (dotted line), ** p < 0.01 (dashed line), *** p < 
0.001 (solid line) 
 Already at a first glance, gene expression results imply that all endocytic inhibitors reduce both the 
transfection level and efficiency (Fig. 9a,b). The strongest inhibitions of the gene expression are obtained for 
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the highest drug concentrations (Fig. 9, black bars). There is a rather good correlation between drug 
concentration and inhibition of the DNA expression. The results, drug per drug, are the following: 
- MCD: highly significant decreases in gene expression are observed for any drug concentration of 
MCD. Indeed, less than half of the cells still express the EGFP reporter protein (37% at 5 µM, Fig. 9a) and 
among them, the efficiency of transfection falls down to 50% of the control cells (Fig. 9b). The higher 
cholesterol depletion, the more the transfection level and efficiency decrease. 
- Wort: strong dose-dependence and highly significant decrease of the percentage of cells expressing 
EGFP (from 85% to 65% of the control, Fig. 9a). The two lowest concentrations almost do not change the 
amount of expressed proteins but the other concentrations efficiently diminish the DNA expression (also 
about 85% and 65% of the control, Fig. 9b). 
- EIPA: the percentage of EGFP positive cells is greatly decreased by any drug concentration giving 
between 65% and 70% of the control expression (Fig. 9a). The effect on the amount of EGFP expressed is 
less obvious, 85% to 90% of the control (Fig. 9b), with only one group being statistically significant. The 
drug has an inhibiting effect, mainly on the transfection level, nevertheless an increase of the drug 
concentration has little or no impact on its inhibiting ability.  
- CPZ: significant inhibition of gene expression is obtained and the inhibition is proportional to the 
amount of drug added in the medium. For the higher concentrations, only about 60% of the cells can express 
EGFP (Fig. 9a) and among them the expression reaches only 55% to about 80% of the control cells 
(Fig. 9b). 
- MDC: The highest concentrations reduce the percentage of EGFP-positives cells down to 70% of 
the control cells (Fig. 9a) and the average fluorescence intensity down to 80% of the control population 
(Fig. 9b).  
- Fil: this is the least inhibiting drug. For most of the concentrations, the decrease of gene expression 
is so small that it is not significant (Fig. 9). However, the highest concentration reduces the transfection level 
and efficiency to 80% and 70%, respectively, of the control. 
- Gen: very high efficiency in reducing the percentage of cells showing EGFP signal (40-60% of the 
control cells) with a strong dependence on the drug concentration (Fig. 9). Among these cells, the amount of 
expressed EGFP can be unchanged or reduced down to about 60% of the control.  
 Clearly, inhibition of the different endocytic pathways induces, most of the time with high statistical 
significance, a reduction of DNA expression into EGFP proteins. This leads to the conclusion that 
endocytosis in general is a route taken by DNA for its internalization and it gives rise to successful DNA 
transfection. DNA is not hijacked in endosomes but instead find its way to reach the nucleus. It seems that no 
specific endocytic pathway is favored since all drugs have an impact on expression. Therefore 
macropinocytosis, clathrin-, caveolin/raft-dependent endocytosis are all involved. This statement is 
confirmed by the fact that disturbance of cholesterol and actin dynamics both of which being involved in all 
endocytic pathway, engender even larger inhibition of DNA expression. Results on the influence of 
disruption and stabilization of the actin network on the DNA expression can be found in Chapter 1, Fig. 2 
and Chapter 3, Fig. 2.  
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I.3. Colocalization study between DNA and endocytic markers 
 The effects of the different endocytic drugs on gene electrotransfer, as well as the role of actin 
reported in chapter 1 of the results and discussions part (Rosazza et al., 2011), prompted us to further 
characterize the pathways of DNA entry into the electropermeabilized cells. In order to confirm the 
involvement of DNA endocytosis, colocalization experiments have been performed. Dual color observations 
of Cy3- or Cy5-labeled DNA and three endocytic markers: Alexa Fluor® 647 labeled transferrin (TF) to 
assess clathrin-mediated endocytosis, Alexa Fluor® 647 labeled cholera toxin subunit B (CTB) to evaluate 
caveolin/raft-mediated endocytosis and rhodamine B labeled dextran (70 kDa) to estimate fluid-phase 
endocytosis which can be macropinocytosis or any endocytosis which engulfs large enough amounts of 
extracellular medium. Images were taken sequentially, to avoid cross-talk, using single-molecule sensitive 
wide-field microscope. To remove background and noise, image processing was performed which consisted 
in applying median and morphological filters (cf. Materials and methods section).  
 
 In a first qualitative approach, microscopy data show that the DNA partially colocalizes with all 
endocytic markers (Fig. 10). This confirms the previous results, giving strong hints at the participation of 
endocytosis in the DNA internalization. Clathrin-mediated endocytosis is confirmed to play a role since 
DNA colocalizes with TF (Fig. 10a). CTB enters cells via several raft-mediated pathways that can be 
caveolae or non-caveolae such as the GEEC pathway. Colocalization with dextran is commonly interpreted 
as a contribution of macropinocytosis. The size of dextran was chosen to be relatively large such that its 
entry is mainly due to macropinocytic process. Nonetheless, to test for the presence of dextran in the other 
pathways, colocalization between it and the two other markers has been performed. It shows that dextran can 
be found in other types of endocytosis as well (Fig. 11). Despite the rather large amount of endosomes in 
both channels, dextran does not colocalize a lot with transferrin (Fig. 11a). Therefore, 70 kDa  dextran is not 
likely to enter via clathrin-mediated endocytosis in our conditions. Colocalization with CTB is more 
pronounced but not systematic (Fig. 11b). A lot of the CTB endosomes do not contain dextran and vice 
versa. Therefore a considerable part of the dextran is internalized by other pathways than clathrin- and 
caveolin/raft-mediated endocytosis. Macropinocytosis is one of the possibilities.  
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Figure 10: Colocalization of DNA with several endocytic markers. Transferrin highlights the involvement of 
clathrin-mediated endocytosis, cholera toxin B the one of caveolin/raft-mediated endocytosis and 70 kDa dextran is a 
fluid-phase marker. DNA was electrotransferred into CHO cells via the application of 10 electric pulses of 5 ms at 1 Hz 
and 0.4 kV/cm. Images were taken sequentially using wide-field microscopy with single-molecule detection sensitivity. 
(a) Cy3-DNA (green), Alexa fluor 647-transferrin (red) and merge of the two channels, (b) Cy3-DNA (green), Alexa 
fluor 647-cholera toxin B (red) and merge of the two color, (c) Cy5-DNA (red), rhodamine-70 kDa dextran (green) and 
merge of the two channels.  
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Figure 11: Colocalization between dextran and transferrin or cholera toxin B. 70 kDa Dextran is a fluid-phase 
marker, transferrin highlights the involvement of clathrin-mediated endocytosis and cholera toxin B the one of 
caveolin/raft-mediated endocytosis. The two markers were incubated with CHO cells for 15 min at 37 °C. Images were 
taken sequentially using wide-field microscopy with single-molecule detection sensitivity. (a) Rhodamine-dextran 
(green), Alexa fluor 647-transferrin (red) and merge of the two channels, (b) Rhodamine-dextran (green), Alexa fluor 
647-cholera toxin B (red) and merge of the two colors.  
 To determine the involvement of each pathway in the DNA internalization more precisely, 
colocalization quantification was performed using object-based approaches, which analyze the spatial 
distribution of the fluorescence signals (Lachmanovich et al., 2003). The colocalization analysis does not 
rely on the coincidence of individual pixels but on the coincidence of structures. Therefore, each pixel is not 
considered as a part of an image but as a part of a unique object. Object-based methods better discriminate 
between signals coming from structures and those originating from the background. These methods are of 
special interest for the analysis of subcellular structures having specific shapes and sizes close to the optical 
resolution limit of microscopes. After processing, the images are segmented (Fig. 12a,b (patches)). All 
pixels above a threshold value are considered to be part of an object, values below are considered as 
background. The edges of the fluorescent structures are then delimited. From each obtained object, the center 
of mass is determined (Fig. 12a-c (dots)).  
 The analysis using the overlap approach tests whether the centers of mass of objects in the first 
channel fall in areas covered by objects of the second channel (Fig. 12a,b). This can be done separately for 
both channels. The number of colocalizing objects (Fig. 12a,b (yellow dots)) among the total amount of 
objects counted is calculated as the percentage of colocalization.  
 The analysis using the nearest neighbor distance approach measures distances between the centers of 
mass of objects in the first channel and the centers of mass of objects in the second channel (Fig. 12c (dots)). 
These distances are compared to the optical resolution limit of the acquisition system. Two events colocalize 
when the distance between their centers of mass is below the optical resolution of the system (Fig. 5c (blue 
and pink dots)). The degree of colocalization is also given as a percentage of objects in channel one 
colocalizing with objects in channel two.  
 Figure 12d shows the two defined percentages of colocalization between the DNA and the three 
endocytic markers. The percentages of colocalization determined by the two different approaches yield a 
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value of approximately 50% ± 7% of colocalization of the DNA with CTB and of 25% ± 7% with TF. 
Concerning the colocalization of DNA with dextran, the percentage differs: the overlap approach gives about 
30% ± 4% while the distance based approach calculates about 45% ± 5%. The sum of the percentages is 
higher than 100% highlighting the fact that a certain amount of markers, most probably dextran, is present in 
the three different groups. The internalization of electrotransferred DNA is largely happening via 
endocytosis. The main endocytic process occurring is caveolin/raft-mediated endocytosis. Clathrin-mediated 
endocytosis is a non-negligible internalization pathway. It is difficult to conclude about macropinocytosis, 
but it remains a possibility as well as other pathways independent from routes taken by TF and CTB. 
 
 
 
Figure 12: Analysis of the colocalization of DNA with the three different endocytic markers. The quantification 
was performed using object-based methods; the overlap approach and the nearest neighbor distance approach 
(Lachmanovich et al., 2003). For the overlap approach, the ImageJ plugin JACoP tested whether the centers of mass of 
each green patch (shown as a green dot) falls within the area covered by a red patch. (a) Cholera toxin B as red patches 
and DNA as green ones. (b) DNA as red patches and cholera toxin B as green dots. Yellow dots represent the 
colocalizing objects. For a comparison, the source images are in figure 10b first column. For the nearest neighbor 
distance approach, the program tests the distance between the centers of mass of green objects and the centers of mass 
of red objects. (c) DNA represented as green dots and cholera toxin B as red dots. When the distance is below the 
optical resolution of the acquisition system, the dots are represented as blue and pink dots respectively. In both cases, 
the percentages of colocalizing objects were thus calculated. The analysis of more than 100 cells with each endocytic 
marker gave the percentages shown in the graph (d).  
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II. Discussion 
 The objectives of this part of the PhD work were to investigate the potential role of endocytosis in 
the process of DNA electrotransfer and to quantify some routes of internalization into cells. This is of high 
importance since the way DNA enters the cells is a question remaining opened for several years. Endocytosis 
was for a long time rather excluded as a possible way DNA could cross the plasma membrane. DNA does 
not have receptors or other proteins with which it can interact and electric fields are thought to create pores 
mediating the process. For any gene delivery method, the plasma membrane represents one first important 
barrier to be overcome and discriminating the routes taken by DNA is a first step into optimizing its transfer. 
Although, this work does not address the question entirely, it provides some new aspects that should be 
considered as a new field of investigation in the context of gene electrotransfer. The investigations in this 
work combine the use of pharmacological inhibitors of endocytosis and of fluorescently labeled endocytic 
markers.  
II.1. Cholesterol is required for the DNA internalization 
 Gene expression is considerably affected in cholesterol-depleted cells. Indeed, our results show that 
both transfection level and efficiency were dramatically lower in MCD-treated cells than in untreated cells 
(up to 40% of the control, Fig. 9). The more cholesterol is removed, the more DNA expression is inhibited. 
Recently published data shows that, at any electric field strength, cholesterol depletion has no significant 
effect on cell electropermeabilization and on the formation and the morphology of the DNA aggregates at the 
plasma membrane (Rosazza et al., 2012). More importantly it seems that the ability of DNA to interact at 
specific competent sites at the membrane is not affected when cholesterol content is reduced. Therefore, the 
first steps of the DNA electrotransfer (electropermeabilization, electrophoretic insertion of DNA into the 
membrane and DNA-membrane interaction) seem to be cholesterol-independent. Nevertheless, the later steps 
are highly dependent on cholesterol which may have an involvement in the DNA translocation across the 
plasma membrane and/or its intracellular trafficking. Because cholesterol is mainly found in the plasma 
membrane (Lange, 1991), we propose that it is the internalization step that is mainly altered by the reduction 
of cholesterol content. This has been demonstrated for the endocytosis of several different particles (Norkin, 
1999; Kabouridis et al., 2000; Norkin et al., 2001; Rejman et al., 2004; Lai et al., 2008a). The reduction of 
the DNA expression for all pharmacological inhibitors of endocytosis (Fig. 9) plus the colocalization with 
the all the endocytic markers (Fig. 10,12) confirms the involvement of endocytosis. Given that all endocytic 
processes depend on cholesterol (Doherty et al., 2009), it appears logical that its depletion affects the DNA 
internalization. One should still not forget that cholesterol depletion can also reduce the further intracellular 
trafficking, endosomal escape, and/or nuclear targeting of the electrotransferred DNA as it is the case for the 
adenovirus type 2 and the cholera toxin (Shogomori et al., 2001; Imelli et al., 2004). 
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II.2. Clathrin-mediated endocytosis of DNA 
 Clathrin-mediated endocytosis is perhaps the pathway that is the least suspected to have a role in 
DNA electrotransfer since DNA has no receptors on cell membranes. Nevertheless, it is partly involved in 
DNA internalization after electroporation. Indeed, the percentage of cells expressing DNA is significantly 
decreased, down to 60% and 70% of the control after treatment with the chlorpromazine and the MDC drugs, 
respectively (Fig. 9a). Transfection efficiency is at about 80% of the control cells although it drops down to 
50% for the highest concentration of chlorpromazine (Fig. 9b). MDC appears to be a relatively specific 
blocker of clathrin-mediated internalization. Its mechanism of action is not clear. The most often chosen 
description says that MDC prevents the assembly of clathrin-coated pits at the plasma membrane (Nandi et 
al., 1981). Another possibility is that MDC stabilizes the clathrin-coated pits (Wang et al., 2003). No studies 
have reported inhibitory actions of this drug on the raft/caveolae-dependent pathway. Furthermore, its effects 
on macropinocytosis remain controversial (Ivanov, 2008). Except for the lowest, all concentrations lead to 
identical inhibitions of the DNA expression (70% of the control, Fig. 9a). This might mean that the blockage 
of the pathway is complete and that clathrin-mediated endocytosis would represent about 30% of the 
internalization routes taken by electrotransferred DNA. 
 Chlorpromazine inhibits clathrin-mediated endocytosis of various plasma membrane proteins (Yao 
et al., 2002; Inal et al., 2005; Tulapurkar et al., 2005). It causes a loss of clathrin and AP2 complex from the 
plasma membrane and their localization and accumulation in endosomal membranes (Wang et al., 1993; Yao 
et al., 2002). There is no evidence in the literature that chlorpromazine affects raft/caveolae-mediated 
endocytosis. Several studies have demonstrated that clathrin-mediated endocytosis, which can be inhibited 
by chlorpromazine, is insensitive to the agents that block internalization via lipid rafts and vice versa (Inal et 
al., 2005; Tulapurkar et al., 2005). Chlorpromazine may interfere with the biogenesis of large vesicles such 
as macropinosomes (Ivanov, 2008). This might explain the difference in expression levels between the 
chlorpromazine and the MDC drugs. 
 Actin cytoskeleton has been proved to be necessary for the membrane invagination, scission, vesicle 
release and transport in clathrin-mediated endocytosis (Qualmann et al., 2002). It can, in addition, contribute 
to the anchoring and clustering of the endocytic machinery at the plasma and help to the initial deformation. 
We measured a clear diminishing of the DNA interaction with the membrane and DNA expression under 
treatment with drugs affecting the actin cytoskeleton (Chapters 1 and 3). Moreover, we observed the 
formation of actin patches colocalizing with DNA and actin-related transport.  
 Earlier studies revealed that MβCD treatment strongly inhibited endocytosis of transferrin, EGF and 
lipoplexes by inhibiting the invagination of clathrin-coated pits, resulting in accumulation of immobile 
shallow coated pits (Rodal et al., 1999; Subtil et al., 1999; Zuhorn et al., 2002). The inhibition, at 3 mM 
MCD for 15 min, of the transferrin uptake was about 90% (Rodal et al., 1999). However, the incubation 
conditions were different from those used here with very high drug concentrations (3 mM to 15 mM) but 
shorter treatment time (15 min). We used comparably low concentrations (1-5 µM) but the incubation time 
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was longer (1 h). We can expect some inhibition of the clathrin-mediated path after MCD treatment, but it 
should be rather low. 
 The colocalization study between DNA and the specific clathrin-mediated endocytosis marker 
transferrin reveal that this pathway is utilized by DNA as well (Fig. 10,12). Indeed, both methods of 
quantification established determine a colocalization at about 25%. It is in good agreement with the 
estimated percentage given by the gene expression experiments.  
 This work shows that expression of DNA is affected by inhibitors such as chlorpromazine, and MDC 
which are quite specific for the clathrin-mediated pathway. In addition, it is sensitive to actin dynamics 
disruption (latrunculin B and jasplakinolide) and depletion of cholesterol (MCD). Furthermore, we show 
that DNA aggregates colocalize with the specific marker transferrin. An article, published in the meantime, 
shows as well a reduction of DNA expression of about 30%, after treatment with chlorpromazine for 1 h at 
28 µM (Wu et al., 2011). This confirms our results since for similar incubation conditions we obtain similar 
effects. Moreover, the authors show that the dynasore drug, an inhibitor of dynamin, drastically reduces 
DNA expression with only 30% of the cells still being able to express the reporter protein. Dynamin is 
crucial for a certain number of endocytic pathways including the clathrin-mediated one, because it is 
responsible for the scission of the pit to become a vesicle. Therefore, we can conclude that the clathrin-
mediated endocytosis participates in the DNA internalization and seems to represent 25% of the total amount 
of DNA that crosses the membrane. 
II.3. Caveolin/raft-mediated endocytosis of DNA 
 Caveolin- and raft-mediated endocytosis represent a large subset of pathways that have been only 
recently discovered and suffer from a lack of precise description. Moreover, they share common features 
such as the presence of cholesterol. Therefore, it is very difficult to find good tools for their investigations. 
Cholesterol is one the main components of lipids rafts (caveolar or not) since it is its local enrichment, 
together with sphingolipids, that defines the rafts (Brown, 1994). Lipid rafts are platform for clathrin-
independent endocytic mechanisms due to their ability to cluster proteins. The depletion of cholesterol by 
MCD and filipin are shown to disrupt the composition of the lipid rafts that are therefore unable to localize 
and segregate proteins and thus to perform endocytosis (Kabouridis et al., 2000). Cholesterol-sensitive 
internalization of lipid rafts can be classified into three major pathways (Doherty et al., 2009; Lajoie et al., 
2010). These include dynamin-dependent endocytosis of caveolae (Rothberg et al., 1990; Rothberg et al., 
1992; Parton et al., 1994; Schnitzer et al., 1994; Parton, 1996; Smaby et al., 1996; Hailstones et al., 1998; 
Orlandi et al., 1998; Rodal et al., 1999) or non-caveolar vesicular carriers (IL-2) (Lamaze et al., 2001) as 
well as dynamin-independent endocytosis via non-caveolar tubular intermediates (GEEC) (Sabharanjak et 
al., 2002; Kirkham et al., 2005; Chadda et al., 2007) or non-tubular carriers (flotillin, Arf6) (Naslavsky et 
al., 2004; Glebov et al., 2006). All these pathways are also genistein- and actin dynamics-sensitive (Sahay et 
al., 2010). Indeed, actin is required for the dynamin-dependent internalization of SV40 via caveolae 
(Pelkmans et al., 2002), for the dynamin-dependent, but caveolae- and clathrin-independent internalization 
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of cytokine receptor  chain (CRc) (Sauvonnet et al., 2005), and for the dynamin, clathrin and caveolae-
independent internalization of GPI-anchored proteins (GPI-AP) (Chadda et al., 2007; Goswami et al., 2008; 
Noel et al., 2009). MCD is the drug which affects DNA expression the most. Very drastic decreases are 
observed in both transfection level and efficiency (respectively 60% and 50% of inhibition, Fig. 9). The 
effect of the depletion of cholesterol is dose-dependent. Similarly to MCD, genistein treatment greatly 
affects gene expression which reaches only 40% of the control (Fig. 9a). Data from chapter 1 and 3 of the 
results and discussions part shows the involvement of actin in the DNA-membrane interaction, DNA 
internalization and transport steps. It seems that raft-mediated endocytosis is involved in the translocation of 
DNA through the plasma membrane after the application of the electric field. In contrast, the inhibition using 
filipin, a drug sequestering cholesterol, is not such severe (down to 70% of the control, Fig. 9b). It has been 
shown, for the internalization of albumin, that filipin, in addition to inhibit any raft-mediated endocytosis, 
can greatly inhibit the degradation of the molecule in the multivesicular bodies (Schnitzer et al., 1994). This 
was not the case of clathrin-mediated ligands. If it is also the case for DNA, it would mean that more DNA 
would be available for efficient targeting of the nucleus and expression. This would give one explanation for 
less drastic effect of the drug as compared to MCD and genistein.  
 In the context of raft-dependent endocytosis, genistein has been shown to inhibit the recruitment of 
dynamin at the surface of the vesicles containing SV40 (Pelkmans et al., 2002). It would mean that non-
clathrin, but dynamin-dependent endocytosis would be more affected by treatment with genistein (caveolae 
and IL-2 pathways). A study about the entry of the adeno-associated virus demonstrates that although 
internalization is clearly mediated by the GEEC pathway, it remains sensitive to EIPA (Nonnenmacher et al., 
2011). EIPA would therefore be a GEEC endocytosis inhibitor. EIPA treatment reduces considerably the 
transfection level which would therefore demonstrate the involvement of the GEEC pathway in the 
internalization of electrotransferred DNA. 
 The lack of specific pharmacological inhibitors is not the only issue in discriminating the different 
pathways since the known raft marker CTB is also non-specific. CTB uptake from the cell surface is not 
inhibited by interfering with clathrin-mediated endocytosis (Orlandi et al., 1998; Nichols, 2002; Nichols, 
2003). Early studies demonstrated CTB to be internalized in a process that involves caveolae (Parton et al., 
1994; Henley et al., 1998; Oh et al., 1998; Lajoie et al., 2007; Lajoie et al., 2009a). However, more recent 
studies suggest that the major raft-dependent endocytic route for CTB is non-caveolar (Kirkham et al., 2005; 
Lajoie et al., 2009b). Flotillin-mediated pathway accumulates both CTB and GPI-APs (Glebov et al., 2006). 
It was shown that the dynamin-independent internalization of CTB occurred predominantly via uncoated 
tubular or ring-shaped vesicular carriers containing GPI-APs (GEEC) but not caveolin (Kirkham et al., 
2005). The colocalization study between DNA and CTB analyses about 50% of shared subcellular structures 
(Fig. 10,12). This is a high percentage that probably reflects the contributions of several of the raft-mediated 
pathways (caveolin, flotillin, IL-2 and GEEC). 
 To conclude, DNA expression is greatly reduced after treatment with MCD, filipin, genistein, 
latrunculin B and jasplakinolide. Inhibitive effects of MCD have been already shown by us (Rosazza et al., 
2012) and the one of genistein by another group, that also measured a decrease of expression under treatment 
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with the dynamin inhibitor, dynasore (Wu et al., 2011). Moreover, 50% of the DNA colocalizes with CTB. 
Therefore, it seems that raft-mediated endocytosis is very important for the transfer of DNA via electric 
fields. It can represent half of the internalization routes. This work does not allow conclusion about which 
types of the rafts are involved, but does not exclude any of them. 
II.4. Macropinocytosis of DNA 
 The first hint at the stimulation of macropinocytosis in electroporated cells came from the 
observation of electric-field induced ruffling and blebbing of the plasma membrane (Lambert et al., 1990; 
Glogauer et al., 1993; Rols et al., 1995). Later, studies about the transfer of proteins in cells via the 
application of electric fields also suggested a mechanism of macropinocytosis (Zimmermann et al., 1990; 
Glogauer et al., 1993; Rols et al., 1995). Our work focuses only on the transfer of plasmid DNA, but it can 
be that some internalization pathways are common. 
 The pharmacological drugs wortmannin and EIPA both very significantly decreased DNA 
transfection level (down to 65% of the control, Fig. 9a) in a dose-dependence manner for wortmannin. The 
efficiency of expression is less affected after EIPA treatment and is significant for the larger concentrations 
of wortmannin (70% of the control, Fig. 9b). EIPA (and amiloride) is sometimes used as the main diagnostic 
test to identify macropinocytosis since it inhibits Na+/H+ exchangers which are very important for the process 
(West et al., 1989; Mercer et al., 2010). The inhibitors prevent induction of membrane ruffling, but it is not 
clear whether they do this by interfering with actin modulation directly or by preventing alkalinization of the 
cytosol (West et al., 1989; Dowrick et al., 1993). Nevertheless, as mentioned before, EIPA could inhibit the 
GEEC pathway (Nonnenmacher et al., 2011). Part of the decrease in DNA expression we observe could be 
not related to macropinocytosis but to the raft-dependent GEEC endocytosis. The inhibition of 
macropinocytosis with EIPA, in our concentration range, is not dose-dependent for both transfection level 
and efficiency. This could mean that all such events are completely suppressed. The amount of DNA 
efficiently internalized by macropinocytosis (+GEEC?) would therefore represent 30-35% of the total 
amount of DNA inside the cells.  
 Wortmannin, a PI3K inhibitor, does not inhibit the membrane ruffling but the closure into 
macropinosomes fails with a receding of the ruffles into the cytoplasm (Araki et al., 1996). The apparent 
inhibition of pinocytosis by wortmannin increases with the molecular size of the probe used to measure it, 
consistent with the interpretation that wortmannin inhibits the formation of large vesicles more than the 
formation of small vesicles. A previous study showed that 70 kDa dextran labels predominantly 
macropinosomes in control cells, and that wortmannin treatment completely inhibits 70 kDa dextran 
endocytosis (about 5% of the control) (Araki et al., 1996). Smaller size probes (3 kDa dextran or lucifer 
yellow) could label both macro- and micropinosomes of controls, and after wortmannin treatment, only small 
vesicles were labeled. Therefore, the decreased uptake of fluid-phase probes by the inhibitors reflects a 
selective effect of wortmannin on macropinocytosis and reciprocally the good selectivity of 70 kDa dextran 
to probe this pathway. The highest concentration of wortmannin gives DNA expression at 65% of the 
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control, like EIPA. If we assume a total inhibition of this pathway, macropinocytosis would represent 35% of 
the internalization routes of electrotransferred DNA. 
 The colocalization study between DNA and the fluid-phase marker 70 kDa dextran confirms the 
previous results (Fig. 10,12). As mentioned above, 70 kDa dextran is a good macropinocytosis marker due to 
its size. Moreover, the study that suggests EIPA as a potent inhibitor of the GEEC pathway shows that 
70 kDa dextran uptake is strongly controlled by macropinocytosis regulators (Nonnenmacher et al., 2011). 
The quantification yields between 30% and 45% of colocalization according to the chosen approach. This is 
in good agreement with the percentage estimated from the inhibition experiments. The difference of values 
between the two approaches can come from the fact that the quality of the image of the dextran channel is 
not ideal. A strong background in the cell was present and even the image processing procedure could not 
completely remove it. The remaining background pixels could have been confused with real objects. If these 
pixels would be located very close to the DNA patches without coinciding, it can be that the distance 
approach considers it as a colocalization event. Therefore, we believe that the value of 45% is an 
overestimation. This being said, the calculated percentages are a little overrated nonetheless since, in our 
case, 70 kDa dextran partially colocalizes with CTB and TF (Fig. 11). However, the colocalization is weak 
with CTB and very weak with TF.  
 Extraction of cholesterol with MCD blocks both the formation of membrane ruffles and 
macropinosomes at the plasma membrane (Grimmer et al., 2002). Cholesterol depletion inhibits the ligand-
induced reorganization of filamentous actin at the cell periphery, a prerequisite for the formation of 
membrane ruffles that close into macropinosomes, most probably through the impaired recruitment at the 
plasma membrane of the activated small GTPase Rac1, Arf6 and other signaling factors (Grimmer et al., 
2002; Mercer et al., 2009). A part of the inhibition of the DNA expression after MCD treatment could be 
assigned to the participation of macropinocytosis in DNA delivery. 
 Mercer et al. listed the experimental criteria required to satisfy the definition of macropinocytosis 
(Mercer et al., 2009). This work together with previously published articles and some experiments described 
in chapters 1 and 3 of the results and discussions part show that DNA electrotransfer fulfills a lot of the 
conditions: electroporation induces membrane ruffles and blebbing (Lambert et al., 1990; Glogauer et al., 
1993; Rols et al., 1995), electrotransferred DNA colocalizes with the fluid-phase marker (70 kDa dextran), 
and gene expression is significantly reduced by inhibition of PI3K (wortmannin), Na+/H+ exchangers (EIPA), 
actin and microtubules dynamics (latrunculin B, jasplakinolide, nocodazole and taxol) and dynamin 
(dynasore (Wu et al., 2011) and maybe genistein). In addition, gene expression is drastically decreased by 
depletion of cholesterol the latter being involved in ruffles formation and closure in macropinosomes through 
failure in recruiting Rac1. Therefore, we can conclude that macropinocytosis is most probably one of the 
paths electromediated DNA utilizes for its internalization into CHO cells. It is difficult to calculate in which 
proportions, because in our case 70 kDa dextran partially colocalize with other pathways, quantifications 
give different results according to the methods of analysis, and complete inhibitions with wortmannin or 
EIPA is uncertain. However a first evaluation would estimate that macropinosomes would represent about 
30-40% of the DNA aggregates visible in cells. 
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II.5. DNA internalization and trafficking 
 The DNA aggregates interacting with the plasma membrane have sizes varying from 100 nm to 
500 nm (Golzio et al., 2002b; Faurie et al., 2004; Faurie et al., 2010). This wide range of sizes may explain 
the several endocytic pathways taken by DNA. A study on the uptake of microspheres showed that particles 
up to 200 nm were internalized mainly by the clathrin-mediated pathway. With increasing diameters, a shift 
to a caveolin/raft-mediated endocytosis was observed and for 500 nm microspheres the latter was the 
predominant endocytic pathway (Rejman et al., 2004). Thus, particle size in itself could determine which 
pathway is followed. DNA aggregate size is often small compared to the usual size of the content engulfed in 
the macropinosomes (500 nm – 1 µm or more). A possible explanation for such a high rate of 
macropinocytosis could come from the fact that electric fields themselves induce membrane ruffling and 
blebbing, as a response to a physical stress. The collapse of these field-induced protrusions could create 
unexpected macropinosome sizes. 
 How can DNA initiate the endocytic process? As mentioned in the previous chapter, the presence of 
the DNA aggregates inserted into the membrane could be sensed by the lipids present in the membrane. It 
could be due to the high density of negative charges of the DNA cluster or simply because any insertion in 
the membrane induce a change in the membrane curvature. Cells possess a large subset of membrane-
curvature sensing proteins (e.g. BAR proteins recruited by lipids PIP2) that in turn would activate signaling 
cascade resulting in endocytosis. If any, the change of membrane curvature could not only be due to the 
presence of DNA but also to the electrophoresis of DNA during the application of the electric field. As 
Klenchin et al. suggested, the electrophoretic force could be strong enough to push the membrane and 
initiate a pit (Klenchin et al., 1991). This would be sensed by the cell that would response by internalizing it. 
 DNA could, however, still enter cells via electropores. This hypothesis, even if not supported by 
experimental data at the present stage, still should be considered as one potential way for DNA to cross the 
plasma membrane as it is postulated based on simulations (Smith et al., 2004) and on results based on DNA 
electrotransfer in GUVs (Portet et al., 2011). In this last paper, it has been shown that the predominant 
pathway of electromediated DNA access into liposomes is undoubtedly the electrophoretic entrance in a free 
form via defects created on the pole of the vesicles facing the cathode. 
 The fact that DNA internalization is largely taking place via endocytosis allows speculations about 
the intracellular trafficking of the DNA. Intracellular trafficking of endosomes is cytoskeleton based (Murray 
et al., 2003). The actin cytoskeleton, in addition to being required for any endosome formation, can be used 
for the early steps of the transport. Further long-range transport takes place via the tubulin network. Previous 
studies have shown the involvement of both the actin and the tubulin networks in the mechanism of gene 
electrotransfer. Indeed, actin polymerization occurs at the membrane sites where the DNA aggregates are 
formed and its alteration prior to gene electrotransfer reduces the DNA accumulation at the membrane and 
the DNA expression (Rosazza et al., 2011). Vaughan et al. have shown that a stabilization of the microtubule 
network enhances electrotransferred DNA expression (Vaughan et al., 2006; Vaughan et al., 2008). They 
also demonstrated the ability of DNA to interact with the microtubules via other proteins. Our findings are in 
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agreement with these studies, as an endocytic process requires the participation of the actin and the tubulin 
filaments. In addition it reinforces the hypothesis of an active intracellular transport of the DNA. 
II.6. Conclusion 
 This part of the work clearly shows that DNA is endocytosed. The quantification of the respective 
pathways indicates that, in CHO cells, approximately 50% of the DNA enters into the cells via the 
caveolin/raft-mediated pathway, 25% via the clathrin-mediated pathway and 30% via macropinocytosis. 
While previous works suggested that an endocytic process could occur during gene electrotransfer (Klenchin 
et al., 1991; Rols et al., 1995; Satkauskas et al., 2001; Antov et al., 2005; Wu et al., 2011), this is the first 
time that this is demonstrated. However, more investigations have to be performed in order to confirm and 
better discriminate between the different pathways. Other inhibitors could be tested such as dynasore, 
LY294002, IPA-3, EH1864 and nystatin, inhibiting dynamin, PI3K, Pak1, Rac1 and cholesterol action, 
respectively. The use of dominant negative cells would be of a great help as well (dynamin, Rac1, Eps15, 
Cav1, Cdc42, Arf6…). Colocalization studies could be performed with (GFP) labeled protein such as 
clathrin, caveolin, flotillin, small GTPases (dynamin, GPI-APs, Cdc42…). By looking at the results, it looks 
as if endocytosis is the main and maybe the only manner electrotransferred DNA can reach the cytoplasm. 
Not only endocytosis occurs but it is an efficient route of DNA delivery since inhibitions do result in 
decreases of DNA expression. The plasmid DNA aggregates are therefore not all lost in presumably 
lysosomal compartments for degradation. 
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Chapter 3: DNA active transport 
 Most of the results reported in this chapter have been published, therefore the text contain portions 
that literally cite the article (Rosazza et al., 2013). After being internalized, DNA must cross the cytoplasm 
to reach the nucleus. DNA molecules larger than 2 000 base pairs are unable to freely diffuse in the 
cytoplasm (Lukacs et al., 2000). The cytoplasm is a highly crowded medium where cellular compartments 
and cytoskeleton, to cite only the most important, greatly hinder the diffusion of molecules (Luby-Phelps, 
2000). However, DNA electrotransfer leads to gene expression. Therefore, plasmids must be able to cross the 
cytoplasm by other means than diffusion. Characterizing how plasmids move through the cytoplasm is 
imperative to understand and enhance transfection efficiencies. One possibility is that plasmids use the cell’s 
own machinery to be transported. It seems possible that DNA interacts with the microtubules and/or the actin 
network, the two relevant structures of the cytoskeleton for efficient transport toward the nucleus. To 
characterize DNA transport properties, the method of choice is single particle tracking (SPT) combined with 
highly sensitive fluorescence live-cell imaging (Braeckmans et al., 2010; Huang et al., 2011; Ruthardt et al., 
2011). It allows for the direct observation as well as the calculation of kinetic parameters of individual 
particles in living single cells with high spatial and temporal resolution. The analysis of hundreds of particles 
gives a strong statistical quantification of transport velocities, diffusion coefficients, durations and 
displacements of each mode of motion followed by the particles. DNA tracking was performed on untreated 
CHO cells. Afterwards, cells were treated with drugs altering or stabilizing each of the filaments, and their 
effects on DNA motion kinetics was measured. Before starting the tracking study, the effects of the drugs on 
gene expression has been measured to point at the involvement of the cytoskeleton in the DNA 
electrotransfer mechanism. 
I. Results 
I.1. Determination of the conditions of incubation for each drug 
 A preliminary step for the investigations is to establish conditions of incubation of the different 
drugs we want to employ such that alterations are efficient (stabilization or disruption) but not affecting too 
strongly cell viability given that all drugs are cytotoxic. A brief description of the drug effect follows here: 
- Nocodazole: disrupts the microtubules. It binds to tubulin dimer and increases its GTPase activity 
(Mejillano et al., 1996). Higher GTP hydrolyzation destabilizes the (+) end protecting cap of the 
microtubules, which results in the depolymerization of the filaments. 
- Taxol: stabilizes the microtubules. It binds to polymerized tubulin and engenders a more rigid 
microtubule structure (Xiao et al., 2006). This increases the polymerization rate and the microtubules 
are more resistant to depolymerization (Yvon et al., 1999). 
- Latrunculin B: disrupts the actin filaments. It binds to the actin monomer, changes its conformation 
and prevents the re-polymerization of the filament. This leads to the depolymerization of the network 
(Morton et al., 2000). 
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- Jasplakinolide: stabilizes the actin filaments. It binds to actin in the filaments and induces a higher 
polymerization rate (Bubb et al., 1994). 
 
 
Figure 13: Structure of the cytoskeleton of CHO cells and cell viability after separate treatment with drugs 
affecting the microtubules and the actin filaments. Cells were labeled with anti--tubulin-Cy3 or phalloidin-
rhodamine respectively to observe the microtubules and the actin network. Cells were treated for 1 h at the different 
concentrations mentioned above each image, fixed immediately after and observed using wide-field microscope. The 
drugs employed to alter the microtubules are (a) nocodazole for their disruption and (b) taxol for their stabilization. The 
drugs chosen to disturb the actin filaments are (c) latrunculin B for their disruption and (d) jasplakinolide for their 
stabilization. (e,f) Cell viability measured 24 h after drug incubations through crystal violet staining. 
 To directly observe the effect of the drugs on the cytoskeleton, immunofluorescence experiments 
were performed. Microtubules were labeled using anti--tubulin conjugated with Cy3 and actin filaments 
were stained using phalloidin-rhodamine. Incubation time was set to 1 h, different concentrations were 
tested. After 1 h of treatment, cells were immediately fixed for observation using wide-field microscopy 
(Fig. 13a-d), whereas for cell viability tests, they were afterwards cultured in normal medium for 24 h 
(Fig. 13e,f). In both networks, disruptions are easier to see than stabilizations. For all drugs, concentrations 
too high lead to cell death or a severe disturbance of the cell morphology. At 5 µM concentration, 
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nocodazole can destroy some of the microtubules, but 10-40 µM are much more efficient concentrations for 
their disruption (Fig. 13a). However, cell viability is also more affected (respectively 60-40% of the control 
cells, Fig. 13e). Concerning taxol, all concentrations preserve the cell viability rather well (60-80%, 
Fig. 13e), so that it seems that 20-40 µM are the optimal for a stabilization of the microtubules (Fig. 13b). 
Up to 2 µM latrunculin B, good cell viability is maintained (Fig. 13f) but the cell morphology at this 
concentration is affected (Fig. 13c). At a concentration of 0.1 µM, a lot of actin filaments remain, thus the 
optimal range is 0.5-1 µM. For jasplakinolide, concentrations higher than 0.5 µM lead to severe alteration of 
the actin filaments and cell morphology (Fig. 13d). Therefore, working concentrations should be between 
0.125 µM and 0.5 µM. 
I.2. Effect of cytoskeleton alteration on gene expression 
 In order to determine whether the cytoskeleton is potentially involved in the DNA electrotransfection 
process, we performed EGFP reporter gene expression experiments in cells where the cytoskeleton has 
transiently been disturbed. The four previously described drugs were incubated 1 h before and after the 
application of the electric field at different concentrations. We measured the transfection level (percentage of 
EGFP fluorescent cells) and the transfection efficiency (mean fluorescence intensity). For all conditions, 
gene expression decreased (Fig. 14a,b). In nocodazole or taxol treated cells, the transfection level declined 
by up to 22 % compared to the control where 31% of the cells expressed the reporter gene (Fig. 14a). In both 
cases, the transfection efficiency was also reduced by 18% (3 700 a.u. against 4 500 a.u., Fig. 14b). 
Concerning the drugs affecting the actin network, both induced a larger decrease of the transfection level and 
efficiency. For instance, the percentage of fluorescent cells dropped to 16% and 18% after the addition of 
1 µM latrunculin B or 0.5 µM jasplakinolide, respectively (Fig. 14a). Similarly, the observed fluorescence 
intensities dropped by 47% and 33% (from 4 500 a.u. to 2 400 and 3 000 a.u., Fig. 14b). 
 
 
Figure 14: Gene expression in CHO cells after alteration of the cytoskeleton. Flow cytometry results of EGFP 
reporter gene expressions 24 h after separate treatment of CHO cells with different concentrations of nocodazole (Noc), 
taxol (Tax), latrunculin B (Lat B), and jasplakinolide (Jas), respectively. Incubations were performed 1 h before and 
after the application of the electric field (10 pulses at 0.4 kV/cm, 5 ms and 1 Hz) in the presence of the pEGFP-C1 
plasmid DNA. (a) Percentage of fluorescent cells (transfection level) and (b) mean fluorescence intensity (transfection 
efficiency) (SEM, n = 5). Controls represent transfected, but otherwise untreated cells. 
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 As suggested by the results of the first chapter about gene expression after latrunculin B treatment, 
DNA expression is rather affected by the alteration of the actin network, most likely due to its involvement 
in the DNA/membrane interaction and DNA internalization. To avoid this effect, the incubation should be 
therefore performed at about 5-15 min after the application of the electric field. In addition, incubation time 
should be as short as possible to be able to observe transport which would begin immediately after the 
internalization. For these reason, the incubation time was set to 15 min. Efficiency of the alteration was 
checked again by labeling the actin filaments with phalloidin-rhodamine after fixation of the cells (Fig. 15). 
Actin filaments are efficiently disrupted after treatment with 1 µM latrunculin B (Fig. 15a) and the highest 
concentration of jasplakinolide that stabilizes the actin network is 0.25 µM (Fig. 15b). These concentrations 
are those used for the further experiments.  
 
 
Figure 15: Structure of the cytoskeleton of CHO cells after treatment with drugs affecting the actin filaments.  
Cells were treated for 15 min at the different concentrations mentioned above each image, fixed, labeled with 
phalloidin-rhodamine and observed using wide-field microscope. (a) Latrunculin B treated cells, (b) jasplakinolide 
treated cells. 
I.3.  DNA mode of motions 
 The first aim was the characterization of intracellular DNA transport in living CHO cells. For this 
purpose, we employed SPT of individual DNA aggregates. Time-series of fluorescently Cy5-labeled DNA 
were taken between 5 min and 1.5 h after the application of the electric field (350 frames with a rate of 10 
frames per second). The images provided are extracted from a movie recorded at 20 min (Fig. 16a-c). We 
generally notice that once the DNA is internalized, it rapidly distributes inside the cell without any apparent 
orientation preference and that DNA aggregates have various sizes (Fig. 16a,c). This is observed despite the 
fact that they are initially formed only at the side of the cell membrane facing the cathode (Golzio et al., 
2002b). Its rapid distribution is not compatible with purely diffusive intracellular transport. Inspection of the 
spatiotemporal DNA trajectories reveals several aspects (Fig. 16b,d-j). One sees that aggregates can move 
over long (Fig. 16d-f) or shorter distances (Fig. 16g-i) or remain almost immobile (Fig. 16j). Both short and 
long distance trajectories spread over one direction and even often had bidirectional movements (Fig. 16d-h, 
white arrows). Bidirected traces can overlap well or can be rather parallel. In most cases, directed movement 
was not permanent, but was instead observed in phases interrupted by periods of slow motion (Fig. 16l).  
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Figure 16: Single particle tracking of DNA aggregates in CHO cells after electrotransfer and characterization of 
the DNA modes of motion. (a) Image extracted from a time series of fluorescently Cy5-labeled DNA aggregates inside 
a cell recorded 20 min after the application of the electric field (10 pulses at 0.35 kV/cm, 5 ms and 1 Hz). (b) Time 
series (a) after particle tracking. The color of the trajectories codes time with blue corresponding to 0 s and white to 35 
s. (c) merge between the time series with trajectories (b) and transmission light image of the cell. (d-j) Zoom into some 
trajectories of the time series (b), scale bars = 1 µm. Trajectories show long (d-f) or short (g-i) distance excursions or 
almost immobile aggregates (j). Different modes of motion can be observed within one trajectory (l). Trajectories were 
automatically divided into segments exhibiting only active transport (red line) or diffusive motion (green circle). Modes 
of motion can be determined by MSD analysis: quadratic fits correspond to active transport (k), linear fits to diffusive 
motion (m) from which can be calculated velocity or diffusion coefficient, respectively. 
 Because of these alternating modes of transport, we segmented the trajectories using home-written 
software. The segmentation relies on the statistical analysis of the distribution of the angles formed between 
two consecutive steps of a trajectory. When a particle follows a random walk, the angle between two 
consecutive steps is arbitrary. The distribution of angles will therefore be uniform. By contrast, if a particle 
undergoes active transport, the trajectory exhibits directionality, i.e. the distribution of angles between 
consecutive steps will have a maximum. A statistical test is applied to a sliding window of the collected 
angles, which yields a sequence of 0s and 1s, where each 1 corresponds to a uniform angle distribution. 
Consecutive 1s are combined into a connected component which is accepted as a segment of pure diffusion, 
if this component is larger than a minimum segment size. Conversely, connected components of 0s are 
accepted as segments of active transport. We thus obtained segments of trajectories with single modes of 
motion, active transport or diffusion, which can be analyzed separately. This approach reduces averaging and 
gives better insight into the details of intracellular transport. Once the segmentation is performed, the mean 
square displacements (MSD) of the segments are analyzed (Fig. 16k,m). A linear fit of the MSD hints at 
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diffusive motion, whereas a quadratic fit indicates active transport (Ruthardt et al., 2011). Therefore, each 
segment is defined by one kinetic parameter (velocity or diffusion coefficient), one maximum displacement 
and one duration. The maximum displacement is defined by the highest displacement that can be found 
between the initial position of the segment and any other position within that segment, which does not 
always correspond to the last position of the segment given that traces have often curved shape. Duration is 
simply defined by the time needed by the DNA aggregate to travel from the initial to the final position of the 
segment. 
 
 
Figure 17: Distributions of the descriptive parameters for each mode of motion in CHO cells after segmentation 
of the trajectories. Distributions for velocities (a), diffusion coefficients (b), maximum displacements (c,d), and 
durations (e,f) for active transport (left row) and diffusion (right row). Parameters are calculated from 3106 segments 
obtained from 1570 trajectories. All distributions except for (b) are fitted using a log-normal distribution (red lines). 
Plot (b) represents already the logarithm of the diffusion coefficients therefore it is fitted using a normal distribution 
(red line). 
 The first result thus obtained was that DNA aggregates are actively transported inside the cells. The 
analysis of 1570 trajectories, resulting in a total of 3106 segments, allowed us to represent the distributions 
of the velocities and diffusion coefficients with high statistical significance (Fig. 17a,b). Both distributions 
are rather broad with velocities varying between 50 nm/s and 3400 nm/s, and diffusion coefficients varying 
between 10-5 µm2/s and 10-1 µm2/s. To describe the processes in more detail, the distribution of the 
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displacements and durations of each type of motion were also plotted (Fig. 17c-f). While active transport 
phases can lead to drift distances of more than 10 µm over 3-20 s, in the case of the diffusion, displacements 
are mainly below 1 µm although the overall time spent in this mode is longer. Under our experimental 
conditions, a typical active motion segment features an average velocity of 250 nm/s, persists for 6 s and 
leads to a displacement of 1.3 µm (Table 1). We additionally determined the proportion of active transport 
and diffusion over the time of a movie, i.e. 35 s. After segmentation, when at least one segment of a 
trajectory showed active transport, we assigned this trajectory into the active transport group; otherwise the 
trajectory was assigned into the diffusive motion group. In this manner, we found that 46% of the trajectories 
contain at least one segment of active transport (Fig. 17f). Almost half of the trajectories have at least one 
active transport phase during the 35 s of observation. 
I.4. Means of intracellular DNA transport 
 Active intracellular transport is commonly observed for a variety of cellular organelles (Ichikawa et 
al., 2000; Pilling et al., 2006; Toshima et al., 2006; Osborne et al., 2009; Li et al., 2012). The driving forces 
behind this type of motion are molecular motors such as kinesins and dyneins operating on microtubules and 
myosins acting on actin microfilaments (Murray et al., 2003; Ross et al., 2008). In order to elucidate the role 
of microtubule- and actin-related motion in the active intracellular transport of DNA aggregates, we 
performed SPT of DNA on living CHO cells treated with microtubules and microfilaments affecting drugs 
and compared the different accessible parameters with those obtained in the experiments with non-treated 
control cells.  
I.4.a. Microtubule-related transport 
 To get a first overview of the effect of the drugs on the DNA aggregates transport, all the recorded 
trajectories for the different conditions were plotted together on the same graph (Fig. 18). For the 
construction of these track plots, each starting point of the different trajectories was set to the origin (x,y) = 
(0,0). They have the advantage of direct visualizing several hundreds of events. The plots clearly show that 
the trajectories of DNA aggregates in nocodazole treated cells are much shorter than those of the control 
cells. As a means of quantification, a circle is drawn. Its radius corresponds to the upper boundary value 
below which 90% of the data fall. The 90% radius (r90%) is 2.74 µm for the control cells and 0.64 µm for 
nocodazole treated cells (Fig. 18a,c), corresponding to a fourth of the control value. The percentage of DNA 
trajectories exhibiting phases of active transport was also drastically reduced (3.5%) compared to the control 
cells (46%) (Fig. 18f). 
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Figure 18: Track plots and percentage of active transport in CHO cells treated with cytoskeleton affecting drugs. 
Track plots group all trajectories recorded for one condition. Starting points are the origin (n = number of movies). (a) 
Nocodazole treated-cells (20 µM, n = 46), (b) taxol treated-cells (20 µM, n = 52), (c) control cells (n = 116), (d) 
latrunculin B treated-cells (1 µM, n = 54), (e) jasplakinolide treated-cells (0.25 µM, n = 48), (f) percentage of 
trajectories exhibiting active transport. 
 These results were confirmed using histograms of velocities and maximum displacements observed 
for the segmented trajectories. (Fig. 19a,c). The 90% value of the velocity is five-fold smaller (v90%control = 
560 nm/s, v90%noc = 110 nm/s) and the mean velocity is 3-fold reduced (from 256 nm/s in the control cells to 
83 nm/s in nocodazole treated cells, Table 1). The graphs of the maximum displacements of segments 
showing active transport also exhibit pronounced differences between control and nocodazole treated cells 
where displacements are never larger than 1 µm (Fig. 19c and Table 1). In contrast to velocity and 
displacement, the time spent in the active transport phase is only slightly reduced from 6.5 s for the control 
cells to 6 s for the nocodazole treated cells (Fig. 19e and Table 1). Altogether we observe that the disruption 
of the microtubule network by nocodazole results in shorter trajectories, in a decrease in active transport 
velocities, and in overall reduction of active transport events. 
 Since the disruption of the microtubule network has detrimental effects on the active transport of the 
DNA aggregates, we performed experiments with taxol treated cells in order to find out whether microtubule 
stabilization might enhance the transport. However, when taxol is present, we observe that the trajectory 
displacement is also reduced (r90% = 1.02 µm, Fig. 18b), that the proportion of active transport decreases 
(from 46% to 21%, Fig. 18f), and that the active transport is slowed down with v90% reaching 211 nm/s and 
vmean amounting to 119 nm/s (Fig. 19a and Table 1). The segment displacement distributions thus also show 
that high displacements are eliminated (Disp90% = 1.1 µm for taxol treated cells, Disp90% = 2.7 µm for the 
control cells, Fig. 19c and Table 1). While these values are reduced, compared to the control cells, the 
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average time spent in the active motion mode remains identical to the control cells (Fig. 19e and Table 1). It 
therefore seems that the main effect of the stabilization of the microtubule network by taxol is the reduction 
of the active transport velocity. 
 
 
Figure 19: DNA velocity, maximum displacement, duration distributions for the control and drug treated-cells 
after electrotransfer. These data refer to the portions of trajectories showing only active transport (n = number of 
segments). (a,b) DNA velocity distributions, (c,d) DNA maximum displacement distributions and (e,f) DNA duration 
distributions in cells treated with (a,c,e) microtubule and (b,d,f) actin filament affecting drugs: nocodazole 20 µM (red, 
n = 19), taxol 20 µM (blue, n = 154), latrunculin B 1 µM (red, n = 346), jasplakinolide 0.25 µM (blue, n = 483) and 
control (black, n = 1077). Distributions were fitted using a log-normal distribution (black, red or blue lines). 
 In order to provide evidence for interactions between the DNA aggregates and the microtubules by 
other means than the analysis of transport kinetics, we performed dual color experiments. Firstly, we 
recorded time series of Cy5 labeled DNA aggregates in cells transiently expressing GFP-tubulin (Fig. 20a-
c). We observed that at the tip of the cell, where the microtubule structure could be seen better, the trajectory 
pattern coincide rather well to the tubulin filaments (Fig. 20b,c). To confirm the involvement of at least one 
of the microtubule-related motors, in a second step, we imaged DNA aggregates and dynein motor proteins. 
30 min after electroporation with Cy3 labeled DNA, cells were fixed and labeled with an antibody against 
the light chain of the dynein motor. Unfortunately, fixation of cells prevent recording of dynamics. Therefore 
single pictures for each color were taken and merged (Fig. 20e-j). DNA and dynein colocalize meaning that 
at least the motor protein dynein can interact with electrotransferred DNA.  
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Figure 20: Two-color fluorescence imaging of electrotransferred plasmid DNA, microtubules and the motor 
protein dynein. (a-c) Single particle tracking of Cy5 labeled DNA aggregates in CHO cells transiently expressing 
GFP-tubulin. (a) Trajectories of DNA aggregates (red spheres) inside a GFP-tubulin expressing cell (white features). 
(b,c) Zoom into the yellow square drawn in the image (a). (b) Five different trajectories from (a), with different colors 
to better distinguish them, overlaid with the microtubule image. (c) GFP-tubulin image alone for a better visualization 
of the microtubule structure. Scale bar = 3 µm (e-m) Colocalization between Cy3 labeled DNA aggregates and dynein 
labeled with an antibody against the light chain 8 (DLC8) conjugated with Alexa Fluor 647. (e,h) DNA aggregates, (f,i) 
anti-dynein, (g,j) merge of the two colors. Scale bar = 2 µm. 
I.4.b. Actin-related transport 
 It has previously been shown that the actin network is involved in the internalization of 
electrotransferred DNA (Rosazza et al., 2011). However, the question whether active transport of the DNA 
aggregates along actin filaments occurs after internalization has not been addressed until now. The large 
portion of DNA aggregates being actively transported at low velocities in untreated cells could be due to the 
action of actin-related molecular motors. We therefore also performed SPT studies with two drugs which 
disrupt or reinforce the cellular actin network, latrunculin B and jasplakinolide, respectively. 
 Since an alteration of the actin network primarily leads to an inhibition of DNA aggregates 
internalization (Fig. 14) (Rosazza et al., 2011), we incubated the cells 15 min after the application of the 
electric field. Inspection of the track plots (Fig. 18d) reveals that the track displacements decreased from 
r90% = 2.74 µm to r90% = 1.75 µm after latrunculin B treatment. The percentage of trajectories exhibiting 
active transport was slightly lowered from 46% in untreated cells to 36% (Fig. 18f). The velocity histogram 
was changed with v90% = 404 nm/s and vmean = 184 nm/s (Fig. 19c and Table 1), whereas the control values 
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are 560 nm/s and 256 nm/s, respectively. Smaller differences between control and treated cells were seen in 
the histograms of the segment displacements (Disp90% = 1.9 µm and Dispmean = 1.0 µm for treated cells, 
Fig. 19d and Table 1). The average time spent in active motion is slightly increased to 7.2 s compared to the 
control cells reaching 6.5 s (Fig. 19f and Table 1). 
 After jasplakinolide treatment, a decrease in the displacements of the trajectories from 2.74 µm to 
1.84 µm was observed (Fig. 18e), whereas the percentage of trajectories exhibiting active transport phases 
remains nearly unchanged at 45% (Fig. 18f). This means that while the active transport occurrence is not 
changed by the actin stabilization, the travelling distances are reduced (Fig. 19d and Table 1). The reason 
for this is found when inspecting the histogram of the calculated velocities in the segments (Fig. 19b) which 
show a reduction of v90% from 560 nm/s to 292 nm/s and of vmean from 256 nm/s to 148 nm/s (Table 1). The 
duration of the active transport segments sensibly increased to 7 s (Fig. 19f and Table 1).  
 
Table 1: Parameters describing active transport and diffusion motions for DNA delivered by electroporation. AT 
= (with) active transport, D= (with) diffusion. 
 
 
I.4.c. Diffusion mode 
 From the single particle tracking analysis, details about diffusion mode can be quantified and 
differences between control and treated cells can be identified. Indeed stabilization or disruption of the 
cytoskeleton might induce a change in the viscosity and the crowding of the cytoplasm that may affect 
diffusion properties of particles in general and DNA aggregates in our case. 
 A typical diffusion phase in control cell exhibits a diffusion coefficient of 6 10-3 µm2/s, persists for 
12 s and leads to a displacement of 0.5 µm (Table 1). Disturbance of the cytoskeleton, disruption or 
stabilization of the microtubules or the actin filaments, induces a decrease of the diffusion coefficient 
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(Fig. 21a,b and Table 1). This effect is the highest in cells treated with drugs affecting the microtubules 
especially with nocodazole where the mean diffusion coefficient equals 9.7 10-4 µm2/s. The displacement 
generated by diffusion remains nearly unchanged when the cytoskeleton is affected, only higher 
displacements are suppressed (Fig. 21c,d and Table 1). The time spent in the diffusion mode is slightly 
increased when affecting the cytoskeleton, with a highest effect when microtubules are disrupted by 
nocodazole (Fig. 21e,f and Table 1). It is interesting to note that, particles staying longer in diffusion mode 
do not exhibit larger associated displacements (Fig. 22e-h). Indeed, the maximum displacement remains 
constant over time. It means that DNA particles diffuse in confined areas which surfaces are related to the 
maximum displacement the particles can travel and their radius. The Dispmean value for the control cells 
equals 0.5 µm (Table 1) and the DNA particle size varies between 0.1 and 0.5 µm, the mean confinement 
surface should therefore be between 0.6 µm and 1 µm. In the presence of drug disrupting or stabilizing the 
cytoskeleton, DNA particles keep on following confined diffusion (Fig. 22e-h). Since the mean maximum 
displacement is only slightly changed for non-control conditions (Table 1), the confinement areas are not 
expected to vary drastically.  
 
 
Figure 21: DNA diffusion coefficient, maximum displacement, duration distributions for the control and drug 
treated-cells after electrotransfer. These data refer to the portions of trajectories showing only diffusion (n = number 
of segments). (a,b) DNA diffusion coefficient distributions, (c,d) DNA maximum displacement distributions and (e,f) 
DNA duration distributions in cells treated with (a,c,e) microtubule and (b,d,f) actin filament affecting drugs: 
nocodazole 20 µM (red, n = 718), taxol 20 µM (blue, n = 742), latrunculin B 1 µM (red, n = 749), jasplakinolide 0.25 
µM (blue, n = 901) and control (black, n = 2029). Distributions were fitted using a log-normal distribution (black, red or 
blue lines). 
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Figure 22: 3D scatter plots for the active transport and diffusion parameters (velocity, diffusion coefficient, 
duration, and maximum displacement) depending on the cytoskeleton state. 3D scatter plots are drawn from the 
values calculated out of the segments bearing (a-d) active transport or (e-h) diffusion (n = number of segments per 
mode of motion). On each plot are represented the values for the control cells (respectively n = 1077, n = 2029) and the 
one for the drug treated cells with (a,e) nocodazole 20 µM (n = 19, n = 718), (b,f) taxol 20 µM (n = 154, n = 742), (c,g) 
latrunculin B 1 µM (n = 346, n = 749), and (d,h) jasplakinolide 0.25 µM (n = 483, n = 901). 
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II. Discussion 
 Understanding the mechanism governing DNA electrotransfer in cells is a prerequisite for the 
development of more efficient protocols based on this approach. This concerns both the use of 
electroporation as a transfection technique used in molecular cell biology as well as its use for DNA 
vaccination or gene therapy of animals and humans (Cemazar et al., 2010; Chiarella et al., 2010). While for 
the latter application, clinical trials have already shown high potential, especially in cancer treatment (Heller 
et al., 2010), its future clinical use requires a much better knowledge of the processes involved at the cellular 
level. The transfection using electrically mediated DNA delivery is a multistep process involving crossing of 
the plasma membrane, migration of the DNA through the cytoplasm and entry into the nucleus (Fig. 23). Our 
interest was focused on unraveling the fate of the DNA inside the cytoplasm.  
II.1. DNA aggregates are actively transported along actin filaments 
 The application of electric pulses is accompanied by an electrophoretic force which causes the DNA 
in the medium to migrate toward the cathode facing cell membrane where DNA aggregates are formed 
(Fig. 23, steps 2 and 3) (Klenchin et al., 1991; Golzio et al., 2002b). We have previously shown that these 
aggregates then interact with the cellular actin network (Rosazza et al., 2011). This interaction can explain 
why the application of drugs, which either stabilize or destabilize the actin network, lead to a decrease in 
transfection level and efficiency (Fig. 14). The interaction between actin and DNA aggregates ultimately 
seems to lead to the engulfment of the aggregates and their internalization (Fig. 23, step 4). Several different 
endosomal internalization pathways have been shown to be accessible to the DNA aggregates (Antov et al., 
2004; Rosazza et al., 2012). The question whether active transport along the actin network plays a role in the 
early stages of intracellular transport of the DNA aggregates has not been addressed so far. The velocity 
distribution obtained from the SPT experiments on untreated CHO cells (Fig. 17a) show that apart from fast 
active transport with velocities of several hundreds of nm/s, always a large part of the aggregates are 
transported more slowly with velocities ranging between some tens and a few hundreds of nm/s. The in vitro 
mean velocities of myosin as actin-related motor proteins were determined to lie between 50 nm/s and 
300 nm/s for myosin VI and between 250 nm/s and 500 nm/s for myosin V (Sweeney et al., 2007; Pierobon 
et al., 2009; Ali et al., 2011). The observed active transport at low velocities might therefore partly be actin-
related (Fig. 23, steps 5). This assumption is further supported by the SPT experiments in which the 
microtubule network is broken down by the treatment with nocodazole. It is interesting to note that not all 
active transport is suppressed in this case (Fig. 19). Yet, all active transport which is then detected takes 
place with low velocities, again in the range expected for myosin motors operating on actin (Fig. 23, 
step 5a). In addition to motor driven transport, actin-related movement could be also due to bursts of actin 
polymerization (Fig. 23, step 5b). It has been observed that these can move viruses, bacteria or endosomes 
from the plasma membrane to the cytosol with mean velocities ranging from 50 nm/s to 600 nm/s (Merrifield 
et al., 1999; Murray et al., 2003). 
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 Surprisingly then, actin disrupting or actin stabilizing drugs both induce a shift to lower mean 
velocities or shorter mean displacements (Fig. 19 and Table 1). This finding can be rationalized by the role 
of actin in the transfer of the DNA aggregates from the cell membrane to the microtubule network. The role 
of the myosins here could be to transport DNA to the microtubules and to distribute the particles over the 
cells (Murray et al., 2003). Examples for this role are the fact that a lack in myosin V leads to the 
aggregation of organelles in axon terminations and to the accumulation of pigment granules at the cell center 
in melanocytes (Murray et al., 2003). There, myosins can indeed compete with microtubule-related motors 
by pulling off granules from the microtubules. Disruption of the actin filaments using the latrunculin B drug 
can disturb the coordination of DNA transfer from the actin filaments to the microtubules. This explains why 
we observe fewer high velocity transport events and long-range displacements after latrunculin B treatment. 
Actin network stabilization by jasplakinolide in turn has the same effects on DNA transport. Since 
jasplakinolide induces a higher actin nucleation rate and prevents its depolymerization (Semenova et al., 
2008), it can cause a disordered polymeric network and a loss of actin dynamics that can affect myosin-based 
transport (Semenova et al., 2008). Denser actin networks can in addition hinder at the intracellular DNA 
motion (Luby-Phelps, 2000). 
II.2. Fast and long-range transport of DNA aggregates is microtubule-dependent 
 In SPT experiments on untreated cells, we generally measure broad velocity distributions and 
transport over large distances (Fig. 17 and 18). As it has been explained above, one can assume that a large 
part of the low velocity components is due to the action of myosin motors. The fast velocities can, however, 
not be explained by myosin propelled active transport. By contrast, much higher velocities with mean values 
of 220-1200 nm/s have been observed for dyneins and for kinesins where velocities from 200 nm/s to 
1600 nm/s have been reported (Mallik et al., 2005; Jamison et al., 2010; Bhat et al., 2012). We therefore 
assume that the fast active transport we observe is driven by microtubule-related motors of the dynein and 
kinesin families (Fig. 23, step 6a). This interpretation is further supported by the observed colocalization 
between DNA trajectories and the microtubules and the colocalization between DNA and the dynein motor 
(Fig. 20). The interaction between plasmid DNA bearing specific sequences and microtubule-related motor 
proteins which has also been recently reported (Badding et al., 2013). The striking effect of the disruption of 
the microtubule network by nocodazole in our experiments confirms this interpretation. The displacements in 
the measured trajectories are much shorter (Fig. 18), the observed average velocities and the active transport 
occurrence are drastically reduced (Fig. 18,19 and Table 1). Therefore, nocodazole treatment effectively 
stalls long-range transport of the DNA aggregates, unambiguously proving that fast active transport of DNA 
aggregates is microtubule-related. Disruption of microtubules also leads to a decrease of transfection level 
and efficiency (Fig. 14). While this indicates the importance of the microtubule-related active transport of 
DNA for successful electrotransfer, the observed decrease was not as drastic as the decrease of the DNA 
transport itself. This can be explained by the fact that the microtubules network had time to recover before 
the gene expression measurements. It is interesting to note that Vaughan and Dean reported that the 
application of nocodazole does not have any effect on gene expression following electroporation of human 
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adenocarcinoma cells (Vaughan et al., 2006). This indicates that the relation between gene expression 
efficiency following electroporation and the active intracellular transport of DNA aggregates is not direct. A 
further hint in this direction comes from experiments in which the cellular microtubule network is stabilized. 
While application of taxol leads to a reduction of gene expression and of active transport in CHO cells, as 
expressed by significantly shorter overall displacements, slower velocities and decrease of the active 
transport events (Fig. 18,19), Vaughan and Dean report a pronounced increase of gene expression in A549 
cells (Vaughan et al., 2006). For the same cell line, another study reports the suppression of high velocities 
after taxol treatment in the case of endocytic trafficking of the epidermal growth factor receptor (Li et al., 
2012). At the same time, only a slight change of the run length associated with the active transport portions 
of the trajectories has been observed. This means that the stepping number of the motor proteins and 
consequently their affinity for the microtubules remain unchanged under taxol treatment. In our system, 
displacements, velocities of DNA aggregates and their active transport occurrence decrease with the 
application of taxol. This could be due to a reduced affinity of the motors for the microtubules as a 
consequence of the direct binding of taxol on tubulin which is known to induce an overall change in the 
microtubule dynamics and conformations (Yvon et al., 1999; Xiao et al., 2006). Slower active transport over 
shorter distances can also be explained by a hindrance of the intracellular DNA motion by the resulting 
denser microtubule network. Since motor proteins do not bind permanently to the cytoskeleton, release of the 
motors from the filament will lead to a diffusive phase terminated by the binding of other motors. Diffusion-
like interruptions of active transport can, however, also be caused by obstacles in the transport direction such 
as intersections of filaments (Ross et al., 2008). Bigger obstacles will induce high resistance to directed 
motion. Motors have limited driving/binding forces (Bhat et al., 2012) that can be overcome when 
encountering such obstacles. Our observations that stabilization of both the microtubules and the actin 
network do not enhance active transport dynamics, could thus be explained by the higher density of the 
respective cytoskeleton, which can act as a barrier for transport of the DNA aggregates, or can result from 
changed motor dynamics due to the drug application. 
II.3. DNA aggregates are transported by simultaneous action of several motors 
 In addition to identifying the cellular structures responsible for the active intracellular transport of 
DNA aggregates, our data indicate that several motor proteins are acting on one DNA aggregate. This 
conclusion is suggested by two facts, namely the duration and displacement of active transport phases and 
the observed bidirectionality of the aggregate motion. Under our experimental conditions, a typical active 
motion segment features on average velocity of 250 nm/s, persists for 6 s and leads to a displacement of 
1.3 µm (Table 1). However, as noted above, the distributions we obtain for these three parameters are rather 
broad with velocities from 50 nm/s to 3400 nm/s, displacements from 0.1 µm to 12 µm and active transport 
durations from 2 s to 30 s. These ranges are in agreements with other types of intracellular particle dynamics 
as observed for viruses (Arhel et al., 2006; Ruthardt et al., 2011), polyplexes (Suh et al., 2004; de Bruin et 
al., 2007), lipoplexes (Sauer et al., 2009; Akita et al., 2010), receptors (Osborne et al., 2009; Li et al., 2012), 
endosomes (Ichikawa et al., 2000; Toshima et al., 2006), and mitochondria (Pilling et al., 2006).  
Results and discussions - Chapter 3: DNA active transport - II. Discussion 
 
- 143 - 
 
 
Figure 23: Mechanisms of DNA electrotransfer in mammalian cells. During the application of the electric field, (1) 
the plasma membrane is permeabilized (orange), (2) the DNA is electrophoretically pushed on the membrane side 
facing the cathode therefore (3) DNA/membrane interactions occur. DNA aggregates are inserted into the membrane 
and remain there for tens of minutes. After the application of the electric field and resealing of the membrane (yellow), 
(4) the DNA can be internalized via endocytosis (DNA in vesicles) and/or through electropores (free DNA). For gene 
expression to occur, (5-6) DNA has to cross the cytoplasm and move towards the nucleus. We find (5) actin-related 
motion that can be (5a) transport using myosins (in both directions) and/or (5b) burst of actin polymerization (actin 
rocketing). Further, we observe (6) microtubule-related motion, either by (6a) transport via kinesin and dynein, (6b) 
DNA interaction with oppositely directed motors, or using (6c) several motors of the same type. (6d) Once being in the 
perinuclear region, (7) DNA has to cross the nuclear envelope, after endosomal escape in case of DNA in vesicles. (8) 
Finally, DNA is expressed in proteins found in the cytoplasm. MTOC = Microtubule-organizing center. 
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 The large displacements and durations of the active transport are hard to reconcile with the action of 
one molecular motor per DNA aggregate. Indeed, single dynein, kinesin and myosin motors are described to 
run over distances from a few hundreds of nanometers to 2 µm with transport durations of less than 3 s 
(Wang et al., 1995; Mallik et al., 2005; Sweeney et al., 2007; Pierobon et al., 2009; Ali et al., 2011; Bhat et 
al., 2012). By contrast, simultaneous action of multiple motors can increase the travelling distance and time. 
Use of multiple dyneins, for example, leads to displacements of up to 8 µm and run durations of up to 25 s 
(Mallik et al., 2005; Bhat et al., 2012). We therefore suppose that the DNA aggregates are driven by multiple 
motors of the same type as it is normally the case for cellular cargo transport (Fig. 23, step 6c) (Provance et 
al., 2008; Soppina et al., 2009).  
 A similar conclusion can be drawn from the fact that we frequently observe a bidirectional motion of 
the DNA aggregates, i.e. the active transport suddenly changes direction and the aggregate is taking a nearly 
identical trajectory in the opposite direction. While this can be caused by (+) ends and (-) ends of 
microtubules lying close to each other, it is more likely that the bidirectionality is caused by the presence of 
several oppositely directed motors on the same aggregate (Fig. 23, step 6b). If not one, but several motors 
act simultaneously on one aggregate, bidirectionality can also result from a tug of war of these motor 
proteins (Provance et al., 2008; Soppina et al., 2009). 
II.4. Diffusion behavior of DNA aggregates 
 The diffusion coefficient distribution of the control cells is spread over several orders of magnitude 
(10-1 and 10-5 µm2/s). Similar profiles can be found for the diffusion of viruses (Ewers et al., 2005), receptors 
(Spendier et al., 2012),  polyplexes (Suh et al., 2004) and lipoplexes (Akita et al., 2010). According to the 
Stokes-Einstein relation, Brownian motion depends on the viscosity of the medium and the size (radius) of 
the particles. The DNA aggregates have different sizes, but this cannot explain the observed distribution 
width (Faurie et al., 2010). It is more likely that the latter is explained by two other factors. Firstly, 
molecular crowding, exclusion, and obstruction in the cytoplasm have an important influence on the mobility 
of particles (Luby-Phelps, 2000). If the viscosity of the fluid-phase of the cytoplasm was estimated to vary 
between 1 cP and 10 cP, the apparent viscosity of the cytoplasm can be 100 to 1000 times higher. A DNA 
aggregate of 100 nm, freely diffusing at 10-3 µm2/s, would see an apparent viscosity of about 230 cP. 
However, the heterogeneous environment of the cytoplasm creates a mesh having sometimes a mean radius 
of 50 nm meaning that Brownian diffusion of free DNA aggregates is improbable (Luby-Phelps, 2000). 
Indeed, we observed that the displacement of diffusing particles does not depend on time meaning that 
confined diffusion is the actual mode of diffusion (Fig. 22). The pronounced spatial heterogeneity of the 
cytoplasm will therefore lead to the wide spread of observed diffusion coefficients. Secondly, in order to 
benefit from active transport, DNA must be in vesicles or interacts with some adapter proteins that allow for 
its binding to the motor proteins (Fig. 23 steps 5 and 6). Therefore, the broad range of diffusion coefficient 
of the DNA could also reflect different sizes and maturation stages of the vesicles on their pathway from the 
plasma membrane to the nucleus (Suh et al., 2004).  
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II.5. Conclusion 
 This part of the PhD work elucidates the intracellular transport of DNA after its delivery by 
electroporation. We have used single particle tracking experiments to follow the fate of DNA aggregates 
formed at the cell membrane of living CHO cells immediately after the application of an electric field. The 
analysis of several thousand trajectories obtained in experiments on untreated cells and cells treated with 
drugs which either stabilize or destabilize the actin or the microtubule network, respectively, gives detailed 
insight into the transport mechanisms of the DNA aggregates. In this analysis, the high statistical relevance 
of our data is of pivotal importance. Firstly, we demonstrated that plasmid DNA is actively transported in the 
cells. This active transport is responsible for the rapid intracellular distribution of the DNA aggregates after 
their internalization. Secondly, we were able to show that fast active transport is microtubule-related, while 
there is also a slow active transport component due to transport along actin filaments. Both the stabilization 
of the microtubule and of the actin network, with appropriate drugs, lead to reduced active transport. In both 
cases, this is explained by a reduction of the transport velocities most likely caused by the denser 
cytoskeletal network or the change of the dynamics/interaction of the motors with the filaments. The 
transport of the DNA by the microtubule network can be very fast and thus should not be a rate-limiting step 
in gene electrotransfer. It is still important to have a better understanding of it to control the process and 
better define following steps (endosomal escape, crossing of the nuclear envelope). An important question to 
address is whether the intracellular structures, responsible for the interaction between the DNA and the 
cytoskeleton, are vesicles and/or adapter proteins. In the first case, one should identify which endosomal 
compartments DNA passes by and the way it escapes from them. In the second case, one should scrutinize 
the relation between the design of the plasmid and the transport efficiency. Plasmids can bear sequence-
specific binding protein sites, such as DNA nuclear-targeting sequences (DTS), which appears to play a role 
both in the DNA import into the nucleus and in the DNA cytoplasmic trafficking (Badding et al., 2013). By 
doing so, electrotransfer can become as efficient as virus-based methods and due to its safety it inherently 
has the potential to become an outstanding method for gene therapy.  
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Chapter 4: DNA intracellular trafficking 
 While from the SPT data described in the previous chapter, it is clear that the DNA aggregates are 
actively transported in the cytoplasm of the cells, SPT experiments alone do not shed light onto the question 
whether the aggregates are transported inside vesicles or as naked DNA. However, the results from chapter 2 
strongly suggest that the major route of DNA internalization is endocytosis. This should mean that DNA 
aggregates are engulfed into vesicles. We would like to confirm this assumption and get more knowledge 
about the intracellular path of DNA by means of identifying which subcellular structures DNA pass by and 
in which proportions. Therefore, we conducted colocalization experiments of DNA and several endosomal 
membranes. This time colocalization was not performed with markers known to be present inside 
compartments but with GFP-labeled proteins that are known to identify the structures. For this purpose, first 
CHO cells were separately transiently transfected with plasmids encoding for the EGFP-tagged proteins 
Rab5, Rab9, Rab11 and Lamp1 which are specific for identifying early endosomes, late endosomes, 
recycling endosomes and lysosomes, respectively (Boisvert et al., 2012). After protein expression, Cy5-
labeled DNA was electrotransferred and the fluorescent signals were recorded with a temporal delay of 
200 ms using the single-molecule sensitive wide-field microscopy setup. In addition, colocalization was 
performed in dynamics meaning that the movements of the fluorescent particles were recorded over time in 
each channel and the analysis was based on the correlation of the trajectories. This method provides a better 
certainty about the colocalization events we observed and the percentage of movement-correlated objects can 
be obtained.  
I. Results 
I.1.  About the method 
 The classic way of analyzing interactions between objects is to compare pixel values between colors, 
for which different quantification methods exist (Bolte et al., 2006; Zinchuk et al., 2009). However, these 
pixel-based methods are very sensitive to intensity differences in the two channels, as well as to background 
fluorescence and image noise. Furthermore, all labeled compounds at distances lower than the microscope 
resolution will contribute to the overall colocalization in the image. Another approach is to search for the 
colocalization of discrete objects, the method we used for the colocalization studies between DNA and the 
endocytic markers (Lachmanovich et al., 2003; Bolte et al., 2006). The objects of interest can be identified 
as separate entities in the microscopy images having intensity weighted center positions. Colocalization can 
be defined by the distance between the center positions being below the resolution of the system or by a 
spatial overlap between one object and the center position of the other object. The object-based methods are 
much better in excluding false positives since object positions are determined with a precision much lower 
than the microscope resolution (Thompson et al., 2002; Ober et al., 2004). A different method was 
developed by the pioneer group of Prof. Dr. Braeckmans with whom we collaborated using their analysis 
algorithm (Vercauteren et al., 2010). The basic principle is to look at trajectories of moving objects in dual 
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color time-lapse movies, as it is done in SPT. When the spatiotemporal correlation between several 
consecutive steps of the trajectories exceeds a certain threshold value, the corresponding objects are 
considered to be correlated (Fig. 24a). This was shown to give even more reliable results than in case of 
classical object-based colocalization analysis (Vercauteren et al., 2010). However, intracellular movements 
can exhibit variable modes of motion, including immobile phases that inherently do not correlate (Fig. 24b). 
This is even more the case when the two objects are not directly bound to each other as in our case. If the 
DNA is inside an endosome, it is probably not bound to the membrane markers. Both objects have then a 
certain degree of freedom that superimposes on the random walk of the structure. By contrast, when the 
endosomes are transported (cytoskeleton-related motions), the drift of both objects is similar such that 
correlation is more probable. The trajectory in Fig. 24a shows the correlated motions during the entire long-
range drift rather well. Photobleaching of fluorescent labels degrades the localization precision in the 
trajectories, which in turn affects their correlation (Fig. 24c). There is also the possibility of transient 
interactions that take place during only a short time span, restricting the correlation to only a part of the 
trajectories. If the uncorrelated part of the trajectories in these situations is sufficiently large, the correlation 
determined for the trajectories will not exceed the correlation threshold, despite (transient) interaction being 
present (Fig. 24d,e). Nonetheless, this type of events might be of high interest to detect since in principle 
phenomena like transfer of material between compartments, scission or fusion of compartments and 
endosomal escape are very important information to investigate in the context of gene delivery. The initial 
program has been modified such that non-correlated trajectories are tested for static colocalization with a 
criteria based on object-methods. The centers of mass of the trajectories are calculated and if the distance 
between the trajectory centers is below the optical resolution then the trajectories are colocalized. The 
colocalization will thus count trajectories of diffusive particles, and may count in the trajectories exhibiting 
lower accuracy in the positioning. Therefore from the analysis, we get a percentage of correlated objects and 
a percentage of colocalized objects.  
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Figure 24: Examples of trajectories obtained during the experiments and visualized through the analysis 
program. Trajectories in green represent endosomal proteins fused with GFP and trajectories in red correspond to Cy5 
labeled DNA. (a) Rab5 and DNA trajectories exhibit apparent long-range active transport and motions are correlated. 
(b) Lamp1 and DNA trajectories do not correlate, most likely due to the apparent diffusion mode of motion. Assuming 
DNA inside the vesicle and the Lamp1/Rab protein into the membrane, each particle has a certain degree of freedom 
that superimposes with the inherent non-correlation of random walks. However, these trajectories are detected as 
colocalized ones. (c) The loss of accuracy for the positioning due to photobleaching alters the apparent initial 
correlation of the trajectories visible when the inaccurate portions are excluded from the traces (4th image). These 
trajectories are detected as non-correlated ones. (d) Endosomal escape or transfer of DNA between two compartments 
might be visualized while performing the analysis. The examples show DNA and Rab5 (1) or Rab9 (2). Despite an 
uncertain correlation at the first steps of the trajectories, a rather visible change of direction between the trajectories 
may be a sign of such events. The program is not built to detect such phenomena and does not recognize the eventual 
transient correlation/colocalization (4th image of 2). (e) The entry of DNA inside a vesicle or most likely the fusion of 
endosomal vesicles (here Lamp1 marked) might as well be visible. The initial steps of the trajectories are 
spatiotemporally well separated (3) but further ones related to each other may appear (1,2). The noticeable low 
localization accuracy in the example impedes a good visualization. 
I.2. DNA and endo-lysosomal trafficking 
 In a first qualitative approach, microscopy data show that the DNA partially colocalizes with all 
endocytic markers (Rab5, Rab11, Rab9 and Lamp1) (Fig. 25). The colocalization can be rather strong. This 
means that in the cytoplasm the DNA are indeed engulfed inside vesicles. The fact that the aggregates are 
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found at all stages of DNA ripening and inside lysosomes indicates that DNA seems to follow a classical 
route of intracellular trafficking. In each case, we see that trajectories that are correlated often exhibit 
apparent active transport whereas the ones only colocalizing often seems to be in phases of diffusion. 
 
 
Figure 25: Dual color SPT of DNA and endo-lysosomal proteins. Cy5 labeled DNA was electrotransferred into cells 
separately expressing EGFP-Rab5, Rab11, Rab9 and Lamp1 plasmid constructs. Using the single-molecule detection 
wide-field microscope, time series were recorded sequentially with a delay of 200 ms between the two channels. Using 
dual color SPT, we can visualize the respective movements of the objects. Correlated trajectories are highlighted in 
orange (DNA) and light purple (EGFP-markers), colocalized ones are drawn in blue (DNA) and pink (EGFP-markers) 
and the non-correlated and non-colocalized ones are in red (DNA) and green (EGFP-markers). (a) DNA in early 
endosomes (Rab5), (b) DNA in recycling endosomes (Rab11), (c) DNA in late endosomes (Rab9), and (d) DNA in 
lysosomes (Lamp1). 
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 The dynamics colocalization analysis provides a better picture of DNA repartition inside the 
different compartments (Fig. 26). Each bar of the histogram sums up the percentage obtained for both the 
correlated and colocalized trajectories such that one can see better the total amount of DNA residing in the 
compartments. For the Rab proteins, acquisitions started about 15 min after the DNA electrotransfer and 
were performed for up to 1.5 h. It is therefore not surprising that DNA correlation and colocalization with 
Rab5 are the highest with respectively 38% ± 4% and 32% ± 2% of DNA. In Rab11 expressing cells, DNA 
correlated with the recycling endosomes at a rate of 33% ± 5% and it colocalized at 17% ± 3%. DNA 
trajectories were found to correlate at 21% ± 5% and to colocalize at 11% ± 4% with Rab9 containing 
structures. For the Lamp1 experiments, acquisitions started about 1 h after the application of the electric field 
in the presence of DNA and were performed for up to 1 h. Correlation of DNA with Lamp1 marked 
membranes was calculated to be at 41% ± 6% and colocalization at 19% ± 4%. 
 
 
Figure 26: Quantification of the correlation and colocalization between DNA and the endo-lysosomal membranes 
in CHO cells. Cy5 labeled DNA was electrotransferred into cells separately expressing EGFP-Rab5, Rab11, Rab9 and 
Lamp1 plasmid constructs. After dual color time lapse recording and SPT analysis, trajectories are tested for correlation 
and colocalization. The histogram shows the percentage of DNA trajectories that correlate (black) or colocalize (gray) 
with the trajectories of the mentioned proteins.  
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II. Discussion 
 DNA electrotransfer in cells is a successful technique for gene delivery. It represents a serious 
alternative to virus-based methods for clinical applications such as gene therapy and DNA vaccination. 
However, the method suffers from a lack of knowledge about the mechanism governing DNA internalization 
and fate in the cells. The aim of this part of the work is to give a first view of the DNA distribution into the 
endo-lysosomal compartments. It is a very important aspect concerning the transfection efficiency achievable 
with DNA electrotransfer since it can give an estimation of the quantity of DNA that can potentially reach 
the nucleus or be lost in degradation paths. 
II.1. DNA aggregates are routed to the endosomal trafficking 
 DNA is found in very significant proportions in all four compartments we tested namely the early, 
late, recycling endosomes and in the lysosomes. It means that DNA is indeed engulfed into vesicles during 
its travelling through the cytoplasm and that it follows the classical intracellular trafficking routes (Rajendran 
et al., 2010; Boisvert et al., 2012). Rab5 compartments represent the organelles where the primary endocytic 
vesicles of almost any nature deliver their content and membranes (Mercer et al., 2010). Given that we show, 
in chapter 2, that high amounts of DNA are endocytosed, it was expected to observe DNA in Rab5-vecicles. 
The sum of the correlation and colocalization percentages indicated that about 70% of the DNA is located in 
such structures. This confirms that DNA internalization is mainly performed via endocytosis and the next 
step of the delivery mainly is the passage by the early endosomes. One should note that some primary 
vesicles such as GEEC ones can be found in Rab5-negative early endosomes (Perret et al., 2005). It may be 
that DNA can be present as well in such organelles. The content of early endosomes can follow several 
routes, that is why one sometimes speaks about sorting endosomes. Indeed, the substances can be recycled to 
the plasma membrane directly or via the recycling endosomes (Maxfield et al., 2004). They can follow 
further trafficking in endosomal membranes by passing through maturating and late endosomes. They can 
also be already transported to the Golgi (Perret et al., 2005). The experiments indicate that an important 
amount of DNA (50%) is directed to the recycling endosomes. Recycling is used to relocalize, for example, 
receptors to the plasma membrane. One may think that DNA, since during its electrophoresis it is inserted 
into the plasma membrane, as a receptor is, the cell machinery may treat it as it does it for a receptor. It can 
also be that DNA due to its insertion into the plasma membrane or a lack of interaction with the proper 
molecules cannot be easily routed to the vacuolar part the early endosomes from which maturating and late 
endosomes are created. Nonetheless, a part of the DNA can be further trafficked into late endosomes since it 
correlates and colocalizes with Rab9 compartments. In the context of our experiments, we found that about 
30% of the DNA coincide with Rab9. But one should remember that the data recording was performed 
between 15 min and 1.5 h after the application of the electric field. It is possible that observations starting at 
later time would give a stronger presence of DNA in Rab9 structures. The fact that we find much higher 
amounts of DNA colocalizing with Lamp1 may as well reflect that not only 30% of the DNA should be in 
Rab9 organelles. From the Rab9 compartments, DNA can be routed to the Golgi or to the lysosomes. The 
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fusion of a late endosome with a lysosome generates a transient hybrid organelle, the endolysosome, in 
which active degradation already takes place (Huotari et al., 2011). What follows is another maturation 
process. The endolysosome is converted to a classical dense lysosome, which constitutes a storage organelle 
for lysosomal hydrolases and membrane components. Late endosomes and endolysosomes have both Rab9 
and Lamp1 proteins in their membranes while lysosomes have only Lamp1. High amounts of DNA are 
localized into the (endo)lysosomes since from 1 h to 2 h after the application of the electric field, about 60% 
of the DNA is colocalized with Lamp1. It means that, as it is the case for other non-viral methods, plasmids 
are significantly lost in the lysosomes. Several reviews mention the possibility of vesicles shuttling between 
the lysosomes and the Golgi or the ER which would give the DNA a last chance to escape degradation 
(Mercer et al., 2010; Huotari et al., 2011). 
II.2. Conclusion 
 We found that the majority of DNA aggregates undergo endosomal trafficking. During the 
maturation process, endosomes are moving towards the perinuclear space along microtubules. Moreover, 
Rab proteins are believed to act as receptors for the motor proteins with either a direct interaction or through 
intermediary proteins (Murray et al., 2003). From the previous chapter, we know that DNA aggregates are 
actively transported along actin filaments and microtubules (Rosazza et al., 2013). We also observed that the 
correlated trajectories between DNA and Rabs/Lamp1 exhibits apparent active transport. Therefore, one can 
suppose that the endosomal membranes mediate the interaction between the DNA and the transport 
machinery. The interpretation that frequently several motor proteins are present on one DNA aggregate is 
strengthened since one endosome possesses several Rabs and is typically interacting with several motors.  
The use of the endosomal trafficking by the DNA allows it to cross the cytoplasm in an efficient manner and 
being relatively protected from cytosolic enzymes. However, if DNA does not escape from endosomes 
before reaching the (endo)lysosomes, it will most probably be lost for any potential gene expression. One 
should note that DNA in recycling endosomes are as well probably lost for transfection. We thus believe that 
the next focus, despite describing more precisely the intracellular distribution of the DNA, is to understand 
how DNA can escape from the endosomal compartments and ideally find a way to assist this process. 
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1. Cells culture 
 The wild-type Chinese Hamster Ovary clone (Toronto strain) was selected due its ability to grow in 
suspension or plated on chambered plastic or glass coverslip. CHO cells were grown in Eagle’s minimum 
essential medium (MEM Gibco®-InvitroGen™, Carlsbad, CA) supplemented with 8% heat inactivated fetal 
bovine serum (Gibco®-InvitroGen™, Carlsbad, CA), 0.584 g/L L-glutamine (Gibco®-InvitroGen™, 
Carlsbad, CA), 3.5 g/L D-glucose (Sigma-Aldrich, St. Louis, MO), 2.95 g/L tryptose-phosphate (Sigma-
Adrich, St-Louis, MO), 100 U/mL penicillin (Gibco®-InvitroGen™, Carlsbad, CA), 1 mg/L streptomycin 
(Gibco®-InvitroGen™, Carlsbad, CA) and BME vitamins (Sigma-Aldrich, St-Louis, MO). The cells were 
routinely sub-cultured every 2 days and incubated at 37 °C in a humidified atmosphere in a 5% CO2 
incubator (Golzio et al., 2002b). 
2. Plasmids 
 The 4.7 kb pEGFP-C1 plasmid (Clonetech, Palo Alto, CA) was the most used in this work. It carries 
the Enhanced Green Fluorescent Protein (EGFP) gene controlled by the cytomegalovirus promoter (CMV). 
The other plasmids used are derived from this plasmid: pEGFP-actin, pEGFP-tubulin, pEGFP-Rab5, pEGFP-
Rab9, pEGFP-Rab11, and pEGFP-Lamp1. Most of these plasmids were kindly provided by Prof. Christof 
Hauck (University of Konstanz, Germany). They were prepared from 200 mL culture of transformed DH5α 
Escherichia coli using the Maxiprep DNA purification system according to manufacturer instructions 
(Qiagen, Chatsworth, CA). 
3. Chemicals 
3.a. Cytoskeleton affecting drugs 
 In order to disrupt or stabilize microtubules, the cells were incubated with medium containing 
respectively nocodazole or taxol (Enzo Life Sciences, Inc., New York, USA) for 1 h prior to the application 
of the electric field. The range of concentration used for both nocodazole and taxol drugs were from 10 µM 
to 40 µM. The drugs were maintained in the cell culture during the microscopy experiments which 
corresponds to an additional hour of incubation. Therefore equivalent incubation times were performed for 
the gene expression experiments. For some concentrations, incubations extended to 24 h were also tested. 
 To disrupt or stabilize the actin cytoskeleton, the cells were incubated with medium containing 
respectively latrunculin B or jasplakinolide (Enzo Life Sciences, Inc., New York, USA). To not disturb the 
internalization step, these drugs were added only 15 min after the application of the electric field. During 
these 15 min the cells were kept at 37 °C, the optimal temperature for the occurrence of endocytosis. The 
endocytic processes could then be done in normal conditions. Afterwards, the cells were incubated with the 
drugs for 15 min before observations. The concentration range for the latrunculin B was between 1 µM and 
2 µM and between 125 nM and 250 nM for the jasplakinolide. Like for the other drugs, the latrunculin B and 
jasplakinolide drugs were maintained in the medium during the microscopy acquisitions and the same 
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conditions of incubations were kept for the gene expression experiments. Extended incubations for up to 24 h 
were performed as well. 
 All solutions were freshly prepared from stock solutions which were 10 to 100 times more 
concentrated and diluted in DMSO (Sigma-Aldrich, St-Louis, MO). 
3.b. Endocytosis affecting drugs 
 In order to alter endocytic processes, several drugs were employed. Their specificity for one pathway 
is partial thus two drugs per main pathway were used and three to four different concentrations tested. 
Incubations were performed for 1 h prior to the application of the electric field at 37 °C. Chlorpromazine 
(1 µM to 50 µM) and monodansylcadaverine (50 µM to 200 µM) inhibit the clathrin-mediated endocytosis 
(resp. Enzo Life Sciences, Inc., New York, USA and Sigma-Aldrich, St-Louis, MO). Genistein (50 µM to 
200 µM) and filipin (0.1 µM to 2.5 µM) affect the raft/caveolin-mediated endocytosis (resp. Enzo Life 
Sciences, Inc., New York, USA and Sigma-Aldrich, St-Louis, MO). Ethyl-isopropyl-amiloride (10 µM to 
100 µM) and wortmannin (0.02 µM to 0.5 µM) alter macropinocytosis (both supplied by Enzo Life Sciences, 
Inc., New York, USA). And the methyl--cyclodextrin drug (1 µM to 5 µM), as a cholesterol sequester, can 
inhibit the clathrin-, raft/caveolin-, or any other cholesterol dependent-mediated endocytosis (Sigma-Aldrich, 
St-Louis, MO). As suggested above, the latrunculin and jasplakinolide drugs could be mentioned in the 
endocytosis affecting drugs, actin cytoskeleton being involved, at least, in the invagination step of the 
process. Gene expression experiments were also carried out with these two drugs in the concentration range 
from 0.5 µM to 2 µM for latrunculin B and from 125 nM to 500 nM for jasplakinolide. 
 All solutions were freshly prepared from stock solutions which were 10 to 100 times more 
concentrated and diluted in DMSO (monodansylcadaverine, genistein, ethyl-isopropyl-amiloride, 
wortmannin), ethanol (chlorpromazine, for the first stock solution) or water (chlorpromazine (second stock 
solution), filipin, methyl--cyclodextrin). 
4. Electropulsation 
4.a. Electropulsation apparatus 
 Electropulsation was performed using the ElectroCell S20 electropulsator (βtech, Toulouse, France), 
which delivers square-wave electric pulses. The pulse parameters; amplitude (U), duration (T), number (N), 
and frequency (f) are controlled independently and monitored using an oscilloscope (HM1507-3, HAMEG 
GmbH, Frankfurt, Germany). For CHO cells, the optimal DNA electrotransfer parameters are 10 pulses of 
5 ms at 1 Hz frequency with an electric field strength between 0.4 kV/cm and 0.8 kV/cm (Golzio et al., 
2002b). Stainless-steel electrodes (megaStil, Ljubljana, Slovenia) were used in order to avoid 
electrochemical reactions of the metal. Parallel plate electrodes (10 mm length) were preferred because the 
electric field generated is uniform and thus easier to control. Several inter-electrodes distances were used 
depending on the applied procedure: (i) electrodes with 4 mm inter-electrodes distance used to pulse cell in 
suspensions (suitable for the drop off of the cell solution), (ii) electrodes with 10 mm gap used to pulse cells 
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in adherence (give a larger area of pulsation thus a larger observation window) (Mazeres et al., 2009). 
Electropulsations were performed in a low conductivity buffer (10 mM K2HPO4/KH2PO4, pH 7.4, 1 mM 
MgCl2, 250 mM sucrose), which minimizes the temperature increase due to the application of the electric 
field. Cells were maintained in the pulsation buffer for 5 min at room temperature after the application of the 
electric pulses to allow for membrane resealing. 
4.b. Electropulsation procedures 
4.b.i. Cells in suspension 
 Around 106 cells were suspended in 100 µL plasmid-containing pulsation buffer and placed between 
the electrodes. The parameters of the electric field were 10 pulses of 5 ms duration, 0.6 kV/cm strength and 
1 Hz frequency at room temperature. The electrotransfer of genes into CHO cells is optimal under these 
conditions (Golzio et al., 2002b). The amount of plasmid was 2 µg for 100 µL of buffer. 
4.b.ii. Cells in adherence 
 24 h before electroporation, cells were grown at a rate of 2.5×105 on 22 mm × 22 mm chambered 
coverglass (Lab-Tek™ II, Nunc, Roskilde, Denmark) or 3.5×104 on 13 mm diameter coverslip 
(Thermanox™, Nunc, Roskilde, Denmark) laid down in a 24-well plate (Corning Incorporated, New York, 
USA). To allow for the immersion of the electrodes, the volume of the pulsation buffer was raised to 
respectively 300 µL or 200 µL. For adherent cells, the value of the electric field strength is optimal at around 
0.4 kV/cm, the other parameters being unchanged (Golzio et al., 2002b). 
5. DNA fluorescence staining 
5.a. Intercalating dye 
 pEGFP-C1 plasmid DNA was stained stoichiometrically with TOTO-1 or POPO-3 (Molecular 
Probes®-InvitroGen™, Carlsbad, CA) (Golzio et al., 2002b). The solution was adjusted to a dye 
concentration of 7.6×10-5 M and a DNA concentration of 1 µg/µL incubated on ice for 60 min. This 
concentration yields an average base pair to dye ratio of 20:1. 
5.b. Covalently linked dye 
 The DNA was covalently labeled with Cy5 or Cy3 dye using the Label IT® Nucleic Acid Labeling 
Kit (Mirus®, Madison, WI) according to manufacturer instructions except for the incubation time which was 
raised to 3 h instead of 1 h. The purification was made by precipitation with ethanol. 
6. Immunofluorescence of the cytoskeleton 
 The following protocol is provided by Molecular Probes. Cells (105), cultured on glass coverslip laid 
down in a 24-well plate, were fixed with 4% paraformaldehyde (Sigma-Aldrich, St-Louis, MO) in PBS for 
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10 min at room temperature and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St-Louis, MO) in 
PBS for 5 min. Afterwards, they were incubated with 1% BSA (Sigma-Aldrich, St-Louis, MO) in PBS for 
30 min to avoid non-specific labeling. To label the actin filament network, phalloidin-rhodamine123 
(Molecular Probes®-InvitroGen™, Carlsbad, CA) was added to the cells for 30 min (1U in 200 µL PBS per 
well) in the dark. Phalloidin-rhodamine123 specifically stains filamentous actin. To label the microtubules 
network, monoclonal anti--tubulin-Cy3 (Sigma-Aldrich, St-Louis, MO) was added for 30 min in the dark 
(200 µL at 10 µg/mL per well). Between each step, the cells were washed 2-3 times with PBS. After drying, 
coverslips were mounted on glass slides with mounting medium and observed using fluorescence 
microscopy. 
7. EGFP-protein transient expression 
7.a. For colocalization experiments 
 The cells were suspended in the pulsation buffer (5×105 to 106 cells in 100 µL) containing 2 µg of 
pEGFP-protein and electrotransfected with the parameters defined for the cell suspensions 24 h to 48 h 
before use. They were seeded on 22 mm × 22 mm chambered coverglass (Lab-Tek™ II, Nunc, Roskilde, 
Denmark). 
7.b. For gene expression experiments 
 3.5×104 cells were deposed as a spread drop of 50 µL on 13 mm diameter coverslip (Thermanox™, 
Nunc, Roskilde, Denmark) that matched the size of the electrodes and was laid down in a 24-well plate 
(Corning Incorporated, New York, USA). After adhesion of the cells (20 min at 37 °C), 1 mL culture 
medium was added and the cells were cultured for 24 h. Drug incubations and pEGFP-C1 electrotransfer 
using the parameters defined for cells in adherence were performed. 24 h later, the cells were washed, 
harvested with trypsin-EDTA, suspended in PBS, and analyzed using flow cytometry (FACScan) via the 
channel FL1 (510 nm ≤ em ≤ 540 nm). The percentage of fluorescent cells gives the percentage of EGFP 
transfected cells (i.e. the level of transfection) and the mean fluorescence intensity associated is proportional 
to the mean amount of EGFP expressed by the cell population (i.e. the efficiency of transfection). All values 
were normalized in relation to the control cells which were transfected but not treated with any drug. 
8. Cell viability 
 Cell viability was determined by the ability of cells to grow and divide over a 24 h period 
(corresponding to more than one generation). Viability was measured by monitoring cell growth trough a 
coloration method with crystal violet. 105 cells were seeded in 24-well plates 24 h prior to the experiments. 
After the drug incubations, the cells were incubated with 0.1% crystal violet in PBS for 20 min at room 
temperature and lysed with 10% acetic acid for 10 min. 100 µL were diluted in 2 mL PBS and the optical 
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density (OD) was measured at 595 nm. The OD is proportional to the amount of cells and the measurements 
were normalized in relation to the control cells (Golzio et al., 1998). 
9. Single particle tracking procedure 
9.a. Image Acquisitions 
 1 µg of Cy5-labeled DNA (pEGFP-C1) was electrotransferred into adherent cells (Lab-Tek™ II 
slides) according to the described procedures (see electropulsation procedures/cells in adherence). The cells 
were washed 3 to 4 times with PBS. Labeled DNA in the extracellular medium gave such a strong 
background signal that observations during the pulsation was impossible and sample washing was necessary. 
Time series of the DNA were performed starting from 5 min to 10 min after the application of the electric 
field and for up to 90 min. Movies of different number of frame and frame rates were recorded. In order to 
estimate fast movements, movies of 350 frames, 10 frames per second i.e. 100 ms exposure time were taken. 
9.b. Image analysis 
 The DNA particle tracking was performed using Imaris® 7.2 software (Bitplane AG, Zurich 
Switzerland). The DNA particle positions were determined for each frame of the movie stack via the “spot 
objects” option. This option supposes that the particles have spherical shapes. The average diameter of the 
objects to be detected was set to 500 nm. From this parameter, the software calculates the fluorescence 
intensity center of mass of the object which therefore represents the particle position. The detection was 
adjusted to a threshold where no artifact particles were detected and where all or as much as possible 
particles were followed all along the movie stacks. 
 The detected positions have to be connected to each other to construct the traces that match the 
particle movements. These paths were built up using the autoregressive motion algorithm of Imaris®, which 
is the most suitable for the modes of motions we expected. It uses previous object speed and directionality 
for predicting future positions as well as weighted intensity information to enable the most accurate tracking 
possible. The algorithm worked rather well even for complex, densely populated, dynamic and noisy areas. It 
can automatically handle with changes from the initial distance constraint (acceleration / deceleration), and 
improves tracking accuracy for objects with strong directionality. Two parameters had to be specified at that 
step, the maximum distance the program should look for the next particle position (2 µm) and the number of 
frames (2-3) for which the algorithm continues to search for candidate objects after the object disappears. 
This later feature is needed for objects that move in and out-of-focus. 
 The obtained trajectories can be checked one by one and frame after frame to ensure that no mistake 
occurred. When this was not the case, the program allows for manual corrections of the traces which can be 
disconnected, deleted, reconnected, shorten. As a standard filtering out, trajectories smaller than 35 frames 
(10% of the 350 frames movies) were deleted. For further analysis, the coordinates of the trajectories were 
exported. 
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9.c. Trajectories segmentation 
 Trajectories of intracellular DNA particle motion typically consist of periods in which the DNA is 
actively transported and periods in which it undergoes diffusive motion. A quantitative analysis of the 
motion behavior therefore necessitates a segmentation of the trajectories with respect to the different types of 
motion. Only then it is possible to indicate meaningful values for the observed velocities and diffusion 
coefficients. We developed an algorithm which allows the segmentation of a given trajectory into segments 
that fall into different motion regimes without prior knowledge of these regimes. The segments are then 
classified and the defining parameters are computed according to standard procedures. The used 
segmentation algorithm is based on simple physical observations. In the first segmentation step, pure 
diffusion is separated from diffusion with drift (active transport) by exploiting the properties of random walk 
motion: the distribution of angles is uniform for random walk motion, which is the case for pure diffusion. A 
standard statistical test (the Kolmogorov-Smirnov-test) is applied to a sliding window of the collected angles, 
which yields a sequence of 0s and 1s, where each 1 corresponds to a uniform angle distribution. Consecutive 
1s are combined to a connected component, and if this component is larger than a minimum segment size, 
the segment is accepted as a segment of pure diffusion. Conversely, connected components of 0s are 
accepted as segments of diffusion with drift. Combining this information gives a first coarse segmentation 
into segments with pure diffusive motion and diffusion with drift. In a second step, segments classified as 
pure diffusion are subdivided into segments with different diffusion coefficients by approximating the 
diffusion coefficient on a sliding window, quantizing these values and again combining connected 
components. The third step is a sub-division of diffusion with drift segments, which works similar to the 
second step, but uses the approximated velocity instead of the approximated diffusion coefficient. Post-
processing consists of computing the approximated diffusion coefficients and velocity values for the 
segments and merging adjacent segments that are too similar. 
10. Colocalization DNA/endocytic ligand procedure 
10.a. Incubations and markers involved 
 The endocytic markers were Alexa Fluor® 647-transferrin (Molecular Probes®-InvitroGen™, 
Carlsbad, CA) in order to test for the clathrin-mediated endocytosis path, Alexa Fluor® 647-cholera toxin 
subunit B (Molecular Probes®-InvitroGen™, Carlsbad, CA) as indicator to test for the caveolin/raft-mediated 
endocytosis path and rhodamine-70 kDa dextran (Molecular Probes®-InvitroGen™, Carlsbad, CA) to 
quantify fluid-phase endocytosis. 24 h prior to electropulsation, 2×105 cells were cultured on Lab-Tek® II 
slides. The cells were incubated at 4 °C for 30 min to inhibit any endocytic process. Subsequently, the cells 
were pulsed in a 300 µL pulsation buffer containing 1 µg Cy3- or Cy5-labeled DNA using the 10 mm length 
plate-electrodes. 5 min after electropulsation, the pulsation buffer was removed and ice cold culture medium 
containing the endocytic marker, 50 µg/mL transferrin or 1 µg/mL cholera toxin subunit B or 500 µg/mL 
dextran, was added. The cells were again incubated at 4 °C for 30 min to allow for the endocytic marker to 
interact with the plasma membrane without endocytosis taking place. Afterwards, the cells were incubated 
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for 15 min at 37 °C to induce the endocytosis. For the colocalization between dextran and the two other 
markers, the procedure was simply to add the two molecules at the same time in the medium at the above 
indicated concentrations and incubate the cells for 15 min at 37 °C. 
10.b. Simultaneous two-color acquisitions 
 A wide-field microscope with laser sources was used (see wide-field microscope set-up section for 
more details). The particularity here was that between the two photo-objectives in the emission path, a 
montage was added allowing for the recording of the signal of both channels at the same time on the camera 
chip (Fig. 27). A dichroic mirror separated green from red emission, and by using silver mirrors, the beams 
were divided and directed onto the camera chip on which two separated areas (one for each channel) were 
generated via the use of a slit positioned at the exit of the microscope. The suitable band pass emission filters 
(described in the wide-field microscope set-up section) were added to the optical paths. The aim was to 
record the two signals at the same time but since some leakage of the green emission were visible in the red 
area, the images were taken sequentially. The montage still was useful to have the emission filters for both 
channels in position without the necessity to exchange the filters for each image. Later, the system was 
replaced by a filter wheel (see wide-field microscope section). The exposure time was between 0.3 to 0.8 s. 
 
Figure 27: Schematic representation of the laser beam paths between the microscope and the camera for the 
colocalization experiments between DNA and endocytic markers. 
10.c. Colocalization analysis 
 Image processing and analysis were performed using ImageJ (NIH, Bethesda, Maryland, USA) and a 
procedure adapted from (Lachmanovich et al., 2003). In detail, point noise on raw images was removed by 
applying a 3 pixel x 3 pixel median filter. To remove diffuse background, an additional filtering step was 
performed. For this purpose, first the short morphology plugin of ImageJ was used with the size set to a 
circle with 15 pixels diameter. The resulting image was subtracted from the point noise filtered image. This 
process allows for the suppression of the background without significantly changing the relative intensities 
of the particles. 
 Further object segmentation and quantification were performed with the JACoP plugin of ImageJ 
(Bolte et al., 2006). The latter was used to manually define the threshold above which all pixels are 
considered to be part of an object. The object counting module of the plugin gives the total number of 
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particles and the number of colocalizing ones for each channel. Two options are available for defining 
colocalization. 
 The first, called the overlap approach, defines the center of mass of each object belonging to the 
group A (e.g. green detection channel) and tests if it falls into the area covered by an object belonging to the 
group B (e.g. red detection channel). Colocalization is then a match between the centers of mass of group A 
objects with the area covered by group B objects. The degree of colocalization is given by the percentage of 
A objects colocalizing with B objects. This operation can be performed separately for each channel. 
 The second option to define colocalizing objects is called nearest neighbor distance approach. Like 
in the overlap method, the center of mass of each object is defined, but in this case for both groups. The 
software measures the distance between the centers of mass of A group objects and the centers of mass of B 
group objects. Since the number of objects often differs from one channel to the other, the program selects 
the channel with fewer objects and searches the nearest neighbor in the second channel which exhibits more 
objects. If this distance is found to be below the optical resolution of the acquisition system, the two objects 
are considered to be colocalized. The degree of colocalization is then given by the percentage of objects in 
the first channel colocalizing with objects of the second channel. 
11. Fluorescence microscopy 
11.a. Wide-field microscope set up 
11.a.i. For the SPT/colocalization experiments  
 Single particle techniques are typically based on ultrahigh sensitive wide-field microscopy (Fig. 28). 
Excitation is performed using lasers since they provide the intensity required to get strong photon emission 
from the fluorophores. In addition, their narrow spectrum facilitates filtering out of the light source without 
blocking the fluorescence light. Two solid state lasers, 491 nm and 561 nm wavelength, (Cobolt Calypso™ 
491 nm and Cobolt Jive™ 561 nm, 75 mW, Cobolt AB, Stockholm, Sweden) and a 658 nm diode laser 
(HL6535MG 658 nm, 90 mW Hitachi, Thorlabs, Newton, NJ) were used as light sources. They were selected 
using mechanical shutters and their power was adjusted with neutral density filters. The coupling of several 
lasers allow for simultaneous imaging of several fluorophores.  
 Laser beams were expanded by a telescope before being coupled into a multimode fiber 
(0.22 ± 0.02 NA, Optronis GmbH, Kehl, Germany) which was shaken to destroy interference patterns, 
otherwise giving uneven illumination of the sample. After the fiber, the laser beams were collimated and 
expanded such that only the area detectable by the camera was illuminated. Expanded beams were coupled 
into the Leica DMI 6000B inverted microscope (Leica Microsystems GmbH, Wetzlar, Germany) equipped 
with a heating stage connected to a temperature controller allowing for living biological samples to be 
maintained at 37 °C.  
 After reflection on the appropriate dichroic mirror, the lasers are coupled into the back aperture of 
the objective. Dual band dichroic mirrors were used according to the desired wavelength (z 491/561, z 
488/658, z 561/660, Dual Line Beamsplitter, Semrock, Rochester, NY). To obtain the highest possible 
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resolution and image quality, the objective was 100×/1.4 NA oil immersion which is corrected for chromatic, 
spherical and field curvature aberrations (HCX PL APO, Leica Microsystems GmbH, Wetzlar, Germany). 
 The fluorescence emission was transmitted through the suitable dichroic mirror and sent to the exit 
of the microscope by a silver mirror. The sample image was expanded by two photo-objectives to gain an 
additional ×3 magnification. Photo-objectives were used instead of simple lenses because they have 
corrections for aberrations. A fast switching filter wheel containing emission filters was placed between the 
two photo-objectives to allow for fast multicolor imaging. All filters were of high quality to optimize spectral 
selection and efficient filtering out of the unwanted signal. The fluorescence emitted from blue labels (e.g. 
EGFP) was selected using a band-pass filter (BrightLine HC 538/25, Semrock, Rochester, NY). The 
fluorescence emitted from the green labels (e.g. Cy3, rhodamine, Alexafluor 547) was selected using a long-
pass filter (Raman emitter RU 568, Semrock, Rochester, NY) or a band-pass filter (BrightLine HC 593/40, 
Semrock, Rochester, NY). The fluorescence emitted from the red labels (Cy5, Alexafluor 647) was selected 
using a long-pass filter (Raman emitter RU 664, Semrock, Rochester, NY) or a band-pass filter (BrightLine 
HC 694/40, Semrock, Rochester, NY).  
 To have as high as possible detection sensitivity, the fluorescence signal was detected by a deep 
water cooled EMCCD (electron multiplier CCD) camera (Andor iXON, Andor Technology PLC, Belfast, 
Ireland) having single photon sensitivity and fast readout rate (maximum 10 MHz). The electron multiplier 
serves to amplify the fluorescence signal and was set to maximal gain. Water cooling reduces camera noise 
and was set to -80 °C. The camera array is made of 512×512 active square pixels with an edge length of 16 
µm. The system performs in total ×300 magnification meaning that each pixel represents 54 nm of the 
sample. Shutters, filter wheel and camera were controlled and synchronized in order to get fast multicolor 
imaging and/or limited illumination time. 
 
 
 
 
Figure 28: Schematic drawing of the single-molecule detection fluorescence microscopy set-up. Several excitation 
wavelengths are available. Lasers, after passage through the multimode fiber, are coupled into objectives in wide-field 
mode where illumination is restricted to the detectable area on the camera. Excitation and emission lights are separated 
by dichroic mirrors. Additional filtering is performed after the microscope by emission filters mounted on a fast 
switching wheel to enable fast multicolor imaging. Two photo-objectives expand and send the image onto an 
ultrasensitive EMCCD camera. 
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11.a.ii. For the DNA/membrane interaction experiments 
 Cells were observed with a Leica 100×/1.3 NA oil immersion objective mounted on a Leica DMIRB 
inverted microscope (Leica Microsystems GmbH, Wetzlar, Germany). The excitation source was a 100 W 
HBO mercury lamp (Leica Microsystems GmbH, Wetzlar, Germany). The wavelengths were selected by 
using the Leica L4 filter block (450 nm ≤ ex ≤ 490 nm; dichroic mirror 500 nm, 500 nm ≤ em ≤ 550 nm) for 
the TOTO-1-labeled DNA and the EGFP-actin fusion protein and the Leica N2.1 filter block (515 nm ≤ ex ≤ 
560 nm; dichroic mirror cut-off 580 nm, 580 nm ≤ em) for the POPO-3-labeled DNA. Images were recorded 
using a CCD camera (Princeton Instruments, Trenton, NJ, USA) and analysed with the MetaVue™ Imaging 
System (Molecular Devices, MDS Analytical Technologies, Downingtown, USA). 
 This digitizing set-up allowed for quantitative localized analysis of the fluorescence emission along 
the cell membrane. Plot histograms detected local fluorescence intensity increase above the background level 
which is directly related to the number of fluorescent molecules locally present. 
11.b. Confocal microscopy 
 Observations were performed with a Leica 100×/1.4 NA oil immersion objective mounted on a Leica 
DMRE upright microscope equipped with the Leica TCS SP2 confocal system and monitored using the 
Leica Confocal Software. A 543 nm laser was used to excite the rhodamine123 fluorophore and a suitable 
region of the emission spectrum was selected. 
12. Statistical analysis 
 Error bars represent the standard error of the mean (SEM). The statistical significance of differences 
between fluorescence intensity of DNA aggregates in the control and the latrunculin B treated cells was 
evaluated using a paired Student’s t-test. The statistical significance of differences in gene expression 
efficiency (percentage of transfected cells and their mean fluorescence level) between the control and drug 
treated cells was evaluated by the non-parametric Mann-Whitney-Wilcoxon test. The degree of significance 
is given with these following labels: NS not significant; * p < 0.05; ** p < 0.01; *** p < 0.001. 
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 Electroporation is a physical method of delivery of molecules (from small chemical agents to 
plasmid DNA) into cells or tissues. It relies on the application of short (µs-ms) but intense electric pulses 
(100-1000 V) that, if higher than a threshold value, modulates the plasma membrane permeability. The 
transfer of small molecules most likely occurs via diffusion through putative induced electropores whereas 
the transfer of plasmid DNA is more complex and remains to be elucidated. During the electric field pulses, 
the membrane becomes permeable (1) and the DNA is electrophoretically pushed on it (2) where it is 
inserted as discrete clusters for a ten of minutes (3). After the electric pulses, DNA is internalized (4), 
navigates through the cytoplasm (5) until it reaches the nucleus (6) where DNA expression is initiated (7). 
The PhD work which I performed, essentially focuses on the internalization and intracellular trafficking of 
the DNA, two steps rather enigmatic in the context of electroporation. The relevant cellular structures that 
could participate into these steps are the endocytic machinery followed by the endosomal trafficking and the 
cytoskeleton (actin filaments and microtubules). Investigations were mainly based on the use of fluorescence 
microscopy techniques and flow cytometry. 
 DNA internalization seems to be mainly performed via endocytosis. The use of pharmacological 
endocytic inhibitors (MCD, CPZ, MDC, Gen, Fil, Wort, EIPA, Lat, Jas) combined with labeled endocytic 
markers (TF, CTB, 70 kDa dextran, actin) led us to the conclusion that clathrin- and raft-mediated 
endocytosis as well as macropinocytosis are involved in proportions estimated to be respectively 25%, 50% 
and 30%. The sum is more than 100% which means that, first, endocytosis is the main (if not the only) path 
by which DNA aggregates can enter the cells and, second, that more investigations have to be done to depict 
a more precise mechanism for the DNA internalization. Moreover, raft-mediated endocytosis represents a 
large panel of possibilities (caveolin, flotillin, GEEC…) which are worth describing. These findings are in 
agreement with the observed spatiotemporal distribution of the DNA aggregates at the membrane (clusters of 
few hundreds of nanometers persisting for few minutes and inaccessible from the extracellular medium). We 
found that the actin cytoskeleton, despite its burst of polymerization in the minutes following the DNA 
electrotransfer, is also involved in the formation of the DNA aggregates. That could be linked to the fact that 
the actin network supports maintaining the membrane integrity which would be necessary for the DNA to be 
stably inserted in.  
 Once inside the cells, DNA seems to follow the classical endo-lysosomal trafficking. Dynamic 
colocalization performed in cells expressing separately several labeled endosomal markers (Rab5, Rab11, 
Rab9 and Lamp1) allows us to conclude with no ambiguity that DNA is present in early, recycling and late 
endosomes in proportions calculated to be respectively 70%, 50% and 30%. These values are averaged over 
the hour following the DNA electrotransfer. This could be the reason why the sum is higher than 100%. 
Between 1-2 h after delivery, 60% of the DNA is located in Lamp1-structures with most probably a 
predominance of the lysosomes. These results are in agreement with the observed DNA being still in clusters 
in the cytoplasm and they reinforces the earlier mentioned mechanism of endocytosis since the endosomal 
trafficking is the further route of endocytosed content and membranes. These results also indicated that a lot 
of the plasmid DNA is probably lost in recycling endosomes and lysosomes. It would be interesting to 
Conclusion and outlook 
 
- 166 - 
quantify the DNA distribution inside the cell over longer time and most importantly to try to find out how 
and where DNA can escape the path to finally reach the nucleus.  
 DNA in the cytoplasm is actively transported by both the actin filaments and the microtubules. The 
use of pharmacological inhibitors (Lat, Jas, Noc, Tax) combined with SPT performed on a high number of 
DNA aggregates do clearly show that cytoskeleton mediates the DNA journey in the cytoplasm. DNA 
exhibits the typical motion of endosomes or other cargo with intermittent phases of active transport and 
diffusion. Under our experimental conditions, active motion phases features an averaged velocity of 250 
nm/s and persistence of 6 s and leads to a displacement of 1.3 µm. However, distributions of theses 
parameters are broad with velocities from 50 nm/s to 3400 nm/s, displacements from 0.1 µm to 12 µm and 
persistence from 2 s to 30 s. Each time series covered only 35 s and already on such a short time scale, we 
measured that 45% of the DNA aggregates display active transport. The interaction between DNA 
aggregates and the cytoskeleton thus is a process that occurs very frequently which means that the 
cytoskeleton controls the traveling of DNA inside the cytoplasm. These findings confirm previously 
published articles pointing at microtubules participating in DNA migration in the cells. It is also in 
agreement with DNA being in endosomes since their membranes possess proteins (probably Rabs) that can 
bind molecular motors. In addition, it explains how such big DNA clusters can travel through the highly 
crowded cytoplasm since to reach the nucleus successfully, diffusion is improbable.  
 To conclude, the DNA journey from the plasma membrane to the nuclear envelop is, after 
electroporation, very similar to the one observed after other non-viral and viral-based delivery methods. The 
DNA is endocytosed, apparently by many different endocytic pathways. While being routed to the different 
endosomal compartments, DNA is actively transported nearby the nucleus. In principle, from any endosomal 
compartment DNA could be transported to the Golgi, the ER or escape the path. The DNA route(s) we 
described correspond to the efficient one(s) since disturbance of any intermediate step results in a reduced 
gene expression. Although our findings must be confirmed and further investigated, the next key step to 
unravel is the putative endosomal escape that has to occur for successful gene expression. The DNA that 
enters via electroporation is naked. It has not such properties that can make it fusing with membranes or 
forcing membrane ruptures to help in evading from the lysosomal degradation. It would be of great interest, 
first, to observe any DNA escape from any compartment and, then, to understand how this process takes 
place. The idea behind it being, besides better understanding the DNA delivery by electroporation, to 
optimize the release of DNA in the cytoplasm thus to increase the probability that DNA reaches the nucleus. 
Actually, the crossing of the nuclear envelop is another significant barrier for successful DNA expression 
and having more DNA approaching the perinuclear region should statistically give higher chance to 
effectively reach the nuclear compartment. Indeed, there are some strong hints at the involvement of 
importins able to recognize specific sequences present of the DNA plasmid construct (NLS, nuclear 
localization sequence) which should mediated the import of the DNA through the nuclear pores. 
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